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Background  Although  immunisation  against  infectious  diseases  is  an  important  aspect 
of  public  health  policy  and  has  played  a  significant  role  in  controlling  the  threat  of  many 
once-common  diseases,  since  the  late  1990s  it  has  been  the  focus  of  controversy.  Much 
of  this  was  fuelled  by  the  publication  in  the  Lancet  of  a  paper  based  on  a  case  series  of  12 
children.  In  this  paper  Wakefield  and  colleagues  raised  the  possibility  of  a  link  between 
the  measles,  mumps,  and  rubella  vaccine  (M114R)  and  autism  and  bowel  disease.  Despite 
the  fact  that  Wakefield's  study  has  received  little  support  from  the  scientific  community 
these  assertions  have  led  to  a  decline  in  MMR  uptake.  Since  then,  few  studies  have 
examined  parents'  understandings,  attitudes  and  experiences  of  childhood  infectious 
diseases  or  of  childhood  immunisation.  This  qualitative  study  examines  how  parents 
have  conceptualised  the  MMR  controversy  and  offers  an  assessment  of  parents' 
perceptions  of  vaccine-preventable  diseases  and  childhood  immunisation. 
Methods-Eighteen  focus  groups  were  conducted  in  central  Scotland  between  November 
2002  and  March  2003,  with  a  diverse  range  of  parents  to  ensure  maximum  variation  in 
terms  of  age,  socio-economic  circumstances,  likely  views  about  vaccination  and  family 
circumstances.  Four  focus  groups  were  conducted  with  parents  who  were  anticipated  to 
have  a  particular  interest  in  the  debate:  two  groups  with  parents  who  had  autistic  children, 
and  two  with  parents  whose  child  had  recently  had  a  compromised  immune  system 
following  chemotherapy. 
Findings-There  are  some  potentially  serious  misunderstandings  and  gaps  in  knowledge 
about  many  of  the  diseases,  which  generally  led  to  a  diminished  sense  of  urgency  for 
vaccination.  Parents  deciding  about  MMR  vaccination  have  to  balance  the  perceived  risk 
of  disease  against  the  perceived  risk  of  MMR,  and  the  perceived  ability  of  their  child's 
immune  systems  to  cope  with  the  challenge  of  vaccines,  or  to  fight  the  disease.  Parents 
often  questioned  the  safety  of  combining  several  antigens  into  one  vaccine,  as  they  were 
concerned  it  could  be  too  potent  for  their  child's  immune  system  and  could  potentially 
1 cause  long-term  damage.  In  some  circumstances  parents  preferred  to  withhold  MMR 
vaccination  because  it  was  easier  for  them  to  live  with  the  risk  of  their  child  naturally 
contracting  one  of  the  diseases  than  with  the  risk  of  causing  their  child  permanent 
damage  as  they  perceived  other  parents  may  have  unwittingly  done. 
Implications-  There  is  a  need  for  a  campaign  that  concentrates  on  offering  parents 
factual  information  about  the  risks,  symptoms,  potential  complications  and  severity  of 
some  of  the  diseases  included  in  the  Childhood  Immunisation  Programme.  However,  it 
is  recognised  that  simply  targeting  parents  with  the  facts  about  diseases  will  not 
necessarily  persuade  them  to  immunise  and  that  culture,  economic  factors,  social  and 
political  values,  trust,  risk  perception  and  world  views  are  all  important  in  influencing 
parents'  attitudes  towards  immunisation.  Nevertheless,  it  seems  crucial  to  provide 
parents  with  accurate  information  so  that  they  can  assess  the  importance  and  relevance  of 
current  immunisation  policy  at  a  time  when  many  are  questioning  whether  children  are 
becoming  over-immunised  against  diseases  that  appear  mild  and  of  no  real  threat  to  their 
child's  health.  Parents'  high  level  of  understanding  of  the  risks  of  meningococcal  disease 
suggests  that  the  high  profile  Men  C  vaccination  campaigns  may  be  a  successful  model  to 
follow  in  communicating  the  risks  of  other  vaccine-preventable  diseases.  Because  of  the 
complex  role  of  personal  and  family  experience  in  the  acceptance  or  rejection  of  risk 
information  about  ill-health,  it  may  be  that  these  issues  should  also  be  explicitly 
addressed  in  vaccination  campaigns.  Further,  whilst  individual  choice  is  important,  so 
too  are  the  community  benefits  of  immunisation,  and  it  may  be  time  for  such  a  campaign 
to  embrace  this  aspect  of  immunisation  more  comprehensively  and  to  recognise  the 
public  health  contribution  of  immunisation  more  openly. 
There  is  also  a  need  for  further  research  to  investigate  how  parents  caring  for  autistic 
children  have  been  affected  by  the  debate  and  to  reassure  parents  based  on  sound 
evidence  that  giving  these  vaccines  in  a  combined  form  is  safe.  Indeed,  as  the  new 
pentavalent  vaccine  (DtaP/IPV/Hib)  is  introduced  into  the  programme,  it  is  crucial  that 
these  concerns  about  immune  overload  are  taken  into  account  to  reassure  parents  in  their 
wider  reappraisal  of  vaccine  risk. 
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8 Chapter  One:  The  MMR  controversy  a  new  era  in  childhood 
immunisation? 
1.1  Introduction 
In  Britain  in  October  1988,  the  combined  measles,  mumps,  and  rubella  (MMR)  vaccine 
was  introduced  into  the  routine  childhood  immunisation  programme.  Its  introduction 
replaced  the  monocomponent  measles  vaccine  in  order  to  improve  measles  and  rubella 
vaccination  uptake,  about  which  there  had  been  widespread  concern  (Campbell,  1983; 
Miller  and  Miller,  1986;  Walker  et  al.,  1988).  It  also  offered  the  opportunity  to  introduce 
protection  against  mumps  into  the  programme  for  the  first  time  in  order  to  reduce  the 
incidence  of  viral  meningitis,  a  serious  complication  of  mumps.  By  the  early  1990s, 
MMR  coverage  for  2-year-old  children  exceeded  90%  nationally  and  cases  of  measles 
fell  to  historically  low  levels  (Hanratty  et  al.,  2000). 
However,  just  as  rates  of  measles  notification  were  reaching  an  all  time  low,  speculation 
about  the  safety  of  the  MMR  vaccine  began  to  emerge.  In  August  1997,  Dr  Andrew 
Wakefield,  a  consultant  gastro-enterologist,  and  colleagues  at  the  Royal  Free  Hospital, 
London,  submitted  a  paper  to  The  Lancet  postulating  the  existence  of  a  link  between  the 
MMR  vaccine,  bowel  disease  and  autism  (Wakefield  et  al.,  1998).  In  1995,  The  Lancet 
had  published  one  of  Wakefield  and  colleagues'  earlier  papers  that  had  later  been 
criticised  in  the  British  Medical  Journal  as  `flawed'  (Metcalf,  1998).  Nevertheless,  after 
being  peer  reviewed  and  discussed  by  The  Lancet's  editorial  committee,  the  controversial 
paper  was  published  in  The  Lancet  on  28`h  of  February  1998.  On  the  day  of  publication, 
The  Royal  Free  Hospital  organised  a  press  conference  in  which  Dr  Wakefield  and  four 
co-authors  fielded  questions  and  explained  their  findings.  However,  at  the  conference  a 
divide  in  opinion  became  evident  as  Dr  Wakefield  suggested  that  there  was  a  case  for 
splitting  the  MMR  vaccine  into  its  three  separate  component  parts,  each  given  a  year 
apart.  Perhaps  predictably,  the  paper  and  conference  sparked  near  hysteria  in  the  press. 
The  following  day  a  Guardian  headline  warned:  `Alert  over  child  jabs'  (Boseley,  1998). 
Unlike  many  other  health  scares  that  are  short-lived,  stories  about  the  safety  of  the  MMR 
9 vaccine  have  made  headline  news  over  many  years,  and  in  common  with  other  long- 
running  public  health  scares  the  debate  has  been  given  a  name  by  the  popular  media;  in 
this  case  `The  MMR  Controversy'.  It  is  against  this  background  that  this  thesis  aims  to 
examine  how  parents  have  conceptualised  the  MMR  controversy  and  to  explore  parental 
immunisation  behaviours,  in  order  to  learn  lessons  that  may  assist  future  policy  on 
childhood  immunisation. 
1.2  The  literature  review 
This  introductory  chapter  aims  to  provide  the  context  for  my  study  by  critically 
examining  the  scientific  evidence  and  events  leading  up  to,  and  following,  the  publication 
of  Dr  Wakefield  and  colleagues'  paper.  Studies  reviewed  in  this  chapter  are  tabulated  in 
Appendix  Al  and  A2.  The  chapter  is  divided  into  two  parts.  The  first  part  considers  the 
scientific  evidence,  and  the  second  part  considers  the  impact  the  controversy  has  had  on 
parents  and  their  children.  The  review  of  the  scientific  evidence  concentrates  on  the 
causal  association  postulated  between  the  MMR  vaccine,  bowel  disease  and  autism. 
Central  to  this  critique  are  the  studies  of  Dr  Wakefield  and  colleagues  at  the  Royal  Free 
Hospital,  and  the  studies  that  contest,  or  support,  their  theories.  In  order  to  develop  an 
understanding  of  how  the  controversy  has  affected  parents,  the  second  part  of  the  chapter 
reviews  studies  that  have  identified  factors  that  influence  vaccine  decision-making 
behaviours,  particularly  when  a  vaccine  is  perceived  by  the  public  to  carry  a  risk. 
The  level  of  coverage  afforded  to  the  MMR  controversy  means  that  this  review  inevitably 
provides  a  selection  rather  than  exhaustive  review  of  the  studies.  However,  in  order  to  be 
more  systematic  about  the  selection  of  these  studies  for  the  review,  inclusion  and 
exclusion  criteria  were  developed.  This  process  involved  two  stages.  Firstly,  a  broad 
search  on  the  Web  of  Knowledge  and  Medline  databases  was  conducted  using  keywords 
and  keyword  combinations  in  their  tittles  and  abstracts  from  1988  when  the  MMR 
vaccine  was  first  introduced  into  the  Childhood  Immunisation  Programme.  Search 
keywords  included:  immunisation;  childhood  immunisation;  vaccination;  childhood 
immunisation  programme;  childhood  infectious  diseases;  vaccine  preventable  diseases; 
10 measles,  mumps  and  rubella;  MMR;  vaccines;  vaccine  development;  history  and 
immunisation;  vaccine  decision-making;  immunisation  behaviours;  parents  and 
immunisation;  attitudes  and  immunisation;  herd  immunity;  and  population  immunity. 
This  process  produced  a  large  number  of  studies.  These  papers  were  then  assessed  to 
determine  whether  they  were  applicable  to  the  MMR  debate  and  whether  they  should  be 
included  for  a  more  thorough  appraisal.  At  this  stage  the  main  criterion  for  exclusion  was 
if  they  were  irrelevant  to  the  topic  of  childhood  immunisation  and  MMR  vaccination. 
For  instance,  even  though  there  is  a  vast  amount  of  literature  on  autism  and  inflammatory 
bowel  disease,  it  was  decided  most  of  this  was  outwith  the  scope  of  this  review. 
Similarly,  literature  examining  the  public's  reactions  to  other  high  profile  public  health 
debates  was  only  included  if  a  parallel  existed  with  the  current  controversy  over  MMR 
safety.  As  I  became  more  familiar  with  the  literature  I  refined  my  search  terms  and 
searched  databases  using  the  names  of  high  profile  authors  in  the  MMR  debate  to  find 
any  articles  or  paper  written  by  them.  This  search  included  the  items  (or  words)  Andrew 
Wakefield;  Elizabeth  Miller,  Brent  Taylor;  David  Elliman;  Helen  Bedford;  and  the 
Inflammatory  Bowel  Disease  Study  Group.  Some  of  the  older  papers  such  as  Asch's 
work  on  omission  bias  (1994),  and  Bogardus  (1926),  Merton  and  Kendall's  (1946) 
focussed  interview  work  were  traced  through  the  bibliographies  of  more  recently 
published  papers.  Although  the  debate  about  the  safety  of  the  MMR  vaccine  is  not 
confined  to  the  shores  of  the  United  Kingdom,  how  parents  conceptualise  the  debate  here 
is  likely  to  be  shaped  by  political  events,  new  stories  and  their  experiences.  Therefore, 
many  of  the  papers  that  were  assessed  as  being  eligible  for  further  appraisal  were  studies 
conducted  in  the  United  Kingdom.  However,  international  studies  (particuarly  those 
which  focused  on  the  evidence  of  a  link  between  MMR,  autism  and  bowel  disease)  were 
also  included  if  they  had  had  a  direct  impact  on  the  debate  about  the  safety  of  the  MMR 
vaccine,  or  added  something  new  to  the  wider  debate  on  childhood  immunisation. 
The  second  stage  in  the  process  was  to  carry  out  a  more  detailed  appraisal  of  each  paper 
to  assess  its  methodology  and  to  decide  whether  it  should  be  included  in  the  final 
literature  review.  This  appraisal  involved  assessing  the  selection  and  recruitment  of  the 
sample,  the  methods  used  and  whether  there  was  evidence  of  selection  or  measurement 
11 bias,  or  if  there  was  confounding  or  bias  interpretation  of  the  conclusions.  The  final 
selection  in  the  review  included  a  mix  of  large  well-designed  epidemiological  studies 
given  some  prominence  by  the  scientific  community  and  small,  in-depth  qualitative 
studies  offering  important  insights  into  parents'  views  on  childhood  immunisation. 
There  was  some  variation  in  the  quality  of  the  studies  included  in  the  review,  and 
attempts  have  been  made  to  convey  this  in  the  chapter.  In  order  to  keep  abreast  of  any 
new  developments  in  the  MMR  debate,  searches  were  repeated  every  three  months; 
however,  the  newsworthy  nature  of  this  topic  often  meant  that  newspapers  were  the  first 
to  publish  articles  about  newly  published  papers  and  this  also  proved  a  useful  source. 
1.3  Part  One:  Vaccine  safety:  speculation,  scepticism  and  scientific 
evidence 
Since  the  inception  of  immunisation  in  the  late  19th  century,  it  has  widely  been  accepted 
that  mass  immunisation  "has  probably  saved  more  lives  than  any  other  public  health 
intervention,  apart  from  the  provision  of  clean  water"  (Bedford  and  Elliman,  2000  p. 
240).  Indeed,  Stone  (1995,  p.  111)  considers  that  without  immunisation  we  in  the 
Western  world:  "...  would  still  be  languishing  in  a  19th  century  nightmare  of  rampant 
epidemics  of  diphtheria,  smallpox,  tuberculosis  and  their  W.  This  stance  is  not  shared 
by  McKeown  (1976)  who  considers  that,  while  immunisation  has  played  a  late  and  small 
role  in  the  decline  in  mortality  and  morbidity  from  diseases,  the  dramatic  improvements 
in  health  and  decline  in  most  infectious  diseases  during  the  20th  century  have  been  largely 
due  to  improvements  in  housing,  hygiene,  sanitation  and  nutrition  conditions.  More 
recently  Szreter  (2002)  has  revisited  McKeown's  theory  and  suggested  that  this 
interpretation  has  failed  to  recognise  the  historical  importance  of  an  accompanying 
redistributive  social  philosophy  and  practical  policies  which  characterised  public  health 
during  its  19`h  century  origins.  Szreter  agrues  that: 
...  political  and  ideological  divisions  and  conflict  and  their  subsequent  resolution  in  favour  of  the 
health  interests  of  the  working-class  majorities  were  key  factors  in  determining  whether 
industrialisation  exerted  a  positive  or  negative  net  effect  on  population  health  (p.  75). 
12 Although  there  is  some  debate  about  the  degree  to  which  immunisation  can  claim 
responsibility  for  the  decline  in  diseases  in  the  past,  it  seems  likely  that  new 
developments  in  vaccines  and  vaccine  delivery  technology  will  fundamentally  change 
how  diseases  are  prevented  and  treated  in  the  future.  It  is  anticipated  that  over  the 
coming  years  new  vaccines  will  become  available  for  use  to  treat  and  prevent  a  range  of 
non-infectious  diseases,  including  some  cancers,  diabetes,  and  Alzheimer's  disease,  and 
to  treat  autoimmune  diseases  and  allergic  disorders  (Lambert  and  Siegrist,  1997).  The 
progress  in  making  vaccines  aimed  at  controlling  infectious  diseases  is  equally 
impressive.  For  children  living  in  developing  countries  work  is  underway  to  produce 
vaccines  that  protect  against  malaria,  tuberculosis  and  diarrhoeal  diseases  (Lambert  and 
Siegrist,  1997).  For  children  living  in  industrialised  countries  new  vaccines  are  being 
developed  to  reduce  further  the  incidence  of  meningitis  and  severe  lower  respiratory 
infections  (Poland  et  al.,  2002). 
However,  the  paradox  of  the  success  of  mass  immunisation  is  that  the  huge  decline  in 
mortality  and  morbidity  from  infectious  diseases  in  industrialised  countries  has  meant 
that  parents  have  less  experience  of  those  diseases  (Bedford  and  Elliman,  2000).  Perhaps 
for  this  reason,  doubts  about  the  efficacy,  safety  and  necessity  of  childhood  vaccinations 
have  been  brought  into  sharp  focus.  The  most  recent  example  of  this  phenomenon  is  the 
MMR  vaccine,  although  controversy  about  the  safety  of  vaccines  is  not  an  entirely  new 
phenomenon;  indeed  opposition  to  mass  childhood  vaccination  is  a  world-wide 
phenomenon  and  is  as  old  as  the  vaccines  themselves. 
13.1.  A  short  history  of  vaccine  controversy 
Perhaps  unsurprisingly,  speculation  and  scepticism  surrounded  the  inception  of 
vaccination.  It  is  documented  that  in  the  mid-1770s,  a  Dorset  farmer  named  Benjamin 
Jesty  observed  that  the  cowpox  infection  appeared  to  protect  his  milkmaids  against  the 
smallpox  disease.  Convinced  that  he  could  protect  his  family  from  the  ravages  of 
smallpox,  Jesty  transferred  matter  from  a  cowpox  pustule  on  a  cow  onto  a  needle  and 
from  there  to  a  scratch  made  on  the  arm  of  each  member  of  his  family  (Horton,  1995). 
These  crude  inoculations  were  the  first  recorded  (Horton,  1992). 
13 Two  decades  later,  in  1796,  Dr  Edward  Jenner  made  the  same  observation  during  an 
epidemic  of  smallpox  and  published  his  findings  in  an  article  entitled:  `An  inquiry  into 
the  causes  and  effects  of  the  variolae  vaccine'.  He  called  his  idea  `vaccination,  '  from  the 
word  `vaccinia'  which  is  Latin  for  cowpox  (Henderson,  1994).  Perhaps  predictably  this 
pioneering  discovery  was  met  with  some  degree  of  sceptism  and  opposition,  and  stories 
about  its  adverse  side  effects  flourished.  According  to  Beggs  and  Nicoll  (1994)  some 
extraordinary  side  effects  were  described:  "A  child  ran  upon  all  fours  like  a  beast, 
bellowing  like  a  cow,  and  butting  with  its  head  like  a  bull"  (p.  1073).  The  artist  James 
Gillray  drew  a  cartoon  showing  cows  coming  out  of  various  parts  of  people's  bodies  after 
they  had  been  vaccinated,  to  illustrate  some  of  the  myths  being  circulated  by  opponents 
of  Jenner's  work  (Figure  1.1). 
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Figure  1.1:  `The  Cow  Pock  or  the  wonderful  effect  of  the  new  inoculation'  (1801).  Photo,  Wellcome 
Historical  Museum. 
14 Today,  opposition  to  vaccination  in  industrialised  countries  mainly  comes  from  groups  of 
parents,  or  from  individual  spokespersons  (Leask  and  McIntyre,  2003).  Leask  and 
McIntyre  (2003)  considered  the  case  of  Dr  Viera  Scheibner,  a  retired 
micropalaeontologist,  with  no  formal  training  in  medicine,  who  tours  the  world  claiming 
that  vaccines  are  ineffective  and  harmful  to  children,  causing  illnesses  such  as  cancer  and 
asthma.  They  highlight  the  fact  that  health  professionals  are  concerned  that  these  self- 
appointed  and  often  non-medical  spokespersons  misrepresent  the  evidence  on  vaccine 
safety,  potentially  damaging  public  confidence  in  immunisation.  However,  perhaps  such 
fears  overstate  the  general  appeal  that  such  fringe  spokespersons  have  on  the  public's 
trust  in  vaccination.  For  in  recent  years,  vaccine  controversies  such  as  that  of  the 
pertussis  vaccine  and  the  MMR  vaccine  have  stemmed  from  ordinary  parents, 
experienced  doctors,  and  respected  academics  whose  public  appeal  may  be  greater. 
1.3.2  The  pertussis  scare 
In  the  case  of  the  pertussis  vaccine,  speculation  about  its  safety  occurred  within  years  of 
its  introduction  into  the  childhood  immunisation  programme  in  the  early  1950s. 
Although  the  Medical  Research  Council's  (1959)  whooping  cough  trials  found  the 
vaccines  to  be  safe,  some  adverse  effects  were  subsequently  reported.  Anderson  and 
Morris  (1950)  suggested  a  link  between  encephalopathy  and  the  pertussis  vaccine. 
Similarly,  Miller  and  Stanton  (1954)  and  later  Berg  (1958)  reported  serious  neurological 
complications  occurring  in  children  following  vaccination.  According  to  Griffith  (1981) 
these  early  reports  in  scientific  journals  had  no  perceptible  effect  on  immunisation 
coverage  in  the  UK,  and  received  only  sparse  media  interest.  Griffith  attributes  this  lack 
of  negative  impact  to  the  fact  that  the  Ministry  of  Health  actively  pursued  a  policy  of 
encouraging  parents  to  have  their  children  immunised.  However,  in  1974,  KulenKampff 
and  colleagues  published  a  report  postulating  a  link  between  the  pertussis  vaccine  and 
neurological  complications  that  was  the  subject  of  a  television  documentary  (Griffith, 
1981;  KulenKampff  et  al.  1974).  The  documentary  featured  two  children  severely  brain- 
damaged  following  vaccination  with  the  pertussis  vaccine.  The  visible  suffering  of  these 
children,  the  emotional  turmoil  faced  by  their  parents  and  the  split  in  medical  opinion  on 
the  risks  of  neurological  damage  from  the  vaccine,  fuelled  media  speculation  and  the 
15 public  lost  confidence  in  the  vaccine  (Harding,  1985).  By  the  late  1970s,  the  pertussis 
debate  was  exacerbated  further  by  the  claim  from  a  prominent  public  health  academic, 
Professor  Gordon  Stewart  (University  of  Glasgow),  that  the  protective  effect  of  the 
vaccine  was  marginal  because  the  epidemiology  of  pertussis  had  changed.  He  suggested 
that  the  disease  had  become  less  frequent,  less  severe,  and  therefore  that  the  vaccine  was 
largely  ineffective  (Stewart,  1977).  In  spite  of  the  Ministry  of  Health's  attempts  to 
reassure  the  public  that  the  vaccine  was  safe,  the  loss  of  confidence  in  the  vaccine  led 
large  numbers  of  parents  to  refuse  it.  Church  (1979)  describes  the  effect  on  uptake  levels 
of  the  vaccine  as  being  instant  and  dramatic.  McKinnon  (1979),  a  specialist  in 
community  medicine,  recalled: 
...  within  days  health  visitors  were  reporting  that  mothers,  having  seen  the  television  programme, 
were  raising  queries  about  whooping  cough  immunisation,  and  a  significant  number,  who  had 
brought  their  babies  for  immunisation  appointments,  were  withdrawing  previously  given  consent 
for  whooping  cough  vaccine  (p.  199). 
Over  the  following  years  Koplan  and  Hinman  (1987)  reported  that  the  vaccine  coverage 
levels  fell  from  approximately  80%  to  a  low  of  approximately  30%.  The  decreased 
coverage  of  the  vaccine  in  the  UK  led  to  the  development  of  a  large  pool  of  susceptible 
people.  The  fall  in  uptake  in  Scotland  resulted  in  four  epidemics  between  1977  and  1991, 
accounting  for  an  estimated  100,000  notifications  and  up  to  75  deaths  (Health  Education 
Board  for  Scotland  (HEBS),  and  Scottish  Centre  for  Infection  and  Environmental  Health, 
(SCIEH),  2001).  Nicoll  et  al.  (1998)  suggest  a  similar  picture  in  England  and  Wales, 
estimating  over  300,000  notifications  and  at  least  70  deaths.  According  to  Gangarosa  et 
al.  (1998)  confidence  in  the  vaccine  was  slowly  restored  by  the  publication  of  a  national 
reassessment  of  the  vaccine  carried  out  by  Salisbury  (1992),  and  by  the  introduction  of 
financial  incentives  to  reward  general  practitioners  who  achieved  government  targets. 
1.33  Events  leading  up  to  the  MMR  controversy 
As  with  the  pertussis  vaccine,  speculation  about  the  safety  of  the  MMR  vaccine  was  also 
first  presented  in  a  television  documentary.  This  programme  aired  in  Denmark  in  1993 
16 and  featured  a  mother  of  twins,  one  of  whom  had  had  the  MMR  vaccine  and  developed 
autism  soon  after.  She  believed  that  the  MMR  vaccine  was  the  cause  of  her  child's 
autism  (HEBS  and  SCIEH,  2001).  Whilst  at  that  time  in  the  UK  no  scientist  had  publicly 
suggested  such  an  association,  Dr  Andrew  Wakefield  and  other  researchers  collectively 
known  as  the  Inflammatory  Bowel  Disease  Study  Group  (IBDSG)  were  already 
theorising  about  a  link  between  the  measles  virus  and  Crohn's  disease. 
In  1990,  an  hypothesis  attracted  the  attentions  of  Dr  Wakefield  and  colleagues  of  the 
IBDSG.  Thayer  (1990)  questioned  whether  the  aetiology  of  inflammatory  bowel  diseases 
(ulcerative  colitis  and  Crohn's  disease)  could  be  attributed  to  a  transmissible  agent  such 
as  a  virus.  By  1993,  Dr  Wakefield  and  colleagues  published  a  paper  suggesting  there  was 
a  resemblance  between  the  Koplik's  spots  that  are  present  on  the  skin  during  the  early 
stages  of  measles,  and  the  ulcers  seen  in  Crohn's  disease  (Wakefield  et  al.,  1993).  Over 
the  next  few  years  the  IBDSG,  working  with  Swedish  colleagues,  reported  a  positive 
association  between  perinatal  exposure  to  measles  and  the  development  of  Crohn's 
disease  in  children  (Ekbom  et  al.,  1994;  Ekbom  et  al.,  1996).  However,  two  larger 
epidemiological  studies  investigating  a  possible  link  between  Crohn's  disease  and 
mothers  infected  with  measles  during  pregnancy  both  failed  to  find  any  children  who 
went  on  to  develop  Crohn's  disease  as  a  result  of  the  measles  infection.  Therefore  both 
studies  concluded  that  no  link  existed  between  perinatal  exposure  to  measles  and  the 
development  of  Crohn's  disease  (Jones  et  al.,  1997;  Nielsen  et  al.,  1998). 
Undeterred,  Wakefield  and  colleagues  expanded  their  theory  in  a  paper  published  in  the 
Lancet  in  1995.  From  their  original  theory  that  wild  measles  virus  could  be  a  risk  factor 
for  the  development  of  Crohn's  disease,  they  raised  the  possibility  that  even  the 
weakened  (attenuated)  live  measles  vaccine  used  in  vaccines  may  also  be  a  risk  factor  in 
the  development  of  Crohn's  disease  (Thompson  et  al.,  1995).  They  examined  the  impact 
of  measles  vaccination  upon  the  incidence  of  Crohn's  disease  by  comparing  a  cohort  of 
children  (n=3545)  vaccinated  with  the  single  vaccine  in  1964  as  part  of  a  randomised 
trial,  with  a  group  of  unvaccinated  children  (n=11  407)  recruited  in  1958.  From  this  they 
believed  that  they  had  found  an  association  between  measles  vaccination,  Crohn's  disease 
17 and  ulcerative  colitis  and  concluded  that  the  measles  virus  had  a  role  in  the  aetiology  of 
inflammatory  bowel  disease.  However,  the  researchers  selected  the  cohorts  using 
different  methods,  at  different  times,  and  from  different  areas,  and  did  not  adequately 
control  for  confounding  factors.  Indeed,  in  view  of  the  study's  lack  of  consistency  and 
rigor  Metcalfs  (1998)  stated  in  a  critique  of  Wakefield  and  colleagues'  study  that: 
...  the  theory  of  measles  as  a  causative  factor  in  the  development  of  Crohn's  disease  therefore 
cannot  be  upheld  and  should  remind  us  of  the  need  for  rigorous  methodological  review  when 
causal  associations  are  proposed  (p.  167). 
In  an  attempt  to  replicate  Wakefield  and  colleagues'  findings  (Thompson  et  al.,  1995), 
Feeney  and  colleagues  at  the  East  Dorset  Gastroentology  Group  conducted  a  case  control 
study  to  compare  measles  vaccination  rates  in  140  patients  with  inflammatory  bowel 
disease  (83  with  Crohn's  disease)  and  280  matched  controls  (1997).  However,  they 
found  no  association  and  concluded:  "the  cause  of  inflammatory  bowel  disease  remains 
to  be  established"  (p.  764).  Likewise,  a  later  study  carried  out  by  Davis  and  Bohlke 
(2001)  did  not  support  the  theory.  Indeed,  a  letter  published  in  The  Lancet,  in  1995, 
commenting  on  a  study  that  investigated  trends  in  incidence  of  Crohn's  disease, 
suggested  that  the  rise  in  incidence  started  before  1968  when  the  monocomponent 
measles  vaccine  was  introduced  into  the  programme,  thus  shedding  further  doubt  on  the 
group's  theory  (Hermon-Taylor  et  al.,  1995). 
It  is  against  this  background  that  in  1998  The  Lancet  published  Wakefield  and 
colleagues'  paper:  `Ileal-lymphoid  nodular  hyperplasia,  non-specific  colitis,  and 
pervasive  developmental  disorder  in  children,  '  (Wakefield  et  al.,  1998).  In  order  to 
theorise  about  the  role  Wakefield  and  colleagues  have  played  in  what  has  become  known 
as  the  `MMR  controversy'  it  is  necessary  to  critically  examine  the  paper  that  is  at  the 
centre  of  the  debate. 
13.4  A  review  of  the  scientific  evidence  that  sparked  the  controversy 
The  hypothesis  posed  by  Wakefield  and  colleagues  was  that  the  MMR  vaccine  causes 
inflammation  of  the  gut  which  makes  it  more  permeable  and  thereby  to  permit  peptides  to 
18 leak  out;  in  turn  these  toxins  affect  the  brain  causing  serious  developmental  disorders 
(including  autism).  Wakefield  and  colleagues  suggested  a  causal  association  between 
bowel  disease,  developmental  regression  and  the  MMR  vaccine.  In  an  attempt  to  infer 
causation  between  the  MMR  vaccine,  bowel  disease  and  developmental  regression, 
Wakefield  and  colleagues  describe  the  findings  from  their  study  based  on  a  case  series  of 
12  children  with  developmental  and  bowel  problems.  Published  alongside  the  paper  was 
a  critical  commentary  of  the  study  from  respected  specialists  in  the  field  (Chen  and  De 
Stefano.,  1998).  They  reviewed  the  evidence  to  consider  how  well  the  features  of  the 
association  reported  by  Wakefield  and  colleagues  fit  with  criteria  for  causality,  and 
warned  that: 
... 
because  of  inherent  methodological  limitations  of  epidemiological  studies,  biological 
plausibility,  consistency,  strength,  and  specificity  of  association  must  also  be  considered  in 
inferring  causation  (p.  611). 
In  considering  the  biological  plausibility  of  the  findings  from  Wakefield's  study,  two 
problems  can  be  identified.  Firstly,  although  Wakefield  reported  finding  viruses  in  the 
bowel  tissues  of  children  with  inflammatory  bowel  disease,  these  findings  have  not  been 
replicated  by  other  investigators.  In  an  attempt  to  reproduce  Wakefield's  findings,  Afzal, 
et  al.  (1998)  examined  gut  mucosal  biopsies  taken  from  19  patients  with  inflammatory 
bowel  disease.  They  concluded  that  even  with  the  best  available  technology  they  had 
been  unable  to  find  vaccine  viruses  in  the  specimens  taken  from  patients.  The  second 
problem  relates  to  the  biological  plausibility.  Serious  vaccine  reactions  are  usually 
characterised  by  specific  laboratory  or  clinical  findings.  However,  the  non-specific 
nature  of  the  symptoms  described  in  the  cases  led  Nicoll  et  al.  (1998)  to  assert  that  the 
study  is  limited  by  the  fact  that  no  precise  case  definition  is  offered.  In  respect  of  this,  it 
is  of  note  that  the  sequence  of  events  Wakefield  postulates  is  that  the  MMR  vaccine  leads 
to  inflammatory  bowel  disease,  which  results  in  toxins  leaking  out  and  causing 
neurological  damage,  and  autism.  However,  Wakefield's  study  reports  that  the  onset  of 
behavioural  symptoms  occurred  before  the  onset  of  bowel  symptoms  in  almost  all  their 
19 cases.  This  suggests  that  Wakefield's  findings  do  not  support  the  sequence  of  events  he 
postulates. 
Payne  (1998)  also  noted  that  a  weakness  of  the  Wakefield  study  was  that  the  sample  was 
highly  selected  and  suggested  that  a  case  control  study  would  have  reduced  bias. 
According  to  Lee  et  al,  (1998)  attribution  of  causality  requires  (among  other  things)  the 
use  of  patients  and  matched  controls,  and  a  sample  size  that  is  capable  of  detecting  a 
statistically  significant  difference  between  the  two  groups.  To  reduce  the  risk  of  bias  in 
the  clinical  assessments,  investigators  would  have  needed  to  be  blinded  to  the  children's 
clinical  conditions.  However,  it  is  of  note  that  in  Wakefield's  study  there  was  no 
blinding  of  the  investigators,  no  selection  of  patients  with  suitable  matched  controls,  and 
a  very  small  sample  size  (n=12).  Indeed,  following  Wakefield  and  colleagues'  earlier 
1993  and  1995  publications,  Nicoll  et  al.  (1998)  believed  that  patients  would  have  been 
selectively  referred  to  the  Infammatory  Bowel  Disease  Study  Group  because  of  their 
research  interest  in  MMR,  inflammatory  bowel  disease,  and  autism,  thus  also  introducing 
a  strong  selection  bias. 
Another  problem  with  the  study  was  the  extent  to  which  parents  were  able  to  accurately 
recall  their  child's  developmental  milestones.  For  example,  in  considering  whether  recall 
bias  may  have  affected  Wakefield's  findings,  Lee  et  al.  (1998)  suggest  that 
developmental  delay  is  likely  to  be  detected  slowly  over  a  period  of  time,  rather  than  on  a 
particular  day.  However,  according  to  Wakefield's  study,  in  eight  of  the  12  children, 
either  parents  or  the  child's  physician  identified  the  MMR  vaccine  as  the  immediate 
precursor  to  the  onset  of  behavioural  problems.  Furthermore,  Wakefield  et  al.  (1998) 
stated  that  in  some  cases  children  were  as  young  as  12  months  when  they  began 
displaying  behavioural  symptoms.  However,  Lee  et  al.  (1998)  suggest  that  autism  is 
usually  only  diagnosed  once  a  child  is  over  the  age  of  18  months  old,  adding  further 
doubts  about  how  accurately  events  were  being  recalled.  Furthermore,  Wakefield  and 
colleagues  fail  to  acknowledge  anywhere  in  their  paper  the  possibility  that  the  association 
between  MMR  and  subsequent  development  of  autism  may  be  temporal  rather  than 
20 causal.  This  criticism  is  based  on  the  fact  that  the  first  dose  of  the  MMR  vaccine  is 
commonly  given  when  children  are  12  to  15  months  old,  and  autism  is  often  detected 
after  this  time  when  children  are  around  18  months  old.  The  temporal  association 
between  both  these  events  means  that  MMR  vaccination  will  often  be  given  before 
autism  first  manifests  itself.  Le  Page  and  Ainsworth  (2001)  suggest  that  by  neglecting  to 
acknowledge  these  facts  the  paper  exaggerated  the  causal  association  between  onset  of 
behavioural  symptoms  and  MMR  vaccine.  In  consideration  of  this  tenuous  relationship, 
they  state:  "as  persuasive  as  such  cases  might  seem  when  looked  at  individually,  they  fall 
well  within  what  would  be  expected  by  chance"  (p.  8). 
Flaws  in  the  design  of  Wakefield's  study  and  questionable  biological  plausibility  led  Lee 
et  al.  (1998)  to  conclude  that:  "Wakefield's  study  fails  at  every  level  to  make  a  causal 
association"  (p.  905).  In  an  attempt  to  test  Wakefield's  hypothesis,  other  researchers 
have  been  quick  to  try  to  replicate,  contest  or  support  their  findings.  Although  the  vast 
majority  of  studies  have  not  supported  Wakefield  and  colleagues'  research,  there  are  a 
few  studies  that  have.  This  review  will  now  examine  both  sides  of  the  argument. 
13.5  Studies  finding  no  support  for  the  MMR/  autism  association 
Wakefield's  study  has  also  largely  been  unsupported  by  other  larger  epidemiological 
studies.  Several  of  these  have  examined  whether  there  has  been  an  increased  incidence 
of  autism  in  relation  to  the  introduction  of  MMR.  In  the  United  Kingdom  Taylor  et  al. 
(1999)  conducted  a  well-designed  epidemiological  study  to  investigate  trends  in  the 
incidence  of  autistic  disorders  before  and  after  the  introduction  of  MMR  vaccine  in 
October  1988.  These  investigators  examined  the  immunisation  records  of  498  cases  of 
autism,  born  between  1979  and  1998,  to  investigate  whether  there  was  any  increase  in  the 
incidence  of  autistic  disorders  after  the  introduction  of  MMR  vaccine  in  October  1988. 
They  used  a  case  series  analysis  method  to  test  for  clustering  of  onsets  within  defined 
post-vaccination  periods.  From  this  work  they  were  unable  to  detect  any  change  in  the 
incidence  of  autistic  disorders  after  the  introduction  of  MMR  and  found  no  difference  in 
the  age  at  diagnosis  of  autism  between  vaccinated  and  unvaccinated  children,  or  any 
21 clustering  of  autism  in  the  months  following  MMR  vaccination.  This  led  them  to  assert 
that  they  did  not  support  the  existence  of  a  causal  association  between  MMR  vaccine  and 
autism. 
A  second  study  was  carried  out  in  the  United  Kingdom  using  a  time  trend  analysis  to 
identify  whether  there  were  any  changes  in  the  diagnosis  of  autism  recorded  by  general 
practitioners  between  1988  and  1999  (Kaye  et  al.,  2001).  Using  data  from  the  UK's 
general  practice  database  they  identified  305  children  aged  12  years  or  younger 
diagnosed  with  autism.  They  reported  a  marked  increase  in  the  incidence  of  autism 
among  boys  born  between  1988  and  1993,  but  highlighted  the  fact  that  MMR  uptake  for 
successive  annual  birth  cohorts  remained  consistently  over  95%.  This  suggested  that  the 
MMR  vaccine  could  not  be  responsible  for  causing  the  increase  in  autism  as  MMR 
uptake  remained  constant  over  the  same  time.  However,  they  also  stated  that  they  were 
uncertain  of  the  reasons  for  the  marked  increase  in  autism  during  this  decade.  In 
considering  the  unexplained  rise  in  autism,  Dr  Fombonne,  a  specialist  in  the  field  of 
autism  has  suggested  that  one  likely  explanation  may  be  that  in  recent  years  there  have 
been  changes  to  the  classification,  and  diagnosis  of  autism  (Fombonne,  2001).  However, 
in  a  letter  published  in  the  British  Medical  Journal,  Yazbak  points  out  that  the  MMR 
vaccine  was  only  introduced  in  1988  and  questions  the  validity  of  Kay's  suggestion  that 
MMR  uptake  remained  consistently  above  95%  from  its  introduction  in  1988  to  1999 
(Yazbak  2001).  Nevertheless,  the  rise  in  incidence  of  autism  has  not  been  confined  to  the 
UK,  and  Kaye's  findings  have  been  mirrored  in  other  countries.  For  example,  a 
Californian  study  compared  the  incidence  of  autism  over  time  with  MMR  vaccine  uptake 
rates  (Dales  et  al.,  2001).  This  study  observed  a  marked  and  sustained  increase  in  autism 
compared  to  a  sustained  level  of  MMR  uptake.  To  investigate  whether  MMR  vaccination 
is  associated  with  an  increase  in  autism  Smeeth  et  al.  (2004)  conducted  a  study  using  the 
UK  General  Practice  Research  Database  to  identify  people  with  autism  who  had  first 
recorded  diagnosis  of  autism  between  1987  and  2001.  They  identified  1294  cases  and 
4469  controls,  which  they  matched  on  age,  sex,  and  general  practice.  They  found  that 
1010  cases  (78.1%)  had  MMR  vaccination  recorded  before  diagnosis,  compared  with 
22 3671  controls  (82.1%)  before  the  age  at  which  their  matched  case  was  diagnosed.  This 
led  them  to  conclude  that  MMR  vaccination  is  not  associated  with  an  increase  in  autism. 
Researchers  have  also  examined  whether  there  is  any  evidence  of  a  new  variant  autism 
which  may  be  induced  by  MMR.  For  example,  Fombonne  and  Chakrabarti  (2001) 
postulated  that  if  a  new  `autistic  enterocolitis'  syndrome  exists,  regression  in  the 
development  of  children  with  autism  would  become  more  common  in  MMR-vaccinated 
children.  Their  retrospective  analysis  of  cohort  data  compared  three  groups  of  English 
children  with  autism.  Ninety-six  children  immunised  with  MMR  were  compared  with 
data  from  two  previous  clinical  samples;  one  pre-MMR  (n=98)  and  one  post-MMR 
(n=68).  They  did  not  find  any  evidence  that  regression  in  the  developmental  course  of 
autism  was  more  common  in  children  immunised  with  MMR.  The  rate  of  developmental 
regression  reported  in  the  post-MMR  sample  was  15.6%,  compared  to  18.4%  for  the  pre- 
MMR  sample.  From  this  work  they  concluded  that  there  was  no  evidence  to  support  a 
distinct  syndrome  of  MMR-induced  autism  or  of  autistic  enterocolitis. 
In  a  population-based  study  in  the  UK,  Taylor  et  al.  (2002)  also  examined  whether  there 
was  any  evidence  of  a  new  form  of  autism  associated  with  MMR  vaccination.  They 
identified  from  computerised  disability  registers  278  children  born  between  1979  and 
1998  with  `core  autism'  and  195  children  with  `atypical  autism'.  Using  information 
abstracted  from  the  clinical  notes  on  any  change  in  the  child's  social  and  behavioural 
developments  or  any  documented  bowel  problems  investigators  were  able  to  link  this  to 
computerised  vaccination  records.  They  found  no  change  in  the  proportion  of  children 
with  developmental  regression  or  with  bowel  disease,  and  no  association  between  MMR, 
bowel  problems  and  regression.  From  this  they  concluded: 
These  findings  provide  no  support  for  an  MMR  associated  `new  variant'  form  of  autism  with 
developmental  regression  and  bowel  problems,  and  further  evidence  against  involvement  of  MMR 
vaccine  in  the  initiation  of  autism  (p.  393). 
23 Researchers  have  also  focused  attention  on  trying  to  detect  measles  virus  in  the  gut  of 
children  with  autism.  Thjodleifsson  et  al.  (2002)  tested  the  hypothesis  that  the  measles 
vaccine  virus  moves  into  the  intestinal  tissue  causing  intestinal  inflammation  in  the 
immediate  period  following  vaccination.  They  did  this  by  examining  the  intestinal 
inflammation  response  in  58  children  before,  and  two  and  four  weeks  after  immunisation 
with  MMR.  They  found  that  MMR  vaccination  was  not  associated  with  any  significant 
intestinal  inflammation  response,  leading  them  to  conclude  there  is  no  evidence  of  the 
hypothesised  `gut-brain'  interaction  central  to  Wakefield's  1998  theory.  In  a  review  of 
the  evidence  from  the  experimental  work  carried  out  to  date  Ghosh  et  al.  (2001) 
concluded: 
There  is  now  enough  experimental  evidence  to  conclude  that  failure  to  detect  measles  virus 
genome  in  JBD  tissue  is  not  due  to  the  inefficiencies  of  the  PCR  based  detection  systems  but  to  the 
absence  of  measles  virus  particle  (p.  752). 
Likewise  in  a  letter  to  the  editor  Afzal  et  al.  (2001)  suggested  that  Wakefield's  findings 
were  due  to  laboratory  contamination,  in  view  of  the  fact  neither  they  nor  other 
researchers  have  been  able  to  identify  measles  virus  persistence  both  in  the  specimens  of 
people  with  IBD  and  non-IBD.  This  is  despite  the  fact  that  more  sensitive  tests  have  now 
been  developed  (lizuka  et  al.,  2001).  The  fact  that  Wakefield's  findings  have  been 
neither  replicated,  nor  supported  by  the  vast  majority  of  studies  has  led  to  criticism  of  Dr 
Wakefield  and  colleagues.  Nevertheless  a  small  group  of  researchers  continues  to 
support  his  theories. 
1.3.6  Support  for  the  MMR/  autism  association 
Whilst  most  researchers  have  failed  to  find  the  measles  or  mumps  virus  in  gut  tissue, 
Professor  O'Leary  and  colleagues  continue  to  support  Dr  Wakefield's  claims.  In  April 
2000  Professor  O'Leary  and  Dr  Wakefield  presented  unpublished  data  to  the  United 
States  Senate's  congressional  committee  in  Washington.  At  the  hearing  O'Leary  and 
Wakefield  explained  the  findings  from  their  work  with  Kawashima  and  colleagues  in 
which  they  had  detected  the  measles  virus  in  24  of  25  autistic  children's  gut  biopsies 
compared  with  one  of  15  controls.  These  claims  were  later  published,  suggesting  they 
24 had  detected  measles  virus  in  patients  with  inflammatory  bowel  disease  and  autism 
(Kawashima  et  al.,  2000). 
On  Yd  February  2002,  claims  of  new  evidence  from  Dr  Wakefield  and  Professor  O'Leary 
were  made  public  in  a  Panorama  documentary.  Following  the  documentary,  a  paper  was 
published  in  the  Journal  of  Clinical  Pathology  and  Molecular  Pathology  (Uhlmann  et  al., 
2002).  The  study  examined  91  samples  of  ileal  lymphoid  tissue  taken  from  children 
affected  with  inflammatory  bowel  disease.  Seventy-five  were  found  to  be  positive  for 
measles  virus  compared  to  five  of  the  70  control  patients.  However,  Morris  and 
Aldulaimi  (2002)  commented  that  the  interpretation  of  these  findings  is  difficult  and 
suggest  it  would  be:  "...  wrong  to  jump  to  the  conclusion  that  measles  component  of 
MMR  causes  the  colitis  or  developmental  disorder  in  these  particular,  or  any  other 
children"  (p.  83).  Indeed,  they  highlight  the  fact  that  causation  is  rarely  simple  and  is 
often  multi-factorial  in  nature  (Morris  and  Aldulaimi,  2002). 
13.7  MM  U?  vaccination  and  adverse  reactions 
MMR  has  been  used  around  the  world  for  30  years.  Since  its  introduction  in  the  UK  in 
1988,  around  13  million  doses  have  been  given  (HEBS  and  SCIEH,  2001).  Although 
vaccines  are  subject  to  testing  to  demonstrate  their  safety,  quality  and  efficacy  before 
being  licensed,  less  common  adverse  reactions  may  only  become  apparent  once  the 
vaccines  have  been  widely  used.  In  the  UK,  any  adverse  reaction  to  vaccines  should  be 
reported  by  doctors,  nurses,  pharmacists  and  parents  to  the  Committee  on  the  Safety  of 
Medicines  (CSM)  using  the  Yellow  Card  Scheme.  In  turn,  the  CSM  and  Medicines 
Control  Agency  (MCA)  investigate  and  assess  all  the  reports  to  determine  any  safety 
issues  associated  with  a  vaccine.  According  to  the  CSM  statistics,  the  MMR  vaccine  has 
received  3,453  Yellow  Card  Reports  since  1988.  Serious  reactions  include:  121  febrile 
convulsions,  42  reports  of  autism,  17  of  autistic  behaviour,  8  cases  of 
meningitis/encephalitis,  three  of  blood  clotting  disorders,  three  of  bowel  disease  and  two 
cases  of  anaphylactic  shock  (CSM  and  MCA,  2003).  However,  the  success  of  this 
passive  surveillance  system  relies  on  the  early,  complete  reporting  of  any  reactions  and 
25 on  doctors  being  meticulous  in  obtaining  the  details  and  appropriate  specimens  in  order 
to  assist  a  thorough  investigation.  Critics  of  the  scheme  suggest  that  it  is  chaotic, 
misconceived  and  subject  to  underreporting,  and  have  called  for  a  critical  appraisal  of  the 
scheme  (Medawar  and  Herxheimer,  2004). 
Studies  investigating  severe  adverse  reactions  to  the  MMR  vaccine  have  also  been 
conducted  in  other  countries.  In  Finland  Peltola  et  al.  (1998)  conducted  a  large 
prospective  study  examining  the  medical  records  of  1.8  million  children  during  a  14-year 
period  in  order  to  identify  any  severe  adverse  reaction  within  a  three  week  period  post- 
MMR  vaccination.  Investigators  identified  those  children  for  whom  gastro-intestinal 
symptoms  were  reported,  and  traced  them  to  estimate  the  incidence  of  autism  following 
MMR.  Out  of  31  children  with  gastro-intestinal  symptoms  none  had  gone  on  to  develop 
autism.  The  study  did  not  find  any  cases  of  autism  or  inflammatory  bowel  disease  and 
concluded  that:  "serious  events  causally  related  to  MMR  vaccine  are  rare  and  greatly 
outweighed  by  the  risks  of  natural  MMR  diseases"  (p.  1127).  However,  one  limitation  of 
this  study  is  the  fact  that  investigators  only  examined  a  relatively  short  time  frame  of 
three  weeks  post-vaccination.  A  further  limitation  is  that  according  to  Lee  et  al.  (1998) 
developmental  delay  is  likely  to  be  detected  slowly  over  a  period  of  time,  rather  than  on  a 
particular  day.  In  consideration  of  this,  Patja  et  al.  (2000)  used  the  same  Finnish  dataset 
to  identify  adverse  drug  reactions  over  a  longer  follow  up  period  (1982-1996). 
Consistent  with  their  earlier  findings  they  found  no  case  of  inflammatory  bowel  disease 
or  autism  linked  to  the  vaccine. 
13.8  Summary  of  the  evidence 
Researchers  who  have  investigated  the  biological  plausibility  of  Wakefield's  theory  have 
identified  an  important  flaw  in  the  gut-brain  part  of  the  theory.  Replications  of 
Wakefield  and  O'Leary's  examination  of  intestinal  specimens  have  not  identified  the 
measles  virus.  In  addition,  researchers  have  not  identified  a  significant  amount  of 
inflammation  in  the  intestine  post  MMR  vaccination.  This  supports  the  findings  of  larger 
epidemiological  studies  which  have  investigated  adverse  reactions  to  the  MMR  vaccine 
and  have  not  identified  bowel  problems  post-vaccination.  Taken  together  these  findings 
26 may  account  for  why  the  symptoms  described  in  Wakefield's  study  were  non-specific, 
and  wide-ranging,  and  why  Wakefield  and  colleagues  were  unable  to  offer  a  specific  case 
definition.  Further,  without  this  central  link  in  the  hypothesized  MMR-autism  chain,  the 
entire  theory  is  undermined.  For  this  reason  it  is  perhaps  less  surprising  that  large-scale 
epidemiological  studies  have  not  found  any  evidence  of  a  new  form  of  autism  associated 
with  MMR  vaccination,  or  any  evidence  that  trends  in  the  increased  incidence  of  autism 
are  related  to  the  uptake  of  the  MMR  or  measles  vaccines.  Despite  the  evidence  from 
these  epidemiological  studies  refuting  Wakefield's  claims,  Bedford  and  Elliman  (2000) 
have  observed  that  his  research  has  received  disproportionate  publicity,  giving  the 
impression  that  a  substantial  body  of  opinion  support  his  views.  This  is  perhaps  all  the 
more  confusing  since  Wakefield  and  colleagues  did  not  suggest  in  their  paper  that  they 
had  proved  an  association  between  MMR  and  autism. 
1.4  Part  Two:  The  public  response:  Impact  on  MMR  uptake 
Despite  the  Government  and  public  health  officials  acting  quickly  to  reassure  parents 
about  the  safety  of  the  vaccine,  parents'  reactions  to  the  controversy  led  to  a  drop  in 
immunisation  uptake.  Between  July  and  September  1998  there  was  a  1.4%  drop  in 
immunisation  uptake  in  children  aged  24  months,  the  largest  fall  since  the  programme 
began.  In  Scotland  MMR  uptake  for  2  year  olds  for  the  first  quarter  fell  from  94.1%  in 
1997  to  87.8%  in  2003  (SCIEH,  2003)  and  in  England,  MMR  uptake  for  2  year  olds  for 
the  first  quarter  fell  from  91.4%  in  1997  to  85.7%  in  2003  (PHIS,  2003).  Figure  1.2 
shows  MMR  coverage  in  the  UK  for  children  aged  2  years,  for  each  quarter,  since  1995. 
27 Figure  1.2:  MMR  coverage  in  the  UK  for  children  aged  2  years,  for  each  quarter, 
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Data  provided  by  the  Public  Health  Laboratory  Services:  Communicable  Diseases  Surveillance  Centre, 
COVER  programme.  Available  at  www.  hpa.  org.  uk/cdr/archive.  htm  (December  2004) 
The  fall  in  MMR  uptake  in  the  months  following  the  publication  of  Wakefield's  paper  led 
prominent  virologists  to  issue  warnings  about  impending  measles  outbreaks  and  to  warn 
that  the  fall  in  MMR  uptake  would  undo  the  recent  near  elimination  of  measles  and 
rubella  in  the  UK  (Beggs  et  al.,  1998).  By  2002  these  early  predictions  were  realised 
when  measles  outbreaks  occurred  in  London,  Wales,  and  in  Fife.  Cases  of  mumps  have 
also  increased  though  mainly  amongst  a  cohort  currently  aged  between  13  to  22  years 
who  did  not  receive  MMR  or  only  received  one  dose  and  confirmed  cases  of  rubella 
remain  low.  According  to  the  Health  Protection  Agency,  during  the  first  three-quarters  of 
2004,3756  confirmed  cases  of  mumps  were  reported,  compared  to  1529  cases  in  2003, 
and  495  cases  in  2002  (available  at  www.  hl2a.  org.  uk/hpa/news/articles/press)  (December 
2004). 
In  recognition  of  the  falling  uptake  rates,  growing  public  concern  about  the  safety  of  the 
vaccine  and  calls  for  the  single  vaccine  to  be  made  available,  the  Scottish  Executive 
established  an  `MMR  Expert  Group'  in  August  2001.  As  part  of  their  remit,  the  group 
28 was  asked  to  consider  the  public  health  consequences  of  pursuing  alternative 
immunisation  policies.  In  May  2002  the  report  was  published.  It  recommended  that: 
...  on  the  basis  of  currently  available  evidence,  there  is  no  proven  scientific  link  between  the 
measles,  mumps,  and  rubella  vaccine  (MMR)  and  autism  or  Crohn's  disease  and  therefore  the 
Committee  has  no  reason  to  doubt  the  safety  of  the  MMR  vaccine.  The  Committee  does  not 
recommend  any  change  in  the  current  immunisation  programme  at  this  time  (Scottish  Executive: 
MMR:  Report  of  the  MMR  Expert  Group  2002,  p.  48). 
Indeed,  the  report  considered  that  population  immunity  would  suffer  as  a  result  of  any 
decision  to  make  single  vaccines  more  widely  available  on  demand,  suggesting  that  this 
policy  would  lead  to  measles  outbreaks.  The  Scottish  Executive  also  reaffirmed  their 
commitment  to  providing  parents  and  health  professionals  with  the  most  up-to-date- 
assessment  of  the  evidence  surrounding  the  safety  of  the  MMR  vaccine  in  the  form  of 
`The  MMR  discussion  pack'  and  leaflets  (IBS  and  SCIEH,  2001). 
1.4.1  Vaccine  decision-making:  The  factors  known  to  influence  uptake 
In  the  UK  parents  have  the  right  to  choose  whether  or  not  they  wish  to  have  their  children 
immunised.  The  voluntary  nature  of  immunisation  means  that  the  success  of  the 
Childhood  Immunisation  Programme  relies  on  immunisation  policy  being  an  acceptable 
and  more  attractive  option  compared  to  opting  not  to  immunse.  Therefore  understanding 
the  factors  that  influence  parents  to  accept  or  refuse  immunisation  for  their  children  is 
important  if  parents  are  to  be  encouraged  to  comply  with  immunisation  policy.  Since  the 
publication  of  `The  Black  Report'  (Townsend  and  Davidson,  1982)  emphasis  has  been 
directed  towards  improving  the  uptake  of  child  preventative  health  services,  including 
that  of  immunisation,  in  socially  and  economincally  deprived  areas.  By  the  early  1990s 
the  drive  to  improve  childhood  immunisation  uptake  levels  heralded  the  introduction  of 
target  payments  to  general  practitioners  and  the  setting  of  a  target  of  95%  uptake  among 
children  aged  2  year  olds  for  all  the  vaccines  in  the  Childhood  Immunisation  Programme. 
As  a  consequence  of  these  new  policies,  the  1990s  appears  to  be  a  period  during  which 
there  were  renewed  efforts  on  the  part  of  researchers  to  identify  the  factors  that  influence 
29 parents'  decisions  about  immunisation.  Much  of  the  research  conducted  during  this 
period  focused  on  those  parents  who  decided  to  withhold  immunisation,  reflecting  the 
fact  that  it  was  important  to  understand  the  view  of  this  minority  group  of  parents  if  the 
target  of  95%  was  to  be  attained. 
One  of  the  first  exploratory  studies  to  investigate  British  mothers'  experiences  of 
childhood  immunisation  was  carried  out  by  New  and  Senior  (1991)  as  part  of  a  larger 
study.  Participants  were  randomly  selected  from  immunisation  records  held  on  the 
computerised  Child  Health  System  which  collects  data  on  the  quarterly  vaccine  coverage 
for  all  children  in  England  at  two  years  of  age.  The  study  used  an  unmatched  case- 
control  design  to  include  parents  whose  children  were  fully  immunised  (n=123),  partially 
immunised  (n=71)  and  parents  who  had  defaulted  on  all  their  invitations  to  immunise 
(n=48).  The  main  findings  were  that  mothers  rather  than  fathers  were  predominantly 
responsible  for  matters  relating  to  immunisation  and  that  they  were  reluctant  to  take  ill 
children  for  vaccination  even  if  the  illness  was  minor.  They  found  that  in  larger  families 
there  was  a  greater  probability  of  the  youngest  being  incompletely  immunised,  which 
they  suggested  may  reflect  the  greater  burden  of  childcare  commitments.  They  also 
found  that  mothers  with  no  formal  educational  qualifications  at  Advanced  Level  in  the 
General  Certificate  of  Education  or  above  were  more  likely  to  have  an  incompletely 
immunised  child,  which  they  thought  may  account  for  lower  vaccine  uptake  in  deprived 
areas. 
Two  years  later,  Pearson  et  al.  (1993)  published  the  findings  of  their  Liverpool-based 
study  that  aimed  to  identify  the  factors  influencing  parents  to  withhold  immunisation. 
Using  immunisation  data  held  on  the  Child  Health  System,  they  used  regression  analysis 
to  assess  the  association  between  parents'  consent  to  immunise,  and  five 
sociodemographic  factors:  the  child's  gender,  the  child's  position  in  the  family,  whether 
the  family  had  one  or  two  parents,  migration  into  Liverpool  since  birth,  and  local 
deprivation,  a  factor  identified  as  important  in  the  earlier  Peckham  Report  (Peckham  et 
al.,  1989).  Of  the  cohort  of  3585  children  (1714  girls,  1871  boys),  they  found  that 
30 consent  to  immunise  with  pertussis  was  least  likely  to  be  given  for  boys,  and  for  children 
with  older  siblings,  and  by  single  parents,  and  parents  living  in  deprived  areas.  They 
suggested  that  health  visitors  should  target  parents  living  in  deprived  areas  and  families 
with  two  or  more  children  and  provide  them  with  consistent  advice  and  support. 
In  an  attempt  to  identify  the  reasons  why  parents  refuse  immunisation,  Simpson  et  al. 
(1995)  also  used  the  computerised  Child  Health  System  to  identify  parents  whose 
children  had  not  been  immunised.  They  identified  106  children  living  in  the  Bath  area  of 
England  who  had  received  no  immunisation  between  1987  and  1993.  The  parents  of 
these  children  were  mailed  a  questionnaire,  87  of  which  were  completed  and  returned 
giving  a  response  rate  of  82%.  The  most  common  reason  for  refusal  to  immunise  was 
that  they  used  homeopathy.  This  accounted  for  22  parents'  refusal.  Religious  beliefs 
accounted  for  a  further  17  parents,  five  parents  gave  medical  reasons  for  not  immunising 
their  children,  and  seven  parents  stated  that  they  were  in  the  process  of  having  their 
children  immunised.  Seventeen  parents  were  described  as  having  various  unidentified 
reasons  for  not  immunising  their  children.  The  parents  of  the  remaining  19  children 
gave  no  reason.  The  fact  that  36  out  of  the  87  parents  gave  no  reason  prevents  drawing 
firm  conclusions  about  which  groups  of  parents  might  benefit  most  from  being  targeted 
with  more  informed  and  accurate  information  about  immunisation. 
In  2001,  Sporton  and  Francis  published  their  small  qualitative  study.  The  study  involved 
semi-structured  interviews  with  13  parents  to  explore  the  decision-making  process  of 
parents  who  had  chosen  not  to  immunise  their  children.  They  used  purposive  sampling 
to  identify  parents  who  had  chosen  not  to  immunise  at  least  one  of  their  children  from  an 
area  of  London  with  a  high  level  of  deprivation.  They  concluded  that  a  major  reason 
given  by  parents  for  choosing  not  to  immunise  was  that  they  feared  the  risks  of  side 
effects  from  vaccines.  Health  visitors  were  not  perceived  as  providing  balanced 
information  and  this  was  identified  as  an  impediment  to  decision-making.  Consistent  with 
Simpson  et  al's.  (1995)  earlier  findings,  they  found  that  some  parents  refused 
immunisation  because  of  religious  beliefs  or  because  they  preferred  to  use  homeopathy. 
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Wakefield's  study,  Sporton  and  Francis's  paper  does  not  mention  the  MMR  debate. 
Therefore  it  is  unclear  whether  Sporton  and  Francis's  findings  about  parents'  fears  about 
side  effects  from  vaccines  specifically  refer  to  the  MMR  vaccine,  or  to  vaccines  in 
general.  The  fact  that  the  paper  omits  to  mention  the  MMR  controversy  at  all  is  puzzling 
given  the  context  in  which  these  findings  were  generated. 
1.4.2  Vaccination  decision-making:  seeking  the  best  balance  of  risks  and  benefits 
Whilst  most  of  these  studies  have  been  helpful  in  identifying  factors  that  may  influence 
parents'  decisions,  these  factors  alone  do  not  fully  explain  vaccine  decision-making 
outcomes.  It  is  recognised  that  although  parents  make  their  own  assessment  of  whether 
to  immunise  their  child,  immunisation  is  about  more  than  just  the  individual  and  is  a 
preventative  measure  that  may  sometimes  bring  more  benefits  to  the  community  than  to 
the  individual.  Rose  termed  this  situation  `the  prevention  paradox'  (Rose,  1981). 
Hershey  et  al.  (1994)  consider  this  conflict  and  suggest  that  when  people  choose  among 
medical  treatments  they  usually  seek  alternatives  which  appear  to  offer  the  best  perceived 
balance  of  risks  and  benefits.  They  suggest  that  this  is  because  this  type  of  decision  does 
not  affect  anyone  else,  and  thus  it  makes  sense  for  individuals  to  keep  their  own  interests 
paramount.  However,  they  point  out  that  when  people  choose  to  become  vaccinated, 
decisions  do  affect  other  people  in  that  not  only  do  they  reduce  their  own  chances  of 
contracting  the  disease,  but  they  also  reduce  their  chances  of  carrying  the  disease  or  of 
transmitting  it  to  others. 
Recently,  Hunt  and  Emslie  revisited  the  prevention  paradox  and  suggested  that  there  may 
be  an  argument  for  acknowledging  it  more  directly  in  health  education  materials,  to  stem 
the  public's  growing  mistrust  of  science  and  health  education  (Hunt  and  Emslie,  2001). 
Indeed,  past  immunisation  campaigns  have  not  acknowledged  the  fact  that  immunisation 
has  this  dual  role  of  protecting  both  the  individual  and  those  around  the  individual, 
despite  the  fact  that  decisions  about  immunisation  may  affect  other  people,  and  be 
influenced  by  the  actions  of  other  people.  To  assess  the  roles  that  altruism,  free-riding, 
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(1994)  asked  472  people  to  consider  six  hypothetical  scenarios.  Regression  analysis 
provided  evidence  that  altruism,  free-riding  and  bandwagoning  are  significant  motivators 
in  the  decision  to  undergo  vaccination.  This  led  them  to  propose  that  people  factor  the 
actions  of  others  into  their  own  decisions  about  whether  to  immunise  or  not.  However, 
whilst  Hershey  and  colleagues  observed  that  some  of  the  subjects  in  their  study  spoke  as 
if  they  cared  about  the  impact  of  their  decisions  on  the  well-being  of  others,  they  also 
appeared  to  act  in  their  own  interests.  This  suggests  that  they  found  some  discrepancy 
between  people's  words  and  actions.  On  the  other  hand,  they  suggest  that  some 
individuals  may  undergo  vaccination  partly  to  help  others.  They  warn  that  this  gives  rise 
to  a  situation  whereby  as  herd  immunity  increases  and  diseases  become  well-controlled 
there  is  a  decreased  individual  benefit  from  being  vaccinated,  compared  with  an 
unchanged  risk  of  reaction  to  the  vaccine.  Hershey  and  colleagues  consider  that  this 
scenario  (free-riding)  creates  an  ideal  opportunity  for  some  people  to  use  herd  immunity 
to  gain  benefit  from  an  immunisation  programme  without  accepting  any  personal  risks. 
However,  free-riding  to  minimise  personal  risk  is  not  a  risk-free  stategy  as  herd  immunity 
is  not  constant.  Indeed,  the  whooping  cough  epidemic  of  the  1970s  is  a  testament  to  the 
fact  that  relying  on  herd  immunity  is  inherently  risky.  Following  adverse  publicity  about 
the  safety  of  the  pertussis  vaccine  in  the  mid-1970s,  large  numbers  of  parents  decided  not 
to  get  their  children  immunised,  and  the  uptake  rate  of  the  vaccine  plummeted  and 
whooping  cough  rates  soared  (Meszaros  et  al.,  1996).  According  to  Preston  (1980) 
population  immunity  was  reduced  to  about  20-40%  in  some  parts  of  the  country.  In  these 
circumstances  parents  deliberately  using  herd  immunity  to  offer  protection  to  their  child 
would  have  suddenly  found  themselves  vulnerable  to  the  resurgent  whooping  cough 
disease. 
1.43  Omission  bias  and  vaccine  decision-making 
The  dramatic  fall  in  pertussis  uptake  rates  following  adverse  publicity  is  evidence  that 
parents'  usual  patterns  of  immunisation  decision-making  behaviour  were  altered.  In  order 
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American  psychologists  Ritov  and  Baron  (1990)  conducted  a  study  using  a  hypothetical 
vaccine  scenario  to  consider  the  role  that  psychological  bias,  termed  omission  bias,  plays 
in  vaccine  decision-making.  Fifty-three  undergradute  students  were  randomly  selected 
on  campus  to  consider  senarios  and  decide  whether  vaccination  or  potentially  contracting 
a  disease  was  in  their  their  hypothetical  child's  best  interest.  They  found  that  some 
students  considered  that  they  would  feel  more  responsible  if  their  hypothetical  child  died 
as  a  result  of  a  vaccination,  than  as  a  result  of  contracting  a  vaccine-preventable  disease. 
They  argue  that  this  reluctance  to  act  is  an  example  of  omission  bias,  whereby  the  person 
withholds  vaccination  because  of  the  perception  that  action  (commission)  is  more 
harmful  than  inaction  (omission).  Moreover,  they  suggest  that  when  ambiguity  exists  in 
relation  to  the  risks  associated  with  the  vaccine,  it  heightens  the  reluctance  to  vaccinate, 
even  when  the  risks  are  small. 
Similarly,  Asch  et  al.  (1994)  investigated  the  role  that  omission  bias  played  in  American 
parents'  decisions  about  whether  to  vaccinate  their  children  against  pertussis.  They 
mailed  200  questionnaires  to  subscribers  of  a  `Parenting'  magazine,  which  had  previously 
published  articles  favouring  and  opposing  pertussis  vaccination.  Parents  were  asked 
about  their  beliefs  about  the  vaccine  and  the  disease  and  whether  they  planned  to,  or  had 
vaccinated  their  own  children.  They  were  given  11  different  statements  about  whooping 
cough  and  pertussis  vaccination,  which  they  had  to  assess  as  either  being  true  or  false. 
One  hundred  and  three  questionnaires  were  completed  and  returned,  of  which  43%  of  the 
respondents  reported  they  did  not,  or  would  not,  allow  their  children  to  be  vaccinated, 
and  57%  respondents  reported  that  they  had,  or  would,  vaccinate  their  children.  Using 
logistic  regression  to  determine  the  role  omission  bias  played  in  parents'  decisions  about 
pertussis,  Asch  and  colleagues  found  that  parents  who  reported  that  they  had  not 
immunised  their  children  were  also  more  likely  to  believe  that  vaccinating  was  more 
dangerous  than  not  vaccinating.  They  concluded  that  omission  bias  plays  a  role  in 
decisions  not  to  vaccinate  with  the  pertussis  vaccine,  beyond  the  role  played  by  belief 
about  the  risk  of  vaccination.  They  asserted:  "...  in  some  circumstances  individuals  favor 
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more  likely  to  lead  to  better  outcomes"  (p.  121). 
1.4.4  Parents'  attitudes  to  the  MMR  controversy  and  to  MMR  vaccination 
Since  the  MMR  controversy  first  began  there  have  been  several  studies  that  have  been 
particularly  useful  in  gaining  new  insights  into  parents'  perceptions  about  MMR 
decision-making.  Evans  and  colleagues  (2001)  recruited  parents  from  the  Avon  and 
Gloucestershire  area  of  the  United  Kingdom  to  take  part  in  six  focus  groups.  The  focus 
of  the  discussions  was  on  the  influences  on  parents'  decisions  to  accept  or  refuse  MMR. 
They  used  a  purposive  sampling  strategy  to  include  parents  from  a  range  of  socio- 
economic  backgrounds  and  different  MMR  decision-making  outcomes.  This  study 
offered  the  first  in-depth  account  of  parents'  perspectives  on  MMR  immunisation.  Evans 
and  colleagues  found  that  parents  are  involved  in  a  risk-benefit  analysis  and  that  for  many 
parents  it  is  easier  to  live  with  the  risk  of  their  child  naturally  contracting  one  of  the 
diseases  than  with  the  risk  of  causing  their  child  damage  through  vaccination,  a  finding 
reminiscent  of  Ritov  and  Baron  (1990)  and  Asch  and  colleagues'  (1994)  work  on 
omission  bias.  Further,  although  these  parents  accepted  that  their  unvaccinated  children 
might  contract  a  disease,  they  were  optimistic  that  their  children  would  make  a  good 
recovery.  They  concluded  that  the  non-immunisers  felt  that  the  potential  risks  from 
MMR  outweighed  the  potential  risks  of  contracting  the  diseases,  and  were  reluctant  to 
comply  with  a  policy  that  offered  them  no  choice. 
In  another  study,  Ramsay  et  al.  (2002)  described  trends  in  mothers'  attitudes  to,  and 
uptake  of,  MMR  vaccine  between  1995  and  2001.  They  utilised  data  from  two  sources, 
the  computerised  Child  Health  System,  and  the  cross-sectional  survey  of  attitudes 
towards  childhood  immunisation  conducted  in  England  bi-annually  by  all  health 
authorities  in  England.  Data  were  obtained  from  26  English  health  authorities/trusts  in 
2001.  The  survey  involved  interviews  with  a  random  sample  of  1000  mothers  of  children 
less  than  three  years  of  age.  From  these  routine  data  sources  they  found  that,  despite  the 
adverse  publicity  surrounding  the  MMR  vaccine,  the  fall  in  MMR  coverage  was  small 
35 (8.6%  between  1995  and  2001)  and  that  the  vast  majority  of  mothers  (92%)  would 
immunise  future  children  with  MMR.  The  interviews  were  structured  and  less  well 
suited  to  exploring  the  views  of  the  parents  who  declined  MMR,  or  to  drawing  any 
conclusion  about  how  they  might  be  encouraged  to  immunise.  Nevertheless,  an 
interesting  finding  from  this  study  was  that  the  decline  in  acceptability  of  the  MMR 
vaccine  appeared  to  be  greater  among  more  socio-economically  advantaged  parents.  This 
is  in  contrast  to  studies  conducted  in  the  late  1980s  and  early  1990s  that  reported  lower 
vaccine  uptake  levels  in  more  socially  and  economically  deprived  areas,  with  the 
exception  of  the  pertussis  vaccine,  (Peckham  et  al.,  1989;  Pearson  et  al.,  1993;  Ramsay  et 
al.,  2002).  This  suggests  that  improving  MMR  uptake  may  require  more  than  simply 
targeting  parents  living  in  deprived  areas  with  more  informed  and  accurate  information 
about  MMR. 
A  study  by  Smailbegovic  et  al.  (2003)  explored  the  attitudes  and  concerns  about 
immunisation  and  vaccine-preventable  diseases.  They  mailed  questionnaires  to  129 
parents  living  in  the  London  Borough  of  Hackney  whose  children  had  not  completed  the 
recommended  course  of  immunisation  (of  children  identified  as  having  defaulted  on  one 
or  more  primary  immunisation  by  18  months  of  age).  Ten  were  later  interviewed. 
Consistent  with  the  findings  of  Evans  et  al.  's  (2001)  study,  they  found  that  23  out  of  68 
(34  9o)  responders  perceived  that  having  their  child  immunised  with  a  particular  vaccine 
was  more  risky  than  non-immunisation.  They  suggested  that  parents  weigh  up  the 
perceived  seriousness  of  a  disease  and  the  likelihood  of  catching  it,  against  the  perceived 
safety  and  efficacy  of  the  vaccine.  They  assert  that  parents  who  consider  that  diseases 
pose  a  threat  to  their  child's  health  and  who  consider  immunisation  to  be  both  safe  and 
effective  are  likely  to  have  their  children  immunised.  In  contrast,  parents  who  consider 
that  the  diseases  pose  little  or  no  threat  to  their  child's  health,  and  who  consider 
immunisation  to  be  ineffectual  or  to  pose  a  risk  to  their  child,  are  more  likely  not  to 
immunise  their  children. 
Another  study  considered  the  views  of  parents  who  had  opted  to  immunise  their  children 
in  order  to  assess  parents'  perceptions  about  vaccine  risk.  Using  convenience  sampling 
36 Raithatha  et  al.  (2003)  recruited  parents  from  two  nurseries  in  Norfolk  with  high  vaccine 
uptake  levels  of  over  90%.  In  addition  to  three  parents  who  took  part  in  pilot  interviews, 
fifteen  parents  whose  children  were  fully  immunised  agreed  to  take  part  in  in-depth 
interviews.  The  authors  proposed  that  parents  weigh  up  the  risks  associated  with 
vaccines  against  the  risks  posed  by  the  diseases,  and  that  this  is  influenced  by  parents' 
attitudes  to  the  immunisation  process  and  by  their  trust  in  government  and  health 
professionals.  Findings  from  this  study  suggest  that  parents  who  immunise  their  children 
have  concerns  about  the  risks  associated  with  vaccines  and  warn  that  it  is  vital  not  to 
assume  that  parents  who  at  present  immunise  will  continue  to  do  so.  They  also  found 
that  the  MMR  vaccine  scare  may  have  triggered  a  reappraisal  of  vaccine  risk,  and 
propose  that  in  order  to  address  parents'  fears  about  a  causal  link  between  autism  and  the 
MMR  vaccine  there  is  a  need  for  further  research  into  the  aetiology  of  autism.  Raithatha 
and  colleagues  recommend  that  parents  are  not  pressurised  to  immunise,  as  this  increases 
their  feeling  of  lack  of  control,  and  that  there  is  a  need  to  improve  parents'  sense  of  trust. 
They  concluded  that:  "Concentrating  messages  on  the  threat  of  infection  for  their  own 
`vulnerable'  children  may  continue  to  help  persuade  parents  to  immunize"  (p.  164). 
1.4.5  Are  parents  reappraising  vaccine  risk? 
The  successful  introduction  of  any  new  vaccine  into  the  Childhood  Immunisation 
Programme  may  depend  on  several  factors,  not  least  the  capacity  of  the  programme  to 
include  new  vaccines.  As  Lambert  and  Siegrist  (1997)  note  "the  infant  immunisation 
schedules  are  already  quite  full  and  may  not  readily  allow  the  addition  of  many  new 
vaccines"  (p.  1597).  Whilst  combination  vaccines  offer  greater  scope  for  the  introduction 
of  new  antigens,  as  more  than  one  antigen  can  be  given  at  any  one  time,  a  major  obstacle 
to  any  introduction  noted  by  Offit  et  al.,  (2002)  is  that  an  increasing  number  of  parents 
are  becoming  concerned  about  the  number  of  vaccines  in  the  programme. 
In  comparing  the  numbers  of  vaccines  included  in  the  Childhood  Immunisation 
Programme  over  the  past  century,  it  is  clear  that  the  UK  programme  has  expanded.  For 
example,  in  the  1900s  a  child  would  only  receive  the  smallpox  vaccine.  Over  the 
37 following  decades  scientific  advances,  combined  with  the  World  Health  Organisation's 
determination  to  set  up  mass  immunisation  programmes,  meant  that  by  the  1950s  this  had 
increased  to  five  vaccines  (diphtheria,  pertussis,  tetanus,  polio  and  smallpox).  Today  the 
Childhood  Immunisation  Programme  currently  offers  protection  against  nine  diseases 
(See  Appendix  B).  In  September  2004  the  new  pentavalent  vaccine  (Dtap/IPV/Hib, 
brand  name  Pediacel)  was  introduced  into  the  programme  offering  protection  against 
diphtheria,  pertussis,  tetanus,  polio  and  Haemophilus  Influenza  type  b  in  one  combined 
vaccine.  This  alteration  to  the  programme  does  not  add  any  new  disease  to  the 
immunisation  schedule  and  has  been  changed  so  that  protection  can  be  offered  "in  a 
slightly  different,  more  acceptable,  formation"  (Bedford  and  Elliman,  2004  p.  411). 
See  Appendix  C  for  a  timeline  illustrating  the  major  changes  to  the  Childhood 
Immunisation  Programme  since  the  1950s. 
Although  the  debate  about  vaccine  overload  in  the  UK  has  largely  been  confined  to  the 
popular  press,  out-with  the  UK  the  scientific  community  have  published  several  studies 
showing  parents'  concerns  about  this  matter.  For  example,  Bond  et  al.  (1998)  conducted 
a  study  in  Melbourne,  Australia  to  investigate  mothers'  perceptions  of  vaccine- 
preventable  diseases  and  associated  vaccines  in  terms  of  perceived  susceptibility, 
severity,  benefits  and  barriers.  They  used  a  purposive  sampling  strategy  to  include 
mothers  of  children  with  different  decision-making  outcomes  and  to  include  first-time 
mothers  and  more  experienced  mothers.  Semi-structured  interviews  were  conducted 
with  45  mothers.  Bond  and  colleagues  found  that  `complete  immunisers'  believed  that 
the  risks  associated  with  vaccines  were  lower  than  the  risks  associated  with  the  diseases, 
and  that  the  likelihood  of  contracting  many  of  these  diseases  was  low.  In  contrast,  they 
found  that  incomplete  immunisers  perceived  vaccines  to  be  less  effective  in  preventing 
diseases,  and  were  often  confused  about  which  diseases  the  vaccines  would  protect 
against.  They  also  suggested  that  non-immunisers  were  more  concerned  about  unknown, 
long-term  side  effects  of  the  vaccines  than  with  the  diseases,  and  that  many  mothers 
believed  that  vaccines  place  stress  on  the  immune  system  rather  than  strengthening  it. 
38 Similarly,  in  a  study  conducted  in  the  United  States  of  America  as  part  of  a  larger  study 
on  immunisation,  Keane  et  al.  (1993)  explored  parents'  perceptions  of  vaccines.  Forty 
parents  participated  in  focus  groups  (they  omit  to  state  how  many  groups  they 
conducted).  They  found  that  parents  perceived  vaccines  to  be  only  partly  effective  and 
did  not  consider  immunisation  to  be  a  high  priority  in  the  broader  context  of  parenting. 
Further,  since  fever  was  viewed  as  a  primary  indicator  of  illness  this  led  some  parents  to 
suggest  that  vaccines  caused,  rather  than  prevented,  illness  and  parents  expected  they 
would  need  to  care  for  an  ill  child  post-vaccination. 
1.4.6  Where  are  we  now?  Outstanding  issues 
In  February  2004  the  General  Medical  Council  conducted  an  investigation  into  Dr 
Wakefield's  study  following  several  allegations,  brought  by  a  journalist  Brain  Deer,  of 
which  the  most  serious  was  that  Wakefield  had  been  paid  for  a  second  study  funded  from 
the  Legal  Aid  Board  into  whether  children  allegedly  damaged  by  the  MMR  vaccine  could 
sue.  In  response  to  these  revelations,  the  editor  of  the  Lancet,  Richard  Horton,  stated  that 
he  would  not  have  published  the  research  in  that  form  had  he  known  about  the  conflict  of 
interest  and  that  he  hugely  regretted  the  adverse  impact  this  paper  had  had,  calling  the 
paper  `fatally  flawed'.  In  the  March  6th  edition  of  the  Lancet,  ten  of  Wakefield's  co- 
authors  formally  disassociated  themselves  from  the  study  in  a  `retraction  of  an 
interpretation'.  However,  Dr  Wakefield  remains  adamant  that  the  scientific  results  of  his 
1998  study  are  still  valid.  After  resigning  from  his  job  in  December  2001,  Wakefield 
moved  to  America  to  work  for  the  International  Child  Development  Resource  Centre  in 
Florida,  a  centre  that  is  associated  with  the  Good  News  Doctor  Foundation,  a  Christian 
ministry. 
In  September  2004,  Richard  Horton  has  revisited  the  events  surrounding  this  controversy 
in  his  book  titled:  MMR:  science  and  Fiction.  The  book  offers  new  and  revealing 
insights  into  the  debate  from  the  perspectives  of  some  of  the  scientists,  physicians  and 
politicians  most  closely  involved  in  the  controversy.  Perhaps  one  of  the  most  revealing 
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states: 
... 
despite  these  uncomfortable  events,  medical  journal  editors  must  not  refrain  from  publishing 
work  that  challenges  mainstream  scientific,  clinical  or  public  health  opinion.  There  are  now 
strong  forces  operating  on  journals  to  protect  the  system  of  health  messages  distributed  to  the 
public.  The  media  is  so  voracious  in  its  appetite  for  controversy,  it  is  so  merciless  in  its  challenges 
to  conventional  opinion,  that  medical  journals  should,  so  many  doctors  will  argue,  avoid  fuelling 
these  fires.  Journal  editors  should  try  to  keep  these  difficult  discussions  within  a  closed 
professional  circle.  I  simply  do  not  accept  this  argument.  It  is  the  recipe  for  the  stagnation  of 
knowledge  and  the  creation  of  a  wholly  undemocratic  technocracy  (p.  169). 
However,  many  still  question  the  Lancet's  wisdom  in  publishing  the  paper  and  the  case 
remains  that  there  is  still  little  known  about  some  of  the  individuals  most  affected  by  the 
debate,  namely  the  parents  of  young  children.  In  particular  it  is  of  note  that,  as  this  PhD 
study  is  completed,  no  studies  have  been  published  presenting  the  views  of  parents  of 
autistic  children  or  parents  whose  children  need  to  rely  on  immunisation  as  a 
consequence  of  having  a  compromised  immune  system  due  to  the  effects  of 
chemotherapy,  yet  it  seems  likely  that  both  these  group  of  parents  will  have  been  affected 
by  the  controversy.  The  fact  that  researchers  have  largely  focused  attention  on  the 
scientific  evidence  appears  to  have  unintentionally  overshadowed  the  need  to  concentrate 
greater  efforts  on  exploring  parents'  understanding  of  the  scientific  evidence  and 
controversy  surrounding  the  safety  of  MMR  vaccination.  Furthermore,  the  wider  context 
within  which  parents  were  assessing  the  MMR  controversy  was  one  in  which  the  public 
had  recently  witnessed  several  other  public  health  scares  such  as  BSE,  Salmonella, 
genetically  modified  food,  contraceptive  pill  scares,  and  failures  in  screening 
programmes.  Perhaps  for  this  reason,  despite  the  growing  body  of  scientific  evidence 
overwhelmingly  supporting  the  safety  of  the  MMR  vaccine,  and  Government  and  public 
health  officials  being  quick  to  endorse  its  safety,  their  endeavors  often  seemed  counter 
productive.  Indeed,  the  longevity  of  the  controversy  may  be  testimony  to  a  wider  crisis 
in  confidence  that  parents  have  in  knowing  who  to  look  to  for  guidance  and  sound 
40 judgment  on  health  matters.  This  PhD  study  aims  to  offer  a  novel  insight  into  the 
controversy  by  exploring  it  from  the  perspective  of  parents  of  young  children. 
Reviewing  the  literature  also  raises  the  question  of  whether  parents  have  more  general 
concerns  about  childhood  immunisation.  The  fact  that  studies  raising  parental  concerns 
about  the  safety  of  vaccines  pre-date  the  publication  of  Wakefield's  (1998)  paper,  and 
that  they  present  the  views  of  parents  from  a  range  of  countries,  suggests  that  concerns 
over  vaccine  safety  are  neither  confined  to  the  UK,  nor  limited  to  the  MMR  debate. 
However,  the  lack  of  recent  literature  exploring  parents'  views  on  childhood 
immunisation  or  how  these  relate  to  the  decisions  they  make  for  their  own  children, 
offers  this  study  the  unique  opportunity  to  provide  a  contemporary  assessment  on  these 
aspects  of  childhood  immunisation.  Further,  although  there  was  general  agreement  in 
the  literature  that  parents  make  decisions  about  immunisation  by  weighing  up  the  risks 
associated  with  the  diseases  against  those  associated  with  the  vaccine,  no  studies  have 
been  published  offering  an  in-depth  exploration  of  parents'  knowledge,  understanding  or 
beliefs  about  childhood  infectious  diseases.  This  gap  in  the  literature  on  disease 
perceptions  seems  particularly  important  to  address,  since  the  success  and  acceptability  of 
immunisation  may  depend  on  parents'  assessment  of  the  diseases  from  which  the 
vaccines  aim  to  protect.  This  study  aimed  to  fill  this  gap  by  conducting  a  thorough 
exploration  of  parents'  understandings  and  beliefs  about  diseases  and  the  perceived 
severity  of  these  diseases,  and  the  role  first  and  second  hand  experience  of  diseases  has 
on  parents'  evaluations  in  the  importance  of  preventing  certain  diseases.  This  study  aims 
to  provide  an  original  and  far-reaching  assessment  of  parents'  perceptions  about 
childhood  immunisation,  the  MMR  controversy  and  parental  decision-making  around 
vaccination,  by  answering  the  following  questions: 
"  What  are  parents'  knowledge,  understanding  and  beliefs  about  childhood  infectious 
diseases,  and  how  do  their  experiences  of  disease  affect  their  evaluations  of  the 
importance  of  preventing  certain  diseases? 
41 "  What  are  parents'  views  on  mass  childhood  immunisation  and  on  the  vaccines 
included  in  the  Childhood  Immunisation  Programme  in  the  light  of  the  MMR 
controversy? 
"  What  are  parents'  perceptions  about  the  current  MMR  controversy  and  how  do  these 
perceptions  translate  into  the  parental  decision-making  process  about  whether  to 
immunise,  or  not? 
The  next  chapter  (Chapter  Two)  describes  the  methods  used  to  explore  parents' 
perceptions  of  childhood  infectious  diseases,  childhood  immunisation  and  vaccine 
decision-making.  Chapter  Three  examines  parents'  understanding,  experiences  and 
beliefs  about  childhood  infectious  diseases.  Chapter  Four  explores  parents'  perceptions 
of  the  MMR  controversy.  Chapter  Five  considers  how  parents'  perceptions  of  the  current 
MMR  controversy  have  affected  their  perceptions  about  vaccines  and  of  their  decisions 
about  whether  or  not  to  immunise  their  children  with  the  MMR  vaccine.  Chapter  Six 
explores  the  MMR  controversy  from  the  perspectives  of  two  quite  different  groups  of 
parents  observed  to  have  a  special  interest  in  the  debate:  parents  caring  for  autistic 
children,  and  parents  caring  for  children  with  a  compromised  immune  due  to  the  effects 
of  chemotherapy  treatment  for  cancer. 
42 Chapter  Two:  Methodology 
This  chapter  begins  by  describing  the  philosophic  underpinnings  that  informed  and 
shaped  this  qualitative  inquiry.  The  chapter  moves  from  description  of  the  theories,  to  a 
detailed  description  of  the  design  and  conduct  of  the  study  with  the  aim  of  showing  how 
subjectivity  was  managed  and  scientific  rigour  maintained.  Consistent  with  this  aim  is 
the  final  section,  which  describes  the  problems  encountered  during  the  research  process, 
reflects  on  my  potential  impact  on  the  reseach  as  facilitator  and  details  how  analysis  was 
carried  out. 
2.1  Choice  of  study  design 
2.1.1  Why  a  qualitative  perspective? 
The  exploratory  nature  of  the  inquiry  predisposed  the  study  to  the  use  of  the  inductive 
techniques  used  in  qualitative  research,  rather  than  the  deductive  techniques  of 
quantitative  research.  In  deductive  research,  the  researcher  begins  with  the  theory  before 
empirical  research  and  analysis.  Using  deductive  reasoning,  the  researcher  derives  a 
testable  proposition  or  hypothesis  from  the  theory,  in  advance  of  the  research  process 
(Mason  2002).  The  researcher  seeks  to  `transcend  the  particular  by  higher  and  higher 
reaching  for  abstraction,  and  in  the  end  disclaim  in  principle  any  explanatory  values  at  all 
where  the  particular  is  concerned'  (Bruner  1986,  p.  56).  Similarly,  Seale  (1999) 
describes  deductive  reasoning  in  these  terms: 
Propositions,  logically  deduced  from  theoretical  statements,  are  operationalised  in  research 
projects,  tested  against  the  objectively  observed,  factual  nature  of  the  real  world,  thus  determining 
the  truth  or  falsity  of  propositions,  which  in  turn  influences  the  content  of  theories  (p.  23). 
In  contrast,  in  inductive  research  the  process  of  scientific  discovery  begins  with  data 
generation  from  which  theory  is  then  extrapolated.  Mason  (2002)  considers  that 
inductive  reasoning  develops  `theoretical  propositions  or explanations  out  of  the  data,  in 
a  process  which  is  commonly  seen  as  moving  from  the  particular  to  the  general'  (p.  180). 
As  such,  inductive  modes  of  thinking  are  particularly  valuable  when  the  aim  is  to 
43 describe,  explore,  understand,  or  explain  a  particular  phenomenon.  It  may  consider  the 
`what',  `why'  and  `how'  of  the  phenomenon,  but  not  in  terms  of  `how  many'  or  `how 
frequently'  (Gantley  et  al.,  1999).  Maykut  and  Morehouse  (1994)  assert: 
The  goal  of  qualitative  research  is  to  discover  patterns,  which  emerge  after  close  observation, 
careful  documentation,  and  thoughtful  analysis  of  the  research  topic.  What  can  be  discovered  by 
qualitative  research  are  not  sweeping  generalizations  but  contextual  findings.  This  process  of 
discovery  is  basic  to  the  philosophic  underpinning  of  the  qualitative  approach  (p.  21). 
Therefore  qualitative  studies  are  designed  to  lead  the  researcher  into  unforeseen  areas  of 
discovery  and  are  useful  in  exploring  behaviour  within  specific  social  settings  rather  than 
broad  populations.  To  explore  and  understand  a  particular  phenonmenon,  Holliday 
(2002)  distinguishes  between  two  major  paradigms  of  qualitative  research,  `naturalism' 
and  `progressivism.  '  In  naturalism  the  researcher  becomes  fully  involved  in  the  research 
setting  either  overtly  or  covertly  for  a  lengthy  period  of  time.  Naturalists  believe  that 
substantiation  is  gained  through  establishing  the  `real'  nature  of  the  social  world  through 
sufficient  weight  of  description  by  `being  there'  using  an  unobtrusive  approach.  In 
contrast,  progressivists'  argue  that  there  is  no  `there'  until  it  is  constructed  and  question 
the  whole  premise  that  a  definitive  picture  of  the  `truth,  '  or  `real'  nature  of  the  social 
world  actually  exists  (Gubrium  and  Holstein,  1997).  Holliday  (2002)  believes  that  the 
progressivists'  break  from  naturalism  enables  "a  far  greater  variety  in  procedure  and 
scope,  in  which  data  is  presented  more  creatively,  with  more  openness  about  who  the 
researcher  is  and  how  she  spins  validity  through  argument"  (p.  21).  Following  a 
progressive  paradigm  would  enable  me  to  engage  actively  with  parents  to  find  out  their 
views,  beliefs  and  understandings  about  vaccines,  diseases  and  the  MMR  controversy. 
Although  this  more  activist  approach  would  be  at  odds  with  a  naturalist  perspective  that 
aimed  to  be  unobtrusive,  I  felt  it  would  offer  more  scope  for  understanding  parents' 
feelings  about  childhood  immunisation  and  diseases.  To  decide  which  method  to 
employ  and  to  develop  a  sampling  strategy  that  would  yield  the  most  interesting  data,  I 
carried  out  a  small  pilot  study  that  included  five  focus  groups  and  four  individual 
interviews. 
44 2.2  The  pilot  study 
2.2.1  Sample  selection 
The  initial  target  population  was  parents  from  a  range  of  socio-economic  backgrounds 
with  children  under  the  age  of  five,  to  take  account  of  the  various  ages  at  which  children 
are  offered  vaccines  in  the  Childhood  Immunisation  Programme. 
Identification  of  areas  of  relative  advantage  and  relative  disadvantage  was  facilitated 
using  Carstairs  Deprivation  Categories  as  a  proxy  indicator  for  socio-economic  status 
(Carstairs  and  Morris,  1991).  McLoone  (1994)  highlights  the  fact  that  the  deprivation 
scores  do  not  measure  the  extent  of  an  individual's  material  well-being  or  relative 
disadvantage,  but  rather  are  measures  applied  to  populations  contained  within  small 
geographical  localities.  By  targeting  the  most  affluent  areas  with  a  DEPCAT  score  1,  and 
the  most  deprived  areas  with  a  DEPCAT  score  7,  there  is  an  increased  likelihood  of 
recruiting  people  from  different  socio-economic  backgrounds  into  the  study.  The 
extremes  of  the  scores  represent  the  increasingly  homogeneous  population  that  live  in  the 
areas  and  so  recruiting  from  these  areas  also  reduces  the  chances  of  focus  groups 
containing  a  mix  of  people  from  vastly  different  socio-economic  backgrounds. 
The  main  criteria  employed  in  the  pilot-sampling  frame  included: 
"  Parents  living  in  a  range  of  socio-economic  areas,  including  parents  living  in  affluent 
(DEPCAT  1  or  2)  and  deprived  (DEPCAT  6  or  7)  parts  of  Glasgow  and  the 
surrounding  areas. 
"  First-time  mothers,  as  well  as  mothers  with  previous  experience  of  motherhood,  to 
identify  any  specific  issues  they  may  have  about  immunisation. 
"  Fathers  as  well  as  mothers. 
45 2.2.2  Timing  of  the  pilot  study 
The  first  tranche  of  pilot  work  was  carried  out  over  a  six-week  period  from  March  2002. 
This  included  three  focus  groups  and  four  interviews.  Two  further  focus  groups  were 
carried  out  in  October  2002.  The  initial  pilot  work  in  March  2002  followed  three  months 
of  intense  media  coverage  about  the  safety  of  the  MMR  vaccine.  Indeed,  it  has  been 
estimated  that  of  561  stories  involving  MMR  reported  over  a  seven  and  a  half  month 
period,  56  per  cent  of  the  stories  were  reported  between  28  January  2002  and  28  February 
2002  (Hargreaves  and  colleagues,  2003).  Three  key  events  led  to  this  increased  interest 
in  the  MMR  debate  during  this  period.  (See  Appendix  D,  which  shows  a  timeline  of  the 
key  events  in  the  MMR  controversy  and  how  these  relate  to  the  data  collection  for  this 
study). 
The  first  event  was  in  December  2001,  when  media  speculation  about  the  safety  of  the 
MMR  vaccine  became  front-page  news  when  Tony  Blair,  the  British  Prime  Minister, 
refused  to  reveal  to  the  nation  whether  his  son  Leo  (then  aged  19  months)  had  had  the 
MMR  vaccine.  Whilst  Tony  Blair  implied  that  Leo  had  been  immunised  with  the  MMR 
vaccine,  speculation  continued  for  many  months,  fuelling  calls  for  the  introduction  of 
single  measles,  mumps  and  rubella  vaccines  on  the  National  Health  Service.  The  second 
event  that  exacerbated  demands  for  the  introduction  of  single  measles,  mumps  and 
rubella  vaccines  happened  in  January  and  February  2002  when  outbreaks  of  measles  were 
confirmed  in  London,  Wales  and  Fife.  Thirdly,  on  the  3rd  February  2002  a  Panorama 
television  documentary  was  broadcast  featuring  Dr  Andrew  Wakefield  defending  his 
earlier  paper  that  suggested  a  causal  link  between  MMR,  autism  and  bowel  disease. 
The  culmination  of  these  events  meant  that  much  of  the  discussion  in  these  early  focus 
groups  tended  to  focus  on  the  `newsworthy'  events  of  the  preceding  two  months. 
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Several  key  lessons  emerged  from  the  pilot  groups.  Firstly,  on  analysis  it  appeared  that 
the  group  interactions  within  the  focus  groups  yielded  more  interesting  and  varied  data 
than  did  individual  interviews.  Secondly,  it  was  clear  that  the  sampling  frame  needed 
further  refinement  in  order  to  capture  a  more  diverse  sample  of  parents  into  the  main 
study.  Thirdly,  the  pilot  showed  the  media's  influence  and  news  events  could  be 
problematic  in  dominating  focus  group  discussion  and  thus  that  it  would  be  prudent  to 
conducted  the  main  study  over  as  short  a  period  of  time  as  possible  to  minimise  this  risk. 
Fourthly,  as  data  from  two  of  the  pilot  focus  groups  were  lost  due  to  unreliable  recording 
equipment,  I  reviewed  and  changed  recording  equipment  to  prevent  further  loss  of  data. 
23  The  main  study 
23.1  Introduction  to  focus  groups 
Contemporary  focus  groups  have  developed  from  well  over  half  a  century  of  evolving 
inquiry  that  had  its  origins  in  Bogardus'  work  in  the  1920s  and  later  Merton  and 
Kendall's  focussed  interview  work  (Bogardus,  1926;  Merton  and  Kendall,  1946).  Market 
researchers  have  employed  focus  groups  since  the  1950s  but  during  the  1980s  there  was  a 
resurgence  of  interest  among  social  scientists  (Catterall  and  Maclaran,  1997).  Kitzinger 
(1994)  suggests  that  they  have  become  more  commonly  used  in  popular  communication 
research,  such  as  in  the  evaluation  of  health  education  materials  and  in  film  and  television 
reception  studies.  Focus  groups  have  become  popular  as  a  means  of  exploring  people's 
experiences  of  health  services,  such  as  health  screening,  and  in  action  research  projects 
involving  grass-root  participation. 
In  response  to  the  growing  popularity  in  the  use  of  focus  groups  by  researchers,  and  in  an 
attempt  to  avoid  social  scientists  uncritically  adopting  market  researchers'  models, 
Barbour  and  Kitzinger  (1999)  recently  refined,  and  redefined,  the  role  of  contemporary 
focus  groups.  In  their  broadest  sense,  they  define  focus  groups  as  "group  discussions  that 
explore  a  specific  set  of  issues,  and  they  are  `focused'  in  that  they  involve  some  kind  of 
47 collective  activity"  (p.  4).  In  attempting  to  distinguish  focus  groups  from  the  broader 
category  of  group  discussions,  Barbour  and  Kitzinger  (1999)  state,  "any  group  discussion 
can  be  called  a  `focus  group'  as  long  as  the  researcher  is  actively  encouraging  of,  and 
attentive  to,  the  group  interaction"  (p.  4-5).  Crucially,  in  refining  focus  group 
methodology,  Barbour  and  Kitzinger  (1999)  explicitly  identify  the  importance  of  using 
group  interaction  to  generate  data,  and  for  the  researcher  to  be  attentive  to  those 
interactions.  Whereas  group  interviews  tend  to  involve  question  and  answer  exchanges 
between  the  researcher  and  participants,  researchers  facilitating  focus  groups  encourage 
participants  to  exchange  stories,  and  to  talk  between  themselves.  In  this  way,  the 
participants  create  an  audience  for  one  another  allowing  the  researcher  to  examine 
people's  different  perspectives  as  they  operate  within  a  social  network,  and  to  explore 
how  accounts  are  articulated,  censured,  opposed and  changed  through  social  interaction 
(Barbour  and  Kitzinger,  1999). 
2.3.2  Why  use  focus  groups? 
The  focus  group  method  was  selected  for  this  study  for  the  following  reasons.  Firstly,  it 
offered  a  flexible  approach  to  exploring  parents'  experiences  and  views  on  childhood 
immunisation  and  diseases.  It  was  anticipated  that  focus  groups  would  enable  parents  to 
question  each  other,  pursuing  issues  of  importance  to  them,  and  thus  encouraging  a 
varied  and  in-depth  dialogue  between  participants,  rather  than  merely  answering  a  pre- 
determined  list  of  questions.  Indeed,  the  emphasis  that  Barbour  and  Kitzinger  (1999) 
place  on  group  interaction  suited  the  current  research  project  which  aimed  to  understand 
parents'  perceptions  of  diseases,  immunisation  and  about  the  ongoing  MMR  safety 
debate,  and  how  these  views  related  to  vaccine  decision  making.  Such  research 
objectives  necessitated  the  use  of  an  in-depth  method  that  encouraged  rich  interactions 
between  participants,  and  that  was  not  too  prescriptive  in  its  focus. 
Secondly,  another  advantage  that  focus  groups  have  is  that  group  interaction  between 
participants  can  diminish  the  researcher's  power  and  influence.  Wilkinson  (1999) 
48 suggests  that  the  balance  of  power  shifts  away  from  the  researcher  `simply  by  the  virtue 
of  the  number  of  research  participants  simultaneously  involved  in  the  research 
interaction'.  Similarly,  Morgan  (1988)  considers  that  participants'  interaction  among 
themselves  replaces  their  interaction  with  the  researcher,  leading  to  a  greater  emphasis  on 
participants'  points  of  view.  Wilkinson  (1999)  notes  that  in  the  group  situation  it  is  easier 
for  participants  to  challenge  views  with  which  they  disagree  and  to  challenge  or  reject 
others'  assertions,  including  those  of  the  researcher.  This  shift  in  the  power  dynamic 
between  researcher  and  participant  can  mean  that  participants  gain  greater  opportunity  to 
set  or  challenge  the  research  agenda,  developing  the  themes  that  are  important  or  salient 
to  them  (Copper  et  al.,  1993).  Thirdly,  Bloor  et  al.  (2001)  argue  that  small  groups  are 
more  typical  patterns  of  interaction  particularly  for  women  and  therefore  may  be 
productive  for  focus  group  purposes.  The  focus  group  method  seemed  particularly  apt  in 
relation  to  childhood  immunisation  because  parents  often  set  up  their  own  parenting 
groups  both  formally  and  informally  to  give  and  receive  support  from  one  another  on 
parenting  and  child  health  issues. 
233  Developing  a  sampling  strategy 
Whilst  statistical  `representativeness'  is  not  an  objective  of  qualitative  research,  sample 
selection  is  nevertheless  important.  Qualitative  samples  aim  to  encompass  diverity. 
Mason  (2002)  suggests  that  the  aim  of  the  sampling  strategy  is  to  produce  a  relevant 
range  of  contexts  or  phenomena  designed  to  encapsulate  a  diverse  sample  in  relation  to 
the  wider  universe,  but  not  to  represent  it  directly.  In  order  to  have  as  wide  a  spectrum 
of  experiences  and  views  on  immunisation  as  possible,  this  study  used  a  purposive 
sampling  strategy  in  an  attempt  to  capture  the  complexity  that  characterises  vaccine 
decision-making.  In  order  to  incorporate  new  ideas  and  to  enable  the  research  questions 
to  become  more  refined,  the  sampling  frame  was  left  flexible  to  allow  the  inclusion  of 
new  groups.  In  fact  the  sampling  frame  was  adapted  six  times  between  the 
commencement  of  the  pilot  work  in  March  2002  and  completion  of  the  main  fieldwork  in 
March  2003. 
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The  initial  target  population  was  parents  with  a  child  under  the  age  of  five  years.  This  age 
range  was  chosen  to  reflect  the  complete  pre-school  immunisation  programme  offered  to 
parents,  including  the  first  MMR  (offered  between  12-15  months)  and  the  pre-school 
booster  MMR  (offered  usually  between  4-5  years  of  age).  However,  on  two  occasions  in 
the  pilot  interviews  parents  indicated  that  the  booster  MMR  vaccines  had  been  delayed 
until  the  children  were  six  years  of  age  following  a  delay  in  the  first  MMR  vaccine. 
Thus,  the  target  population  for  the  main  study  was  changed  to  ensure  the  inclusion  of 
children  up  to  six  years  old.  (The  only  exceptions  to  this  were  two  groups  with  parents 
caring  for  children  with  compromised  immune  systems). 
Almost  without  exception  participants  who  took  part  in  the  pilot  groups  (including  fathers 
themselves)  considered  that  fathers  played  a  secondary  role  in  issues  relating  to 
childhood  immunisation  to  that  of  mothers,  a  finding  supported  by  Kilmartin  et  al. 
(1998).  However,  initial  analysis  of  the  pilot  study  data  revealed  that  concerns  over  the 
safety  of  the  MMR  vaccine  meant  that  `normal'  decision-making  processes  appeared  to 
be  disrupted,  and  that  fathers  appeared  to  be  playing  a  more  prominent  role  in  the 
decision-making  process  about  the  MMR  vaccine.  Thus,  it  seemed  wise  to  include  some 
fathers  in  the  study.  Initially,  the  plan  was  to  make  contact  with  both  fathers  and  mothers 
at  the  usual  venues  and  groups  that  they  frequent  with  their  children.  However,  this 
strategy  only  resulted  in  the  recruitment  of  five  men  into  the  study,  of  whom  three 
appeared  well-educated  and  lived  in  affluent  areas.  In  order  to  recruit  more  men  from 
less  affluent  areas,  a  group  of  fathers  with  sole  responsibility  for  their  children  was 
recruited  from  a  single  fathers'  group  that  is  run  in  a  deprived  part  of  Glasgow. 
As  the  study  progressed  it  became  clear  that  the  sampling  frame  needed  further 
refinement  to  include  parents  with  less  common  vaccine  decision-making  outcomes. 
Target  groups  included  parents  who:  had  decided  not  to  let  their  children  have  the  MMR 
vaccine;  were  not  planning  to  have  any  of  the  vaccines  in  the  schedule;  or  had  opted  to 
pay  privately  for  the  single  measles,  mumps  and  rubella  vaccines.  Barbour  and  Kitzinger 
50 (1999)  consider  that  focus  group  guidelines  often  overemphasise  the  extent  to  which  the 
researchers  can  control  for  all  characteristics  of  participants  which  are  likely  to  be 
relevant.  They  state:  "...  some  details  are  likely  to  emerge  only  once  discussion  has  been 
initiated  and  the  precise  composition  of  groups  will  often  be  a  product  of  circumstance 
rather  than  planning"  (p.  8).  As  this  was  my  experience  with  some  of  the  groups  in  the 
pilot  study,  this  reaffirmed  the  need  to  purposefully  target  parents  on  their  likely  views 
and  decisions  about  immunisation.  The  criteria  used  for  the  composition  of  each  of  these 
groups  were  not  seen  as  fixed,  inflexible  or  mutually  exclusive.  Rather,  they  aimed  to 
include  participants  with  a  range  of  decision-making  outcomes,  and  to  bring  together 
groups  of  parents  with  `roughly'  shared  decision-making  outcomes. 
In  an  attempt  be  more  systematic  in  reflecting  varying  uptake  levels  within  the  Greater 
Glasgow  National  Health  Service  Board  area,  the  Information  and  Statistics  Division  of 
the  National  Health  Service  was  asked  to  supply  a  list  of  vaccine  uptake  rates  by 
postcode  sector.  Using  the  Standard  Immunisation  Recall  System  (SIRS  database)  two 
groups  from  postcode  areas  with  high  MMR  vaccine  uptake  rates  were  targeted  (one  an 
affluent  area,  DEPCAT  1  and  2,  and  one  a  deprived  area,  DEPCAT  6  and  7).  Similarly 
two  groups  from  postcode  areas  with  low  MMR  uptake  rates  were  sought  (one  an  affluent 
area,  DEPCAT  1  and  2  and  one  a  deprived  area,  DEPCAT  6  and  7). 
As  the  study  progressed  two  special  interest  groups  of  parents  were  identified  as  having 
specific  concerns  relating  to  childhood  immunisation.  The  first  was  parents  of  autistic 
children  as  the  speculation  about  a  causal  link  between  autism  and  the  MMR  vaccine 
suggested  that  they  would  have  a  particular  interest  in  immunisation  and  in  the  MMR 
vaccine.  The  second  group  of  parents  was  those  caring  for  immuno-compromised 
children.  As  I  became  increasingly  aware  that  some  parents  questioned  the  need  for 
immunisation,  I  wondered  whether  these  parents  were  factoring  the  actions  of  others  into 
their  own  decisions  about  immunisation,  thus  relying  on  herd  immunity.  To  explore  some 
of  the  issues  relating  to  herd  immunity  further,  the  sampling  frame  was  extended  to 
include  parents  who  had  recently  cared  for  a  child  with  a  compromised  or  deficient 
51 immune  system  due  to  the  effects  of  chemotherapy  treatment  for  cancer.  Additional 
criteria  were  developed  with  the  help  of  a  Cancer  Support  Worker.  This  meant  that  I  only 
approached  parents  whose  children  were  in  the  maintenance  phase  of  their  treatment,  or 
had  completely  finished  treatment.  Including  parents  with  children  recovering  from 
cancer  meant  they  would  be  able  to  reflect  on  the  problems  that  they  encountered  as  a 
result  of  reintegrating  children  with  compromised  immune  systems  into  mainstream 
society. 
23.5  Sample  selection:  limitations 
One  limitation  of  the  study  was  that,  although  the  sample  was  diverse,  some  groups  of 
participants  were  difficult  to  recruit.  For  example,  it  was  difficult  to  obtain  access  to 
recruit  parents  who  had  opted  for  the  single  measles,  mumps  and  rubella  vaccines. 
Despite  strenuous  efforts,  it  was  only  possible  to  recruit  three  such  parents  into  the  study. 
(Box  2.1  shows  the  sampling  frame). 
Box  2.1:  The  sampling  frame 
First-time  mothers,  as  well  as  mothers  with  previous  experience  of  motherhood. 
Fathers  as  well  as  mothers. 
Parents  living  in  affluent  and  deprived  areas. 
Parents  with  a  range  of  vaccine  decision-making  outcomes. 
Specific  target  groups 
Parents  of  autistic  children. 
Parents  with  recent  experience  of  caring  for  immunocompromised  children  following 
chemotherapy  for  cancer. 
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2.4.1  Sample  size:  determining  the  number  of  groups 
Since  the  aim  of  qualitative  research  is  not  to  test  for  statistical  significance,  there  is  no 
formula  for  estimating  sample  size  as  is  necessary  in  quantitative  studies.  Bloor  et  al. 
(2001)  suggest  that  the  appropriate  number  of  focus  groups  will  depend  on  the  research 
plan  including  which  sub-groups  the  researcher  might  want  to  target,  which  groups' 
views  one  might  wish  to  compare,  the  variability  of  responses,  and  time  and  resource 
limitations.  Zeller  (1993)  proposes  that  projects  should  consist  of  three  to  five  groups. 
However,  Barbour  and  Kitzinger  (1999)  suggest  that  the  sample  size  in  focus  group 
studies  can  range  from  just  three  to  over  fifty  depending  on  the  scope  of  the  study. 
Whilst  there  is  a  range  of  opinions  about  how  many  groups  are  desirable,  there  is  general 
agreement  in  the  literature  that  it  is  wise  to  build  in  flexibility  in  the  planning  stage,  and 
only  to  conduct  as  many  groups  as  are  required  to  provide  a  trustworthy  answer  to  the 
research  questions  due  to  the  costs  involved.  Morgan  (1997)  suggests  that  the  most 
important  factor  in  determining  the  number  of  groups  is  the  "variability  of  the 
participants  both  within  and  across  the  groups"  (p.  43).  He  considers  that  projects  that 
bring  together  heterogeneous  participants  and  projects  that  compare  several  distinct 
populations  will  typically  require  more  groups  in  total  because  the  diversity  between  and 
within  groups  "makes  it  more  difficult  to  sort  out  coherent  sets  of  opinions  and 
experiences"  (p.  44).  He  also  suggests  that  lack  of  group  structure  and  low  levels  of 
facilitator  involvement  increase  the  variability  from  group  to  group,  and  therefore  the 
number  of  groups  required. 
Whilst  aiming  to  provide  trustworthy  and  full  answers  to  the  research  questions,  there 
was  a  need  to  be  pragmatic  about  time  and  resources  allocated  for  this  study.  The  final 
number  of  focus  groups  conducted  was  18  (excluding  two  pilot  groups  lost  as  a  result  of 
the  recording  equipment  failing  to  work).  This  included  three  pilot  groups  and  fifteen 
main  study  groups. 
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Guidance  on  focus  group  methodology  typically  advises  that  the  optimum  number  of 
individuals  in  a  group  should  be  between  six  and  eight  participants  (Bloor,  2001)  whilst 
market  research  literature  tends  to  suggests  larger  numbers  of  between  eight  and  twelve 
participants.  Attempts  to  prescribe  the  ideal  size  of  focus  groups  have  led  Barbour  and 
Kitzinger  (1999)  to  declare  that:  "Advice  about  group  size  and  composition  in  existing 
guides  to  focus  group  research  is  often  too  didactic.  This  can  seriously  hamper 
imaginative,  or  even  appropriate,  application  of  focus  group  methods"  (p.  8).  The  pilot 
work  undertaken  for  this  study  suggested  that  much  smaller  groups  with  three  and  five 
participants  were  likely  to  be  most  suitable  and  productive  for  this  study.  Morgan  (1997) 
highlights  some  of  the  advantages  and  disadvantages  of  running  small  focus  groups.  On 
one  hand,  he  suggests  that  in  some  small  groups  it  can  be  difficult  to  sustain  active 
discussion  because  small  numbers  can  be  so  sensitive  to  the  group  dynamics  among  the 
individuals.  He  also  points  out  that  `friendship  pairs',  `experts'  or  `uncooperative 
participants'  can  easily  disrupt  the  functioning  of  small  groups  (p.  42).  Bloor  et  al., 
(2001)  consider  "...  that  small  groups  run  the  risk  of  cancellation  if  just  one  or  two 
participants  fail  to  turn  up"  (p.  27).  On  the  other  hand,  Morgan  (1997)  suggests  that 
small  groups  are  useful  when  the  researcher  desires  a  clear  sense  of  each  participant's 
feelings  on  a  topic  because  each  participant  is  given  more  time  to  talk.  He  suggests  that 
small  groups  may  be  useful  if  the  topic  under  discussion  is  a  particularly  complex  one  or 
if  the  participants  are  highly  involved  with  topic.  He  concludes  that:  "small  groups  work 
best  when  the  participants  are  interested  and  respectful  of  each  others'  views"  (p.  42). 
Pilot  work  demonstrated  that  childhood  immunisation  and  the  `safety'  of  MMR  were 
topics  that  parents  with  young  children  were  keen  to  debate  with  each  other  and  most 
participants  were  quick  to  get  involved  in  making  contributions  to  the  discussion.  The 
larger  groups  of  seven  and  eight  participants  presented  problems  because  participants' 
enthusiasm  to  express  their  views  and  opinions  led  to  too  many  interruptions  and  too 
much  `talk-over'.  These  groups  were  difficult  to  facilitate  and  there  was  a  palpable  sense 
54 of  frustration  when  participants  did  not  feel  they  were  given  enough  time  to  air  their 
views.  The  persistent  tendency  of  dominant  participants  to  talk  over  other  people  meant 
that  only  a  small  proportion  of  those  present  were  actually  contributing  to  the  discussion, 
and  productive  discussion  was  stifled.  Attempts  to  bring  in  quieter  members  and  to  ask 
participants  not  to  talk  over  one  another  made  little  difference.  As  a  consequence  these 
larger  focus  groups  were  difficult  to  transcribe,  particularly  when  I  was  trying  to  attribute 
talk-over  and  sets  of  rapid  interaction  to  specific  members  of  the  group.  It  was  also 
difficult  to  analyse  subtler  group  interactions.  This  led  to  the  decision  to  use  smaller 
groups  for  the  main  study.  Smaller  groups  not  only  made  it  easier  to  encourage 
interrupted  parents  to  return  to  any  broken  train  of  thought,  but  also  allowed  each 
participant  to  have  enough  time  to  explain  themselves  fully,  so  there  were  fewer 
interruptions  and  the  discussions  could  be  transcribed  more  accurately,  allowing  for  more 
detailed  analysis. 
2.43  Determining  the  group  composition 
To  determine  the  optimal  focus  group  composition  the  researcher  needs  to  consider  two 
factors  that  may  impact  on  the  group  dynamics.  Firstly,  whether  to  have  homogeneous  or 
heterogeneous  groups,  and  secondly,  whether  to  use  pre-existing  groups  or  whether  to 
convene  groups  of  individuals  especially  for  the  purposes  of  the  study.  In  consideration 
of  whether  to  have  homogeneous  or  heterogeneous  groups,  Morgan  (1997)  suggests  that 
participants  must  feel  able  to  talk  to  one  another,  and  warns  that  if  the  gaps  in  lifestyle  or 
social  background  are  too  wide  participants  will  not  feel  comfortable  with  each  other. 
Similarly,  Murphy  (1992)  considers  that  `to  enhance  freedom  of  expression,  it  is 
preferable  that  groups  be  homogeneous  with  respect  to  age,  gender,  and  particular  health 
problem  or  behaviour'.  However,  Kitzinger  (1994b)  takes  a  less  prescriptive  stance 
suggesting  that  whilst  bringing  together  people  on  the  basis  of  some  shared  experience  is 
often  productive,  differences  between  participants  can  be  illuminating.  Morgan  (1997) 
also  warns  `that  if  all  the  participants  share  virtually  identical  perspectives  on  a  topic,  this 
can  lead  to  a  flat,  unproductive  discussion'.  In  view  of  these  recommendations  I  decided 
to  aim  to  bring  together  participants  from  similar  social  backgrounds,  and  to  try  to  avoid, 
55 as  far  as  possible,  bringing  together  participants  with  opposing  views  on  immunisation  as 
this  could  result  in  high  levels  of  conflict,  and  cause  distress  for  parents. 
In  order  to  attempt  to  reduce  variation  within  the  groups,  I  recruited  parents  on  the  basis 
of  a  few  key  characteristics  that  were  explicitly  identified  in  the  recruiting  letters  and 
posters.  The  careful  planning  that  went  into  recruiting  relatively  homogeneous  groups  of 
parents  meant  that  moments  of  conflict  and  upsetting  situations  that  arose  during 
discussion  tended  to  be  dealt  with  sensitively  between  participants,  and  participants  were 
generally  respectful  of  each  others'  opinions.  This  was  particularly  salient  during 
discussions  with  parents  of  autistic  children  and  parents  caring  for  children  recovering 
from  cancer.  However,  even  with  careful  planning  there  were  still  challenging  moments. 
To  illustrate;  on  one  occasion  members  of  a  group  were  discussing  what  appeared  to  be  a 
safe  topic,  when  a  young  woman  suddenly  spoke  of  her  wish  for  her  severely 
handicapped  sister  to  die.  In  response  another  woman  spoke  of  her  nephew's  sudden 
death.  These  examples  were  not  isolated  and  highlight  how  difficult  it  can  be  to 
anticipate  the  direction  of  discussion.  What  seemed  to  me  to  be  an  innocuous  topic  in 
fact  triggered  a  series  of  sensitive  revelations.  Indeed,  Farquhar  and  Das  (1999)  remind 
researchers  that:  "the  sensitivity  of  a  given  research  topic  is  not  fixed,  but  socially 
constructed  within  a  complex  framework  of  taboos  and  norms,  then  sensitivity  can  be 
seen  to  be  not  only  fluid,  but  highly  unpredictable"  (p.  51). 
The  other  key  consideration  in  determining  the  group  composition  was  whether  to  use 
pre-existing  groups  or  whether  to  bring  together  strangers.  According  to  Bloor  et  al. 
(2001)  market  researchers  have  traditionally  used  groups  of  strangers,  but  the  virtues  of 
using  pre-existing  groups  are  increasingly  being  recognised.  Indeed,  Kitzinger  (1994) 
argues  that  by  using  formed  groups  the  researcher  may  tap  into  naturally  occurring  data 
and  that  they  can  provide  one  of  the  social  contexts  in  within  which  ideas  are  formed  and 
decisions  made.  Nevertheless,  Agar  and  MacDonald  (1995)  warn  that  although 
acquaintances  can  converse  more  readily,  this  is  often  due  to  their  ability  to  rely  on  the 
kind  of  taken-for-granted  assumptions  that  are  exactly  what  the  researcher  is  trying  to 
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are  likely  to  have  established  their  norms  and  to  have  hierarchies  within  the  group. 
Nevertheless,  they  consider  that  using  pre-existing  groups  can  be  a  `source  of  insight'. 
This  study  consisted  of  focus  groups  that  involved  both  some  pre-existing  groups,  and 
some  specially  convened  groups  in  order  to  answer  the  study's  research  questions. 
Sometimes  it  was  impossible  to  recruit  parents  who  were  complete  strangers  because  they 
were  part  of  a  wider  support  network;  for  example  the  groups  run  with  parents  with 
autistic  children  and  children  recovering  from  cancer.  In  other  groups  parents  were 
familiar  to  each  other  only  by  sight  because  their  children  attended  the  same  nursery  or 
play  scheme  and  there  were  also  groups  that  brought  complete  strangers  together  who 
had  never  met,  seen,  or  heard  of  one  another.  In  consideration  of  the  fact  that  it  is 
sometimes  impossible  to  recruit  a  full  group  of  acquaintances  and  likewise  that  it  is 
sometimes  impossible  to  avoid  it,  Morgan  (1997)  advises  that  the  decision  should  be 
based  on  the  criterion  of  whether  a  particular  group  of  participants  can  comfortably 
discuss  the  topic. 
2.4.4  Determining  the  level  of  group  structure 
According  to  Morgan  (1997)  less  structured  approaches  to  focus  groups  are  useful  when 
the  basic  issues  are  poorly  understood  and  when  the  goal  is  to  learn  something  new  from 
the  participants.  More  structured  approaches  are  useful  when  there  is  a  strong  pre- 
existing  agenda  for  the  research.  This  study  used  a  less  structured  approach  during  the 
pilot  work  phase  in  order  to  reflect  the  exploratory  nature  of  the  initial  enquiry  and  to 
allow  participants  the  freedom  to  identify  their  own  priorities  for  discussion.  As  the 
study  progressed  the  approach  became  more  structured,  and  my  involvement  as  facilitator 
became  a  more  prominent  feature  of  the  group  discussion.  A  standardised  topic  guide 
was  developed  (see  Appendix  E)  and  several  key  questions  were  asked  of  each  of  the 
groups  to  make  sure  that  all  of  the  groups  discussed  these  issues  in  a  relatively 
comparable  manner.  However,  participants  were  still  encouraged  to  state  their  own 
views  and  where  new  ideas  emerged  participants  were  encouraged  to  explore  them. 
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"  Understanding,  experiences  and  beliefs  about  childhood  infectious  diseases. 
"  Perceptions  about  childhood  immunisation  and  the  vaccines  within  the  programme. 
"  Perceptions  about  the  safety  of  the  MMR  vaccine  and  current  debate  about  it. 
"  Exploration  of  the  factors  that  shape  their  decisions  about  vaccination,  particularly  in 
relation  to  the  MMR  vaccine. 
2.5  Ethical  considerations 
Ethical  approval  for  the  study  was  obtained  from  the  Glasgow  University  Ethics 
Committee. 
2.5.1  Informed  consent 
Participants  were  provided  with  a  simple  but  comprehensive  information  sheet  (see 
Appendix  F)  either  by  myself  or  a  gate-keeper  usually  a  week  before  the  focus  group  was 
held.  Before  commencing  the  focus  group  I  checked  that  participants  had  read  the 
information  sheet  and  answered  any  questions  they  had  about  the  study.  Special  care  was 
taken  to  advise  parents  that  it  was  unlikely  that  the  study  would  be  of  direct  benefit  to 
themselves  and  that  they  were  under  no  obligation  to  take  part  in  the  study,  but  that  it  was 
hoped  that  by  participating  in  the  study  they  might  help  future  parents.  Once  this  was 
explained  they  were  each  asked  to  sign  a  written  consent  form  (see  Appendix  G)  and 
advised  that  they  could  withdraw  at  any  point  from  the  session  without  giving  a  reason. 
At  the  end  of  the  session  participants  were  reminded  that  if  they  were  interested  in  the 
findings  of  this  study,  a  summary  would  be  available  to  them  on  request  once  the  study 
was  completed. 
58 2.5.2  Confidentiality 
Before  commencing  the  session  I  assured  participants  that:  the  data  collected  would  be 
anonymised;  pseudonyms  would  be  used  for  participants  and  group  location;  and  that 
only  the  members  of  the  research  team  would  have  access  to  the  tapes  and  transcripts. 
Participants  were  informed  that  all  research  documents  would  be  kept  secure  for  ten  years 
and  then  destroyed  in  accordance  with  MRC  guidelines  on  good  practice.  Once  the 
transcripts  were  checked  I  immediately  replaced  the  names  of  participants,  their  children, 
and  partners  with  pseudonyms  and  logged  the  changes  on  a  sheet  of  A4  kept  separate 
from  the  transcripts  in  a  locked  drawer. 
An  ethical  issue  that  arose  during  the  course  of  the  focus  group  work  was  that  during 
discussions  some  participants  misinformed  the  group  on  issues  about  immunisation  or  on 
particular  vaccines.  The  dilemma  I  faced  was  that  if  I  did  not  say  anything  participants 
might  construe  that  I  was  legitimising  inaccurate  comments,  but  neither  did  I  want  to  set 
myself  up  as  an  expert  on  immunisation.  I  occasionally  felt  it  was  appropriate  to 
intervene  during  the  discussion,  to  counteract  the  more  potentially  damaging  comments. 
For  example,  one  woman  informed  the  group  that  a  daughter's  friend  had  contracted 
meningitis  from  the  MMR  vaccine  and  that  experts  were  well  aware  of  the  link  between 
MMR  and  meningitis.  The  horror  on  the  other  participants'  faces  indicated  the  need  for 
clarity  on  this  matter,  but  I  generally  refrained  from  intervening  and  used  the  debriefing 
session  at  the  end  of  the  focus  group  to  clear  up  any  misunderstandings.  The  debriefing 
session  also  offered  the  opportunity  to  hand  out  to  parents  immunisation  contact  details 
and  leaflets  produced  by  the  Greater  Glasgow  National  Health  Service  and  the  (then) 
Health  Education  Board  for  Scotland. 
2.6  Characteristics  of  Participants 
Seventy-two  parents  took  part  in  the  study.  The  sample  included  64  mothers  (age  range 
15  to  53  years,  mean  age  32  years),  and  eight  fathers  age  (range  31  to  51  years,  mean  age 
39  years).  Forty-two  parents  described  their  marital  status  as  `married',  fourteen  as 
`single',  thirteen  as  `co-habiting'  and  three  as  either  `separated'  or  `divorced'.  Appendix 
59 H  shows  the  characteristics  of  each  of  the  18  focus  groups.  Parents  lived  in  a  range  of 
socio-economic  areas.  Figure  2.1  shows  that  the  sample  included  more  participants 








Figure  2.1  The  areas  in  which  participants  lived 
F7 
IIIII 
2  3  4  5 
DEPCAT  deprivation  categories  (post  code  sector) 
6  7 
Thirty-eight  parents  described  their  youngest  child's  immunisation  status  as  `complete', 
that  is,  up-to-date  for  their  age,  having  received  all  the  recommended  vaccines  in  the 
Childhood  Immunisation  Programme.  Twenty-four  parents  described  their  child's 
immunisation  status  as  `partial'.  This  category  included  five  parents  who  had  fallen 
behind  schedule  with  some  of  the  vaccines,  twelve  parents  who  had  decided  not  to  have 
one  or  more  of  the  recommended  vaccines  in  the  programme,  and  seven  parents  who 
were  undecided  about  whether  to  immunise  their  child  with  the  MMR  vaccine.  The  third 
category,  `none,  '  comprised  of  six  parents  that  did  not  plan  to  immunise  their  children 
with  any  of  the  recommended  vaccines  although  two  stated  that  they  planned  to  use 
alternative  homeopathic  protection.  The  fourth  category  described  as  `other'  included 
two  parents  who  did  not  know  the  immunisation  status  of  their  child  because  they  were 
not  living  with  the  child,  and  two  parents  with  children  under  eight  weeks  old  who  were 
too  young  to  be  immunised. 
60 2.7  Conducting  the  study 
2.7.1  Timing  of  the  main  study 
Appendix  D  shows  a  timeline  of  the  key  events  in  the  MMR  controversy  and  how  these 
relate  to  the  data  collection  for  this  study.  In  recognition  of  the  view  that  place  and 
meaning  are  continuously  being  constructed  and  influenced  by  the  social  world,  and  in 
order  to  conceptualise  the  relationship  between  the  timing  of  the  data  collection  and  the 
MMR  debate,  a  diary  was  kept  which  logged  key  dates  and  events.  Over  the  Spring  and 
Summer  of  2002  there  was  growing  speculation  in  the  press  about  an  impending  legal 
action  to  be  brought  by  parents  of  vaccine  damaged  children  against  the  pharmaceutical 
companies  responsible  for  manufacturing  the  MMR  vaccine.  However,  during  the 
Autumn  of  2002  growing  speculation  about  war  with  Iraq  dominated  the  news  and  MMR 
assumed  a  lower  profile.  In  order  to  reduce  the  media's  immediate  influence  on  the  focus 
group  discussions,  the  main  study  was  conducted  over  a  relatively  short  period  of  time, 
between  November  2002  and  March  2003. 
2.7.2  Access  and  recruitment 
Recruiting  participants  for  this  study  was  a  complex  and  time-consuming  undertaking, 
primarily  because  eleven  of  the  groups  were  specially  convened  for  the  purposes  of  the 
study.  These  groups  took  longer  to  organise  than  the  seven  pre-existing  groups. 
Bringing  participants  together  to  form  a  group  involved  negotiating  with  different  gate- 
keepers  and  required  co-ordinating  busy  parents  to  co-operate  in  travelling  to  a  common 
venue. 
The  decision  mainly  to  bring  together  groups  of  parents  for  the  purposes  of  the  study, 
rather  than  to  access  only  pre-existing  groups  meant  that  there  was  an  increased 
dependency  on  gate-keepers.  One  of  the  difficulties  of  relying  on  gatekeepers 
highlighted  by  Barbour  and  Kitzinger  (1999)  is  that  they  may  inadvertently  or  advertently 
screen  potential  participants.  To  minimise  the  influence  they  had  in  selecting  potential 
61 participants,  I  generally  asked  them  to  pass  covering  letters  and  information  sheets  to  all 
the  parents  in  their  group,  so  that  participants  could  decide  themselves  whether  or  not  to 
participate.  On  several  occasions  gate-keepers  played  a  minimal  role  and  did  not  have 
any  direct  contact  with  the  participants.  However,  they  were  still  useful  in  giving  me 
access  to  premises  so  that  I  could  place  posters  advertising  the  study  in  strategic  places, 
or  in  granting  permission  to  conduct  a  focus  group  on  the  premises.  There  were  also 
occasions  when  the  knowledge  and  experience  that  gate-keepers  possessed  were  useful  in 
helping  to  screen  potential  participants.  For  example,  it  was  advantageous  to  have  gate- 
keepers  to  help  screen  participants  for  the  immuno-compromised  groups.  In  this  group 
deliberate  attempts  were  made  to  screen  out  parents  with  either  very  ill  children  in  the 
middle  of  treatment,  or  parents  whose  children  had  died. 
Once  potential  gate-keepers  were  identified,  they  were  contacted  by  telephone  to  ask  if 
they  might  be  interested  in  helping  me  contact  relevant  parents.  If  they  agreed,  they  were 
sent  information  about  the  study  or  a  meeting  was  organised  to  discuss  the  study.  The 
information  sheets  provided  information  about  the  study  (see  Appendix  F),  detailed  the 
anticipated  uses  of  the  findings,  and  identified  the  Medical  Research  Council  as  the 
funder.  They  highlighted  the  number  of  participants  required,  the  expected  duration  of  the 
discussion,  and  the  fact  that  the  discussion  was  to  be  recorded.  They  also  gave 
reassurances  about  confidentiality  and  anonymity,  and  my  name  and  contact  details. 
Discussions  that  were  organised  with  pre-existing  groups  were  set  up  with  relative  ease 
once  the  gatekeeper  had  received  the  information  sheet.  Where  possible  I  met  with  the 
group  to  hand  out  information  sheets  in  person  and  to  arrange  when  to  carry  the  focus 
group.  Where  recruitment  involved  bringing  together  new  groups,  gate-keepers  were 
either  given  brightly  coloured  posters  inviting  parents  to  take  part,  or  given  envelopes 
containing  a  study  information  sheet  and  cover  letters  to  be  handed  to  parents  (see 
Appendix  1).  The  cover  letters  were  tailored  to  meet  the  individual  requirement  of  the 
group.  The  letter  included  a  short  description  of  the  study,  an  invitation  to  join  a  focus 
group  and  stated  that  participants  would  receive  £10  towards  any  expenses  incurred. 
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contact  with  myself. 
2.7.3  Recruitment  difficulties 
Ensuring  attendance  is  a  problem  facing  researchers  using  focus  group  methods.  Morgan 
(1995)  asserts  that  inadequate  recruitment  efforts  are  the  single  most  common  source  of 
problems  in  focus  group  research.  Bloor  et  al.  (2001)  considers  that  it  is  standard 
practice  to  recruit  more  participants  than  required  on  the  assumption  that  a  number  will 
not  turn  up  on  the  day.  However,  following  this  suggestion  meant  that  in  one  of  my 
groups  there  were  eight  participants  when  I  really  only  wanted  four  or  five  participants. 
On  the  other  hand,  because  I  preferred  to  use  small  groups,  under-recruitment  could  have 
meant  that  nobody  turned  up.  In  order  to  recruit  low  numbers  of  participants  for  each 
group  I  realised  that  it  was  not  just  enough  to  simply  locate  participants  and  get  them  to 
agree  to  turn  up,  so  I  developed  additional  strategies  for  recruiting.  Once  participants 
agreed  to  take  part  I  kept  in  contact  with  them  via  the  telephone  and  email,  contacting 
them  the  day  before  to  check  they  were  still  available  to  attend.  Whilst  this  meant  that  on 
a  couple  of  occasions  groups  needed  to  be  re-convened,  it  ensured  that  no  group  was 
cancelled  at  the  last  minute. 
However,  despite  my  best  attempts  some  groups  were  difficult  to  set  up.  For  example, 
setting  up  the  Single  Vaccine  Group  involved  negotiating  with  two  gate-keepers  over  an 
eight  week  period;  these  negotiations  consisted  of  three  letters,  eight  telephone 
conversations  and  one  meeting.  From  this  it  was  agreed  that  clinic  staff  would  hand  out 
180  cover  letters  and  information  sheets  to  parents  attending  the  private  clinic  for  the 
single  vaccines  over  a  weekend.  In  the  letter  parents  were  asked  to  contact  me  if  they 
were  interested  in  taking  part  in  a  group  discussion.  Unfortunately,  these  efforts  only 
resulted  in  three  parents  contacting  me,  which  was  puzzling  given  the  fact  that  these 
parents  were  obviously  motivated  and  concerned  enough  about  the  MMR  vaccine  to  have 
sought  three  separate  injections  at  considerable  expense  and  inconvenience.  On 
reflection,  one  explanation  may  be  that  the  gate-keepers  did  not  grant  me  access  to  speak 
63 to  the  parents  directly  and  therefore  I  had  to  rely  on  them  contacting  me  and  was  not  able 
to  send  a  reminder  letter.  Nevertheless,  it  highlighted  the  important  role  gate-keepers  can 
play  in  assisting  recruitment. 
The  success  of  recruitment  may  also  depend  on  the  choice  of  venue.  Known  venues 
within  easy  access  to  the  participants  are  generally  advocated  (Barbour  and  Kitzinger, 
1999).  Whilst  I  endeavoured  to  do  this  as  far  as  possible,  I  found  that  for  some  of  the 
more  specific  groups,  (such  as  the  `single'  vaccine  group,  the  autism  groups  and  one  of 
the  non-MMR  groups)  there  was  no  obvious  meeting  place.  These  parents  lived  in 
different  parts  of  Glasgow  and  the  surrounding  areas.  Some  of  these  parents  travelled 
several  miles  in  order  to  attend  the  group  and  I  ensured  travel  expenses  were  fully 
reimbursed  and  encouraged  transport  by  taxi  where  appropriate.  Where  possible,  groups 
were  convened  in  local  community  centres,  churches,  leisure  facilities,  schools  or  support 
centres,  but  where  no  mutual  meeting  place  existed  small  conference  rooms  were  booked 
in  conveniently  located  hotels. 
2.7.4  Recording,  transcribing  and  overcoming  recording  difficulties 
Audio-recording  appears  to  offer  the  best  possible  method  of  ensuring  an  accurate  record 
of  focus  group  disussion  (Bloor  et  al.,  2001;  Barbour  and  Kitzinger.,  1999;  Murphy  et  al., 
1992).  Initially  I  used  a  mini-disc  recorder  with  an  external  flat  microphone,  but 
problems  with  the  mike  attachment  meant  that  the  recording  for  one  pilot  group  was  of 
such  poor  quality  that  the  transcript  was  unreliable,  and  therefore  not  included  in  the 
study.  Data  from  a  second  group  were  lost  when  the  recorder  failed  to  work.  This  led  me 
to  change  recording  equipment  and  instead  to  use  a  high-quality  tape  recorder  with  an 
external  multi-directional  flat  mike.  In  addition  to  the  tape  recorder,  and  perhaps  a 
reflection  of  my  own  growing  paranoia,  I  used  a  discrete  digital  Dictaphone  as  a  back  up. 
The  tape  recorder  was  placed  nearby  under  the  table  and  the  mike  and  Dictaphone  were 
strategically  placed  on  the  table  to  ensure  that  all  the  members  of  the  group  were  being 
adequately  recorded.  Before  switching  on  the  recording  equipment  I  reminded 
64 participants  of  the  intent  to  record  the  group  discussion  and  explained  that  the  recording 
equipment  was  there  to  ensure  that  I  would  obtain  an  accurate  account  of  what  was  said. 
Comprehensive  field  notes  were  also  recorded  on  the  Dictaphone  and  logged  in  a  diary. 
These  data  included  observations  on  the  characteristics  of  each  participant  in  the  group, 
and  on  participant  exchanges  and  interactions  and  group  dynamics.  To  aid  voice 
recognition,  I  drew  a  sketch  of  the  room  including  the  participants'  seating  arrangements 
and  assigned  the  more  memorable  comments  or  stories  to  the  individual  participant 
drawn  on  the  sketch.  The  diary  also  included  reflections  and  thoughts  on  the  content  of 
the  discussion,  my  own  feelings  about  `how  facilitating  the  group  went'  and  any 
problems  encountered. 
There  is  agreement  that  the  transcripts  produced  from  focus  group  data  are  distinct  from 
data  collected  by  other  qualitative  methods,  because  of  the  emphasis  placed  on  group 
interaction.  Drawing  on  a  study  of  AIDS  media  messages,  Kitzinger  (1994a)  recalls  the 
chaotic  nature  of  focus  group  data,  describing  how  participants  brainstormed,  argued, 
misunderstood  and  ridiculed  each  other.  She  details  instances  of  over-talk  and  where 
sentences  were  unfinished,  or  where  participants  contradicted  themselves  and  others.  In  a 
later  text,  Barbour  and  Kitzinger  (1999)  also  reason  that  focus  group  transcription  can  be 
difficult  to  interpret  because  participants  tend  to  make  sudden,  apparently  `illogical' 
leaps.  All  these  traits  of  focus  group  transcripts  were  features  of  the  transcripts  in  this 
study  and  meant  that  transcription  was  time-consuming.  Barbour  and  Kitzinger  (1999) 
suggest  that  focus  groups  should  be  carried  out  in  rooms  that  are  `...  quiet,  comfortable, 
and  free  from  interruptions...  '  (p.  11),  but  in  practice  there  were  a  few  occasions  when 
groups  had  to  be  held  in  less  than  ideal  circumstances.  There  were  times  when  nursing 
mothers  needed  to  feed  their  babies  or  an  older  child  being  looked  after  in  a  nearby  room 
was  upset  and  wanted  to  rejoin  their  parent. 
I  transcribed  the  pilot  groups  myself  but  because  of  time  constraints  sent  the  main  group 
tapes  to  be  transcribed  by  a  specialised  audio-typist.  Focus  groups  can  generate  large 
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create  more  than  100  pages  of  transcript.  Whilst  the  duration  of  the  groups  in  this  study 
was  shorter  (lasting  between  55  minutes  and  82  minutes),  these  sessions  could  still 
generate  transcripts  of  up  to  56  pages  in  length.  Despite  the  shorter  transcripts  and  the 
assistance  with  transcription,  the  process  of  ensuring  each  transcript  was  accurate  was 
time-consuming.  Each  transcript  took  between  eight  to  twelve  hours  to  check  accuracy 
of  dialogue,  identify  participants  and  to  add  in  additional  notes  or  impressions.  Once 
participants  were  identified  each  participant  was  given  a  pseudonym  and  then  the 
transcript  was  imported  as  a  rich  text  file  into  NVivo. 
2.7.5  Facilitating  the  groups 
Generally  the  groups  took  place  around  a  table,  and  chocolates  or  biscuits  and  teas  and 
coffees  were  provided  to  create  an  informal  setting  and  relax  participants.  Prior  to 
commencing  the  discussion,  participants  were  reminded  that  the  discussion  was  expected 
to  last  approximately  one  hour  and  that  they  could  withdraw  from  the  group  discussion  at 
any  time  without  giving  a  reason.  Once  consent  forms  were  signed,  a  short  questionnaire 
(see  Appendix  I)  was  handed  to  each  participant  to  collect  some  basic  demographic 
information  including,  name,  post-code  address,  age,  marital  status,  occupation  and 
details  on  their  children's  immunisation  histories.  During  the  sampling  phase  this 
information  assisted  in  monitoring  sample  socio-economic  and  demographic  diversity 
and  helped  ensure  that  the  sample  contained  a  mix  of  parents  with  respect  to  vaccine 
decision-making  outcomes.  I  reviewed  the  questionnaires  briefly  before  commencing  the 
discussion.  The  responses  provided  useful  background  information  and  I  frequently  noted 
remarks  or  interesting  stories  from  participants  on  the  back  of  their  questionnaires  to  help 
with  later  identification. 
The  running  order  of  the  topics  and  questions  generally  involved  starting  with  a  broad 
question  on  immunisation,  while  more  specific  ideas  about  the  MMR  debate  and 
childhood  diseases  were  explored  towards  the  end  of  the  group.  The  decision  to  order 
questions  this  way  was  made  to  gently  broach  the  subject  of  immunisation  in  a  non- 
threatening  way.  On  completion  of  the  group  discussion  parents  were  also  given  contact 
details  of  support  groups,  the  National  Service  Helpline  and  Immunisation  Public  Health 
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were  offered  the  opportunity  to  take  away  with  them  a  selection  of  recently  published 
leaflets  on  MMR  and  childhood  immunisation,  produced  by  the  Health  Education  Board 
for  Scotland  and  Greater  Glasgow  National  Health  Service  Board.  After  the  de-briefing 
session  I  generally  stayed  around  so  that  participants  could  speak  to  me  privately  if  they 
wished  to  do  so.  There  were  several  occasions  when  participants  wanted  more 
information.  For  example,  one  parent  with  a  child  with  autism  wanted  the  details  of  a 
recently  published  report  carried  out  by  the  Medical  Research  Council  on  autism,  and  I 
later  sent  her  the  report  details.  But  there  were  many  occasions  when  participants  just 
wanted  to  talk  about  something  they  had  said  or  felt  during  the  discussion.  These 
comments  were  logged  in  my  field  notes  when  appropriate.  In  order  to  ensure  everyone 
had  the  opportunity  to  have  their  say,  reply-paid  envelopes  were  provided  at  the  end  of 
the  discussion  for  those  who  wished  to  post  further  comments.  In  the  event  no  one 
posted  back  any  comments.  Before  leaving,  parents  were  thanked  and  advised  that  if  they 
kept  my  details  they  could  request  a  summary  of  the  findings  once  the  study  was 
completed. 
2.7.6  Facilitator  skills,  persona  and  reflexivity 
In  contrast  to  the  naturalistic  paradigm  defined  by  Holliday  (2002)  that  suggests  that 
substantiation  is  gained  via  minimal  researcher  interference  using  a  `fly  on  the  wall 
approach'  (p.  20),  this  study  required  that  I  intervene  from  time  to  time.  An  essential 
aspect  of  facilitating  the  groups  was  to  ensure  the  validity  of  participants'  responses,  so 
that  ambiguous  statements  could  be  clarified  (where  possible),  incomplete  sentences 
finished,  and  all  participants  got  the  opportunity  to  speak.  Therefore  during  discussions  I 
sometimes  prompted  participants  to  explain,  confirm  or  justify  their  position  so  that  their 
opinions  could  be  examined  in  greater  depth.  However,  the  decision  to  intervene  needed 
to  be  balanced  with  the  need  to  keep  quiet  (Barbour  and  Kitzinger,  1999)  and  I  tried  to 
carry  out  any  intervention  in  a  non-threatening,  non  judgmental  manner,  to  avoid 
participants  feeling  under  pressure.  In  general,  I  felt  my  role  was  to  keep  the  group 
relatively  focused  on  the  topic  areas,  but  to  be  a  background  figure  in  the  group,  keen  to 
learn  from  them,  rather  than  a  controlling,  knowledgeable  foreground  figure.  Indeed, 
67 Bloor  et  al.  (2001)  advise  that  a  facilitator  who  seeks  to  control  the  group  may  be  doing 
the  study  a  disservice  because  the  group  norms  and  interactions  may  be  distorted. 
However,  despite  my  attempts,  there  were  many  occasions  when  parents  asked  me 
questions  on  the  vaccines  or  on  specific  childhood  infectious  diseases,  and  I  had  to 
explain  that  I  was  not  an  expert  on  immunisation  and  would  give  them  information  on 
immunisation  at  the  end  of  the  session.  I  decided  that  I  would  not  tell  parents  that  I  was  a 
qualified  nurse  or  midwife  because  neither  training  course  included  much  education  on 
childhood  immunisation  (work  largely  undertaken  by  health  visitors,  practice  nurses  and 
GPs).  Less  clear-cut  in  my  mind  was  whether  to  tell  participants  that  I  was  a  parent. 
After  careful  consideration  I  decided  that  I  would  not  tell  participants  that  I  have  children 
to  try  to  avoid  taking  on  the  role  of  an  experienced  parent.  Nevertheless,  there  were 
several  occassions  when  parents  asked  me  if  I  had  any  children  and  whether  I  had  had 
them  immunised.  In  this  situation  I  revealed  that  I  did  have  children  and  that  they  were 
all  fully  immunised,  however  these  conversations  all  occurred  during  the  debriefing 
sessions  after  the  focus  groups  were  completed. 
My  prior  experience  in  carrying  out  qualitative  research  using  one-to-one  interviews  and 
focus  groups  was  useful  in  developing  group  facilitation  skills;  however  I  probably  drew 
on  my  wider  life  experiences  equally.  For  example,  in  one  group  conducted  with  young 
mothers  living  in  a  deprived  part  of  Glasgow  one  fifteen-year-old  mother  did  not  speak 
once  during  the  whole  session  despite  looking  happy  to  be  part  of  the  group  and  keenly 
listening  to  what  the  other  group  members  were  saying.  Perhaps  previous  experience  of 
working  closely  with  people  meant  that  I  felt  acutely  aware  of  her  vulnerability  and  it  felt 
appropriate  to  let  her  silently  take  part,  rather  than  to  focus  any  attention  on  her  by 
encouraging  her  to  talk.  Importantly,  in  her  silence  she  interacted  with  the  other  members 
of  the  group.  On  one  occasion  when  her  friend  spoke  she  squeezed  her  friend's  hand  and 
smiled  supportively  and  I  felt  sure  that  her  presence  was  reassuring  to  her  friends.  At  the 
end  of  the  session  when  I  was  asking  for  everyone  to  fill  in  the  receipt  for  payment  forms 
her  friend  discreetly  took  her  form  and  filled  in  the  details  on  her  behalf.  Later  it  turned 
out  that  she  was  unable  to  read  and  write  and  had  not  spoken  much  since  being  in  an 
abusive  relationship  that  resulted  in  her  becoming  pregnant  and  having  a  son.  I  was  glad 
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felt  sure  that  the  discussion  was  richer  for  her  presence. 
2.8  Focus  group  analysis 
2.8.1  Which  analytical  approach? 
One  of  the  advantages  of  using  focus  group  methods  is  that  it  can  generate  rich  and 
dynamic  data  by  encouraging  discussion  between  group  members.  However,  whilst 
methodological  textbooks  often  highlight  that  analysis  of  group  interactions  provides  the 
researcher  with  unique  and  rich  data,  there  is  very  little  guidance  on  the  analysis  of  group 
interactions.  Perhaps  the  most  insightful  contributions  on  this  were  from  the  experiences 
of  researchers  in  Barbour  and  Kitzinger's  `Developing  Focus  Group  Research'  (1999) 
book  in  which  Frankland  and  Bloor  suggest  using  deviant  case  analysis  in  the  analysis  of 
focus  group  data.  They  consider  that  the  lack  of  detailed  advice  on  the  analysis  of  focus 
group  data  may  be  due  to  the  fact  that  focus  groups  have  developed  from  market 
research,  where  less  emphasis  has  traditionally  been  placed  on  rigorous  analysis. 
However,  deviant  case  analysis  often  involves  collecting  and  analysing  simultaneously  to 
explore  new  propositions  and  I  was  not  able  to  either  return  to  the  participants  for  later 
clarification  or  to  collect  additional  data.  Nevertheless,  reading  about  this  approach 
heightened  my  awareness  of  the  importance  of  concentrating  on  `deviant'  or 
contradictory  cases  to  explore  some  of  the  less  obvious  aspects  of  parents'  perceptions 
and  decisions  about  immunisation.  Another  approach  I  drew  upon  to  ensure  that  analysis 
was  systematic  was  the  constant  comparative  method.  Although  Glaser  and  Strauss 
(1967)  developed  this  method  for  theory-building,  Lincoln  and  Guba's  (1985)  later 
adaptations  to  the  method  meant  that  its  use  has  become  suited  to  other  inductive 
approaches  to  data  analysis.  Although  I  was  unable  to  find  any  real-life  detailed 
examples  of  research  using  this  method,  textbooks  such  as  Maykut  and  Morehouse 
(1994)  offered  useful  step  by  step  instructions.  This  approach  was  useful  in  highlighting 
how  systematic  and  simultaneous  comparison  of  all  the  units  of  data  could  be  conducted 
to  ensure  that  all  the  data  from  all  the  cases  would  contribute  to  some  extent  in  the 
analysis,  thus  avoiding  the  selective  use  of  data.  It  also  proved  useful  in  illuminating 
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topics  varied  between  groups.  Perhaps  crucially  there  was  a  need  to  consider  how  to 
analyse  group  interaction. 
2.8.2  Group  analysis:  balancing  the  group  picture  against  the  voices  of  the  individuals 
According  to  Catterall  and  Maclaran  (1997)  understanding  group  dynamics  in  focus 
group  research  is  important  for  two  reasons.  Firstly,  as  discussed  earlier  in  the  chapter, 
understanding  group  composition  helps  researchers  identify  the  conditions  that  promote 
interaction  and  open  discussion  amongst  participants.  Secondly,  it  helps  them  to 
appreciate  what  was  happening  in  the  group  and  why  it  might  have  been  happening.  It  is 
the  second  aspect  of  group  dynamics,  often  termed  `group  effect,  '  that  I  wish  to  consider 
here.  On  one  hand  `group  effect'  is  to  some  extent  viewed  in  negative  terms,  as  a  threat 
to  the  authenticity  of  individual  participants'  views.  The  inference  is  that  the  group  effect 
may  distort  the  views  of  the  individual  members.  On  the  other  hand,  the  counter- 
argument  is  that  the  `group  effect'  is  a  considerable  resource  in  exploring  how  accounts 
may  be  altered,  opposed  or  censured  through  group  interaction,  representative  of  real-life 
interactions.  Indeed,  Myers  and  Macnaghten  (1998)  challenge  the  idea  that  opinions  and 
attitudes  are  attributes  of  research  participants  at  all,  and  suggest  that  all  conversation  is 
influenced  by  the  context  in  which  it  is  generated.  Barbour  and  Kitzinger  (1999) 
consider  that,  in  order  to  analyse  focus  group  data,  consideration  needs  to  be  balanced 
between  looking  at  the  picture  provided  by  the  group  as  a  whole  and  recognising  the 
individual  voices  within  it.  They  suggest  that  the  researcher  should  aim  to: 
... 
distinguish  between  opinions  expressed  in  spite  of,  or  in  opposition  to,  the  group  and  the 
consensus  expressed  or  constructed  by  the  group.  Analysis  will  involve,  at  the  very  least,  drawing 
together  and  comparing  discussion  of  similar  themes  and  examining  how  these  relate  to  the 
variation  between  individuals  and  between  groups  (p.  16). 
To  enable  me  to  become  more  familiar  with  the  data  and  to  construct  an  interpretive 
version  of  what  I  considered  to  be  the  interplay  between  what  was  said  and  the  context  in 
which  it  was  said,  I  read  my  field  notes  of  my  observations  on  the  group  dynamics  of 
each  focus  group.  I  also  listened  to  the  tape  recordings  whilst  annotating  the  margins  of 
the  transcripts  with  thoughts  about  the  group  interactions  between  participants.  Notes 
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these  arose  or  were  modified  by  the  group.  This  was  a  useful  means  of  building  a  picture 
of  the  issues  which  participants  disagreed  on.  It  was  often  less  apparent  which  issues 
participants  agreed  on  from  reading  the  transcripts,  and  the  field  notes  made  about 
participants'  body  language  and  facial  expression  proved  particularly  useful  in  this 
respect.  At  this  stage  it  was  also  noted  which  participants  remained  silent  and  on  which 
subject,  and  whether  they  appeared  to  be  self-censoring  an  alternative  point  of  view,  or 
whether  they  appeared  to  have  no  view  to  offer  on  the  subject.  Indeed,  knowing  how  to 
interpret  passive  voices  was  extremely  difficult  and  whilst  there  were  many  times  I 
intervened  to  encourage  participation  during  the  focus  groups,  at  the  analysis  stage 
representing  silence  was  done  by  annotating  the  margins  of  the  transcript.  Indeed,  on 
reflection,  this  part  of  the  process  was  one  of  the  most  challenging  aspects  of  focus  group 
analysis  and  striking  a  balance  between  analysing  the  content  of  what  was  said  and 
determining  how  and  sometimes  why  it  was  said,  was  far  from  straightforward.  There 
were  many  instances  when  participants  were  interrupted  or  silenced  by  other  group 
members,  or  when  participants  would  not  be  drawn  on  a  subject  and  seemed  impartial  to 
any  viewpoint.  These  situations  were  difficult  to  interpret  and  I  often  inserted  bold 
question  marks  in  the  text  of  the  transcript  to  show  my  uncertainty.  During  this  stage  in 
the  process  short  descriptions  were  added  to  the  transcript  on  how  sensitive  moments 
were  managed,  how  jokes  were  used,  and  how  minds  were  changed  or  where  participants 
contradicted  themselves  or  each  other.  Key  questions  I  asked  of  the  data  were:  why  did 
the  participants  say  what  they  said?  And  what  were  the  responses  of  the  other  group 
members?  The  outcome  of  this  process  was  that  each  transcript  seemed  more 
complicated  and  unwieldy  than  it  had  before,  and  so  began  the  process  of  organizing  and 
coding  the  data  to  enable  systematic  comparisons  to  be  made  across  all  the  data. 
In  an  attempt  to  show  that  analysis  was  conducted  systematically  and  rigorously,  and  that 
neither  the  content,  nor  the  process  were  treated  as  separate  units  of  analysis  and  to 
acknowledge  the  continuous  interplay  between  these  two  levels  of  analysis,  a  more 
detailed  account  of  the  analytical  process  is  now  presented. 
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Despite  concerns  over  the  methodological  implications  of  using  software  in  qualitative 
analysis  (Catterall  and  Maclaran,  1997)  the  use  of  Computer  Assisted  Qualitative  Data 
Analysis  Software  (CAQDAS)  has  become  a  popular  organisational  tool  for  qualitative 
researchers.  Concerns  have  largely  centered  on  the  extent  to  which  the  requirements  of 
the  software  might  alienate  the  researcher  from  their  data  and  distort  the  underlying 
context  and  meaning  of  remarks  (Kidd  and  Parshall,  2000).  With  respect  to  using 
software  to  organise  focus  group  data  this  later  concern  may  be  particularly  relevant  in 
view  of  the  complex  group  interactions.  As  Catterall  and  Maclaran  (1997)  have  observed 
there  is  relatively  little  discussion  in  the  social  science  literature  on  the  use  of  CAQDAS 
with  focus  group  data.  In  an  attempt  to  identify  issues  specific  to  the  computer-aided 
analysis  of  focus  group  data,  they  reviewed  the  literature  and  concluded  that: 
...  the  focus  group  is  not  simply  a  data  gathering  technique  where  data  collected  are  analysed  for 
their  specific  content  such  as  all  text  relating  to  a  particular  theme.  Important  and  potentially 
insightful  communication  and  learning  processes  occurs  in  focus  groups  as  a  result  of  participant 
interaction.  These  processes  in  the  data  can  only  be  identified  by  several  readings  of  the  whole 
transcript  and  tracing  an  individual's  text  in  the  context  of  other  participants'  text;  this  is  difficult 
to  effect  on-screen.  Thus,  we  recommend  that  transcripts  are  coded  on-screen  for  content  and  off- 
screen  for  process  (p.  1). 
Nevertheless,  with  the  new  generation  of  more  advanced  computing  packages  the 
argument  that  the  process  of  group  interaction  would  be  lost  if  coded  electronically  now 
seems  outdated.  Indeed,  Richards  (1999)  asserts  that  the  software  package  NVivo  is 
designed  to  preserve  and  enhance  richness  of  records,  and  that  data  can  be  connected 
electronically  in  many  ways.  Similarly,  Kidd  and  Parshall  (2000)  used  a  software 
package  to  enhance  rigour  in  the  analysis  of  the  large  amount  of  data  generated  in  their 
focus  group  study.  In  order  to  pay  attention  to  the  group  interaction  they  suggest  coding 
large  chunks  of  narrative,  including  questions,  comments,  asides  and  elaborations,  as  well 
as  the  coding  for  content.  In  essence  they  used  a  combination  of  broad-brush  coding  for 
certain  types  of  discourse,  and  fine-grained  (line-by-line)  coding  of  substantive  content. 
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used  sensitively,  I  imported  the  transcripts  into  NVivo  2.0. 
The  first  step  in  the  process  of  analysis  was  to  code  pieces  of  transcripts  thematically  to 
allow  for  a  full  range  of  later  possible  interpretations  of  the  data.  These  sections  were 
commonly  assigned  several  thematic  codes  in  order  to  allow  for  a  number  of  different 
interpretations.  I  used  the  speed-coding  bar  to  attach  codes  to  extracts  of  text  pertinent  to 
particular  themes  or  topics.  In  an  attempt  to  avoid  hierarchical  thinking  and  to  keep  the 
codes  free  of  organisation,  I  decided  to  code  the  transcripts  using  the  `free-node'  option. 
Richards  (1999)  suggests  that  free  nodes  are  useful  when  categories  are  being  created 
from  the  data  early  in  coding.  At  this  stage  in  the  analytical  process,  thematic  coding  of 
the  transcripts  gave  rise  to  72  free  nodes.  However,  as  Bloor  et  al.  (2001)  advise,  in  the 
early  stages  codes  should  be  kept  quite  broad,  and  become  narrower  as  the  study 
develops. 
In  order  to  check  and  compare  all  the  text  carrying  the  same  code,  I  used  the  search  tool 
to  retrieve  all  the  extracts  of  data  that  were  pertinent  to  a  particular  free  node.  This 
allowed  me  to  read  and  check  that  I  had  included  all  possibly  relevant  material,  that  the 
coding  had  been  systematic  and  that  I  had  not  excluded  relevant  material.  Once  this 
check  had  been  completed,  I  re-read  the  whole  transcripts  and  using  these  nodes  mapped 
out  tentative  relationships  between  them  on  pieces  of  A4  paper.  This  visual  mapping  of 
the  nodes  was  transferred  into  a  PowerPoint  presentation  and  with  the  help  of  my  two 
supervisors  we  identified  key  themes,  and  started  to  build  a  coding  frame  around  the  key 
areas  of  interest. 
In  order  to  avoid  losing  the  richer  picture  of  group  interaction  and  conversation  referred 
to  by  Reed  and  Roskell  (1997),  I  worked  between  a  version  of  the  whole  transcripts  with 
the  coding  strips  and  group  interactions  on  them,  and  the  retrieved  extracts  of  data 
pertinent  to  a  particular  free  node.  I  decided  not  to  follow  Kidd  and  Parshall's  (2000) 
suggestion  of  coding  both  content  and  group  interaction  separately  as  it  would  have  been 
too  time  consuming  with  little  benefit  over  the  method  I  used.  As  I  became  more  familiar 
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respect  this  part  of  the  process  was  essentially  inductive  in  nature  and  the  process  of 
reading,  coding  and  describing  the  data  was  cyclical.  Any  changes  to  the  codes  were 
logged  in  my  research  diary  and  I  then  returned  to  earlier  transcripts  and  made  these  new 
changes.  As  the  coding  frame  became  more  refined  the  number  of  free  nodes  increased 
from  72  to  96. 
2.8.4  Describing,  interpreting  and  reporting  the  data 
As  I  began  to  think  and  write  about  the  data  more  conceptually,  mapping  codes  on  paper 
became  a  useful  way  of  building  up  ideas  and  linking  ideas  into  webs  of  theory.  At  this 
stage  Richards  (1999)  suggests  the  re-coding  of  free  nodes  into  tree  nodes  to  help  clarify 
concepts  and  illustrate  relationships  between  codes  and  their  sub-codes.  However,  I 
decided  not  to  re-code  the  data  on  the  grounds  that  it  seemed  to  offer  little  analytical 
benefit  to  what  already  seemed  a  complex  task.  In  this  respect  it  could  be  argued  that 
NVivo  was  not  used  to  its  full  coding  potential.  Nevertheless,  at  this  stage  I  felt  NVivo 
had  served  its  purpose  in  enabling  me  to  code  the  data  rigorously. 
In  the  early  descriptive  stages  I  found  it  useful  to  count  participants'  comments  to  get  an 
overall  impression  of  the  data.  However,  this  approach  was  only  useful  where 
discussions  had  been  quite  structured.  For  example,  this  approach  was  useful  in  relation 
to  the  question  and  answer  exchange  that  occurred  across  all  the  groups  on  participants' 
perceptions  of  the  various  childhood  infectious  diseases.  However,  most  conversation 
was  more  unstructured,  and  crude  strategies  such  as  tallying-up  would  have  been 
unhelpful  in  offering  a  realistic  representation  of  the  data.  The  only  way  I  found  to  make 
sense  of  this  more  complex  data  was  to  compare  and  write  interpretive  and  descriptive 
summaries  of  this  data.  However,  in  reviewing  the  methodology  of  over  40  published 
reports  that  purported  to  use  focus  groups,  Kitzinger  (1994)  noted  that  none  of  the  studies 
reported  on  the  interactions  between  participants.  She  states  that  she  "...  could  not  find  a 
single  one  concentrating  on  the  conversation  between  participants  and  very  few  that  even 
included  any  quotations  from  more  than  one  participant  at  a  time"  (p.  139).  To  decide  on 
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longer  quotations  should  be  given  and  that  as  a  minimum  the  preceding  turn  of  speech 
should  be  reported.  However,  in  practice  I  felt  the  danger  of  uncritically  adopting  a  set 
procedure  in  my  writing  was  that  it  may  become  bland,  and  moreover  the  chaotic  nature 
of  focus  group  conversation  meant  that  the  preceding  comments  were  not  always 
relevant.  Thus,  I  decided  that  the  majority  of  quotes  would  reflect  the  discussion  between 
participants,  and  that  individual  comments  and  the  preceding  turn  of  speech  would  only 
be  included  where  appropriate.  Similarly,  a  balance  needed  to  be  struck  between  offering 
a  summary  of  the  discussions  and  using  direct  quotes.  I  tended  to  use  direct  quotes  that 
seemed  important,  or  offered  rich  examples  of  the  topic  under  discussion,  and  summaries 
of  discussion  that  were  either  less  important  or  more  amenable  to  being  condensed. 
Another  consideration  in  reporting  the  data  related  to  the  kind  of  language  most 
appropriate  to  convey  the  varying  levels  of  agreement  or  disagreement  between  the 
participants,  and  to  offer  an  accurate  representation  of  participants'  opinions.  Although 
occasionally  participants'  opinions  on  a  given  topic  were  counted,  this  was  only  used  to 
give  an  initial  and  superficial  impression  of  the  data.  In  general  I  felt  that  employing 
numbers  to  portray  an  accurate  picture  of  this  complex  data  in  the  findings  chapters 
would  be  inadequate.  After  reviewing  several  other  researchers'  theses,  I  decided  that 
descriptive  words  such  as  some,  commonly,  rarely  and  exceptionally  would  be  helpful  in 
communicating  this  overall  picture. 
Following  these  principles,  the  next  four  chapters  describe  and  explain  the  findings  from 
the  18  focus  groups. 
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childhood  infectious  diseases 
The  purpose  of  this  chapter  is  to  describe  and  explain  parents'  understanding,  experiences 
and  beliefs  about  childhood  infectious  diseases. 
3.1  Summary  of  literature  on  perceptions  about  childhood  infectious 
diseases 
Understanding  parents'  experiences  and  beliefs  about  childhood  infectious  diseases  is 
important  because  the  success  and  acceptability  of  immunisation  may  depend,  to  some 
extent,  on  parents'  assessment  of  the  diseases  from  which  the  vaccines  aim  to  protect.  As 
Dr  David  Salisbury,  a  leading  specialist  in  infectious  diseases  in  the  Department  of 
Health,  observed: 
If  parents  have  fear  of  disease  but  no  fear  of  vaccines,  the  argument  in  favour  of  vaccination  is 
clear-cut.  If  they  have  no  fear  of  disease  but  also  no  fear  of  vaccine,  there  may  be  inertia.  When 
they  have  no  fear  of  disease,  but  fear  of  vaccines,  parents  are  likely  to  refuse  immunization  (Gellin 
et  al.,  2000  p.  1097) 
Likewise,  Bedford  and  Elliman  (2000)  have  proposed  that  because  many  parents  have  no 
experiences  of  the  diseases  prevented  by  immunisation,  they  do  not  appreciate  how 
damaging  these  diseases  can  be. 
However,  despite  these  assertions  there  are  surprisingly  few  studies  that  have  explored 
parents'  perceptions  of  childhood  infectious  diseases  in  any  depth.  Typically,  studies 
have  tended  to  concentrate  on  parents'  perceptions  of  the  vaccines,  rather  than  on  the 
diseases  (Klein  et  al.,  1989;  Raithatha  et  al.,  2003)  or  alternatively  to  limit  the  focus  to  a 
few  diseases,  most  recently  measles,  mumps  and  rubella  (Pareek  and  Pattison,  2000). 
Where  studies  have  considered  parents'  views  on  a  range  of  vaccine-preventable  diseases 
they  have  tended  to  focus  on  perceptions  of  disease  severity  and  prevalence  rather  than 
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Sporton  and  Francis,  2001).  For  example,  Bond  and  colleagues  (1998)  conducted  a  study 
in  Melbourne,  Australia,  to  investigate  mothers'  perceptions  of  vaccine-preventable 
diseases  in  terms  of  perceived  susceptibility,  severity,  benefits  and  barriers.  They  used  a 
purposive  sampling  strategy  to  include  mothers  of  children  with  different  decision- 
making  outcomes  and  to  include  first-time  mothers  and  more  experienced  mothers. 
Semi-structured  interviews  were  conducted  with  45  mothers.  Bond  and  colleagues  found 
that  mothers  perceived  poliomyelitis,  diphtheria,  tetanus,  and  meningitis  as  serious 
diseases  that  were  life  threatening,  but  with  the  exception  of  meningitis,  considered  that 
their  children  were  unlikely  to  contract  any  of  them.  They  also  found  that  mothers 
assessed  measles,  mumps  and  rubella  as  not  serious.  In  a  recent  UK  study,  Smailbegovic 
and  colleagues  (2003)  explored  parents'  perceptions  about  vaccine-preventable  diseases. 
They  mailed  questionnaires  to  129  parents  living  in  the  London  Borough  of  Hackney 
whose  children  had  not  completed  the  recommended  course  of  immunisation.  Parents 
were  asked  to  rate  the  seriousness  of  each  of  the  vaccine  preventable  diseases  included  in 
the  Childhood  Immunisation  Programme  as  very  serious,  serious  or  mild.  More  than 
50%  of  parents  rated  meningitis  as  the  most  serious  and  rubella  as  a  mild  disease.  The 
fact  that  there  are  no  in-depth  studies  that  explore  parents'  understanding  of,  or  beliefs 
about,  the  specific  diseases  suggests  a  need  for  further  research  in  this  area. 
The  current  study  set  out  to  explore  participants'  perceptions  and  experiences  of  diseases 
more  comprehensively  by  asking  participants  in  each  focus  group  to  describe  their 
images  and  experiences  of  each  of  the  vaccine-preventable  diseases  included  in  the 
Childhood  Immunisation  Programme.  In  order  to  tap  into  participants'  factual 
knowledge  about  each  of  the  diseases,  they  were  asked  to  describe  how  they  would 
recognise  it  and  how  they  thought  it  was  transmitted.  I  was  aware  that  by  asking 
knowledge-based  questions  there  was  the  risk  that  discussion  could  become  derailed  if 
participants  did  not  know  much  about  the  diseases.  So  in  order  to  make  it  as 
unthreatening  as  possible,  this  topic  was  introduced  late  in  the  discussion  once  the  group 
members  appeared  comfortable  with  one  another.  Also,  before  beginning  this  more 
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factual  and  non-factual  issues  were  of  equal  interest  and  importance. 
In  fact,  these  question  and  answer  exchanges  led  to  enlightening  and  lively  discussions 
and  participants  generally  appeared  to  enjoy  them.  Perhaps  most  surprising  was  the  fact 
that  participants  appeared  comfortable  admitting  to  one  another  that  they  did  not  know 
much  about  some  of  the  diseases.  There  were  no  groups  in  which  one  person  appeared  to 
know  vastly  more  than  the  other  members  of  the  group,  and  whilst  some  of  the  older 
participants  in  the  groups  had  vague  recollections  of  some  of  the  diseases,  younger 
participants  appeared  fascinated  to  hear  their  accounts.  Further,  even  when  participants 
had  no  direct  experience  themselves  of  the  diseases  this  did  not  preclude  them  from 
describing  vivid  images  of  the  disease,  albeit  sometimes  inaccurately.  Three  key  themes 
emerged  from  these  discussions  on  disease  perception: 
"  Understandings,  images  and  beliefs  about  diseases 
"  Perceived  threat  of  disease 
"  Experience  of  disease  (both  direct  and  indirect) 
Guided  by  these  themes  this  chapter  presents  an  in-depth  account  of  participants' 
understandings,  beliefs  and  experiences  of  the  individual  diseases  included  in  the 
Childhood  Immunisation  Programme.  Each  of  the  diseases  is  considered  in  order  of 
perceived  disease  severity,  as  described  by  participants,  so  as  to  reflect  their  views  on 
which  of  the  diseases  pose  the  greatest  and  smallest  threat  to  their  children's  health. 
Participants'  accounts  of  diseases  are  interspersed  with  factual  textbook  accounts  of  the 
diseases  to  enable  some  immediate  comparison.  However,  for  a  more  comprehensive 
clinical  and  epidemiological  picture  of  each  of  the  disease  see  Appendix  K.  Throughout 
the  chapter  data  extracts  are  preceded,  or  followed,  by  discursive  commentary  to 
highlight  the  significance  of  participants'  comments  and  to  show  where  their  comments 
link  into  the  wider  debate  on  immunisation.  The  chapter  concludes  with  a  summary  of 
the  main  findings  to  have  emerged  from  these  discussions. 
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to  minor 
Within  each  of  the  groups  participants  were  asked  to  identify  which  of  the  vaccine- 
preventable  diseases  covered  by  the  Childhood  Immunisation  Programme  they 
considered  to  be  the  most  severe.  From  discussions  on  these  topics  it  emerged  that 
participants  categorised  diseases  into  three  quite  distinct  groups,  largely  dependent  on 
whether  the  diseases  were  perceived  as  a  tangible  or  theoretical  threat  to  their  child's 
health.  The  first  category  consisted  of  diseases  that  participants  categorised  as  posing  a 
major  threat  to  their  child's  health.  These  diseases  included  meningococcal  disease  and 
to  a  lesser  extent  measles  and  whooping  cough.  Although  rubella  was  described  as  a  mild 
disease,  it  was  viewed  as  a  major  threat  because  of  the  serious  harm  that  it  could  do  to 
unborn  babies.  The  general  consensus  that  emerged  from  the  focus  groups  was  that 
meningococcal  disease  was  perceived  to  be  the  most  severe  of  all  the  diseases  included  in 
the  programme.  Participants  appeared  to  find  it  easy  to  conceptualise  what  `severe' 
meant  and  equated  it  with  meaning  `life-threatening',  or  with  having  a  long-lasting 
damaging  impact  on  their  child's  health.  Conversely,  participants  conceptualised  `minor' 
as  being  non  life-threatening,  and  not  causing  long-lasting  damage.  Participants  viewed 
mumps  and  haemophilus  influenza  as  minor.  The  third  category  consisted  of  diseases 
that  were  described  as  no  longer  posing  a  threat  to  their  children  whilst  living  in  the 
United  Kingdom.  Diphtheria  and  poliomyelitis  were  both  viewed  as  `no  longer  posing  a 
threat'. 
3.3  Diseases  considered:  `A  major  threat' 
3.3.1  Meningococcal  disease  group  C:  A  tangible  threat  `a  killer' 
In  Scotland  there  are  between  300  and  400  notifications  of  meningococcal  disease  each 
year,  of  which  sera-type  group  C  is  most  common,  causing  acute  bacterial  meningitis. 
The  symptoms  usually  start  abruptly  and  as  the  severity  of  the  disease  progresses  the 
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impaired  hearing  (see:  www.  show.  scot.  nhs.  uk/scieh/surveillance). 
With  the  exception  of  the  Non-Vaccine  Group,  there  was  very  little  variation  between  the 
groups  in  suggesting  meningococcal  disease  and  its  associated  meningitis  was  the  most 
severe  of  the  diseases.  Participants  most  often  cited  meningitis  caused  by  meningococcal 
disease  as  `life-threatening': 
Facilitator.  Which  of  those  then  do  you  think  are  the  most  severe,  or  which  are  the  ones  that  you 
would  worry  about  most.  Is  that  the  same  thing? 
Angie:  I'd  say  personally  the  meningitis  and  measles. 
Facilitator.  What  about  everyone  else,  is  that...? 
Tracy:  I'd  say  meningitis.  (Everyone  nodding  yes) 
Lydia:  Meningitis. 
Facilitator.  What  is  it  then,  about  that? 
Angie:  They  can  be  life-threatening  mair  than  anything  else. 
Facilitator.  Mhm.  Is  that  the  same  for  everyone? 
Samantha:  Uhuh.  (All  the  group  agreeing-nodding  heads) 
Crafts  Group:  Angie  aged  29;  Tracy  aged  32;  Lydia  aged  39;  Samantha  aged  24 
Not  only  was  there  a  high  level  of  agreement  between  the  groups  that  meningococcal 
disease  was  the  most  severe,  but  also  within  each  of  the  groups.  This  agreement  between 
participants  was  particularly  noticeable  in  the  Low  Uptake  Area  Group: 
Facilitator.  So  which  of  these  ones  do  you  think  are  severe  and  which  would  you  say  are 
mild?  Are  any  of  them  mild,  and  are  any  of  them  severe? 
Joan  :  They've  all  got  different  bad  points. 
Sheila:  I  think  you  think  of  the  meningitis  as  being  the  ... 
Joan:  The  killer...  (interrupted  by  Sheila) 
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Alan  :  The  killer  aye.  I  would  say  that  would  be  the  worst.  (All  nodding  their  heads  in  agreement) 
Low  Uptake  Area  Group:  Joan  aged  20;  Sheila  aged  36;  Alan  aged  33 
In  this  particular  group,  agreement  between  participants  tended  to  be  validated  by  group 
members  using  encouraging  body  language,  such  as  approving  nods  of  the  head,  by 
repeating  the  same  words,  and  by  rapidly  completing  each  other's  sentences. 
Meningococcal  disease  was  directly  associated  with  meningitis.  Participants  almost 
without  exception  were  able  to  accurately  describe,  in  detail,  the  disease  process  from 
first  signs  of  the  infection  to  coma  or  eventual  death.  The  symptoms  they  described 
included  a  red  rash,  severe  headache,  stiff  neck  and  light  sensitivity  (photophobia). 
Perhaps  unsurprisingly,  meningococcal  disease  was  described  as  "...  your  worst  fear" 
(First-Time  Mothers  Group;  Catrina  aged  27)  and  was  commonly  associated  with  a 
speedy  death.  Participants  spoke  at  length  on  this  disease  and  attributed  their  knowledge 
to  the  high  profile  Men  C  publicity  campaign.  Jill  described  the  posters  advertising  Men 
C  vaccine  as  being  "etched  in  ma  brain"  (Outpatient  Cancer  Group;  Jill  aged  38). 
Similarly,  Aleena  stated  "well,  it's  a  lot  more  publicised  isn't  it?  You  see  the  signs  and 
symptoms  of  meningitis  everywhere  really.  Don't  you?  It's  well  publicised"  (Non-MMR 
Group;  Aleena  aged  35). 
Whilst  it  was  common  for  participants  to  be  aware  of  the  Men  C  campaign  and 
knowledgeable  about  meningococcal  disease,  participants  in  the  Non-Vaccine  Group 
appeared  oblivious  to  the  campaign  despite,  as  parents  of  young  children,  being  a  prime 
target  of  the  1999  campaign.  Kitty  reviewed  the  immunisation  schedule  handed  out 
during  the  focus  group  and  noted: 
Kitty:  Em,  I  don't  really  know  anything  about  this  meningitis  C  (pointing  to  schedule)  to  be 
honest,  really,  all  I  know  is  that  it's  something  that  students  have  been  getting,  or  something.  I 
don't  really  know  anything. 
Debbie:  Big  people.  Small  people  don't  get  it. 
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yeah.  It  wouldn't  have  applied  when  my  children  were  born,  em... 
Molly:  Well  none  are  really  life  threatening  as  such  now...  (goes  on  to  talk  about  diphtheria  and 
whooping  Cough). 
Non-Vaccine  Group:  Kitty  aged  37,  three  children  younger  than  6  years  old;  Debbie  aged  33, 
four  children  younger  than  5  years  old;  Lola  aged  32,  three  children  younger  than  6  years 
old;  Molly  aged  37,  two  children  younger  than  5  years  old 
The  comments  made  by  the  Non-Vaccine  Group  inaccurately  suggested  that  students 
were  the  only  people  at  risk  from  meningococcal  disease.  They  also  inferred  that  their 
own  children  were  neither  at  risk  from  the  disease,  nor  eligible  for  the  vaccine.  Despite 
these  inferences  and  given  the  age  range  of  their  children,  it  is likely  that  they  would  have 
been  offered  the  vaccine  on  several  occasions.  However,  it  is  possible  that  they 
appeared  less  aware  about  meningococcal  disease  and  Men  C  due  to  the  fact  that  they 
preferred  to  seek  alternative  health  care  services,  and  may  have  been  less  exposed  to  the 
advertising  campaign.  Further,  since  none  of  them  subscribed  to  orthodox  immunisation 
practices,  preferring  to  use  homeopathic  alternatives  instead,  such  immunisation 
campaigns  may  have  limited  appeal  and  influence.  For  example,  Debbie,  a  33-year-old 
mother  of  four  described  herself  as  "anti-immunisation",  and  described  immunisation 
advertising  as  "propaganda"  and  on  vaccination  felt  that  "the  whole  concept  may  be  a  bad 
idea".  This  group  generally  talked  dismissively  about  the  need  for  orthodox  vaccines  in  a 
wealthy,  healthy,  Western  society  and  suggested  that  none  of  the  diseases  really  posed 
much  threat  to  healthy  children.  Thus,  Molly  did  not  believe  that  immunisation  was  in 
her  children's  best  interests  and  she  displayed  a  degree  of  scepticism  about  the  publicity 
about  the  Men  C  vaccine: 
It's  not  the  one  that's  the  danger.  The  meningitis  C  is  just  the  one  that  they've  got  the  vaccination 
for  so  they're  giving  it  to  all  these  children  and  you  don't  get  it  (the  vaccine)  if  you're  a  teenager 
so  why  are  they  vaccinating  two  month  old  babies  who  are  already  getting  all  these  other,  other  5 
anyway,  why  are  they  doing  that? 
Non-Vaccine  Group;  Molly  aged  37 
Nevertheless,  for  the  most  part  participants  across  the  groups  identified  immunisation 
campaigns  and  media  coverage  as  the  key  sources  in  raising  their  awareness  about 
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publicity  and  attention  afforded  to  a  specific  disease.  Paradoxically,  whilst  the 
participants  in  the  Non-Vaccine  Group  appeared  sceptical  about  the  motives  behind 
immunisation  campaigns,  other  participants  viewed  the  Men  C  campaign  as  proof  that 
health  `experts'  were  concerned  about  the  risks  posed  by  meningococcal  disease.  As 
William  explained: 
To  me  that's  scary,  (referring  to  meningococcal  disease)  you  know  what  I  mean?  'Cause  that's  in 
the  newspapers  and  when  somebody's  got  meningitis,  whether  it's  meningitis  C...  that's  the 
impression  I  get,  it's  meningitis  C  or  it  could  be.  You  know  what  I  mean?  And  as  soon  as 
somebody's  got  it,  they're  up  in  arms and  they're  trying  to  investigate  it.  Where  did  this  come  from 
and  how  many  people  have  got  it?  So  therefore  to  me,  to  me  that's  one  of  the  major  eh,  diseases 
out  of  the  group  that's  oot  there. 
Single  Fathers  Group:  William  aged  51 
Similarly,  the  issue  of  the  Men  C  campaign  and  its  perceived  relationship  to  disease 
severity  was  raised  in  a  first-time  mothers'  group: 
Ros:  It's  a  severe  one  (referring  to  meningococcal  disease). 
Margaret:  Ah  widnae  have  known  it  wiz  severe-  know  like  when  ye  go  intae  the  doctors  there's 
always  posters  and  there's  always... 
Facilitator.  Right. 
Margaret:  Ah  widnae  have  known  it  was  so  severe  if  there  wisnae  aw  that-  know  how  their 
campaigns... 
First-time  Mothers  Deprived  Area:  Ros  aged  20;  Margaret  aged  20 
Whilst  the  general  consensus  across  the  groups  was  that  meningococcal  disease  was 
severe,  there  were  no  participants  who  had  direct  experience  either  themselves  or  as 
parents  of  their  child  contracting  meningococcal  disease  or  meningitis.  However,  across 
the  groups,  participants  justified  their  decision  for  selecting  meningoccoal  disease  as  the 
most  severe  disease  by  reasoning  that  they  had  either  heard  of,  or  knew  of  someone  who 
had  died  or  nearly  died  as  a  consequence  of  contracting  meningitis.  Discussions  relating 
to  meningoccoal  disease  tended  to  produce  rich  descriptive  anecdotes  and  indirect 
accounts  of  experiences  of  meningitis.  Participants  appeared  to  be  particularly  fearful  of 
83 meningitis  because  they  had  heard  stories  about  it  being  misdiagnosed,  or  they  were 
worried  about  the  speed  at  which  an  individual  could  become  seriously  ill  or  die  from  it: 
Facilitator.  What  diseases  do  you  feel,  most  concerned  about? 
Joanne:  Meningitis. 
Facilitator.  Why  do  you  think  that  is? 
Elaine:  I  think  because  the  diagnosis  of  it  is  so  difficult.  It  seems  to  strike  so  fast,  so  quickly  and 
again  I  know  someone  who  lost  a  baby  at  four  months  because  of  that. 
Joanne:  Yes,  my  husband  got  meningitis  twice  when  he  was  a  teenager,  not  the  bacterial  one,  the 
other  one.  Also,  someone  at  work  had  to  rush  their  child  into  hospital  recently.  Just  the  thought  of 
not  knowing  that  the  rash  is  the  rash,  or  they  have  a  temperature  or  that  they  have  the  symptoms 
and  you  didn't  realise.  You  hear  of  stories  of  parents  going  to  their  doctors  and  the  doctors  telling 
them  to  go  home,  boom-  next  thing  they  are  in  hospital  a  few  hours  later. 
Elaine:  Well,  my  mum  had  an  older  brother  who  died  of  meningitis  and  my  nanny  was  a  nurse 
and  it  was  exactly  that,  and  God  love  her,  she  said  she  knew  it  was  something  else,  but  in  those 
days  especially-  you  didn't  question  the  GP. 
Joanne:  Well,  that's  right  you  trust  them  don't  you. 
Elaine:  Yes,  within  about  a  week  of  him  (referring  to  own  baby)  coming  home  from  hospital  I 
was  checking  him. 
New  Mothers  Group:  Joanne  aged  37;  Elaine  aged  34;  Beathan  aged  29 
The  Single  Vaccine  Group  also  expressed  similar  fears  about  the  difficulty  of  diagnosis 
and  the  speed  at  which  meningitis  can  affect  an  individual: 
Dave:  Meningitis,  that's  the  one  I  worry  about  the  most. 
Facilitator.  Why  do  you  think  you  worry  most  about  meningitis? 
Joe:  I  think  well  that's  probably  one  of  the  worst  because...  I  know  somebody  that,  you  know, 
had  had  it  and...  he  had  it  for  two  days  and  his  dad  was  an  ambulance  driver  and  luckily  they 
managed  to  sort  of  get  it  in,  you  know,  get  him  in-  in  time  and  he  was  alright. 
Jenny:  I  think  the  reason  that  I  worry  about  it  as  well  is  that  I  know  a  wee  girl  who  went  to  the 
church  and  she  had  it  and  was  really  ill  with  it.  I  think  the  reason  why  I  worry  about  it  most  is  it's 
the  hardest  to  diagnose.  And  you  know,  you  know,  with  the  rash,  when  it  forms,  you  know,  if  it 
doesn't  go  away  but  you  know,  sometimes  that  doesn't  happen  till  it's  too  late  so  I  think  it's  the... 
I  think  it's  the  fact  that  it's  quite  deadly  and  it's  difficult  to  diagnose.  Yeah,  I  mean  that's  the  one 
84 that  any  time  my  boy's  ill,  he  might  just  have  the  cold  but  if  he  gets  a  rash  with  it,  that's  me  -  I'm 
out  with  the  glass,  you  know?  Checking-over. 
Facilitator.  Is  there  any  other  ones  that  you  think  are  equally  severe,  like  meningitis? 
Joe:  No,  just  meningitis.  I  think...  I  think  it's  a  difficulty  in  diagnostics.  I  mean  things  like 
mumps,  you  know,  you  don't  really  hear  -  do  you  -  people  really  dying  with  mumps,  not  really... 
Single  Vaccine  Group:  Dave  aged  38;  Jenny  aged  19;  Joe  aged  36 
Perhaps  the  most  harrowing  story  demonstrating  the  speed  with  which  meningitis  can 
affect  a  child  and,  in  this  case,  the  slow  response  of  the  medical  profession  to  a  call  for 
help,  was  told  by  Ros,  when  she  recalled  the  night  her  boyfriend's  nephew  died: 
Ros:  Ah  know  somebody  that  had  meningitis.  Ma  boyfriend's  wee  nephew. 
Facilitator.  Yeah? 
Ros:  He  died  wi  it  when  he  was  four.  In  the  hoose. 
Natalie:  Ah  don't  know  anybody. 
Ros:  And  the  doctors,  they  were  terrible  that  night. 
Facilitator.  Right. 
Ros:  Erm,  he  had  a  high,  high  temperature  and  he  wiz  sick  a  lot  and  they  phoned  the  emergency 
doctor  tae  come  oot  tae  him,  and  they  took  two  oors  tae  come  oot.  And  when  they  came  oot  they 
said  it  was  jist  a  cauld.  And  he  wiz  tae  lie  up  on  the  couch  and  if  he  got  any  worse  tae  phone  them 
back.  So  they  left  and  the  wean  was playing  on  the  toybox  oot  in  the  hall  wi  ma  boyfriend,  munits 
latter  the  wean  died  in  his  arms  and  he  brought  him  back,  and  then  they  had  tae  phone  an 
ambulance  and  they  took  hauf  an  oor  tae  come,  and  when  the  ambulance  came  the  wean  had  died 
and  the  rash  had  all  come  oot  in  him.  But  it  never  came  oot  until  eftir  he  died. 
Facilitator.  Yeah. 
Ros:  So  it  wiz. 
Facilitator.  What  is  it  about  that  do  you  think  then?  Is  it  the  speed  or  is  it  the...? 
Ros:  It's  jist  how  quick  it  affects  them.  Do  ye  know  what  Ah  mean? 
(over-talking) 
Ros:  Like  as  Ah  says,  his  wee  nephew  wiz  no  well  one  minute  and  the  next  minute  he  had  died. 
Facilitator.  Yeah. 
85 Natalie:  Ah  know,  like  see... 
Ros:  Within  an  oor. 
Young,  Single  Mothers  Group:  Ros  aged  20;  Natalie  aged  18 
What  appeared  to  be  particularly  unsettling  about  meningitis,  setting  it  apart  from  the 
other  diseases,  was  the  fact  that  so  many  participants  knew  of  a  harrowing  story 
involving  a  young  child  where  the  outcome  resulted  in  long-term  damage,  or  was  fatal. 
Therefore  participants  could  appreciate  how  damaging  the  disease  was,  which  in  turn, 
made  the  disease  a  tangible  threat  to  their  own  children.  As  such  participants  feared 
meningococcal  diseases  and  often  mentioned  that  they  were  glad  their  children  were 
protected  with  the  Men  C  vaccine.  As  Ros  stated:  "That  was  the  one  right,  like,  you 
would  insist  on  getting"  (Young,  Single  Mothers  Group;  Ros  aged  20).  Similarly, 
Michelle  believed  meningococcal  disease  was  the  most  prevalent  of  the  diseases  and 
suggested:  "The  others  are  not  so  much  aboot,  but  meningitis  is  bad  if  yer  wean  gets  it.  I 
think  it  kills  most  weans"  (Multiple  Parenting  Problem  Group;  Michelle  aged  21). 
In  summary,  participants  were  knowledgeable  about  meningococcal  disease  and 
accurately  described  its  symptoms.  The  main  reasons  why  participants  feared 
meningococcal  disease  was  that  they  had  read  or  heard  about  it  leaving  children  with 
severe  long-term  neurological  disability  or  causing  death.  Participants  were  also  anxious 
about  the  speed  with  which  meningitis  can  affect  a  child  and  about  the  difficulty  in 
diagnosing  it  early  enough  to  manage  it  effectively.  These  fears  largely  stemmed  from 
hearing  stories  about  the  children  of  other  parents.  The  fact  that  the  Men  C  vaccine  was 
so  well  publicised  led  participants  to  consider  meningococcal  disease  posed  a  real  danger 
to  their  children's  health  and  as  such,  most  participants  were  keen  to  vaccinate  and 
protect  their  children  from  it. 
86 3.3.2  Rubella:  `Is  that  the  same  as  German  measles?  ' 
Rubella  is  a  mild  disease  characterised  by  a  discrete  macular  rash.  However,  if  rubella  is 
contracted  during  early  pregnancy  it  can  result  in  fetal  damage  in  up  to  90%  of  cases 
(congenital  rubella  syndrome).  The  baby  may  be  still-born  or  suffer  from  severe  life-long 
handicap.  Clinical  diagnosis  is  unreliable  since  the  symptoms  are  often  fleeting  and  can 
be  caused  by  other  viral  infections  (Salisbury  and  Begg,  1996). 
Rubella  is  commonly  known  as  German  measles  due  to  the  great  interest  German 
physicians  had  in  the  disease  during  the  mid-18`h  to  mid-19`h  centuries  (Feigin  and 
Cherry,  1998).  However,  its  name  caused  confusion  as  participants  were  often  unsure 
whether  rubella  was  the  same  disease  as  German  measles  and  whether  measles  was  a 
slang  term  for  German  measles.  For  instance,  Debbie  implied  that  German  measles  was  a 
separate  disease  from  rubella  when  she  stated: 
Em,  I  remember  em  being...  having  spots,  florid  kind  of  rash  but,  em,  you  know,  I  was  lucky,  I 
think  I  was  off  school  for  a  couple  of  weeks  with...  I  had  German  measles  and  I  had  rubella  as 
well  and  I  don't  remember  it  being  particularly  distressing  but  primary  school,  em  ... 
(interrupted) 
Non-Vaccine  Group,  Debbie  aged  33 
Similarly,  there  was  a  degree  of  confusion  among  a  group  of  participants  whose  children 
were  recovering  from  cancer  about  the  differences  between  German  measles  and 
measles: 
Cara:  I  think  I...  I...  my  mum  says  she  didnae  know  if  I  had  measles  or  German  measles,  I  don't 
know  the  difference  between  them. 
Jill:  German  measles  I  think... 
Cara:  Is  that  rubella? 
Jill: 
...  you  can  miss  it  cos  it  can  come  quickly,  aye,  well  that's  the... 
(over-talking) 
87 Cara:  Is  that  one,  you  get  the  rubella  injection,  does  it  affect  your  fertility  or  something  that  you 
can  damage  your  children  if  you're  pregnant  and  you  get  German  measles,  doesn't  it? 
Jill:  Mmm,  you  don't  want  to  have  German  measles  if  you're  pregnant. 
Cara:  Is  it  blindness  it  causes  or  something? 
Jill:  But  you  don't  hear  of  people  having  it,  so  that's  why...  mostly  why  we're  not  too  sure.  I 
mean  I'm  not  sure  because  I'm  covering  my  mouth  (covering  her  mouth  with  her  hand,  laughter). 
It's  almost  like  you're  telling  a  He. 
Cara:  People  don't  have  the  confidence  to  say  it  because  they  don't  really  know. 
Outpatient  Cancer  Group:  Jill  aged  38;  Cara  aged  36 
The  confusion  some  participants  felt  between  measles  and  rubella  may  in  part  explain 
this  story  recalled  by  Sheila,  which  occurred  during  her  second  pregnancy: 
... 
it  was  actually  Jordan.  And  he  was  about  a  year  old  at  the  time.  And  I  was  bathing  him  and  he 
was  really  blotchy  and  that  and  I  phoned  the  doctor  out.  Eh  and  I  was  about  8  or  9  weeks 
pregnant.  And  he  was  just  out  the  bath  and  he  was  sitting  in  his  towel.  She  says  "No  he's  got  the 
German  measles  at  the  top  and  the  measles  at  the  bottom.  "  And  I  thought  `fine'.  And  because  I 
had,  because  I  was  pregnant  em  she  basically  said  "there's  no  point,  we  can't  give  you  the  jag  now 
against  it.  You  should  have  had  it  at  school.  "  I  said  "I  did  have  it  at  school". 
Low  Uptake  Area  Group;  Sheila  aged  36 
Whilst  the  complexity  of  this  story  makes  it  difficult  to  interpret  fully,  it  was  interesting 
that  nobody  in  the  group  questioned  her  report  of  her  baby  having  the  top  half  of  his  body 
infected  with  German  measles  whilst  simultaneously  having  the  bottom  half  infected  with 
measles.  The  most  likely  explanation  to  account  for  this  was  the  participants'  difficulty 
in  distinguishing  between  rubella  and  measles. 
In  the  groups  that  were  able  to  establish  that  rubella  was  the  same  disease  as  German 
measles,  participants  were  usually  able  to  describe  accurately  the  mode  of  transmission 
and  the  long-term  damaging  effects  of  rubella  on  the  foetus  if  contracted  during 
pregnancy.  The  female  participants  often  recalled  having  their  rubella  vaccination  at 
88 school  and  having  their  subsequent  immunisation  status  checked  during  pregnancy.  The 
fact  that  participants  knew  that  contracting  rubella  during  early  pregnancy  could  result  in 
long  term  foetal  damage  led  this  otherwise  trivial  infection  to  be  generally  viewed  as  a 
severe  disease.  However,  this  knowledge  also  led  some  participants  to  view  rubella  as  a 
disease  only  affecting  girls  and  women,  and  to  question  the  need  for  boys  to  have  the 
vaccine  at  all.  As  Sue,  a  mother  of  three  boys,  suggested: 
Sue:  I  think  you  see,  they  give  you  this  funny  mixed  message,  em...  they  say  `the  MMR,  measles 
is  a  dreadful  disease,  you  know,  the  effects  of  measles,  there  was  an  epidemic  in  Dublin,  you 
know,  the...  '  you  know,  all  this  sort  of  stuff.  But  then  if  you  actually  research  into  it  a  wee  bit 
further,  you'd  discover...  well  I  think  what  I've  discovered  is  that  it's  not  the  measles  that  they're 
actually  worried  about,  it's  the  German  measles,  rubella,  that's  what  they  really  want  you  to  take  it 
for.  But  it's  almost  like  they've  got  this  scare  tactic,  we'll  frighten  them  into  getting  it  because  of 
measles  but  it's  because  of  rubella.  They're  not  going  to  do  it  for  rubella  and  that's  what... 
because  that's  what  they're  really  trying  to  immunise  for,  em,  and  they've  combined  it  in  this  nice 
convenient  package. 
Facilitator.  So  you  think  part  of  it  is  that  combining  it  encourages  you  to  get  ones  that  you  might 
not  get  necessarily? 
Sue:  Yes,  because  they  wouldn't  get  take-up  because  the  parents  of  boys  wouldn't  take  their 
babies  to  get  immunised  for  rubella  because  the  parents  would  consider  it  irrelevant  and  so  in 
order  to  get  the  rubella  vaccine  out,  em...  they're  sort  of  touting  it  basically  as  being  measles.  It's 
the  scary  one. 
Non-MMR  Group;  Sue  aged  36 
These  comments  not  only  imply  an  understanding  that  rubella  is  a  mild  disease,  other 
than  if  contracted  during  pregnancy  by  unvaccinated  mothers,  but  also  the  fact  that 
rubella  vaccination  of  boys  is  a  wholly  altruistic  act  in  that  it  has  no  direct  benefit  to  the 
boy  himself.  Sue's  assertions  are  interesting  in  that  they  highlight  a  dilemma  faced  by 
parents  of  boys.  Sue  was  concerned  about  autism  and  aware  that  it  affects  more  boys 
than  girls,  and  so  she  perceived  MMR  to  be  additionally  risky  for  her  boys.  Couple  this 
with  her  perception  that  the  rubella  component  may  be  irrelevant  for  her  sons  and  it  goes 
some  way  to  explaining  why  she  felt  that  the  argument  for  getting  MMR  to  confer 
immunity  to  others  was  not  persuasive. 
89 Another  related  idea  that  emerged  from  discussions  on  rubella  was  that  instead  of 
routinely  immunising  all  children  with  rubella,  women  could  be  given  it  as  part  of  pre- 
conceptual  care.  For  example  some  participants  thought  rubella  vaccine  efficacy  was 
limited  and  not  long-lived  and  therefore  suggested  giving  it  to  young  children  was  of 
limited  use.  The  following  conversation  occurred  in  a  group  of  first-time  mothers  who 
were  asked  to  describe  their  images  of  rubella: 
Celia:  Rubella?  Oh  that's  just 
... 
Charlotte:  Bad  for  girls  to  have.  That's  why  girls  got  vaccinated. 
Rhona:  Birth  defects  in  your  baby  if  you  catch  it  when  you  are  pregnant  because  you  checked 
birth  defect  that's  why  if  you're,  if  you're  planning  a  pregnancy  they'll  try  and  check  you 
beforehand. 
Charlotte:  Because  we  all  got  done  when  we  were  at  school  about  13  years-  that's  why  yeah. 
Rhona:  But  a  lot  of  people  like  don't  keep  their  immunity  and  like  throughout  pregnancy  they 
have  got  to  be  immunised  again. 
Catrina:  They  check  you  while  you  are  pregnant  I  don't  know  why  they  bother  because...!  don't 
know  why  they  bother. 
Rhona:  So  you  know  if  you  come  near  anybody  there's  nothing  they  can  do  about  it  but  if  you  go 
near  anybody  you  know.  Don't  like  to  stay  away  from  them  because  it  can  cause  growth  problems 
in  the  baby. 
First-Time  Mothers  Group:  Rhona  aged  31;  Catrina  aged  27;  Charlotte  aged  34;  Celia  aged 
33 
In  another  debate  about  rubella  vaccine  efficacy,  Aleena,  a  35-year-old  mother  of  three 
girls  considered  that: 
... 
if  girls  got  rubella  when  they  were  children,  they  would  have  life-long  immunity,  not  just 
immunity  until  they're  12  or  whatever,  but  they  would  have  life-long  immunity  and  eh...  ' 
(Interrupted  by  child  screams). 
Non-MMR  Group;  Aleena  aged  35 
Although  the  age  range  of  the  participants  that  took  part  in  the  focus  groups  meant  that 
many  of  them  thought  that  they  had  had  rubella  as  a  child,  participants  found  it 
particularly  difficult  to  recall  their  experience  of  having  rubella.  Often  this  led  to 
90 confusion  about  whether  it  was  measles  or  rubella  they  had  actually  had.  For  example, 
William  recalled: 
I  think  it  was  German  measles  I  had.  There  was  a  wee  rash  and...  I  think...  noticed  it,  I  was  in  ma 
pyjamas.  I  just  thought  it  was  a  wee  scab.  And  it  was  at  the  time  there  was  an  epidemic  in  the 
school,  because  everybody  was  aff  a  fortnight... 
Single  Fathers  Group;  William  aged  51 
William  appeared  unsure  whether  he  had  had  rubella  and  the  description  given  by  him 
was  vague  so  it  is  difficult  to  establish  whether  he  was  recalling  rubella  or  some  other 
viral  infection.  More  precise  accounts  of  rubella  were  offered  by  Jul,  who  warned:  "you 
can  miss  it  cos  it  can  come  quickly"  (Outpatient  Cancer  Group;  Jill  aged  38).  Similarly 
Rebecca  recalled:  "it's  sort  of  a  ...  pinpoint  rash  and  you're  not  usually  unwell  with  it 
particularly,  I  think"  (Cancer  Support  Group;  Rebecca  aged  49).  Although  a  few 
participants  were  able  to  recall  the  experience  of  having  rubella,  it  was  more  often  the 
case  that  participants  were  either  unsure  whether  they  had  it,  or  knew  they  had  had  it  but 
could  not  remember  their  experience  of  it.  Perhaps  the  most  likely  explanation  of  this 
gap  in  memory  lies  in  the  mild  nature  of  the  disease  itself.  Since  rubella  is  a  mild  disease 
often  the  only  symptoms  are  a  discrete  rash  and  a  feeling  of  generally  being  unwell  and  it 
is  therefore  not  memorable.  Indeed,  Mandal  and  Mayon-White  (1984)  suggest  that  whilst 
many  people  will  show  serological  evidence  of  previous  infection  they  will  not  be  able  to 
recall  a  history  of  infection  and  so  this  disease  can  be  difficult  to  diagnose  clinically. 
The  participants'  silence  on  this  matter  is  interesting  because  it  feeds  into  a  greater 
problem.  Namely  that  since  rubella  symptoms  are  inconspicuous  attempting  to  reduce 
the  transmission  of  this  disease  from  young  children  to  pregnant  women  is  difficult;  this 
is  one  of  the  reasons  why  rubella  was  included  in  the  Childhood  Immunisation 
Programme  in  the  first  place.  However,  across  the  groups  no  one  noticed  that  its  mild 
nature  and  inconspicuous  transmission  could  itself  pose  a  problem.  Ironically,  it  was 
suggested  that  the  transmission  of  rubella  was  more  controllable  because  women  could 
91 plan  pregnancies  and  plan  to  have  their  immune  status  checked  prior  to  conception.  For 
example,  Debbie  reasoned: 
...  at  least  with  the  girls,  they  can  choose  their  own  course,  you  know,  em,  if  they're  going  to  start 
a  family,  they  can  make  their  own  decision  if  they  believe  in  vaccination,  they  can  you  know,  get 
rubella  vaccination  then,  but  with  boys,  you  know,  I  don't  think  it  would  be  safe  for  them  to  get  a 
mumps  vaccination  if  that's  what  they  wanted  to  do... 
Non-Vaccine  Group;  Debbie  aged  33 
However,  even  disregarding  its  inconspicuous  presentation  and  thus  transmission,  this 
argument  ignores  the  fact  that  vaccines  do  not  work  one  hundred  percent  of  the  time  and 
some  vaccinated  individuals  do  not  produce  an  adequate  antibody  response  to  offer 
protection  to  the  disease. 
In  summary,  participants  appreciated  that  this  otherwise  mild  disease  had  serious 
implications  for  pregnant  women  and  their  unborn  children,  and  thus  described  it  as  a 
serious  disease  against  which  children  should  be  immunised.  However,  a  few 
participants  questioned  the  need  for  boys  to  have  the  vaccine  at  all,  believing  girls  should 
be  the  primary  target,  with  women  planning  to  become  pregnant  the  secondary  targets  of 
the  rubella  immunisation  programme.  However,  whilst  participants  implied  that  rubella 
symptoms  are  mild  and  inconspicuous,  there  was  a  lack  of  appreciation  that  this  could 
pose  a  problem  in  preventing  the  transmission  of  this  disease  to  pregnant  women. 
3.4  Diseases  considered:  `Less  of  a  major  threat' 
3.4.1  Measles:  `itchy  spots'  and  `calamine  lotion' 
Measles  is  a  highly  contagious  viral  disease  transmitted  by  droplet  infection.  It  is 
characterised  by  Koplik  spots,  fever,  upper  respiratory  catarrh  and  conjunctivitis. 
Complications  are  reported  in  one  in  15  notified  cases  and  include:  otitis  media, 
bronchitis,  pneumonia,  febrile  convulsion,  encephalitis,  subacute  sclerosing 
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Begg,  1996). 
Participants  generally  described  the  symptoms  accurately  and  associated  measles  with 
spots  which  were  often  described  as  `itchy  spots'.  Some  participants  spoke  of  cold-like 
symptoms  and  mentioned  that  the  eyes  were  affected,  but  there  was  a  lack  of  consensus 
about  whether  the  eyes  were  runny  or  dry.  Measles  was  regarded  by  some  participants 
as  not  serious  whilst  for  others  as  a  serious  disease  on  the  basis  that  in  severe  cases  it 
could  cause  long-term  sensory  damage,  or  be  fatal.  For  example,  Judith  considered: 
"measles  has  got  like  horrendous  side  effects.  It  can  make  you  blind,  it  can  make  you 
ill 
... 
it  can  be  fatal"  (First-Time  Mothers  Group;  Judith  aged  34).  Similarly,  Lydia 
suggested  that  measles:  "can  make  you  go  deaf  and  all  that,  you  can  go  deaf  wi  that.  It 
can  affect  your  hearing  and  that...  "  (Crafts  Group;  Lydia  aged  39).  Likewise  Rebecca 
and  Pamela  also  mentioned  that  it  could  cause  blindness  and  deafness  (Cancer  Support 
Group;  Rebecca  aged  49;  Pamela  aged  42). 
It  is  not  clear  why  this  extremely  rare  complication  was  discussed  in  so  many  of  the 
groups,  because  unlike  meningococcal  disease,  no  one  mentioned  that  they  knew  of 
anyone  that  had  suffered  long-term  damage  as  a  consequence  of  measles.  It  seems 
unlikely  that  participants  were  simply  confusing  measles  with  the  symptoms  of 
congenital  rubella  because  participants  spoke  passionately  and  unambiguously  when 
discussing  measles,  in  a  way  they  had  not  done  when  discussing  rubella.  However,  in  the 
absence  of  any  obvious  explanation  and  in  view  of  the  fact  that  participants  mentioned 
that  they  had  gained  much  of  their  knowledge  on  matters  of  immunisation  from  the 
media,  one  explanation  might  lie  in  the  way  measles  has  been  portrayed  during  the  MMR 
debate.  In  response  to  poignant  stories  of  children  seemingly  being  adversely  affected  by 
MMR,  media  coverage  about  measles  has  often  highlighted  the  more  extreme 
complications  of  the  disease.  Emotive  stories  involving  children  who  have  developed 
rare  complications  of  measles  such  as  encephalitis,  subacute  sclerosing  panencephalitis 
and  associated  subsequent  long-term  sensory  damage,  have  had  a  more  prominent  place 
in  the  debate.  These  emotive  media  stories  of  measles  causing  severe  and  long-term 
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complications  appear  to  have  taken  such  precedence  in  the  minds  of  participants. 
Out  of  all  the  diseases  covered  by  the  Childhood  Immunisation  Programme  measles  was 
the  disease  participants  were  mostly  likely  to  report  having  had  direct  experience  of  as 
children  themselves,  and  as  parents  with  their  own  children.  In  contrast  to  meningococcal 
disease,  in  which  having  experience  (albeit  most  commonly  third-hand  experience)  made 
the  disease  a  more  tangible  threat,  experience  of  measles  often  made  it  less  threatening. 
Whilst  participants  with  no  experience  of  measles  tended  to  contemplate  the  long-term 
damage  that  it  could  inflict,  those  with  experience  of  it  tended  to  minimise  these  risks. 
For  example,  when  asked:  which  of  the  diseases  are  mild?  Hannah,  replied: 
For  me  I  think  ...  the  MMR,  measles  and  mumps,  I  don't  know  about  rubella  but,  you  know.  I've 
had  measles  and  mumps  when  I've  been 
... 
I  was  younger  and  I've  not  had  any  ...  and  I  don't 
know  any...  All  my  peers  all  had  measles  almost  and  have  survived  and  I 
... 
I'm  not  sure  of  the 
seriousness  of  it... 
Non-MMR  Group;  Hannah  aged  40 
Remarkably,  in  light  of  the  low  prevalence  rates  of  measles  over  the  past  few  years,  there 
were  seven  participants  who  reported  that  one  or  more  of  their  children  had  had  measles 
recently.  The  following  story  was  recalled  by  Cara,  whose  daughter  Emma  was 
recovering  from  leukaemia: 
Cara:  Well,  Emma  had  measles  the  last  time.  She  had  her  MMR  and  then  she  got  measles,  em,  it 
makes  me wonder  if  I  should  have  spotted  something  before  she  was  actually  diagnosed  (referring 
to  Leukaemia)  as  well,  you  know,  but  they've  said  'No,  there's  no  connection'. 
Facilitator.  What  did  you  think  the  connection  was? 
Cara:  It  was  just  that  there  was  something  wrong  with  her  system  but  that  was  only  with 
hindsight.  Because  I  remember  taking  her  to  the  doctor  and  he  said  'Oh  it's  measles,  '  I  said  'How 
could  she  have  measles  when  she's  had  her  MMR,  '  and  he  said  'Oh  there's  1  in  1,000  or 
something'. 
Facilitator.  And  was  it  some  time  after  it,  she  had  measles? 
Cara:  No,  it  was  within  months  of  having  the  MMR,  she  got  the  measles,  you  know,  but,  em... 
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Cara:  No,  no,  no  idea  where  it  came  from.  I  mean  she  wasn't  really  unwell  and  the  doctor... 
Facilitator.  Did  he  diagnose  it...  did  they  take,  you  know,  like  a  saliva  test? 
Cara:  No.  Just  by  looking  at  her,  the  GP  just  said,  to  him,  it  looked  like  measles. 
Facilitator.  Right. 
Outpatient  Cancer  Group;  Cara  aged  36 
Similarly,  Anna,  a  mother  of  four,  explained  her  third  child's  experience  of  measles: 
I  was  delaying  with  Abby  because  I,  well,  firstly  she's  had  measles  and  I  had  taken  her  to  the 
doctor's  and  they  said  it  was  the  first  case  in  surgery  in  five  years.  And  he  had  the  health  visitor  out 
and  a  junior  doctor  in  to  have  a  look  at  her  and  the  health  visitor  said  well  well  come  and  take  a  test, 
they've  got  to  come  from,  don't  know  the  health  board  or  whatever  and  she  came  about  two  weeks 
later,  but  the  test  came  back  inconclusive.  They  said  that  you  know,  they  could  determine  whether 
she  had  it  or  not  with  a  blood  test  and  I  felt  by  that,  by  that  time  well,  the  doctor  said  she  had  had  it, 
I  thought  she  had  it,  she  looked,  she  had  the  same  symptoms  as  a  child  with  measles  and  I  wasn't 
particularly  bothered  about  getting  her  the  blood  test... 
High  Uptake  Area  Group;  Anna  aged  33 
Of  note  was  the  fact  that  her  youngest  child  (then  aged  10  months)  did  not  contract  this 
highly  contagious  disease  from  her  older  sibling.  Nevertheless  Anna  did  not  appear  to 
have  any  doubts  that  Abby  had  had  measles.  For  similar  reasons  Dawn,  a  mother  of  two, 
was  convinced  that  both  of  her  children  had  contracted  measles,  and  she  was  therefore 
sceptical  about  media  reports  that  suggested  that  an  outbreak  of  measles  in  Fife  in  March 
2002  were  the  first  confirmed  cases  of  measles  in  Scotland  for  some  time.  She  said: 
Dawn:  Yeah,  but  the  headlines  saying  first  two  cases  is  a  lie.  I  can  sit  here  and  say  it  is  an  absolute 
lie,  because  of  my  two  who  caught  it  from  nursery,  and  at  the  same  time  another  nursery  had  it.  I 
still  knew  of  at  least  two  other  cases  in  Glasgow  so  I  can't  imagine  that  those  were  the  only  ones 
at  the  time.  There  must  have  been  more. 
Facilitator.  Can  you  remember  whether  they  were  confirmed  by  bloods  being  taken,  or  saliva 
tests  (interrupted) 
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and  then  we  went  on  holiday  to  Australia.  Two  days  after  we  got  to  Australia  they  both  came 
down  with  measles.  It  was  confirmed  by  a  doctor  in  Australia,  and  that  was  it.  When  we  came 
back  we  informed  our  GP,  that's  why  mine  weren't  counted. 
Facilitator.  Do  you  know  about  the  other  people? 
Dawn:  I  don't  know  really,  but  they  must  have  told  their  doctor,  because  there  was  a  notice  up  at 
nursery.  I  don't  know  what  was  done  about  that,  but  I  do  know  they  had  very,  very  mild  cases,  and 
they  definitely  both  had  measles.  The  doctor  out  there  said  -they  had  a  classic  case.  It  just  seems 
awfully  convenient,  a  big  newspaper  headline  at  this  particular  moment  in  time. 
Antenatal  Group;  Dawn  aged  36 
Dave,  a  father  of  two,  who  opted  to  pay  for  single  vaccines  for  measles,  mumps  and 
rubella  for  his  youngest  daughter,  also  recalled  a  similar  story  concerning  his  older 
daughter.  He  stated: 
When  my  daughter  was  very  wee,  she  caught...  well,  we  took  her  up,  she  basically  woke  up  one 
morning  and  she  had  a  rash  all  over.  We  took  her  up  to  Yorkhill.  The  doctor  there  said...,  she 
had  the  runny  nose  as  well,  and  all  the  symptoms  and  he  said  `that's  measles'  and  em...  we  went 
in,  em...  you  know,  we  took  her  up  and  they  said  `oh  no,  that's  definitely  measles'.  So  you  know, 
we  phoned  all  our  friends  and  family  and  said  `don't  come  round  for  a  few  days'  and  my  mum, 
em,  you  know,  my  wife's  mum,  they  saw  her  and  they  said  'oh  yeah,  that's  definitely  measles,  I 
remember,  you  know,  what  measles  looks  like'  and  em,  but  anyway,  two  weeks  later,  cos  you 
know  what  it's  like,  you  can't  get  an  appointment  for  the  doctor's,  two  weeks  later  we  go  to  the 
doctor's  and  the  doctor  says  `no,  there's  no  way  that  that  was  measles'  and  he  wouldn't  believe  it, 
he  never  wrote  it  down.  And  you  just  think,  you  know,  all  the  time  it's  like  deny,  deny,  deny. 
Even  the  doctors,  cos  you  know,  they  don't  want  to  say  that  they  have  a  confirmed  case  of 
measles.  And  yet,  you  know,  I  mean  I  don't  ask  my  mum  and  my  mother-in-law  for  much  advice 
but  on  this  one  I'm  sure  they're  right  cos  they'd  seen  measles  before  as  well,  you  know?  But  no, 
the  GP's  surgery,  not  interested. 
Single  Vaccine  Group;  Dave  aged  38 
Similar  accounts  cropped  up  in  several  other  groups.  On  closer  examination  there  may 
be  several  possible  explanations  as  to  why  there  were  so  many  accounts  of  children 
having  had  measles  and  it  being  denied  or  not  reported  by  doctors.  The  first  and  perhaps 
the  most  likely  explanation  is  the  recent  increased  attention  afforded  to  measles.  As  the 
MMR  uptake  rates  declined  this  gave  rise  to  an  increasing  number  of  forecasts  of  an 
impending  measles  epidemic  both  by  public  health  officials  and  the  media.  These 
warnings  to  the  public  may  have  led  some  participants  to  have  perceived  measles 
prevalence  to  be  far  greater  than  it  actually  was,  resulting  in  them  taking  their  children  to 
the  doctors  with  measles-like  symptoms.  Indeed  according  to  SCEIH  the  three 
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media,  along  with  a  fourth  case  in  Edinburgh,  were  the  first  cases  in  Scotland  since  April 
2000.  However,  in  2002,315  salivary  samples  were  submitted  compared  to  147  the 
previous  year.  In  this  respect,  participants  in  this  study  were  acting  like  many  other 
parents  in  taking  their  children  with  measles-like  symptoms  to  the  doctors.  Participants 
reported  that  their  doctors  clinically  diagnosed  measles  on  appearance,  with  the  exception 
of  Anna,  who  recalled  saliva  tests  being  carried  out  but  stated  that  the  results  were 
`inconclusive'.  Since  confirmed  cases  are  only  counted  when  laboratory  test  results  are 
positive,  none  of  the  participants'  children  were  confirmed  cases  and  would  have  been 
counted  as  notified  cases. 
However,  the  fact  that  many  doctors  did  not  carry  out  diagnostic  tests  raised  another  issue 
for  some  participants.  It  was  explicitly  suggested  that  doctors  were  contributing  to  the 
low  numbers  of  confirmed  cases.  The  fact  that  some  doctors  were  viewed  as  actively 
denying  or  playing  down  the  number  of  cases  caused  some  participants  to  talk  sceptically 
about  the  disease  statistics.  Further,  some  participants  perceived  doctors  to  be 
contradicting  each  other  in  their  diagnosis  of  measles  and  this  in  turn  led  some 
participants  to  question  doctors'  clinical  skills  in  identifying  and  thus  monitoring  its 
prevalence.  Ambiguity  about  the  actual  prevalence  of  measles  led  to  a  degree  of 
uncertainty  which  fuelled  anxiety.  As  Ella  observed:  "uncertainty  is  fear  and  fear  is 
uncertainty"  (Saturday  Club  Group;  Ella  aged  45) 
There  is  also  another  explanation.  On  further  examination  of  the  group  dynamics  and 
group  interactions  between  members  in  some  of  the  focus  groups,  it  was  noted  that  on 
occasions,  participants  appeared  to  be  justifying  their  reasons  for  rejecting  the  MMR 
vaccine  to  other  group  members.  This  was  particularly  noticeable  in  Dawn  and  Anna's 
cases,  both  of  whom  appeared  aware  that  they  held  views  and  had  made  decisions  about 
MMR  that  were  contrary  to  most  of  the  other  group  members.  By  explaining  their  child's 
experience  of  measles  to  the  group,  they  avoided  potentially  becoming  marginalized  or 
being  seen  as  insensitive  to  other  group  members.  Since  they  believed  that  their  children 
had  already  had  measles  they  were  no  longer  a  potential  threat  to  others  and  by 
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interest  of  their  child,  whilst  remaining  sensitive  to  the  viewpoints  of  others.  These 
interactions  between  participants  highlight  the  importance  that  self-presentation  plays  in 
group  situations  and  the  impact  of  the  group  effect  on  individual  accounts.  This  issue 
will  be  more  fully  explored  in  Chapter  Five,  which  examines  how  parents'  perceptions 
about  the  MMR  controversy  translate  into  their  decisions  about  MMR  vaccination. 
In  summary,  some  participants  tended  to  view  measles  as  a  serious  disease  based  on  the 
long-term  sensory  damage  that  it  could  cause.  However,  other  participants  who  had  had 
measles  as  children  themselves  and  had  survived  without  any  long-term  damage 
contested  the  severity  of  measles.  In  this  respect,  there  was  a  degree  of  ambiguity  about 
the  risk  posed  by  measles  to  their  children.  There  was  also  ambiguity  surrounding  the 
perceived  prevalence  of  measles.  On  one  hand,  there  was  a  surprising  number  of 
participants  who  reported  that  their  children  had  had  measles,  leading  some  participants 
to  be  sceptical  about  statistics  reporting  low  prevalence  rates  of  measles.  Indeed,  it  was 
suggested  that  measles  was  more  prevalent  than  was  admitted  by  the  media,  public  health 
officials  and  doctors.  However  on  the  other  hand,  participants  viewed  measles  as  a  rare 
disease  and  as  such  acknowledged  that  many  doctors  would  have  little  or  no  experience 
of  it  and  would  not  therefore  be  able  to  reliably  diagnose  measles.  Despite  this  assertion, 
all  of  the  participants  who  reported  that  their  children  had  had  measles  had  only  received 
a  clinical  diagnosis,  but  seemed  adamant  the  diagnosis  had  been  accurate. 
3.4.2  Whooping  cough  (pertussis):  `...  it  hasn't  done  me  any  harm,  that's  the  thing' 
Whooping  cough  is  a  highly  infectious  bacterial  disease  of  the  respiratory  tract.  The 
disease  is  transmitted  via  droplets  that  are  sneezed  or  coughed  out  and  inhaled  by  others. 
It  is  characterised  by  violent  coughing,  often  accompanied  by  high-pitched  inspiratory 
`whoop'  sounds  and  vomiting.  Complications  of  whooping  cough  may  include 
convulsions,  pneumonia,  lung  damage,  temporary  and/or  permanent  brain  damage, 
subconjuctival  haemorrhage  or  death.  Complications  and  deaths  from  whooping  cough 
are  most  prevalent  in  babies  less  than  six  months  old.  Whilst  over  the  years  there  has 
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notifications  in  2002,22  of  which  were  children  under  one  year  of  age 
(www.  showsoot.  nhs.  uk/scieh/surveillance). 
Perhaps  unsurprisingly  the  descriptive  name  of  the  disease  led  participants  to  describe 
images  of  children  coughing  persistently  and  to  mention  that  the  cough  had  a  `whoop' 
sound.  It  was  common  for  participants  to  accurately  suggest  that  transmission  was 
airborne  and  through  saliva.  Indeed,  out  of  all  the  diseases  considered  by  participants, 
whooping  cough,  along  with  meningococcal  disease,  generated  the  most  accurate 
descriptions.  Nevertheless,  Mel,  aged  35,  suggested  that  it  was  related  to  croup  (a  mild 
viral  infection)  and  likewise  in  the  Young  Single  Mothers  Group,  Kate  confused  it  with 
Croup: 
Facilitator.  What  about  whooping  cough?  Does  anyone  know  about...? 
Kate:  Aye,  is  that  no  that  (she  makes  a  whooping  sound} 
Uaidenti&d:  Aye. 
Kate:  Ye  need  tae  take  them  into  the  toilets  and  run  the  hot  tap  so's  that  the  steam  goes  in  their 
mooch.  Ahve  had  that. 
(over-talking) 
Lyanes  Naw 
Kate:  Ah  that's  croup  int  it? 
Young.  Single  Mothers  Group;  Kate  aged  22 
Participants  were  divided  about  whether  they  felt  whooping  cough  was  a  severe  disease 
or  not.  Some  participants  considered  that  it  was  severe  and  Stella  described  it  as  "nasty, 
aye  that's  a  nasty  one,  that's  a  long  horrible  cough"  (Autism  Support  Group;  Stella,  aged 
37).  Generally  there  was  little  mention  of  any  long-term  damaging  consequences  of 
whooping  cough,  and  no  participants  mentioned  the  fact  that  it  could  be  life-threatening. 
This  was  interesting  given  the  fact  that  since  the  MMR  debate  the  media  and  scientific 
community  have  highlighted  the  whooping  cough  controversy  as  a  case  in  point  for 
preventing  deaths  through  preventing  epidemics. 
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few  participants  spoke  fearfully  about  whooping  cough,  fearing  the  distressing  nature  of 
the  disease.  For  example  Aleena  spoke  about  an  immunisation  talk  that  she  had  attended 
and  recalled: 
...  there  was  a  health  visitor  she  got  up  and  she  showed  a  ...  eh  a  videotape  of  a  baby  with 
whooping  cough  and  the  baby  must  have  been  about  three  months  old  and  it  was  absolutely 
horrific  and  of  course  there  were  loads  of  nursing  mothers  and  everything  in  the  room  and  half  of 
them  had  to  get  out,  they  were...  it  was  so  distressing. 
Noi  -MMMR  Group;  Aleena  aged  35 
The  image  of  babies  and  young  children  violently  coughing  was  a  distressing  image.  As 
Rebecca  recalls  from  personal  experience:  "the  face  goes  blue  and  actually  stops  you 
breathing  or  stops  you  getting  air  into  your  lungs  and  your  brain...  "  (Cancer  Support 
Group;  Rebecca  aged  49).  For  some  participants  these  images  meant  they  appeared  keen 
to  prevent  their  children  contracting  whooping  cough  and  thus  to  have  them  immunised 
with  the  pertussis  vaccine. 
When  asked  about  whooping  cough,  a  few  participants  spontaneously  recalled  the 
whooping  cough  epidemics  in  the  1970s  and  1980s,  as  they  had  contracted  whooping 
cough  themselves  as  children  during  the  outbreaks.  Charolotte,  a  29-year-old  mother  of 
one  young  baby,  considered: 
I  just  want  to  say  something  about  whooping  cough.  It's  funny  because  my  mum  said  because  I 
said  what  the  first  lot  of  immunisations  were  just  for  her  (pointing  to  her  daughter)  and  she  said 
'oh"  she  said  "she's  so  tiny,  do  I  get  them  when  I  actually  ask,  you  know,  because  she's  so  small 
dots  she  still  get  them.  "  And  they  said  "Oh  I  think  you  give  it  to  premature  babies.  "  So  em  and 
then  fine.  But  my  mum  said  "Oh  you  know,  whooping  cough  is  not  so  bad,  you  had  whooping 
cough,  you  know.  If  there's  any  risk  with  the  injections  don't  get  it  because  whooping  cough's 
fine,  you've  had  it  and  you  survived"  I  think  I  probably  didn't  have  a  very  nice  time  but  that's  my 
mum's  perception  of  whooping  cough.  It  wasn't  very  bad  because  I  had  had  it.  But  then  again  I 
just  wasn't  ...  (goes  silent} 
flat-d  a  Mothers  Croup;  Charolotte  aged  29 
Similarly,  Dave,  a  38-year-old  father  of  two,  stated: 
100 -I  was  one  of  the  children  that  got  whooping  cough,  but  you  know  it  hasn't  done  me  any  harm, 
that's  the  thing.  and  then  there  was  all  this  query  about  did  whooping  cough  cause,  you  know, 
mental  problems?  You  know,  em,  for  children,  you  know,  brain  damage,  you  know.  And  I 
thought  it  concluded  really  that  for  a  small  percentage  there  was  that  possibility,  you  know?  And 
it's  the  same  with  %`1%R-  is  there  a  small  possibility  that  for  some  children  it  causes  damage  but 
that  nobody's  acknowledging  it,  and  if  you  think  your  child  might  be  one  you're  not  gonna  take 
that  risk. 
Single  Vaccine  Group;  Dave  aged  38 
These  comments  highlight  the  fact  that  experiencing  a  disease  does  not  mean  that  a 
person  will  necessarily  have  a  negative  impression  of  it.  In  fact  these  comments 
highlight  how  complex  the  relationship  is  between  participants'  experiences  of  disease 
and  their  subsequent  beliefs  about  its  severity.  Where  participants  experienced  the 
disease  and  eithcr  fully  recovered,  or  had  difficulty  remembering  it,  the  risk  may  not  be 
vied  as  a  threat  to  health. 
In  summary,  whilst  whooping  cough  was  spoken  about  accurately  and  often  as  being  a 
severe  disease,  participants  did  not  talk  about  any  long-term  damage  it  could  cause,  or 
mention  the  fact  that  it  could  be  fatal.  Nevertheless,  participants  were  keen  to  have  their 
children  immunised  against  whooping  cough  and  some  participants  were  aware  of,  or  had 
been  affected  by  the  1970s  and  19SOs  whooping  cough  epidemics.  For  some  participants 
the  relatively  recent  epidemics  appeared  to  serve  as  a  reminder  that  whooping  cough  is  a 
highly  contagious  disease  and  as  such  viewed  it  as  a  potential  threat.  However,  as  with 
measles,  participants  who  had  had  whooping  cough  and  survived  without  any  long-term 
damage  tended  to  view  the  disease  as  less  severe  than  some  of  their  counterparts  with  no 
experience  of  it. 
3.5  Diseases  considered:  `A  minor  threat' 
3.5.1  Mumps:  'Noata4  big  baw  face,  w  sore  balls' 
Mumps  is  an  acutc  viral  disease  characterised  by  localised  inflammation  and  enlargement 
of  the  parotid,  and  or  salivary  glands.  Complications  include:  viral  meningitis  (1  in  20 
101 cases),  encephalitis,  orchitis,  oophoritis,  sensorineural  hearing  loss,  pancreatitis  and 
death.  There  is  no  evidence  that  mumps  causes  sterility  (Salisbury  and  Begg,  1996). 
Despite  this,  across  the  groups  it  was  commonly  thought  to  leave  men  sterile.  Frank 
stated: 
I  think  that's  the  wan  Ah  hud  when  I  wis  a  wean.  I  think  it  wis  like  sore  balls  and  it  wis 
something  that  makes  you  no  hiv  weans,  you  know  like  you've  been  snazzled  (castrated)  and  hiv 
no  weans.  But  see  it  didnae  affect  me  cos  I've  got  the  boys. 
Multiple  Parenting  Problems  Group;  Frank  aged  31 
Similarly,  Kenny  suggested  that  mumps:  "can  make  you  infertile  or  something,  can't  it?  " 
(Single  Fathers  Group;  Kenny  aged  43).  Likewise,  the  Low  Vaccine  Uptake  Group 
spoke  about  infertility  resulting  from  mumps: 
Sheila:  It  makes  the  men  sterile,  that's  the  only  thing  that... 
Alan:  That's  what  I  look  on  it  as. 
Joan:  Makes  what? 
Sheila:  Makes  the  men  sterile. 
Joan:  Oh,  I  never  knew  that. 
Sheila:  If  they  take  it  later  in  life,  uhuh.  I  said  I  can  always  mind  the  old  ones  saying  you're  better, 
boys  were  better  getting  mumps  early.  That  was  the  only  thing  that  ever  ... 
Joan:  I've  never  heard  of  that. 
Low  Vaccine  Uptake  Area  Group;  Joan  aged  20;  Sheila  aged  36;  Alan  aged  33 
While  some  participants  explicitly  spoke  about  the  association  between  mumps  and  male 
infertility,  it  was  more  common  for  participants  to  merely  imply  an  association  by 
suggesting  that  mumps  was  only  a  problem  for  boys.  Just  as  rubella  was  viewed  largely 
as  a  disease  affecting  girls,  mumps  was  viewed  as  a  disease  affecting  boys.  This 
gendering  of  the  disease  is  perhaps  best  illustrated  by  Debbie,  a  mother  of  two  girls  and 
two  boys: 
102 I  worry  about  my  boys  not  catching  mumps  as  a  child  because  there's  not  so,  so  much  around,  em, 
and  then  them  getting  it  as  adults  and  I  guess  the  same  with  the  girls,  with  Rubella  but  at  least  with 
the  girls,  they  can  choose  their  own  course,  you  know,  em,  if  they're  going  to  start  a  family,  they 
can  make  their  own  decision  if  they  believe  in  vaccination,  they  can,  you  know,  get  the  rubella 
vaccination  then  and  with  the  boys,  you  know,  I  don't  think  it  would  be  safe  for  them  to  get  a 
mumps  vaccination  if  that's  what  they  thought  they  wanted  to  do.  So  I  feel,  em,  kind  of 
responsible  for  my  children's  future  in  a  way,  that  way,  whether  they  might  be  into  vaccinations, 
you  know,  but  I  made  that  choice  as  a  parent. 
Non-Vaccine  Group;  Debbie  aged  33 
It  was  extremely  common  for  participants  to  associate  mumps  with  male  infertility  and  to 
mention  that  it  was  preferable  for  boys  to  contract  mumps  when  they  were  young  rather 
than  as  adults.  Couple  this  notion  with  the  fact  that  across  the  groups  mumps  was  not 
associated  with  meningitis,  despite  this  being  the  reason  for  its  introduction  into  the 
programme,  it  is  clear  participants  underestimated  the  severity  of  the  mumps. 
Participants  across  the  groups  viewed  mumps  as  a  mild  disease,  with  little  or  no  long- 
term  implications  if  contracted  as  a  child.  William  described  mumps  as:  "...  you  know 
they  might  have  a  few  spots,  or  a  few  more  irritations  and  you  know  maybe  be  laid  up  for 
a  few  days"  (Single  Fathers  Group;  William  aged  51).  Similarly,  Joe  considered:  "...  you 
don't  really  hear  people  dying  from  mumps,  not  really"  (Single  Vaccine  Group;  Joe  aged 
36).  Sue's  assessment  of  mumps  was: 
It's  not  a  serious  one.  People  don't  take  it  seriously  I  don't  think,  you  know,  or  maybe  it's 
because  when  we  were  wee,  you  knew  people  that  had  it  and  it's 
... 
it's  as  far  as  I'm  aware,  it's  not 
particularly  a  life  threatening  thing,  you  know,  what  you  would  call  ... 
like  chicken  pox,  it's  like  a 
childhood  disease,  it's  like  a  rite  of  passage. 
Non-MMR  Group;  Sue  aged  36 
Sue's  comments  that:  `people  don't  take  it  seriously'  were  borne  out  on  several 
occasions  during  the  focus  groups.  On  being  asked  about  mumps  there  were  occasions 
when  participants  held  their  breath,  puffed  out  their  cheeks  and  burst  out  laughing. 
Similarly,  in  groups  with  male  participants  some  of  them  puffed  out  their  cheeks  and 
crossed  their  legs  clasping  their  hands  over  their  groins  as  if  in  pain.  To  the  amusement  of 
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experiences  of  mumps: 
The  reason  I  said  mumps  was  because  I  thought  it  was  funny.  Because  I  used,  my  young  brother 
was  a  lot  younger  than  me...  and  I  used  to  drag  my  mates  hame  from  school  to  see  him  when  he 
had  mumps  because  his  face  was  that  thick  (puffing  out  his  cheeks-  everyone  laughing)  you  had 
big  baws.  My  mates...  (said  laughing)  it  was,  you  need  to  come  hame  to  see  my  wee  brother,  he's 
got  mumps.  I  used  to  bring  all  my  pals  in  to  see  him.  Just  a  big  baw  face'  (said  while  puffing  out 
his  cheeks,  tears  in  his  eyes  now  and  laughing-  everyone  else  laughing  uncontrollably). 
Single  Fathers  Group;  Kenny  aged  43 
The  vivid  images  participants  had  of  swollen  faces  appeared  to  be  based  on  either  having 
had  mumps  themselves  or  having  witnessed  a  close  member  of  the  family  with  mumps. 
Samantha  recalls: 
Aye  ma  face  was  just  a  balloon,  right  up,  (puffing  out  her  cheeks)  I  mean  my  mum's  got  pictures 
of  me  and  you  would  not  even  see  me,  imagine  that  it's  me  honestly.  (Laughing)  Cos  I've  always 
been  quite  thin,  but  when  I  had  these  I  was  just  pure...  puff,  bloated  right  oot.  It  was  just  mastly 
ma  face. 
Crafts  Group;  Samantha  aged  24 
In  summary,  across  the  groups  participants  considered  that  mumps  was  a  mild  and  mildly 
funny  disease.  Amusing  images  and  stories  were  commonplace  and  the  more  serious 
consequences  -  meningitis  -  were  not  mentioned  in  any  of  the  groups.  Just  as  rubella  was 
seen  as  a  disease  concerning  girls,  mumps  was  viewed  as  a  disease  with  negative  health 
consequences  for  boys  in  relation  to  male  sterility.  This  disease  was  largely  viewed  as  a 
mild  disease  and  participants  appeared  unconcerned  about  their  children  contracting  it, 
provided  boys  caught  it  when  young. 
3.5.2  Tetanus:  `Is  that  like  Rabies?  ' 
Tetanus  is  an  acute  disease  caused  by  a  spore-forming  bacillus.  In  its  spore  form  it  is 
found  in  soil  and  animal  faeces  and  it  enters  the  body  after  injury  through  a  puncture 
wound.  Toxin  from  the  tetanus  bacilli  causes  painful  muscle  spasms.  Complications 
104 include  lockjaw,  painful  muscular  spasms  or  death.  Although  tetanus  is  extremely  rare  in 
the  UK  now,  because  it  is  found  in  the  environment  tetanus  can  never  be  eradicated  and 
therefore  remains  a  threat.  Unlike  the  other  diseases  in  the  Childhood  Immunisation 
Programme  tetanus  can  not  be  spread  from  person  to  person  (Salisbury  and  Begg,  1996). 
Across  the  groups  participants  closely  associated  tetanus  with  the  disease  rabies  and 
therefore  considered  it  likely  that  tetanus  would  be  contracted  from  a  dog  bite.  Joanne, 
was  unsure  about  tetanus  and  guessed:  "Well,  that  would  be  rabies  ... 
frothing  at  the 
mouth  being  bitten  by  a  dog...  (starts  laughing)  I  don't  know"  (New  Mothers  Group; 
Joanne  aged  37).  A  similar  response  was  elicited  from  Trudie,  who  thought  the 
symptoms  of  tetanus  would  be:  "Frothing  at  the  mouth,  like  rabies,  I'm  probably  wrong, 
but...  "  (NCT  Group;  Trudie  aged  38)  In  some  cases  tetanus  was  described  as  the  vaccine 
for  rabies: 
Facilitator.  Right.  What  about  tetanus? 
Alan:  Tetanus,  well  that's  ... 
Facilitator.  What  do  you  think  on? 
Joan:  Rabies  and  stuff  like  that  where  you  get  your  tetanus  ... 
Sheila:  Jag  aye. 
Alan:  Getting  bit  wi  dogs  and  that. 
Joan:  Aye  exactly.  That's  what  I  think  of  them  aye. 
Alan:  Bit  wi  cats  and  all  that. 
Low  Uptake  Area  Group;  Joan  aged  20;  Sheila  aged  36;  Alan  aged  33 
Another  vivid  image  that  participants  commonly  associated  with  tetanus  was  `rusty 
nails': 
Catrina:  Well  that's....  yeah. 
Facilitator.  What  did  you  say? 
Catrina:  Rusty  nails. 
Celia:  Yeah.  Is  it  in  the  soil  and  in  dirty  food. 
Judith:  Doesn't  it  swell,  doesn't  it  give  you  swelling? 
105 First-Time  Mothers  Group;  Catrina  aged  27:  Judith  aged  34;  Celia  aged  33 
These  two  images  were  mentioned  frequently,  but  it  is  unclear  why  the  particular  images 
of  `dog  bites'  or  `rusty  nails'  should  so  consistently  come  up  across  all  the  groups.  It 
seems  likely  that  they  have  something  to  do  with  images  of  the  skin  being  punctured,  but 
this  still  does  not  address  why  these  specific  sharp  objects  were  mentioned  over  other 
potentially  hazardous  items. 
Whilst  some  participants  associated  tetanus  with  rabies,  dog  bites  and  rusty  nails,  it  is  of 
note  that  they  then  went  on  to  describe  the  signs  and  symptoms  of  tetanus  reasonably 
accurately.  The  Non-Vaccine  Group  accurately  described  the  symptoms  of  tetanus  and 
was  one  of  the  few  groups  to  accurately  describe  the  transmission  pathway: 
Facilitator.  What  about  tetanus  and  how  would  you  catch  tetanus  and  what  is  tetanus? 
Molly:  A  deep  puncture  wound  and  I  know  that  tetanus  is  in  soil,  you  get  through  it  to  the  inside, 
a  deep  puncture  wound  like  an  incision. 
Facilitator.  And  what  would  be  the  symptoms  if  your  child  had  that? 
Kitty:  Em,  it's  lockjaw  isn't  it?  So  kind  of  noticeable  isn't  it? 
Molly:  It's  localised  at  first,  stiff  kind  of  muscles  around  the  area  first  and  I  would  imagine  that 
would  spread. 
Non-Vaccine  Group;  Molly  aged  37;  Kitty  aged  37 
Similarly,  Rebecca  suggested  that  tetanus  would  present  as: 
The  limbs  are  paralysed  or  something,  something  happens  and  your  limbs  get  paralysed  and  you 
have  to  go  em...  I  think  you  also  have  to  have  a  respirator,  you  know,  because  your  whole  system 
shuts  down.  Your  muscles  are  paralysed  or  something  like  that. 
Cancer  Support  Group;  Rebecca  aged  49 
Why  participants  should  accurately  describe  the  signs  and  symptoms  of  tetanus  after  so 
inaccurately  describing  its  mode  of  transmission  is  puzzling  and  there  is  nothing  in  the 
data  to  explain  why  participants  consistently  confused  these  two  diseases.  However,  the 
significance  of  this  disparity  is  profound  because  it  may  explain  why  some  participants 
dismissed  the  need  for  very young  infants  to  be  given  tetanus.  Further  it  may  have  also 
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children's  health.  During  focus  group  discussions  it  was  evident  that  some  participants 
felt  that  their  young  children  would  be  unlikely  to  be  near  rusty  nails  or  dogs.  Further  it 
was  suggested  that  even  in  the  unlikely  event  that  infection  should  occur  there  was  still  a 
course  of  action  that  they  could  take  to  prevent  their  child  from  becoming  ill.  Several 
conversations  implied  as  much: 
Anna:  The  tetanus  one  I'm  not  too  sure  because  I  remember  like  if  you  were  bitten  by  a  dog  your 
mum  took  you  to  the  hospital  to  get  a  tetanus  injection  so  I  don't  know  why...  I  don't  know  why 
you  have  to  have  that,  I  don't  know  what  benefit... 
Karen:...  how  quickly  you  get  it.  Maybe  there  wasnt  the  accessibility  to  hospital  at  the  time. 
Anna:  I  just  remember  when  we  were  young  if  a  dog  bit  you,  it  was  like,  and  did  it  break  your 
skin?  Yeah,  right.  Come  down  to  the  hospital  for  tetanus  and  that  was  it.  It  was  like,  it  was  just  sort 
of  routine  it  wasn't  anything  and  then  they  asked  when  was  the  last  time  you  had  a  tetanus  so  it 
seems  you  know,  if  they  are  injecting  babies  at  two  months  with  tetanus  it's  unlikely  that  they  are 
going  to...  I  mean  they  don't  get  to  play  with  dirt.... 
High  Vaccine  Uptake  Area  Group;  Anna  aged  33;  Karen  aged  36 
Similarly,  Rhona  mentioned: 
... 
I  was  saying  to  Chris,  why  does  he  have  to  have  tetanus  when  he  is  so  little.  You  know,  I  mean 
he's  not  going  to  be  cut  in  rusty  nails,  but  Chris  said,  `yeah,  but  if  he's  out  in  the  garden  picking 
up  things  like  that  then  it  get  to  that  as  well,  '  which  I  didn't  realize  you  know,  I  didn't  know  the 
reason. 
First-Time  Mothers  Group;  Rhona  aged  31 
Although  Rhona  had  been  encouraged  to  rethink  her  views  on  tetanus,  other  participants 
had  decided  that  they  would  only  give  the  tetanus  vaccine  in  an  emergency.  Dawn 
argued  that  she  would  know  if  her  child  had  had  an  accidental  injury  that  warranted  the 
vaccine  and  felt  comfortable  with  her  decision  not  to  have  her  son  immunised  with 
tetanus.  However  for  the  most  part,  participants  merely  questioned  the  need  for  the 
vaccine  but  preferred  to  err  on  the  side  of  caution  in  having  them  immunised  against 
tetanus. 
107 Whilst  participants  often  described  the  signs  and  symptoms  of  tetanus  accurately,  none  of 
the  participants  knew  anyone  that  had  contracted  tetanus.  Nevertheless,  there  were  many 
accounts  of  participants  being  given  a  prophylactic  tetanus  vaccine  following  accidental 
injury.  Robert  had  worked  on  a  building  site  previous  to  becoming  unemployed,  and 
recalled: 
Aye.  Could  get  lockjaw  and  heart  problems...  just....  cause  ... 
I  carried  on  working.  Then  ma  foot 
started  swelling  up,  then  I  couldnae  get  ma  boot  back  on.  So  I  might  have  got,  you  know, 
poisoned  from  the  nail  and  they  said  it  could...  the  guys  in  the  work  at  times  says  you  end  up  with 
lockjaw  and  all  that.  So  I  got  took  to  the  hospital  and  just  got  another  jag...  but  Ah've  had  the  jag  a 
few  times  for  tetanus,  just  in  case.  Like  you  only  need  one  every  five  year  or  something? 
Single  Fathers  Group;  Robert  aged  27 
Similarly  in  the  Young,  Single  Mothers  Group,  participants  remembered  being  given  the 
tetanus  vaccine  for  accidental  injuries,  one  of  which  was  a  dog  bite.  They  recalled  their 
experiences: 
Usa:  Aw,  Ahwe  hid  hunners  eh  them. 
Margaret:  Ahwe  had  wan  cos  Ah  got  sick. 
Facilitator.  What's  it  for  do  you  know? 
Natalie:  Well  Ah  got  it  when  Ah  split  ma  fit  open.  That's  how  Ah  got  it,  cos  Ah  split  ma  fit  open. 
Lisa:  Ah  got  bit  on  the  arse.  (Laughing)  And  two  nurses  had  tae  haud  me  doon.  And  then  by  the 
time  Ahd  got  the  jag  Ah'd  fainted.  Ah  hate  jags,  Ah  jist  dae!  Ah  hid  tae  get  it  on  the  arse!  Cos 
Ah  got  bit  on  the  arse. 
Natalie:  Oh  naw  man,  Ah  got  it  on  the  arm. 
Margaret:  Ah  canny  even  remember  where  Ah  got  it,  ye  know,  cos  Ah  was  sleeping  by  the  time 
they  gave  me  it. 
Young,  Single  Mothers  Group;  Usa  aged  20;  Margaret  aged  20;  Natalie  aged  18 
In  summary,  generally  participants  spoke  accurately  about  the  signs  and  symptoms  of 
tetanus.  It  was  often  implied  that  puncture  wounds  were  important  in  the  transmission  of 
the  disease,  but  there  was  some  ambiguity  as  to  where  the  disease  might  come  from  and  it 
was  often  confused  with  rabies.  On  several  occasions  the  soil  was  mentioned  as  a 
possible  source  of  transmission,  but  it  was  more  often  the  case  for  participants  to  suggest 
that  dog  bites  or  rusty  nails  were  the  most  likely  sources.  In  turn,  this  led  some 
108 participants  to  consider  that  tetanus  posed  little  threat  to  their  children,  as  they  were  not 
considered  to  be  in  direct  contact  with  any  of  these  sources. 
3.53  Haemophilus  Influenza  type  b:  `...  that  one  doesn't  ring  a  bell' 
This  disease  mostly  affects  children  under  the  age  of  five  and  can  cause  meningitis  and 
bacteraemia  in  up  to  60%  of  cases.  Thus,  the  signs  and  symptoms  are  similar  to  those 
seen  in  meningococcal  disease  group  C.  Complications  include:  septic  arthritis, 
cellulites,  osteomyelitis,  pericarditis  and  empyema.  Neurological  damage  may  occur  as  a 
consequence  of  meningitis  causing  impaired  hearing,  mental  retardation  or  death 
(Salisbury  and  Begg,  1996). 
Initially  it  was  thought  that  the  organism  was  the  cause  of  influenza  and  it  was  known  as 
Pfeiffer  influenza  bacillus  after  Robert  Pfeiffer  isolated  it  from  sputum  of  patients  during 
the  1889-1892  influenza  pandemic.  Although  there  were  doubts  about  its  aetiology  it 
was  not  until  the  1918  pandemic  that  its  true  aetiology  was  understood.  The  organism 
was  renamed  haemophilus  influenza  to  acknowledge  its  mistaken  historic  association 
with  influenza,  and  to  emphasise  its  requirement  of  blood  factors  for  growth; 
`haemophilus'  from  the  Greek  meaning  `blood-loving'  (Feigin  and  Cherry,  1998). 
Out  of  all  the  diseases  included  in  the  Childhood  Immunisation  Programme  this  was  the 
disease  participants  knew  least  about,  and  its  misleading  name  led  participants  to 
commonly  reason  that  it  was  related  to  flu: 
Facilitator.  What  about  haemophilia  influenza? 
Charlotte:  Would  that  be  like,  is  that  Spanish  `flu  or  something  is  it?  I  don't  know. 
Facilitator  :  Do  you  get  that?  Do  your  children  get  vaccinated  does  anyone  know? 
Charlotte:  I've  no  idea. 
Rhona:  I  don't  think  so,  I  haven't  seen  it  on  the  lists. 
109 Judith:  No...  that  one  doesn't  ring  a  bell,  no. 
Facilitator.  I-iib? 
Rhona:  Yeah,  he  got  the  Hib.  Is  that  what  it  is?  Because  I  didn't  even  know  that.  I  wondered  what 
Hib  was. 
Facilitator.  What  do  you  think  Hib  is  for?  What  are,  what  are  the,  what  do  you  know  about 
haemophilis  influenza? 
Judith:  Nothing. 
Rhona:  Not  a  thing. 
Facilitator.  This  is  the  one  that  nobody  knows? 
Judith:  Only  through  work  thinking  about  people  coming  in  with  chest,  a  chest  infection  is  what  I 
would  associate  it  with.  With  community  acquired  infections  em  I  think 
First-time  Mothers  Group;  Rhona  aged  31;  Judith  aged  34;  Charlotte  aged  29 
In  the  absence  of  any  images  or  knowledge  about  haemophilus  influenza  Lauren,  a  29- 
year  old  mother  of  one,  asked:  "...  is  that  like  a  flu  jab?  "  (High  Uptake  Group;  Lauren 
aged  29).  Similarly,  Bob  questioned:  "was  it  the  flu?  "  Dave  stated:  "No,  I've  never 
heard  of  that.  Is  that  to  do  with,  em  ... 
is  that  haemophilus  to  do  with  ...  you  know,  that 
blood  clotting  thing  where  your  blood  can't  clot?  Haemophilia?  "  (Single  Vaccine  Group; 
Dave  aged  38). 
By  far  the  most  common  response  in  relation  to  haemophilus  influenza  was  a  shrug  of  the 
shoulders,  blank  expressions  or  participants  simply  saying  that  they  did  not  know. 
Facilitator.  What  about  haemophilis  influenza? 
Fiona:  Is  that...? 
Anna:  Don't  know. 
Alison:  Really  don't  know.  (Silence  everyone  looking  blank) 
Facilitator.  Okay. 
110 Anna:  Is  that  short  for  something? 
Facilitator.  Yeah. 
Anna:  I  don't  even  know  what  it's  short  for. 
Facilitator.  It's  short  for  haemophilus  influenza. 
Anna:  Ah  ha,  flu.  (Laughing,  everyone  chants  flu  together) 
High  Uptake  Area  Group;  Fiona  aged  32,  Anna  aged  33,  Alison  aged  31 
Almost  all  the  participants  stated  that  they  had  never  heard  of  haemophilus  influenza, 
leaving  participants  guessing.  For  example  Kenny,  a  43-year-old  asked  "Is  that  for 
HIV?  "  (Single  Fathers  Group).  In  fact  there  were  only  two  participants  in  the  study  who 
knew  about  haemophilus  influenza:  one  was  a  mother  whose  child  had  had  haemophilus 
influenza,  and  the  other  was  a  nurse  who  was  familiar  with  the  disease  through  her  work. 
The  lack  of  any  knowledge,  images  or  experiences  of  this  disease  meant  that  discussion 
on  this  disease  was  short  and  swift.  Ironically,  it  was  viewed  as  only  posing  a  minor 
threat  because,  unlike  meningococcal  disease  with  its  associated  meningitis,  haemophilus 
influenza  did  not  raise  any  negative  associations  in  participants'  minds. 
After  the  focus  groups  were  completed,  participants  were  given  immunisation  leaflets 
that  explained  the  different  diseases.  Some  participants  commented  that  they  were 
surprised  to  read  that  haemophilus  influenza  could  cause  a  number  of  major  illnesses, 
including  meningitis. 
In  summary,  participants  did  not  know  about  haemophilus  influenza.  Guided  by  its 
historically  inaccurate  name  participants  commonly  guessed  that  it  was  to  prevent  flu.  In 
turn  this  led  participants  to  consider  that  this  was  not  a  disease  that  posed  a  threat  to  their 
children's  health.  However,  on  discovering  that  it  was  not  related  to  the  flu,  but  was  in 
fact  introduced  to  help  reduce  the  prevalence  of  meningitis,  participants  seemed 
genuinely  surprised  that  they  knew  so  little  about  the  disease  and  wondered  why  this  was 
the  case.  Thus  this  disease  was  viewed  as  only  posing  a  minor  threat  because  as  one 
111 participant  noted  during  the  debriefing  session  "you  don't  worry  about  things  you  don't 
know  about  really"  (High  Uptake  Group;  Anna  aged  33). 
3.6  Diseases  considered:  `No  longer  a  threat' 
3.6.1  Diphtheria:  `Is  it  something  out  of  the  jungle?  '  `Something  that  happened  along 
time  ago?  ' 
Diphtheria  is  an  acute  infectious  disease  affecting  the  upper  respiratory  tract  and 
occasionally  the  skin.  It  is  characterised  by  a  sore  throat,  pyrexia,  general  malaise, 
headache  and  vomiting  and  in  severe  cases  by  membrane  formation  in  the  larynx  (throat) 
which  can  cause  airway  obstruction  (Salisbury  and  Begg,  1996).  Its  effects  are 
particularly  severe  in  children  and  it  was  one  of  the  most  feared  epidemic  diseases  of 
childhood,  hence  the  name  given  in  the  late  19th  century  of  the  `strangling  angel  of 
children'  (Hendriksen  2000).  In  severe  cases  the  absorption  of  exotoxin  damages  heart 
muscle  and  nerve  tissue  which  can  cause  paralysis  or  death. 
Across  the  groups  diphtheria  was  commonly  associated  with  a  water-borne,  cholera-like 
illness  and  thought  to  be  transmitted  by  contaminated  water. 
Facilitator.  What  about  diphtheria  how  do  you  think  you  catch  diphtheria? 
Charlotte:  Well  that  is  like 
...  well  that  would  be  down  to  water. 
Catrina:  Unsanitary  conditions  down  to  water. 
First-Time  Mothers  Group;  Charlotte  aged  29;  Catrina  aged  29 
Similarly,  Cassie  guessed  transmission  was  through  water  and  suggested:  "Water, 
infected  water  or  something?  "  (High  Uptake  Area  Group;  Cassie  aged  29)  and  Stella 
questioned  "Well  I  just  think  diphtheria,  I  don't  know,  do  you  get  it  from  dodgy  water 
or...  "  (Autism  Support  Group;  Stella). 
112 In  the  groups  in  which  participants  related  diphtheria  to  water-borne  transmission,  this 
led  some  participants  to  think  that  that  the  likely  signs  and  symptoms  might  relate  to  the 
digestive  system.  For  example  Fiona  wondered:  "is  it  not  like  a  being  sick  sort  of  thing? 
Like  a  sickness,  no  idea...  like  a  stomach  upset  thing"  (High  Uptake  Area  Group;  Fiona 
aged  32).  Likewise,  Dawn  believed  diphtheria  was:  "...  a  stomach  infection,  something 
really,  really,  nasty  that  you  don't  get  anymore"  (Antenatal  Group;  Dawn  aged  36).  In 
fact,  diphtheria  is  transmitted  via  droplet  infection  usually  by  coughing,  sneezing  or 
talking  and  in  severe  cases  can  cause  airway  obstruction.  Perhaps  for  this  reason 
Rebecca,  an  ex-nurse,  related  diphtheria  to  the  respiratory  system: 
It's  a  lung  thing,  isn't  it?  You  know,  when  it's  affected  your,  your  lungs  and  your  trachea  and  all 
these  bits  up  here  (pointing  to  neck  and  chest)  I  think  doesn't  it?  I  can't  remember  but  something 
to  do  with  that  and  people  were  seriously  ill  and  had  to  go  on  respirators  and  iron  lungs  and  all 
that  stuff  with  diphtheria,  I  think, 
Cancer  Support  Group;  Rebecca  aged  49 
Diphtheria  was  one  of  the  diseases  that  participants  found  most  difficult  to  describe 
accurately;  however  they  usually  suggested  that  this  was  because  they  had  no  experience 
of  it  as  the  disease  has  not  been  prevalent  in  the  United  Kingdom  for  some  time.  Whilst 
there  was  a  general  perception  that  diphtheria  was  no  longer  a  threat,  Sue  described  a 
recent  experience  that  had  made  her  realise  how  severe  and  prevalent  diphtheria  once 
was.  She  recounted  this  discovery  to  the  group: 
...  em,  I've  been  researching  my  family  tree  and  eh,  one  of  the  things  that  I  have  discovered,  em, 
actually  had  me  in  tears  when  I  did  discover  it  was,  em,  my  great,  great,  great  grandfather's,  em, 
first  wife  and  four  of  his  five  sons,  they  all  died  within  two  months  of  each  other  in  1863  of 
diphtheria  and  as  I  was  just...  as  I  found  all  these  death  certificates,  I  was  in  tears  because  it  took 
me  about...  I  was  downloading  it  from  the  computer  and  I  couldn't  believe  it  and  I  thought,  you 
know,  we  just  have  no  idea  what  these  diseases  do.  We  have  no  fear  of  them  and  that  was  a  whole 
family  wiped  out  including  an  adult  and  it  was,  it  really  made  me  reassess,  you  know,  the  whole... 
my  whole  position  on  this.  So  I'm  kind  of...  after  having  been  so  sure  that  oh  no,  I'm  not  going  to 
immunise  and  it's  dreadful  this  mercury,  blah,  blah,  blah.  I'm  almost  back  to  square  one  now 
because  I've  seen  it,  you  know,  and  it  meant  something  to  me  because  okay,  it  was  1863  but  it  was 
really  shocking  to  see  it,  you  know?  Child  after  child  that  I  was  looking  up,  the  death  was  all... 
you  know  and  it...  and  it  was quite  scary.  ' 
Non-MMR  Group;  Sue  aged  36 
113 Sue  felt  the  most  likely  reason  for  the  lack  of  knowledge  and  fear  of  diphtheria  was  that  it 
is  extremely  rare  in  the  United  Kingdom  and  stated: 
The  only  thing  I'd  known  about  diphtheria  before  was  I  know  my  aunt  had  it  when  she  was  a 
child,  em,  and  my...  you  know,  she  had  to  go  to  the  fever  hospital,  eh...  and  this  was,  this  must 
have  been  in  the  forties,  em,  but  it's  like...  it's  almost  like  a...  to  me now,  it's  almost  like  a  sort  of 
an  ancient...  it's  like  Latin,  a  dead  language... 
Non-Vaccine  Group;  Sue  aged  36 
Indeed,  there  were  many  comments  that  suggested  that  participants  no  longer  thought  that 
diphtheria  was  a  threat  to  their  children.  Karen,  for  example,  associated  diphtheria  with: 
"...  something  in  London,  and  like  the,  the  plague,  that  sort  of  thing"  (High  Uptake  Area 
Group;  Karen  aged  36).  Helen  considered  it  was:  "something  in  the  past"  (Saturday  Club 
Group;  Helen  aged  39)  and  Stella  said  it  reminded  her  of:  "something  that  you  seen 
happening  years  ago,  you  know,  you  see  old  films...,,  (Autism  Support  Group;  Stella). 
Perhaps  for  similar  reasons  Jenny  suggested  the  image  of:  "...  overflowing,  the  Thames" 
(Single  Vaccine  Group;  Jenny  aged  19).  Some  participants  thought  of  it  as  a  disease 
affecting  other  counties;  Rhona  mentioned:  "it's  a  Third  World  illness  really,  isn't  it" 
(First-Time  Mothers  Group;  Rhona  aged  31).  Similarly,  it  was  associated  with  India  and 
described  as  something  to  come  from  swamps  in  the  jungle.  Taken  together  these 
comments  offer  both  historical  and  geographical  reasons  to  explain  why  participants 
living  in  the  United  Kingdom  felt  removed  from  the  threat  of  diphtheria.  In  turn  this  led 
some  participants  to  question  the  need  for  the  diphtheria  vaccine  to  be  included  in  the 
Childhood  Immunisation  Programme  at  all.  It  was  proposed  that  it  should  just  be  given 
only  if  the  family  had  plans  to  travel  abroad.  However,  Karen  feared  that  the  recent 
increase  in  the  numbers  of  asylum  seekers  to  Glasgow  vindicated  the  need  to  continue 
vaccination  of  diseases  more  prevalent  in  other  countries,  to  avoid  outbreaks  occurring  in 
the  United  Kingdom  (High  Uptake  Area  Group;  Karen  aged  36). 
In  summary,  diphtheria  was  a  disease  that  participants  had  great  difficulty  in  describing. 
Generally  it  was  incorrectly  associated  as  being  water-borne  and  causing  problems  in  the 
digestive  system.  Participants  acknowledged  that  their  knowledge  about  diphtheria  was 
limited,  reasoning  that  this  was  because  they  had  neither  direct,  nor  much  indirect, 
114 experience  of  it  because  it  has  not  been  prevalent  in  the  United  Kingdom  for  some  time. 
In  turn,  this  led  participants  to  view  diphtheria  as  no  longer  posing  a  direct  threat  to  their 
children's  health.  Nevertheless,  generally  participants  felt  that  diphtheria  was  probably  a 
severe  disease  in  its  time. 
3.6.2  Polio:  `Cripples',  `calipers'  and  `sugar  lumps' 
Poliomyelitis  is  an  acute  infectious  disease  spread  via  the  faecal-oral  route.  The  last 
notification  of  poliomyelitis  in  Scotland  was  in  1994,  and  was  vaccine-associated  rather 
than  derived  from  wild-type  polioviruses  (see  www.  show.  scot.  nhs.  uk/sc1eh/surveillance). 
In  children  most  cases  are  sub-clinical  or  show  as  a  mild  febrile  illness.  However  in  a 
minority  of  cases  the  virus  invades  the  nervous  system,  causing  either  aseptic  meningitis 
or  more  rarely  paralytic  polio.  Paralysis  can  be  temporary  or  permanent,  with  lameness 
in  mild  cases  and  in  severe  cases  paralysis  of  the  respiratory  muscles  or  death  (Salisbury 
and  Begg,  1996).  In  cases  where  the  respiratory  muscles  were  paralysed  poliomyelitis 
patients  were  nursed  in  respiratory  machines  called  `Iron  lungs'.  Figure  3.1  depicts  Iron 
Lungs  in  use  in  a  ward  in  a  Los  Angeles  Hospital  during  a  poliomyelitis  epidemic  in  the 
1950s. 
Figure  3.1  Iron  Lung  machines 
115 The  image  of  Iron  Lungs  came  up  in  three  groups;  however,  it  was  only  associated 
correctly  with  poliomyelitis  once  and  was  associated  with  diphtheria  and  tuberculosis  on 
two  occasions. 
A  common  image  that  participants  associated  with  poliomyelitis  was  the  vaccine  itself. 
Participants  often  mentioned  that  polio  was  given  orally  and  some  participants  recalled 
fondly  stories  of  being  given  it  in  the  form  of  a  sugar  cube  at  school.  Margaret  a  20-year 
old  single  mother  remembered  lining  up  outside  the  gym  hall  to  receive  the  polio  sugar 
lump.  Similarly,  Robert  recalled: 
... 
Ah've  had.  Cause  when  I  was  young...  I  was  always  aff  school  at  primary  school.  When  you 
were  getting  all  the  immunisations.  When  I  went  back  to  go  and  see  the  nurse,  'cause  I've  missed 
getting  the  jags 
...  and  the,  'cause  I  always  remember  the  teacher  telling  me  to  tell  the  class  what  I 
got  and  I  got  the  wee  lump  of  sugar. 
Single  Fathers  Group;  Robert  aged  47 
Some  participants  spoke  of  carefully  washing  their  hands  after  changing  their  child's 
nappy  in  the  weeks  following  getting  the  polio  vaccine,  but  were  not  sure  why  they 
needed  to  do  this  and  did  not  associate  the  mode  of  administering  the  vaccine  with  how 
poliomyelitis  might  spread.  This  led  Catrina  to  wonder  whether  you  could  absorb  it 
through  your  hands  (First-Time  Mothers  Group;  Catrina  aged  27).  Similarly,  Kenny 
appeared  puzzled  by  the  fact  that  he  had  been  told  to  wash  his  hands  after  changing  his 
son's  nappy  (Single  Fathers  Group;  Kenny  aged  43).  The  lack  of  a  full  explanation 
meant  that  participants  were  unable  to  connect  the  relevance  of  its  faecal-oral 
transmission  route  to  the  importance  of  hand  washing. 
In  the  absence  of  an  understanding  about  how  it  is  transmitted  some  participants 
suggested  it  was  genetic  and  that  you  were  bom  with  it.  Celia  wondered:  "maybe  it 
was  ... 
from  birth,  maybe  it  was  from  the  parents  in  the  genes  or  something,  something 
that  the  mother  ate...  "  (First-Time  Mothers  Group;  Celia  aged  33).  Similarly  Margaret 
stated: 
116 Margaret:  Well  Ah  worry  quite  a  lot  about  polio  as  well.  Cos  ma  Da  had  polio  when  he  was  a 
wee  boy. 
Facilitator.  Right. 
Margaret:  And  he's  got  limps.  His  leg,  he's  nae  muscles  in  his  foot,  so  he  limps  noo... 
Facilitator.  Right. 
Margaret....  so  Ah  wiz  quite  worried  about  that  as  well,  cos  maybe  it's  hereditary  and  kind  of 
stuff.  Ah  don't  know  if  it  is,  but  that  was  just  cos  ma  Dad  had  it  it  was  on  my  mind  all  the  time. 
Young,  Single  Mothers  Group;  Margaret  aged  20 
Although  only  one  participant  stated  that  you  might  ingest  the  virus,  several  participants 
implied  that  transmission  was  via  the  faecal-oral  route.  Participants  in  the  Non-Vaccine 
Group  felt  concerned  that  the  vaccine  itself  may  infect  unvaccinated  individuals  with  the 
poliomyelitis  virus,  and  discussed  their  fears  about  cross  contamination  of  poliomyelitis 
at  swimming  pools: 
Kitty: 
... 
I  was  hearing  that  yeah,  you  can  catch  that  you  know  in  the  swimming  pool  and  I  haven't 
taken  my  youngest  son  to  the  pool  for  that  reason  actually. 
Facilitator.  What  age  is  he? 
Kitty:  Two  and  a  half  and  I  just  wondered  about  that,  but  that  was  the  first  one  that  jumped  out 
most...  mostly  to  me.  Em,  and  I  have  got,  I've  got  the  homeopathic  alternative,  as  well,  em,  so  I 
suppose.  But  I'm  thinking  well  when  can  I  take  my  son  swimming,  you  know,  when  will  it  feel 
safe  to  do  that,  you  know. 
Non-Vaccine  Group;  Kitty  aged  37 
The  conversation  moved  on  to  meningitis  and  pertussis,  but  later  came  back  to  the  subject 
of  whether  polio  can  be  transmitted  via  the  water  at  swimming  pools.  Debbie  stated: 
Whereas  I  don't  have  a  fear  about  polio  because,  apart  from  that  the  only  polio  in  the  western 
world  seems  to  be  from  the  vaccinations,  you  know,  children  passing  it  on  through  the 
vaccinations  because  it's  live.  But  I  have  taken  my  children  swimming  quite  young  because 
there's  chlorine  in  the  water  and  they're  getting,  they're  only  getting  rid  of  the  amount  that  they've 
taken  in  and  it's  diluted  by  a  whole  swimming  pool  and  I  don't  have  any  fear.  I  obviously  did 
read  something  that  was  anti  vaccination  that  was  saying  that  it's  quite  safe  to  take  your  children 
to  the  pool.  So  I've  never  really  been  bothered  about  that. 
117 Non-vaccine  Group;  Debbie  aged  33 
Indeed,  since  1993  there  has  only  been  an  average  of  one  case  per  year,  of  which  two  out 
of  three  were  vaccine-related  but  these  cases  have  mostly  involved  transmission  between 
family  members  rather  than  at  swimming  pools  (Mayon-White  and  Moreton,  1998). 
Whilst  most  participants  appeared  unsure  as  to  how  poliomyelitis  was  transmitted, 
participants  had  no  difficulty  in  describing  the  visible  disabilities  that  they  associated 
with  the  disease.  Most  commonly  mentioned  was  the  fact  that  the  disease  affects  the 
lower  limbs,  and  a  few  of  the  older  participants  remembered  seeing  children  at  school 
that  had  had  poliomyelitis  and  wore  callipers  as  a  consequence: 
William:  I  remember  a  boy  at  school  with  it. 
Robert:  And  his  legs  his  legs  crippled  with  it. 
William:  One  boy  in  the  class  had,  not  in  my  class  at  school,  had  it.  He  could  run  aboot  the 
Football  pitch  but  he  had  a  calliper. 
Robert:  I've  seen  when  I  was  young,  there  was  a  few,  a  fair  few,  there  was  a  few  at  my  school  as 
well  with  the  callipers  on.  Aye  that  it,  polio,  aye. 
Single  Fathers  Group;  Robert  aged  43;  William  aged  51 
Even  younger  participants  with  no  experience  of  the  disease  had  no  difficulty  in 
describing  some  of  the  visible  limb  disabilities  associated  with  poliomyelitis. 
Facilitator.  What  about  polio.  What  do  you,  what  are  your  images  of  polio? 
Catrina:  Cripples. 
Judith:  Iron  lungs? 
Catrina:  Iron  lungs?  What  do  you  mean  by 
... 
? 
Judith:  (Nurse)  the  machines  that  we  used  to  have. 
Charlotte:  Walking  with  a  stick.  Victorian  children. 
Catrina:  Didn't  they  have  like  a  club  foot? 
First-Time  Mothers  Group;  Catrina  aged  27;  Charlotte  aged  29;  Judith  aged  34 
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and  participants  often  recalled  stories  of  being  given  it  in  the  form  of  a  sugar  cube  at 
school.  Some  participants  spoke  of  carefully  washing  their  hands  after  changing  their 
child's  nappy  in  the  weeks  following  getting  the  polio  vaccine,  but  did  not  associate 
either  this,  or  the  mode  of  administering  of  the  vaccine,  with  how  poliomyelitis  might 
spread.  Although  there  were  a  few  participants  who  thought  transmission  was  via 
ingestion,  participants  were  generally  unsure  of  how  it  spread.  Concerns  were  raised  that 
vaccinated  individuals  may  infect  unvaccinated  individuals.  One  place  that  it  was 
thought  this  could  happen  was  in  swimming  pools.  Across  the  groups,  participants  had 
no  difficulty  in  describing  the  visible  disabilities  that  poliomyelitis  caused  in  its  victims. 
Most  commonly  mentioned  was  the  fact  that  the  disease  affects  the  lower  limbs,  and  a 
few  of  the  older  participants  remembered  seeing  children  at  school  wearing  calipers. 
Even  younger  participants  with  no  experience  of  the  disease  had  vivid  images  of 
poliomyelitis. 
3.7  Discussion  of  findings 
In  order  to  compare  and  reflect  the  views  from  the  wide  range  of  participants  who  took 
part  in  the  study,  each  focus  group  was  asked  to  describe  the  images,  experiences  and 
knowledge  of  each  of  the  vaccine  preventable  diseases  included  in  the  Childhood 
Immunisation  Programme.  To  assess  participants'  knowledge  of  the  diseases  they  were 
asked  to  describe  how  they  would  recognise  the  disease  and  how  they  thought  it  was 
transmitted.  These  discussions  raised  several  important  issues. 
Of  the  vaccine  preventable  diseases  included  in  the  childhood  immunisation  programme, 
participants  categorised  meningococcal  disease  and  its  associated  meningitis  as  the  most 
severe.  This  finding  is  consistent  with  the  findings  of  Bond  et  al.  (1998)  and  with  those 
of  Smailbegovic  et  al.  's  (2003)  study;  however  neither  of  these  studies  offers  any 
explanation  as  to  why  meningococcal  disease  was  considered  the  most  severe.  In 
contrast,  participants  in  this  study  identified  several  reasons  to  explain  why  they 
perceived  meningococcal  disease  to  be  particularly  threatening.  Firstly,  participants 
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in  the  programme.  They  attributed  their  knowledge  levels  to  the  high  level  of  publicity 
surrounding  the  Men  C  vaccine  since  its  introduction  into  the  Childhood  Immunisation 
Programme  in  1999.  Secondly,  participants  considered  that  the  high  profile  Men  C 
campaign  showed  that  public  health  experts  were  concerned  about  meningococcal 
disease.  As  such,  participants  viewed  meningococcal  disease  as  one  of  the  more 
prevalent  and  severe  diseases  affecting  children  and  in  turn,  judged  it  a  more  likely  and 
grave  threat  to  their  children  than  any  other  disease  vaccinated  against  in  the  programme. 
Thirdly,  the  perception  that  meningococcal  disease  was  a  severe  and  growing  threat  to 
their  children  seemed  to  be  confirmed  by  having  read  or  heard  stories  about  children 
contracting  meningitis.  The  main  features  of  these  stories  that  participants  identified  as 
being  particularly  alarming  were:  the  speed  with  which  meningitis  can  affect  a  child,  the 
difficulty  both  parents  and  the  medical  profession  have  in  identifying  and  diagnosing  it 
during  its  early  stages,  and  the  perceived  likelihood  of  the  child  having  severe  long-term 
neurological  damage  or  of  dying.  These  fears  seemed  to  be  largely  derived  from  media 
coverage  about  meningitis  and  to  be  fuelled  and  corroborated  by  hearing  other  parents' 
experiences  of  meningitis,  though  these  were  more  often  third-hand  accounts  than  first- 
hand  experience.  Indeed,  on  several  occasions  the  focus  group  itself  become  the  forum 
for  the  retelling  of  these  third-hand  accounts.  These  emotional  and  sometimes  harrowing 
experiences  appeared  to  serve  as  powerful  reminders  to  participants  not  to  be  complacent 
about  meningococcal  disease.  In  this  respect,  Bedford  and  Elliman's  (2000)  assertion  that 
if  parents  know  about  diseases  they  can  appreciate  how  damaging  these  diseases  can  be, 
appears  to  be  true  in  relation  to  meningococcal  disease.  A  particularly  striking  feature  of 
these  discussions  on  meningococcal  disease,  which  will  be  discussed  in  Chapter  Seven, 
was  the  weight  of  evidence  these  anecdotal  stories  contributed  in  informing  parents' 
perceptions  about  the  disease. 
The  combination  of  the  Men  C  campaign  and  the  media's  coverage  of  the  disease  acted 
as  a  powerful  warning  about  the  dangers  of  meningococcal  disease  and  meningitis,  and  as 
a  prompt  to  seek  immunisation.  However  the  sense  of  fear  participants  spoke  of  in 
relation  to  meningococcal  disease  was  in  stark  contrast  to  their  lack  of  concern  about 
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leaving  them  to  take  clues,  albeit  misleading  clues,  from  its  name.  Despite  it  also  being 
associated  with  causing  meningitis,  no  participant  made  this  connection.  Guided  by  its 
name,  participants  often  suggested  that  it  was  a  vaccine  to  prevent  flu  and  thus  perceived 
the  disease  as  mild  and  as  posing  little  threat  to  their  children's  health.  Perhaps 
unsurprisingly  no  participants  recalled  any  publicity  about  the  Hib  vaccine  following  its 
introduction  into  the  programme  in  1992,  as  most  of  the  participants  were  not  parents 
then.  The  complete  lack  of  interest  in,  and  understanding  of,  haemophilus  influenza 
shown  across  all  the  groups  was  in  stark  contrast  to  their  interest  in  meningitis,  and 
suggests  that  immunisation  education  has  been  inadequate  in  explaining  this  disease  to 
the  public. 
Likewise,  although  the  mumps  vaccination  was  introduced  in  1988  into  the  Childhood 
Immunisation  Programme  as  part  of  the  MMR  vaccine  to  reduce  the  incidence  of  viral 
meningitis,  the  more  serious  consequences  of  mumps  as  being  viral  meningitis  was  not 
mentioned  in  any  of  the  groups.  Participants  generally  considered  mumps  to  be  a  mild 
disease  and  only  harmful  to  boys  if  contracted  when  older  as  it  was  believed  that  it  could 
make  them  sterile.  This  inaccurate  belief  led  some  participants  to  seek  mumps  protection 
for  their  sons  and  to  view  mumps  immunisation  as  irrelevant  for  their  girls.  Similarly, 
some  participants  believed  rubella  immunisation  was  irrelevant  for  their  boys  on  the  basis 
that  the  disease  only  had  serious  implications  for  the  unborn  children  of  pregnant  women. 
This  led  a  few  participants  to  question  the  wisdom  of  giving  mumps  and  rubella  vaccines 
to  girls  and  boys  and  to  view  these  `blanket  policies'  as  contributing  to  a  state  of  over- 
immunisation  of  children.  Although  participants  commonly  suggested  that  rubella 
symptoms  are  mild  and  inconspicuous  no  participants  raised  the  possibility  that  this  could 
pose  a  problem  in  identifying  and  preventing  the  discrete  transmission  of  this  disease  to 
pregnant  women.  Without  such  information,  participants  generally  did  not  appreciate  the 
importance  of  the  role  vaccination  of  boys  play  in  reducing  the  numbers  of  potential 
carriers  of  the  disease  transmitting  it  to  unprotected  pregnant  women.  The  significance  of 
rubella  infection  of  unprotected  women  (  and  thereby  the  risk  to  their  unborn  babies) 
highlights  how  important  it  is  for  parents  to  understand  the  factors  that  contribute  to 
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to  parents. 
Another  disease  some  participants  felt  confused  about  was  tetanus.  Although  participants 
generally  spoke  accurately  about  the  signs  and  symptoms  of  tetanus,  there  was  some 
confusion  about  where  the  disease  might  come  from.  On  several  occasions  soil  was 
correctly  identified  as  a  possible  source  of  transmission.  However,  participants  often 
suggested  that  rusty  nails  or  dog  bites  were  the  most  likely  sources  of  infection.  The  most 
logical  explanation  to  account  for  why  these  images  came  to  so  many  participants'  minds 
was  that  they  would  both  cause  puncture  type  injuries  to  the  skin.  However,  the  fact  that 
participants  thought  dog  bites  were  involved  led  them  to  suggest  tetanus  was  the  vaccine 
for  preventing  rabies.  This  is  despite  the  fact  that  rabies  and  tetanus  are  unrelated 
diseases  and  the  vaccine  for  rabies  is  not  given  routinely  in  the  United  Kingdom.  This 
finding  highlights  the  importance  of  educating  parents  about  the  diseases  so  that 
commonly-held  misconceptions  can  be  dispelled. 
Further,  as  some  participants  thought  it  unlikely  their  children  would  be  in  direct  contact 
with  any  of  these  sources  of  infection  they  assessed  tetanus  as  only  posing  a  minor  threat 
to  their  children.  This  finding  is  consistent  with  Bond  et  al.  's  (1998)  study  that  found  that 
mothers  thought  it  unlikely  their  young  children  would  contract  tetanus.  For  some 
participants  this  risk  appeared  to  be  reduced  further  by  the  fact  that,  even  in  the  unlikely 
event  that  their  child  should  come  into  contact  with  these  sources,  they  could  still  have 
the  prophylactic  tetanus  vaccine  to  prevent  them  becoming  ill.  On  this  premise  a  few 
participants  intimated  that  they  had  not  given  their  child  tetanus  protection.  A  point  worth 
noting  is  that  no  participant  made  any  distinction  between  tetanus  and  the  other  diseases 
in  relation  to  the  fact  that,  unlike  the  other  diseases,  tetanus  is  not  a  communicable 
disease,  and  therefore  does  not  pose  a  threat  to  those  around  an  infected  individual. 
Diptheria  was  another  disease  participants  knew  very  little  about,  and  incorrectly  defined 
it  as  being  a  water-borne  diarrhoeal  disease.  However,  unlike  haemophilus  influenza, 
participants  were  able  to  offer  an  explanation  as  to  why  they  knew  so  little  about 
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neither  having  direct  nor  indirect  experience  of  it,  due  to  its  low  prevalence  in  the  United 
Kingdom.  Although  a  few  participants  appreciated  that  diphtheria  could  be  imported  into 
the  United  Kingdom  from  countries  where  there  are  still  epidemics  of  the  disease,  many 
participants  did  not  know  this  and  therefore  questioned  the  reason  for  its  continuing 
inclusion  in  the  Childhood  Immunisation  Programme.  Similar  to  Bond  et  al.  's  (1998) 
study,  the  participants  in  this  study  considered  it  unlikely  that  their  children  would  come 
into  contact  with  diphtheria  or  poliomyelitis  living  in  the  United  Kingdom. 
So  far  these  findings  seem  to  indicate  that  the  less  people  know  about  the  diseases  the 
less  they  assess  them  as  a  threat.  However,  the  relationship  between  people's  experience 
of  disease  and  their  subsequent  fear  of  the  disease  seems  less  obvious  and  their 
relationship  is  much  more  complex.  For  example,  measles  and  whooping  cough  were  the 
diseases  that  participants  had  the  most  direct  experience  of  either  as  children  themselves, 
or  as  parents.  However,  it  was  observed  that  having  direct  experience  of  a  disease  as 
children  themselves  did  not  necessarily  mean  participants  would  assess  the  disease  as 
threatening  to  their  child's  health.  This  was  especially  true  if  they  had  cared  for  a  child 
that  had  made  an  uneventful  recovery,  or  had  little  or  no  memory  of  their  own  experience 
of  the  disease.  Indeed,  these  participants  tended  to  view  the  diseases  as  less  severe  than 
did  some  of  their  counterparts  with  no  experience  of  it.  In  this  respect  the  strategy  of 
some  public  health  officials  in  highlighting  the  whooping  cough  epidemic  to  persuade 
parents  to  avoid  a  similar  pattern  of  events  with  measles,  may  lack  persuasive  power  if 
parents  have  survived  with  little  or  no  memory  of  ill  effects  of  the  disease.  It  also 
highlights  a  problem  in  that  often  the  most  severe  reactions  to  the  diseases  are 
experienced  by  babies  and  very  young  children,  who  are  too  young  to  accurately  recall 
their  experiences.  In  general  there  seemed  to  be  a  lack  of  awareness  that  the  effects  of 
childhood  infectious  diseases  may  be  worse  if  contracted  as  a  baby  than  as  older  child, 
leading  some  participants  to  actually  underestimate  the  potential  risks  associated  with  the 
disease  to  the  more  vulnerable  members  of  society. 
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measles,  as  SCIEH  reports  state  that  in  2000  and  2001  there  were  no  confirmed  cases  of 
measles  in  Scotland  and  that  in  2002  none  of  the  four  cases  of  measles  occurred  in 
Glasgow  (see  www.  show.  scot.  nhs.  uk).  However,  several  participants  were  adamant  that 
their  children  had  had  measles  and  believed  public  health  officials  were  underplaying  the 
true  incidence  of  measles  in  Scotland.  This  was  despite  the  fact  that  these  participants 
also  questioned  how  accurately  doctors  could  clinically  diagnose  measles  as  they  felt 
many  young  doctors  had  little  or  no  experience  of  it,  and  they  had  not  had  it  confirmed  by 
saliva  test.  In  turn,  this  led  to  a  sense  of  confusion  among  participants  about  the 
magnitude  of  the  threat  of  measles  and  scepticism  about  the  accuracy  of  information 
disseminated  to  the  public. 
The  relationship  between  a  person's  experience  of  a  disease  and  their  knowledge  and 
perceptions  of  that  disease  is  complex.  Despite  the  fact  that  participants  had  little  or  no 
experience  of  poliomyelitis  they  often  described  vivid  images  of  the  disease.  The  fact 
that  participants  found  it  difficult  to  describe  diphtheria  and  easy  to  describe 
poliomyelitis  suggests  that  even  when  parents  have  little  or  no  experience  of  diseases 
themselves,  some  diseases  appears  to  be  more  memorable.  The  physical  impairment  that 
poliomyelitis  caused  in  its  victims  appeared  to  have  created  a  lasting  visual  impression  in 
many  participants'  minds.  Perhaps  for  this  reason,  and  because  polio  is  a  pain-free  oral 
vaccine,  participants  did  not  question  the  need  for  its  continuing  inclusion  in  the 
programme. 
The  fact  is  that  there  is  very  little  literature  on  people's  understanding  of  the  diseases 
prevented  by  immunisation  programmes,  which  has  made  it  difficult  to  compare  and 
contrast  these  findings  with  other  studies.  Therefore  these  findings  contribute  original 
and  highly  policy-relevant  research  to  the  wider  body  of  knowledge  on  childhood 
immunisation. 
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This  chapter  considers  parents'  perceptions  of  the  MMR  controversy.  It  begins  by 
presenting  a  short  review  of  the  most  relevant  and  up-to-date  literature  on  parents' 
perceptions  on  MMR  immunisation.  It  is  of  note  that  much  of  this  literature  has  been 
published  since  fieldwork  begun  for  this  study.  This  short  review  is  intended  to  recap 
and  complement  the  more  comprehensive  review  offered  in  Chapter  One.  At  the  end  of 
the  chapter  a  short  conclusion  draws  together  the  most  salient  findings  to  have  emerged 
on  parents'  perceptions  of  the  MMR  controversy. 
4.1  Summary  of  literature  on  the  MMR  controversy 
In  recent  years  the  public  may  have  considered  themselves  to  have  been  misled  or  offered 
incomplete  information  on  a  range  of  public  health  issues.  These  include  the  risks  posed 
to  humans  from  Bovine  Spongiform  Encephalopathy,  Eschericichia  Coli,  Samonella 
infection,  and  from  genetically  modified  food.  This  growing  distrust  of  the  Government 
in  safeguarding  public  health  is  the  backdrop  against  which  parents  have  observed  and 
assessed  the  speculation  surrounding  the  safety  of  MMR.  Across  the  United  Kingdom 
the  fall  in  MMR  uptake  rates  provides  evidence  that  some  parents  remain  anxious  about 
its  safety.  This  is  also  suggested  by  the  fact  that  before  legal  aid  was  denied  in 
September  2003  there  were  more  than  1000  claimants  suing  the  pharmaceutical 
companies  responsible  for  manufacturing  the  MMR  vaccine.  This  suggests  that  there  are 
thousands  of  parents  convinced  that  MMR  has  damaged  their  children's  health  (Dyer, 
2003). 
Since  the  MMR  controversy  first  attracted  public  attention  in  1998  there  has  been  huge 
interest  in  it  from  the  media,  politicians,  health  professionals,  and  parents  alike.  However, 
much  of  what  has  been  written  about  parents'  views  on  MMR  has  stemmed  from  media 
reports  and  newspapers,  rather  than  from  the  scientific  community.  In  recognition  of  this 
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been  several  papers  that  have  considered  how  the  controversy  has  been  communicated  to 
parents,  and  in  turn,  how  parents  have  conceptualised  it. 
As  described  more  fully  in  Chapter  One,  the  studies  by  Evans  et  al.  (2001)  and 
Smailbegovic  et  al.  (2003)  are  particularly  important  in  offering  an  insight  into  parents' 
perceptions  about  the  MMR  vaccine  and  debate  surrounding  its  use.  The  main  findings 
from  these  papers  were  as  follows.  Evans  et  al.  's  (2001)  carried  out  a  small  qualitative 
study  involving  six  focus  groups  and  found  that  parents  were  not  convinced  by  the 
Department  of  Health's  reassurances  that  MMR  was  the  safest  and  best  option,  and  that 
on  some  occasions  parents  had  accepted  MMR  unwillingly.  They  also  suggested  that 
many  parents  did  not  have  confidence  in  the  recommendations  of  health  professionals 
because  they  were  aware  that  GPs  need  to  reach  immunisation  targets  and  that  some 
parents  experienced  -  unwelcome  pressure  from  health  professionals  to  comply  with 
immunisation  policy.  Similarly,  a  later  study  conducted  by  Smailbegovic  et  al.  (2003) 
also  found  that  parents  considered  the  information  provided  by  health  professionals  was 
biased,  and  that  information  about  vaccine  safety  was  withheld.  They  found  that  parents 
who  rated  immunisation  information  as  poor  were  more  likely  to  access  Internet  sites  for 
information.  They  concluded  that  parents  would  benefit  from  more  detailed  factsheets 
given  out  by  well-informed  professionals.  Flynn  and  Ogden  (2004)  conducted  a  study  to 
find  out  parents'  beliefs  about  the  MMR  vaccine.  Five  hundred  and  eleven  parents  living 
in  East  Sussex  completed  questionnaires  prior  to  receiving  a  letter  to  attend  for  their 
child's  vaccination.  Attendance  data  were  collected  at  follow-up  by  the  age  of  two  years 
in  order  to  explore  the  best  predictors  of  uptake  by  that  age.  They  found  that  the  uptake 
of  the  MMR  vaccination  was  related  to  previous  uptake  of  vaccination  given  to  the  child 
at  3,4,  and  5  months.  Similar  to  Smailbegovic  et  al.  's  study  (2003)  they  also  found  that 
uptake  was  affected  by  parents'  trust  in  the  medical  profession  and  that  many  parents 
held  conflicting  beliefs  about  the  MMR  vaccination  and  the  doctors  who  administer  it. 
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understanding  of  science,  Hargreaves  and  colleagues  at  Cardiff  University  (2003) 
published  an  in-depth  report  that  considered  the  MMR  controversy  amongst  other  public 
health  debates.  The  study  involved  two  nationwide  surveys,  both  with  representative 
samples  of  over  1000  members  of  the  public,  to  explore  what  they  knew  and  thought 
about  MMR.  In  addition  to  this,  they  conducted  a  content  analysis  of  521  media  reports 
on  MMR  over  a  seven  and  a  half-month  period,  in  order  to  explore  exactly  how  MMR 
was  reported,  framed  and  interpreted.  From  this  work  they  suggested  that  media 
coverage  of  the  MMR  debate  was  unintentionally  misleading  in  creating  the  impression 
that  the  evidence  for  the  link  with  autism  was  as  substantial  as  the  evidence  against  it. 
Although  press  reports  often  tried  to  make  it  clear  that  the  bulk  of  evidence  indicated  that 
MMR  was  safe,  what  people  appeared  to  have  understood  was  that  there  were  two  sides 
to  the  debate.  This  led  most  respondents  (53%)  to  assume  that  since  both  sides  got 
roughly  equal  coverage,  they  must  correspond  to  equal  bodies  of  evidence.  Similarly, 
Clements  and  Ratzan  (2003)  commented  on  the  responsibility  and  role  of  the  media  in 
their  reporting  of  the  MMR  debate  and  considered: 
The  British  public  have  been  fed  by  the  media  on  a  mixed  diet  of  scientific  evidence,  theories, 
views,  and  other  verbal  roughage.  Because  of  the  huge  amount  of  media  coverage  of  the  safety  of 
MMR,  the  public,  not  unreasonably,  have  come  to  the  conclusion  that  there  is  no  smoke  without 
fire;  there  must  be  some  truth  in  all  this  alarmism...  (p.  23). 
Clements  and  Ratzan's  suggestion  is  that  once  the  public  felt  misled,  they  became 
suspicious  and  would  no  longer  accept  information  unquestioningly.  However,  Bellaby 
(2003)  pointed  out  that  the  public's  reaction  to  the  MMR  debate  should  be  viewed  in  a 
broader  historical  context.  Bellaby  suggested  that  in  a  democracy  it  should  be  expected 
that  authority  is  challenged,  and  under  these  circumstances  some  people  would  choose 
not  to  comply  with  some  public  health  measures.  He  considered  that,  if  compliance  is  to 
occur,  communicating  risk  effectively  to  the  public  is  about  more  than  providing 
information.  However,  he  also  acknowledged  that  a  difficulty  in  communicating  risk  to 
parents  is  that  "science  cannot  prove  a  negative,  but  where  their  children  are  concerned, 
parents  want  to  be  reassured  that  the  risk  is  zero"  (p.  725). 
127 Indeed,  Lewis  and  Speers  (2003)  suggested  that  there  have  been  two  key  failures  to 
communicate  messages  about  MMR  safety  and  risks  to  the  public.  Firstly,  there  was  a 
failure  to  expose  the  limits  of  Wakefield's  claims.  This  failure  has  been  addressed  to 
some  extent  by  the  partial  retraction  published  in  the  Lancet  in  March  2004,  in  which  ten 
of  the  co-authors  of  Dr  Wakefield  formally  disassociated  themselves  from  his  hypothesis 
that  MMR  may  cause  autism.  The  second  failure  that  Lewis  and  Speers  highlighted  was 
that  there  have  been  inadequate  attempts  to  stress  the  risk  of  instituting  an  untested 
programme  of  three  separate  vaccines.  In  an  attempt  to  draw  lessons  from  the  MMR 
controversy  they  advised  that  there  is  a  danger  in  health  professionals  relying  on 
government  or  established  bodies  to  make  the  case  for  MMR,  as  it  may  lead  to 
unwelcome  comparisons  with  the  BSE  crisis.  Lewis  and  Speers  warn  that  the  battle  for 
public  trust  needs  to  be  based  on  an  understanding  of  the  nature  of  public  concern. 
Whilst  recognition  of  this  fact  has  led  some  researchers  to  focus  their  efforts  on 
investigating  parents'  anxieties  about  MMR  immunisation,  the  scope  of  these  studies  has 
often  been  limited.  No  published  studies  have  included  the  diversity  of  parents  that  have 
taken  part  in  the  current  study  and  none  of  the  studies  has  included  the  views  of  parents 
with  autistic  children.  Yet  if,  as  Lewis  and  Speers  suggest,  the  battle  for  public  trust  is  to 
be  won  by  understanding  the  nature  of  public  concern,  then  it  is  clear  that  there  is  a  need 
to  hear  from  a  greater  diversity  of  parents  affected  by  the  debate.  Indeed,  in  Horton's 
book  published  in  September  2004,  he  notes  that  parents  have  been  marginalised  from  the 
debate.  With  this  in  mind,  this  chapter  aims  to  consider  parents'  perceptions  about  the 
evidence  on  MMR  safety,  and  parents'  beliefs  about  how  the  MMR  controversy  has  been 
handled. 
4.2  Perceptions  of  the  MMR  controversy:  `Who's  got  my  wee  boy's  best 
interests  at  heart?  ' 
Although  one  of  the  aims  of  this  study  was  to  explore  parents'  perceptions  of  the  current 
MMR  controversy  there  was  a  danger  that  this  aspect  of  the  focus  group  discussion  could 
dominate  the  entire  focus  group  session.  Therefore  I  deliberately  avoided  using  the  word 
128 MMR  on  any  of  the  letters  and  information  sheets  handed  out  to  potential  participants.  I 
also  planned  to  introduce  the  topic  of  the  MMR  debate  myself  towards  the  end  of  the 
focus  group  if  it  had  not  already  arisen  during  the  course  of  the  discussion.  This  was  an 
attempt  to  try  to  control  and  manage  the  amount  of  discussion  on  the  debate  to  avoid  it 
dominating  the  whole  session.  In  practice,  this  was  naive:  MMR  was  often  the  first  issue 
parents  discussed  and  there  was  never  a  need  for  me  to  introduce  it.  Indeed,  although 
MMR  was  not  mentioned  on  the  information  sheets  given  to  potential  participants,  it 
became  clear  that  the  MMR  debate  was  the  sub-text  that  drew  participants  into  taking 
part  in  the  study.  Participants  eagerly  discussed  the  MMR  debate  and  the  volume  of  data 
generated  on  this  topic  was  substantial.  After  much  coding,  re-coding  and  deliberation, 
four  main  themes  were  identified  around  which  to  present  the  data  in  this  chapter.  These 
themes  reflect  the  main  topics  participants  spoke  about  in  relation  to  the  MMR 
controversy. 
"  Participants'  understanding  of  the  evidence  about  the  safety  of  MMR  vaccine. 
"  Participants'  perceptions  of  the  role  the  media  have  played  in  reporting  the  evidence. 
"  Participants'  perceptions  of  the  role  politicians  and  public  health  officials  have  played 
in  the  debate. 
"  Participants'  perceptions  of  the  role  Dr  Wakefield  and  other  medical  and  health 
professionals  have  played  in  the  debate. 
Guided  by  these  themes  this  chapter  offers  an  insight  into  participants'  perceptions  of 
how  the  MMR  controversy  has  been  handled  and  of  their  understanding  of  the  state  of  the 
scientific  evidence  about  the  safety  of  the  MMR  vaccine.  The  chapter  concludes  by 
discussing  how  the  findings  of  this  study  compare  with  those  of  other  studies  and  by 
summarising  the  main  points  to  have  emerged  from  discussions  on  the  public  health 
debate  about  the  safety  of  MMR  immunisation. 
129 4.2.1  Participants'  understanding  of  the  evidence  about  the  safety  of  MMR  vaccine: 
`No  smoke  without  fire' 
The  general  perception  among  participants  was  that  the  evidence  of  a  causal  link  between 
MMR  and  autism  was  not  convincing  at  the  moment,  but  that  in  time  further  evidence 
may  come  to  light  that  shows  MMR  is  damaging  for  some  children.  In  this  respect  there 
was  a  sense  that  for  many  participants  the  evidence  of  a  link  between  MMR  and  autism  is 
incomplete  and  uncertain  at  the  moment.  Indeed  it  was  common  for  participants  to 
demonstrate  their  uncertainty  about  the  state  of  evidence  by  directing  questions  to  each 
other,  and  to  myself  as  the  facilitator.  Participants  often  sounded  unconfident  when  they 
spoke,  and  talked  hesitantly,  using  frequent  pauses  and  unfinished  sentences  to  encourage 
other  group  members  to  comment  on  their  suggestions.  Their  body  language  tended  to 
mirror  this  uncertainty,  and  participants  encouragingly  nodded  their  heads  when  other 
group  members  spoke  and  tended  to  use  eye  contact  to  show  they  were  finding  each 
others'  point  of  view  interesting.  As  such,  participants  did  not  tend  to  sound  as  if  they 
were  entrenched  in  their  views  on  MMR  safety,  and  they  often  appeared  willing  to 
consider  the  debate  from  various  perspectives.  However  there  were  some  notable 
exceptions  to  this.  These  exceptions  included  participants  who  had  decided  not  to  give 
their  children  MMR:  the  Non-Vaccine  Group,  the  Single  Vaccine  Group  and  the  two 
groups  conducted  with  parents  of  children  with  autism.  These  four  groups  consisted  of 
participants  who  had  considered  the  debate  and  had  made  up  their  minds  not  to  vaccinate 
their  children  with  MMR;  therefore  they  spoke  with  more  conviction  about  MMR  safety. 
The  Non-Vaccine  Group's  concerns  were  about  immunisation  more  generally  and  were 
not  confined  to  the  MMR  vaccine,  whereas  parents  in  the  Single  Vaccine  Group  were 
primarily  concerned  with  the  MMR  vaccine  and  their  worry  did  not  extend  as  much  to 
the  other  vaccines  in  the  programme. 
In  considering  the  evidence  about  MMR  safety  it  was  clear  that  many  participants  found 
it  confusing  to  decipher  what  counts  as  evidence  and  to  assess  the  trustworthiness  of  the 
studies  being  debated  in  the  public  domain.  For  example,  Sue  referred  to  a  Finnish  study: 
130 Yes,  uhuh,  and  this  Finnish  study  as  well,  em,  they  always  quote...  this  Finnish  study  only 
followed-...  it  didn't  follow  children  up.  It  was  something  like,  it  was  a  month  afterwards  and 
they  weren't  looking  for  autism,  it  wasn't  a  study  looking  for  autism,  it  was  a  study  looking  for 
reactions  in...  after  your  MMR  after  a  couple  of  weeks.  So  you  would  have  your  initial 
temperature  and  all  that,  em,  but  no,  there's  no  proved  link  with  autism  because  they  weren't 
looking  for  autism.  That  wasn't  what  that  study  was  about  and  that  keeps  continually  being... 
touted  and  trotted  out  and  it's  almost  like  false  information  because  the  study  wasn't  to  do  with 
that  as  far  as  I'm  aware.  You  know,  the  autism  wouldn't  develop  within  the  first  four  months 
although  I  know  somebody  that  said,  you  know,  some  people  who've  had  the  injection, 
something's  happened  to  their  child  but  there  has...  but  as  far  as  I'm  aware,  there  has  not  been  a 
study  done  that  follows  up  children  specifically  looking  for  autism  from  MMR. 
Non-MMR  Group;  Sue  aged  36 
Sue's  comments  were  interesting  because,  by  referring  to  a  specific  research  study,  she, 
like  other  participants,  demonstrated  how  highly  involved  parents  have  become  in  trying 
to  comprehend  the  evidence.  However,  despite  her  efforts  she  appeared  to  feel  sceptical 
about  the  evidence,  sensing  that  studies  are  selectively  chosen  to  be  communicated  to  the 
public  and  that,  as  yet,  research  attempts  have  been  inadequate  in  addressing  the  real 
issue  of  a  link  between  MMR  and  autism.  Likewise  Trudie  considered  that  she  had  tried 
to  gather  as  much  information  as  she  could.  She  stated:  "I  didn't  really  get  very  far,  I 
was  quite  confused  and  I  don't  have  the  scientific,  medical  sort  of  background  to  be  able 
to  understand  the  information  that  I  need  in  order  to  understand,  to  make  a  decision.  It  is 
all  kind  of  anecdotal and  quite  emotive  the  way  it  is  presented...  "  (NCT  Group;  Trudie 
aged  38).  Even,  Bob,  a  father  of  two,  who  talked  about  specific  authors  and  studies, 
considered  that  the  studies  he  had  read  about  in  the  press  were  difficult  to  assess.  He 
summed  up  his  feelings  thus:  "I  have  no  way  of  knowing  that  that  paper  is  any  more 
relevant  in  any  way  to  the  greater  good.  There's  no  way  of  knowing  that  one  paper  is 
... 
is 
the  method  used  to  test  the  hypothesis  is  in  any  way  rigorous...  "  (Saturday  Club  Group; 
Bob  aged  31). 
A  common  view  expressed  by  participants  was  that  in  order  to  reassure  parents  that 
MMR  has  no  risks  associated  with  it  there  is  a  need  for  further  research  to  show  that  there 
is  no  link  between  MMR  and  autism.  For  Joanne,  the  lack  of  research  made  her  feel  that 
the  Government  was  not  taking  her  concerns  seriously  (New  Mothers  Group;  Joanne 
aged  37).  The  NCT  Group  also  debated  the  issue  of  the  lack  of  research  and  thought: 
131 Trudie:  I  just  don't  think  enough  research  has  been  done  really,  one  way  or  the  other,  to  say 
whether  it  is  completely  safe. 
Mel:  I  still  feel  as  if  there  is  something  underlying,  something  there,  you  know  these  children 
were  they  (interrupted) 
Violet:  You  know  though  that  these  parents  weren't  just  making  it  up,  I  don't  think,  you  know. 
Mel:  No,  I  know. 
Violet:  I  think  to  say  there  is  no  evidence  that  it  causes  harm,  is  not  comforting,  because  that  just 
means  there  has  not  been  the  research  done  on  it.  You  could  say  that  about  virtually  anything 
practically. 
Trudie:  That's  true. 
They  then  moved  on  to  talk  about  feeling  misinformed  about  BSE,  before  Violet  summed 
up  her  assessment  of  the  evidence  on  MMR  safety: 
Violet:  I  don't  think  you  can  just  keep  saying  to  parents,  it's  safe,  it's  safe,  it's  safe,  and  you  are 
putting  your  child  at  risk  if  you  don't  give  it.  They  are  not  really  allowing  anything  of  the  other 
side  of  the  story.  I  don't  think  that  Dr  Wakefield  has  ever  said  he  can  prove  a  link.  I  think  his 
research  has  been  validated  as  research.  There  is  nothing  wrong  with  the  processes  he  has  gone 
through,  and  I  think  parents  would  be  more  comforted  if  they  would  allow  the  other  side  of  the 
story  to  come  out  a  bit  more... 
NCI'  Group;  Mel  aged  35;  Violet  aged  36;  Trudie  aged  38 
This  conversation  is  interesting  because  it  highlights  some  of  the  difficulties  participants 
had  in  trying  to  interpret  the  language  used  by  politicians  and  scientists  to  convey 
messages  about  MMR  safety  to  the  public.  Participants  were  often  dismissive  of  phrases 
such  as  `no  proven  risk,  '  and  `minimal  risk,  '  and  of  blanket  messages  that  MMR  is  safe, 
as  they  felt  that  the  lack  of  research  contributed  considerably  to  the  difficulty  they 
experienced  in  assessing  MMR  safety.  Participants  appeared  to  interpret  these  messages 
from  politicians  and  scientists  as  meaning  that  they  are  not  aware  of  any  risk  `at  the 
moment'.  For  example,  Patsy  stated  that  as  far  as  she  was  concerned  until  scientists  get 
the  proof  to  show  there  are  absolutely  no  risks  associated  with  MMR  they  are 
experimenting  with  children's  health  (Multiple  Parenting  Problem  Group;  Patsy  aged  23). 
132 In  the  absence  of  feeling  able  to  make  sense  of  the  biological  plausibility  of  Wakefield 
and  colleagues'  theory,  participants  tended  to  focus  their  attention  on  what  they 
considered  to  be  the  facts  about  the  epidemiology  of  autism.  Participants  often 
speculated  about  why  the  incidence  of  autism  seems  to  be  increasing,  and  about  which 
children  they  thought  might  be  at  most  risk  of  developing  autism.  For  example,  in  the 
First-Time  Mothers  Group  when  Celia  stated  that  she  felt  worried  about  her  daughter 
receiving  MMR,  Charlotte  tried  to  reassure  her  by  saying: 
I  think  actually  as  a  girl,  you've  got  hardly  any  chance  of  them  becoming  autistic  because  it's 
about...  almost  every  autistic  baby  is  a  boy.  It's  not,  I  mean  it  does  happen  to  girls,  I  mean  every 
so  often  we  get  a  girl  but  it's  really  very,  very  low  percentage  that  we  see. 
First-Time  Mothers  Group;  Charlotte  aged  29;  Celia  aged  33 
Charlotte's  attempts  to  reassure  Celia  were  mirrored  by  comments  from  participants  in 
other  groups.  Whilst  this  appeared  to  be  reassuring  for  those  participants  with  girls,  those 
with  boys  found  it  worrying,  and  this  was  evident  when  they  talked  about  the  factors  that 
influenced  their  decisions  about  MMR.  Indeed,  on  closer  examination  of  the  data,  it  is  of 
interest  to  note  that  the  participants  who  opted  to  take  part  in  the  study  were  more  likely 
to  have  boys  than  girls.  Collectively  they  had  78  sons  compared  to  51  daughters.  One 
possible  explanation  for  this  may  be  that  participants  with  boys  were  keener  to  volunteer 
to  take  part  because  many  of  them  were  aware  that  there  is  a  higher  incidence  of  autism 
among  boys.  This  knowledge  may  have  led  them  to  consider  that  their  boys  were  at 
greater  risk  from  developing  autism  after  receiving  MMR.  In  fact,  reviewing  the 
responses  from  the  short  questionnaire  completed  by  participants,  it  is  interesting  that  out 
of  the  78  boys,  34  of  them  had  either  not  had  their  MMR,  were  not  going  to  be  given 
their  MMR,  or  were  having  their  MMR  delayed;  this  compared  to  only  seven  of  the  51 
girls.  This  finding  supports  the  need  for  further  research  into  the  aetiology  of  autism  as  it 
is  of  concern  that  parents  of  boys  to  be  particularly  worried  about  the  causal  link  between 
MMR  and  autism. 
Another  group  of  children  that  some  participants  felt  future  research  might  reveal  to  be  at 
risk  from  having  an  adverse  reaction  to  MMR  were  children  with  vulnerable  immune 
systems.  Some  participants  identified  childhood  illnesses  (such  as  recurrent  ear  and  chest 
133 infections,  or  asthma,  eczema  or  allergies)  as  being  indicative  of  a  slightly  deficient 
immune  system.  This  led  some  participants  to  fear  that  future  MMR  research  might 
suggest  that  these  children  should  not  be  immunised  with  the  combined  MMR  vaccine. 
For  example,  in  the  New  Mothers  Group,  Joanne  wondered  whether  her  son's  eczema 
might  be  an  indication  that  he  could  be  vulnerable  to  having  an  adverse  reaction  to 
MMR: 
Well,  I'm  a  journalist  so  I've  been  reading  quite  a  lot  about  it-  though,  I  must  admit  I'm  not 
entirely  convinced  that  I  want  him  to  have  the  MMR.  Six  months  ago  I'd  have  probably  said  yes, 
I  wouldn't  have  had  any  problem  with  it,  but  I  just  think  the  lack  of  the  Government's....  not 
allowing  a  study  to  be  done  into  whether  there  is  any  definite  effect.  I  don't  think  MMR  causes 
autism  as  Wakefield  suggested,  but  I  think  if  there  is  enough  mothers  that  are  worried  to  think  that 
there  is  something  there,  to  think  that  if  their  child  has  asthma  or  eczema  or  whatever  that  it  could 
act  as  a  trigger.  The  fact  that  the  Government  won't  do  anything  about  studying  whether  that  is  a 
possibility  or  not,  I  just  think  just  makes  me worried,  you  know.  He  has  actually  got  baby  eczema, 
so  could  MMR  could  be  a  trigger?  I  don't  know  whether  it  is  true  or  not,  but  it  just  makes  me 
think  the  single  vaccines  would  be  better. 
Conversation  moves  on  to  the  single  vaccines,  before  Joanne  sums  up  her  feelings: 
...  I  am  only  concerned  because  I  read  somewhere  about  possible  triggers.  I  read  that  asthma  and 
eczema  are  possible  triggers  and  I  would  never  forgive  myself  if  that  was  a  trigger  and  I  went 
ahead  and  got  him  jabbed.  Are  they  triggers  that  cause  autism?  But  there  again,  he  could  end  up 
autistic  anyway.  So  I  don't  know,  I  just  feel  completely  confused  about  the  whole  thing. 
New  Mothers  Group;  Joanne  aged  37 
Joanne  clearly  felt  apprehensive  about  her  son  and  used  rhetorical  questions  to 
demonstrate  to  the  other  group  members  that  she  considered  there  to  be  many 
unanswered  questions  about  the  safety  of  MMR.  By  introducing  herself  as  a  journalist 
and  referring  to  Wakefield's  study,  she  immediately  let  the  other  group  members  know 
that  she  was  an  educated  professional.  But  by  then  admitting  that  she  found  the  debate 
complicated,  she  endeared  herself  to  the  other  group  members  who  also  went  on  to  talk 
about  finding  the  evidence  confusing.  This  subtle  interaction  was  noticeable  because  it 
was  one  of  several  conversations  in  which  Joanne  appeared  to  hold  court  over  the  other 
group  members.  On  one  hand,  it  may  be  that  because  Joanne  stood  out  as  the  most  vocal 
and  confident  member  of  the  group,  her  comments  directly  influenced  the  other  group 
members'  comments.  There  is  no  doubt  that  Barbour  and  Kitzinger's  (1999)  suggestion 
that  data  are  influenced  by  the  context  in  which  they  are  produced  holds  true  here. 
134 However,  one  of  the  useful  aspects  of  keeping  the  transcripts  intact  and  writing  field- 
notes  on  to  them  was  that  it  offered  greater  insight  into  the  group  dynamics.  It  was 
observed  that  when  participants  agreed  with  each  other  for  the  sake  of  group  consensus, 
these  participants  often  affirmed  their  position  or  contradicted  themselves  in  later 
discussions.  This  was  not  a  feature  in  the  New  Mothers  Group  and  therefore  it  seems 
likely  that  the  high  level  of  agreement  that  the  evidence  was  confusing  and  incomplete 
was  genuine. 
Although  the  general  feeling  among  participants  was  that  further  research  would  help 
clear  up  some  of  the  confusion  surrounding  MMR  and  thus  dispel  parents'  fears,  not  all 
the  participants  felt  concerned  about  MMR  safety.  Some  participants  were  quite 
dismissive  of  the  evidence  of  a  link  between  MMR  and  autism.  Margaret,  a  mother  of 
one  boy,  stated:  "...  fur  aw  the  children  in  the  world  that  has  had  MMR  there's  only  like  a 
small  minority  that  have  maybe  got  it  and  it's  no  even  proven  is  it?  That  they've  actually 
got  autism  because  o'  that  jag,  so  ye  don't  know...  "  (Young,  Single  Mothers  Group; 
Margaret  aged  20).  Although  Catrina,  a  mother  of  one  girl,  mentioned  that  she  was 
concerned  about  MMIt,  she  also  made  reference  to  the  pertussis  controversy  in  the  1970s 
and  1980s.  She  considered  that:  "...  in  20  years  time  it  will  be  a  different  one  that  they, 
you  know,  that's  in  the  press  and  they  are  creating  fuss  over"  (First-Time  Mothers  Group; 
Catrina  aged  27).  Similarly,  whilst  Angie,  a  mother  of  two  boys,  urged  the  need  for 
further  research,  she  felt  convinced  that  the  higher  incidence  of  autism  in  boys  was 
evidence  that  genetics  would  eventually  be  cited  as  a  major  factor  in  the  development  of 
autism,  and  took  solace  from  the  fact  that  she  had  no  family  history  of  autism  (Crafts 
Group;  Angie  aged  29). 
4.2.2  Perceptions  about  the  media's  role  in  reporting  the  evidence 
Participants'  views  on  the  role  that  the  media  have  played  in  the  MMR  controversy 
varied  enormously.  Some  participants  viewed  them  as  scaremongers,  only  interested  in 
selling  newspapers,  whilst  others  thought  of  them  as  valuable  information  providers.  For 
example,  Ellen  thought  that  they  were  useful  in  raising  the  public's  awareness  of  issues 
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newspapers  are  trying  to  let  the  everyday  people  know  the  inside  story"  (Multiple 
Parenting  Problems  Group;  Frank  aged  31).  In  contrast,  Cathy  denounced  the  media's 
involvement  in  the  MMR  controversy,  stating: 
... 
it's,  it's  just  the  media  being  the  media.  You  know,  we've  got  to  have  something  to  sort  of  ... 
the  minute  a  bit  of  scandal  comes  along  they  just  sort  of,  you  know,  they  just  go  mad  with  it.  I 
think  they  take  it  out  of  all  contexts.  Yeah,  I  think  we  do  have  a  right  to  know  if  there  are 
problems  with  it.  But  there  again,  it's  like  Helen  said,  it's  kind  of  blanket  everything,  you  know, 
it's  just  too  blanket. 
Saturday  Club  Group;  Cathy  aged  29 
Likewise,  the  participants  in  the  Crafts  Group  considered: 
Angie: 
...  they  make  it  into  a  big  issue  an  just  get  a  wee  bit  carried  away. 
Mary:  Aye  (group  members  nodding  heads). 
Tracy:  Aye  the  usual. 
Angie:  It  is.  It  is  but  that's  their  policy,  they  dae  that  anyway,  I  mean.  As  long  as  they're  getting 
the  weans  they're  no  caring,  I  mean,  cos  that's  all  it  is  really.  Just,  dunno,  they  dae  it  all  the  time, 
they  just  over-dramatise  it,  if  you  could  call  it  that. 
They  went  on  to  discuss  the  media's  role  in  other  public  health  scares,  before  coming 
back  to  talk  about  the  MMR  controversy. 
Mary:  It's  ridiculous,  and  then  people...  are  unsure  about  going  in  to  buy  eggs  and  ...  what  do 
we  dae?  Do  we  buy  them  or  do  we  no  buy  them?  And  again  the  same  wi  the  CJD  an  beef. 
Angie:  Doesnae  matter  what  you  eat  don't  eat  this  and  don't  eat  that. 
Lydia:  Autism  and  stuff  like  that. 
Angie:  If  we  didnae  eat  anything  we  wouldnae  survive,  know  what  I  mean? 
Mary:  Just  say,  as  long  as  the  media  attention  and  they're  getting  the  ratings  they're  fine  init? 
Crafts  Group;  Angie  aged  29;  Mary  aged  43;  Tracy  aged  32 
Indeed,  when  some  participants  spoke  about  the  media's  involvement  in  the  debate,  it 
was  almost  with  a  sense  of  resignation  that  the  media  can  be  expected  to  act 
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looked  dejected  when  they  spoke  about  the  media,  and  talked  about  being  tired  of  the 
spin  that  the  media  put  on  stories  about  health.  It  was  implied  that  the  competitive  nature 
of  newspapers  and  journalists  to  sell  newspapers  may  have  played  a  substantial  role  in 
creating  much  of  the  furore  about  MMR  safety.  A  few  participants  sounded  fed  up  with 
this  state  of  affairs  and  occasionally  spoke  angrily  about  the  media's  antics.  For  example, 
Iona  demanded  that:  "...  the  media  have  a  responsibility  to  stop  just  taking  bits  of 
research  and  throwing  it  into  the  press  to  alarm  us"  (Antenatal  Group;  Iona  aged  39). 
Participants  talked  about  the  fact  that  health  stories,  especially  those  involving  children, 
are  of  huge  interest  to  the  general  public  and  that  the  media  are  acutely  aware  of  this  fact. 
The  Single  Fathers  Group  considered  that  this  interest  in  health  in  the  media  has  grown 
over  the  years.  They  said  that  when  they  were  young,  their  parents  did  not  have  access  to 
the  level  of  information  that  today's  parents  have,  and  questioned  whether  the 
information  on  MMR  had  helped  or  hindered  parents'  assessment  of  MMR  safety. 
William  summed  up  the  current  situation  as  he  saw  it,  stating:  "there  was  no  controversy 
to  the  amount  there  is  today"  (Single  Fathers  Group;  William  aged  51).  Similarly,  Joan 
considered  "it's  never  off  the  television"  and  Alan  later  replied  to  Joan's  point  stating: 
I  feel  as  if  the  media  has  got  a  lot  to  play  in  everything.  They've  got...  because  you  would  never 
really  hear  about  this  if  it  wasnae  for  the  media.  The  media  is...  you  just  take  it  in...  how  many 
papers  is  there  now  to  before?  There  wasnae  as  many  papers  before  as  what  there  is  nowadays. 
You  know  you  go  into  the  shop  and  you've  got  a  choice  of  maybe  20  or  30  papers.  And  the  TV, 
the  TV,  there's  news  on  all  the  time  and  I  feel,  you  feel  as  if  they're  just  searching  for  something. 
Low  Uptake  Area  Group;  Joan  aged  20;  Alan  aged  33 
Indeed,  whilst  some  participants  considered  that  they  would  not  know  anything  about  the 
MMR  debate  if  it  were  not  for  the  media's  involvement  in  it,  they  often  considered  that 
media  involvement  had  confounded  rather  than  illuminated  their  understanding  of  the 
MMR  issue.  This  led  a  few  participants  to  state  that  they  had  stopped  reading  the  articles 
on  MMR  in  newspapers.  Nevertheless,  other  participants  had  found  it  difficult  to 
distance  themselves  from  the  debate  and  spoke  of  feeling  particularly  drawn  to 
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was  because  they  could  relate  to  them  more  as  parents  than  they  could  to  commentary  by 
scientists  and  politicians  with  whom  they  felt  they  had  less  in  common.  Parents'  stories 
were  also  viewed  as  being  more  impartial  and  as  having  no  hidden  agenda.  In  addition 
they  were  able  to  relate  to  these  stories  easily,  and  this  seemed  to  make  this  kind  of 
evidence  very  persuasive.  For  example,  Dave  thought: 
... 
I  think  there's  a  sense  that  there's  a  kinship  with  other  parents  that  you  just  don't  have  with, 
you  know,  doctors  and  you  know,  the  reason  why  it  was  moving,  the  article  that  Quentin  had 
written,  was  because  he  was  a  parent  writing  about  his  son.  But  you  know,  if  that  was  just  a 
journalist  writing  about  autism,  it  wouldn't  have  the  same  impact  because  you're  not  relating 
experiences  as  parents.  And  I  think  as  well,  you  know,  that  the  evidence  that  scientists  use,  it's 
just  stuff  that  just  goes  in  and  out  your  ears.  You  just  can't  comprehend  it.  It's  not  written  for 
parents,  and  then  when  they  do  write  it  for  parents  you  just  wonder,  you  know,  what  their  motives 
are  because  there  are  so  many  big  players,  so  many  people  with  their  own  interests  that  it's  easier 
to  believe  other  parents.  You  want  to  believe  other  parents. 
Single  Vaccine  Group;  Dave  aged  38 
In  this  respect  these  personal  stories  appeared  to  carry  as  much,  if  not  more,  weight  of 
evidence  than  research  studies  or  comments  from  politicians  and  public  health  officials. 
This  was  because  participants  could  relate  to  this  kind  of  evidence  compared  to  research 
studies  which  many  participants  felt  ill-equipped  to  assess  for  themselves.  However,  a 
few  participants  complained  that  newspapers  and  television  programmes  have  tended  to 
contrast  the  scientific  and  anecdotal  evidence  alongside  each  other,  leaving  a  confusing 
picture  that  did  not  assist  them  to  come  to  any  conclusions  about  the  safety  of  MMR.  For 
example,  Joanne  mentioned  that  the  Daily  Mail  is  a  health  newspaper,  and  she  went  on  to 
make  an  important  point  about  the  way  that  the  media  presents  stories: 
Well,  newspapers  have  different  agendas  anyway;  I  mean  the  Daily  Mail  is  normally  the  health 
newspaper.  They  ran  an  article  on  the  MMR  story  and  they  had  a  page  for  and  a  page  against  it. 
But  again,  like  the  Panorama  programme  there  is  nothing  in  the  middle  saying  -  the  conclusion  is 
you've  got  to  make  your  own  mind  up.  In  the  end  it  comes  down  to  you  as  a  parent,  you  decide 
one  whether  you  think  it  is  a  risk,  then  whether  it  is  it  is  a  risk  you  want  to  take,  or  whether  you 
don't  think  the  disease  is  a  risk  worth  vaccinating  against. 
New  Mothers  Group;  Joanne  aged  37 
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experiences  of  MMR,  and  the  level  of  media  coverage  paid  to  the  debate,  appeared  to 
have  influenced  participants'  assessment  of  the  evidence.  It  was  implied  on  several 
occasions  that  the  level  of  attention  afforded  to  the  MMR  debate  and  the  fact  that  some 
stories  involved  parents  who  were  adamant  that  MMR  had  caused  their  child's  autism, 
was  evidence  enough  for  them  to  conclude  that  MMR  is  unsafe.  "No  smoke  without  fire" 
was  a  term  used  and  Angie  expanded  on  this  when  she  said  "obviously  there  is 
something,  there  is  something  that  links  it  or  it  wouldnae  be  going  on,  do  you  know  what 
I  mean,  all  the  discussion  about  autism"  (Crafts  Group;  Angie  aged  29). 
4.23  Perceptions  about  politicians  and  public  health  officials 
The  general  consensus  among  participants  about  how  politicians  and  public  health 
officials  were  perceived  to  be  handling  the  MMR  debate  was  that  politicians  were 
untrustworthy,  and  that  public  health  officials  were  not  persuasive.  Participants  talked 
about  public  health  officials  and  politicians  interchangeably  and  they  rarely  differentiated 
between  the  two.  In  this  respect  any  announcement  of  reassurances  about  the  safety  of 
MMR  from  public  health  officials  were  subjected  to  the  same  critical  appraisal  as  that 
from  politicians.  Alison  considered  that  the  attempts  by  politicians  and  public  health 
spokespersons  to  discredit  Dr  Wakefield  and  co-authors  were  not  reassuring  (High 
Uptake  Area  Group;  Alison  aged  31).  A  few  participants  implied  that  as  doctors, 
Wakefield  and  co-authors  were  more  likely  to  be  acting  in  the  public  interest  and  thus 
were  more  trustworthy  than  politicians,  who  were  often  viewed  as  acting  primarily  in 
their  own  interests.  This  was  interesting  because  when  participants  later  came  to  discuss 
the  role  of  GPs  and  other  health  professionals  in  the  MMR  debate,  they  often  talked  about 
not  being  able  to  trust  them  either.  The  general  feeling  was  of  mistrust.  For  instance  in 
relation  to  public  health  spokespersons,  there  was  a  sense  that  they  were  speaking  on 
behalf  of  the  Government  and  thus  were  not  viewed  as  impartial.  This  led  participants  to 
dismiss  messages  from  them  about  MMR  safety.  For  example,  when  the  Low  Uptake 
139 Area  Group  were  asked  if  they  felt  that  the  Government  and  public  health  officials  had 
reassured  them,  the  question  was  interrupted  by  Sheila: 
Sheila:  No  I  think  they've  just  said  its  safe,  that's  it. 
Joan:  It's  always  the  same  thing.  It's  always  the  same  statement  you  read  that  its'  safe.  There's 
no  evidence. 
Facilitator:  Does  that  reassure  you?  Or  does  that  not  reassure  you? 
Alan:  No. 
Sheila:  No  it  doesn't  reassure  me. 
Alan:  See  really  afore  this  all  came  out,  surely  they  should  have  had  their  facts  perfect,  the  facts 
that  they  should  have  been  right  before  they  came  away  out  with  all  this.  It  just  seems  as  if  they've 
blew  it  all  out  of  proportion  and  then  they  retract  some  of  it. 
Low  Uptake  Area  Group;  Joan  aged  20;  Alan  aged  33;  Sheila  aged  36 
A  key  reason  given  by  participants  for  not  feeling  reassured  by  the  Government  and 
public  health  spokespersons  was  that  participants  recalled  their  handling  of  the  recent 
BSE  crisis.  Dawn  felt  that  since  then  the  public  has  become  less  trusting  of  Government 
reassurances,  and  stated: 
I  think  throwing  blanket  statements  at  you,  we  are  right  and  you  are  wrong,  is  not  very  helpful  and 
the  big  studies,  you  know  they  have  just  said  we  are  going  to  look  at  autism,  but  we  are  not  going 
to  look  at  MMR  because  that  is  not  the  reason.  It  is  like 
.... 
it  is  just  treating  us  like 
... 
It  reeks  of  all 
the  other  health  scare  scandals.  Where  we  are  told,  there  is  not  a  problem,  not  a  problem  -oh 
whoops!  There  is  a  problem. 
Antenatal  Group;  Dawn  aged  36 
It  was  commonly  mentioned  that  the  Government  had  failed  the  public  during  the  BSE 
crisis,  and  so  could  not  be  trusted  to  accurately  communicate  risks  to  the  public. 
Participants  were  of  the  view  that  the  Government's  reassurances  of  the  minimal  risk 
posed  to  human  health  by  BSE  greatly  underplayed  the  actual  risk.  In  turn,  just  as  the 
image  of  John  Gummer  the  Minister  of  Agriculture  feeding  his  daughter  a  hamburger 
during  the  BSE  crisis  was  mentioned  by  participants  as  symbolising  the  Government's 
handling  of  the  crisis,  the  image  participants  associated  with  the  MMR  debate  was  of 
Tony  Blair,  the  British  Prime  Minister,  refusing  to  confirm  whether  his  son  Leo  had  had 
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debated  at  length  the  rights  and  wrongs  of  Tony  Blair's  decision  not  to  disclose  this 
information  to  the  public.  (See  Appendix  D  for  MMR  events/  PhD  study  timeline).  For 
example,  Violet  considered: 
... 
I  think  Tony  Blair,  I  mean,  I  don't  really  think  it  is  an  issue  of  the  baby's  privacy,  either  he  has 
had  it,  or  not.  It  is  not  going  to  make  any  difference  to  anybody  one  way  or  the  other.  He  should 
come  out  and  say,  particularly  if  these  recent  stories  are  true  that  he  delayed  getting  it  till  Leo  was 
19  or  20  months.  Because  it  is  unfair  to  be  saying  to  parents  it  is  safe  for  your  child  to  have  it  at  13 
months. 
NGT  Group;  Violet  aged  36 
Similarly,  the  Single  Fathers  Group  discussed  it  and  they  considered: 
Kenny:  See  a,  the  thing  that  annoyed  me  as  well  with  the  ...  the  media.  The  way  it's  brought 
across  the  media.  If  I'm  correct  em...  when  eh,  Tony  Blair's  kid,  was  to  get  a  jag...  it  wasn't  made 
public  knowledge  at  the  time.  Whether  he  went  for  it  or  not.  Whereas  if  they  were  pushing 
policies  and  especially  with  him  being  head  of  government,  he  should  have  made  it  public 
knowledge. 
Robert:  Practice  what  he  preached. 
Kenny:  Their  choice.  They're  pushing  a  programme  and  what  better  to  push  a  programme  than 
the  head  of  state  having  their  kid...  disclose  whether  they've  had  it  or  not.  Because  the  fact  that  he 
didn't  disclose  that...  put  a  lot  of  fear  into  parents.  Because  he  doesn't  go...  he's  being  cagey  with 
us.  He  may  be  pushing  a  programme  he  doesn't  believe  in  because  he's  not  made  it  public 
knowledge  about  his  own  kid.  So  I  think  that  caused  a  bit  of  hysteria  as  well. 
Single  Fathers  Group;  Kenny  aged  43;  Robert  aged  47 
Participants  were  asked  to  expand  on  why  they  thought  these  two  images  were 
particularly  memorable.  The  response  usually  was  because  they  both  involved  children. 
However  a  few  participants  also  drew  some  interesting  parallels  between  the  two  images. 
For  example,  Charlotte  considered  that  the  image  of  John  Gummer  and  his  daughter 
represented  the  fact  that  his  daughter  probably  did  not  have  any  choice  as  to  whether  she 
wanted  to  eat  the  hamburger  in  front  of  the  assembled  press.  She  sympathised  with  his 
daughter's  predicament,  as  she  felt  that  whilst  not  overly  concerned  herself,  other  parents 
were  being  denied  the  right  to  choose  between  the  single  vaccines  and  the  MMR  vaccine 
(First-Time  Mothers  Group;  Charlotte  aged  29).  Likewise  Sue  compared  the  two  images, 
she  stated.  "I  think  it's  a  whole...  it's  like  a  metaphor  for  the  way  the  Government  treats 
141 the  public  ... 
(spoken  in  loud  commanding  voice)  `I  know  what  is  best  for  you'  -  have  a 
burger  sort  of  thing  public.  "  She  later  expanded:  "...  I'm  a  dad,  this  is  my  child,  I'm  the 
Government  and  you're  the  public  and  it's  that  relationship  I  think  that  it  illustrates.  " 
(Non-MMR  Group;  Sue  aged  36). 
Another  incident  that  many  participants  also  mentioned  as  having  dented  their  confidence 
in  the  Government  and  in  public  health  officials'  abilities  to  communicate  health  risks  to 
the  public  was  the  cryptosporidium  incident  that  occurred  in  Glasgow  in  the  summer  of 
2002.  Many  of  the  participants  who  took  part  in  this  study  were  directly  affected  by 
having  their  water  cut  off  during  the  outbreak  and  many  of  them  were  pregnant,  and  or 
had  young  children  at  the  time.  Rhona,  who  was  pregnant  at  the  time,  considered  that  the 
public  health  officials  were  slow  to  respond  and  were  deliberately  selective  in  the 
information  they  gave  to  the  public  (First-Time  Mum  Group;  Rhona  aged  31).  Similarly, 
Karen  who  had  just  recently  given  birth  to  a  baby  boy  recalled:  "...  when  it  came  to  that 
breakout  in  the  news  I  was  really  upset,  I  think  I  was  hormonal,  but  I  was  very  upset  you 
know?  I  just  bathed  my  baby  that  morning,  you  know...  "  (High  Uptake  Area  Group; 
Karen  aged  36). 
Between  and  within  the  groups  there  was  a  high  level  of  agreement  among  participants 
that  the  handling  of  these  public  health  debates  had  contributed  to  their  lack  of  trust  in 
politicians  on  the  MMR  debate.  The  general  view  expressed  by  participants  was  that 
politicians  serve  their  own  interests  and  those  of  their  party  before  that  of  the  public. 
Joanne  summed  up  what  many  participants  implied  when  she  said:  "...  there  is  a  lack  of 
trust  in  prime  ministers,  health  ministers,  food  ministers,  politicians  generally"  (New 
Mothers  Group;  Joanne  aged  37).  Debbie  and  Molly  both  believed  politicians  would 
readily  manipulate  statistics  and  tell  the  public  half  truths  and  Kitty  considered  that  this 
and  being  brought  up  around  Members  of  Parliament  had  influenced  her  and  made  her 
think  that  politics  was  quite  corrupt  (Non-Vaccine  Group;  Molly  aged  37;  Debbie  aged 
33;  Kitty  aged  37). 
142 The  distrust  with  which  politicians  were  regarded  spilled  over  to  a  distrust  of  their 
motives  for  supporting  the  combined  MMR  in  preference  to  the  single  measles,  mumps 
and  rubella  vaccines.  It  was  common  for  participants  to  consider  the  wider  public  debate 
about  the  pros  and  cons  of  making  the  single  measles,  mumps  and  rubella  vaccine 
available  on  the  NHS  alongside  the  MMR  vaccine.  On  one  hand,  some  participants  were 
content  to  accept  the  Governments'  recommendations  that  the  MMR  vaccine  is  the  most 
effective  means  of  protecting  a  child  from  measles,  mumps  and  rubella.  However,  it  was 
more  common  for  participants  to  focus  attention  on  the  fact  that,  by  not  allowing  parents 
the  right  to  choose  between  the  vaccines,  the  Government  was  denying  parents  the 
fundamental  right  to  follow  their  own  preferences  as  parents.  This  view  was  expressed 
both  by  participants  who  had  and  had  not  opted  for  MMR  alike.  However,  the  tone  of  the 
conversation  among  those  participants  living  in  socially  and  economically  deprived  areas 
sounded  a  particularly  aggrieved  note.  For  these  participants  being  able  to  afford  to  pay 
privately  for  single  measles,  mumps  and  rubella  vaccines  was  not  an  option.  They  felt 
that  the  Government's  policy  on  MMR  was  harsh  and  penalised  parents  like  them  in 
particular,  putting  their  children  at  greater  risk  of  either  contracting  an  infectious  disease 
through  opting  not  to  immunise  with  MMR,  or  from  having  an  adverse  reaction  following 
receiving  MMR.  Kenny  spoke  angrily  on  the  predicament  that  he  considered  the  policy 
put  his  son  in,  stating  "...  so  ... 
is  he  not  to  get  the  jags?  And  it's  not  the  wean's  fault.  I 
mean  he  can't  even  talk,  and  he's  probably,  he's  probably  got  his  wee  thoughts  in  his 
heid  about  that,  naebody  knows.  So  he,  he's  getting  punished...  "  (Single  Fathers  Group; 
Kenny  aged  43). 
Some  groups  discussed  the  reasons  for  the  Government's  policy  on  MMR  and  the 
decision  not  to  give  parents  the  choice  between  MMR  and  the  single  vaccines.  The  main 
reason  participants  gave  for  the  Government's  stance  on  MMR  policy  was  financial. 
Participants  considered  that  the  Government  was  motivated  by  saving  money  and  thought 
that  the  single  vaccines  would  be  more  expensive  to  produce  and  more  time  consuming 
for  health  professionals  to  administer.  A  less  commonly  cited  reason  was  that  the 
separate  single  vaccines  take  a  comparatively  longer  time  to  protect  children,  leaving 
these  children  exposed  for  a  long  period  to  the  risk  of  contracting  a  disease.  However, 
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the  incidence  of  measles,  mumps  and  rubella  to  be  low  and  therefore  dismissed  this 
reasoning  as  irrational  and  as  evidence  of  the  Government  bullying  frightened  parents 
into  having  MMR.  Lastly,  a  few  participants  suggested  that  some  parents  might  not 
complete  the  course  of  single  vaccines.  This  reason  was  usually  given  by  participants 
living  in  affluent  areas,  and  whilst  they  considered  this  a  possibility,  they  were  always 
quick  to  discount  the  possibility  that  they  themselves  would  default  on  any  appointment, 
implying  that  people  living  in  more  deprived  areas  would  be  the  more  likely  to  do  so 
(First-Time  Mothers  Group;  New  Mothers  Group). 
4.2.4  Perceptions  about  Dr  Wakefield  and  other  medical  and  healthcare  professionals 
There  was  quite  a  mixed  response  to  the  role  the  medical  and  health  professionals  have 
played  in  the  MMR  controversy.  As  mentioned  earlier,  some  participants  spoke 
positively  about  the  individual  doctors  involved  in  the  debate.  For  example,  Andrew 
Wakefield  and  colleagues  were  viewed  by  some  participants  as  being  on  the  side  of 
ordinary  parents.  However,  interspersed  between  occasional  positive  remarks  were  more 
subtle  and  disparaging  remarks  about  him.  For  example  he  was  often  referred  to  as  "that 
doctor"  implying  that  he  should  shoulder  much  of  the  blame  for  causing  the  uncertainty 
surrounding  MMR  safety.  When  participants  talked  more  generally  about  the  medical 
and  health  professions,  they  tended  to  speak  of  them  with  caution.  The  dilemma  that 
many  participants  appeared  to  face  was  one  of  knowing  who  to  trust  to  give  them 
impartial  advice.  For  example,  Lesley  a  mother  of  a  boy  with  autism  questioned: 
What  do  you  do  as  a  parent?  You  don't  know  who  to  trust.  Because  these  are  the  people-  you're 
meant  to  trust  your  doctor  implicitly  and  yet  people  are  saying  well,  you  know,  they're  getting 
paid  for  having  so  many  people  vaccinated  and  all  this  and  you  start  thinking  `well,  who's  got  my 
best-  who's  got  my  wee  boy's  best  interests  at  heart?  ' 
Autism  Club  Group;  Lesley 
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profession  to  given  them  impartial  advice.  Helen  stated  that  she  felt:  "...  suspicious  of 
some  of  them,  I  just  sort  of  don't  know  their  motives,  so  you  know,  that  does  concern  me, 
because  you  know  is  there  profit  involved  in  it?  "  (Saturday  Club  Group;  Helen  aged  39). 
Central  to  this  dilemma  about  trust  seemed  to  be  the  fact  that  the  MMR  debate  has 
heightened  parents'  awareness  of  the  fact  that  GPs  receive  payments  for  meeting 
Government  immunisation  targets.  The  issue  of  immunisation  targets  appeared  to  have 
forced  some  participants  to  question  the  motives  and  integrity  of  their  own  GP  and  health 
visitor  on  the  question  of  MMR  safety.  A  common  theme  was  that  participants  did  not 
know  to  what  extent  they  could  trust  their  own  GP  and  health  visitor  to  act  in  their  child's 
best  interest,  as  opposed  to  their  public  health  role  as  advocates  of  public  health  policy. 
For  example,  Joanne  recalled: 
... 
I  saw  my  health  visitor  the  other  day.  I  just  wanted  to  get  some  honest  advice.  You  know-  I 
said,  I  know  your  supposed  to  recommend  MMR  and  all  the  rest  of  it,  but  they  just  won't,  they 
just  can't  get  involved  so  you're  left.  Who  do  you  go  to  for  advice?  You're  just  completely  stuck. 
You  know  you're  relying  on  doctors  and  health  professionals  to  help  you  with  the  help  of  your 
child,  but  they're  just  touting  the  government  line,  unless  they  are  this  surgery  in  Edinburgh  or 
whatever.  They  know  they  will  lose  money  for  the  number  of  vaccines  they  carry  out.  They  have 
to  reach  government  targets,  so  they  are  not  going  to  say  don't  have  it  done,  go  and  have  your 
single  jabs. 
New  Mothers  Group;  Joanne  aged  37 
For  Sue,  the  MMR  debate  had  highlighted  the  close  relationship  between  the  Government 
and  the  medical  and  health  professions.  This  had  made  her  adamant  that  health 
professionals  are  biased.  She  stated:  "...  they  are  part  of  the  system  of  dispensing  it; 
they're  not  there  to  question.  They  don't  know...  "  (Non-MMR  Group;  Sue  aged  36). 
Likewise,  Debbie  was  not  impressed  with  the  health  and  medical  profession's  role  in 
immunisation.  She  considered: 
I  think  the  medical  profession  believe  that  they're  fantastic  and  they  are  so  narrow-minded  and 
single  focussed  that  they  come  up  with  this  idea  and  they  think  it's  great  and  they  go...  they  run 
with  it  and  it's  not  until  it's  fully  established  and  they've  been  telling  everybody  how  great  it  is 
that  they  think,  ohhh...  maybe  it's  not  that  great  and  so,  either  they  cover  it  up  or  they  say,  well, 
we'll  just  invent  a  new  one  that  is  great  instead  of  thinking,  well,  is  the  whole  concept  may  be  a 
bad  idea  in  the  first  place.  I  think  they  just...  I  don't  necessarily  believe  that  they're  doing  it  on 
purpose  to...  to...  oh  let's  not  worry  about  how  we're  going  to  get  something  out  of  this,  I  do 
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look  at  the  whole  picture  and  say,  you  know,  what  -  is  this  really  as  valuable  as  we're  making  it 
out  to  be. 
Non-Vaccine  Group;  Debbie  aged  33 
Although  her  views  were  unorthodox  and  were  mainly  held  by  other  participants  like 
herself  who  had  chosen  not  to  immunise  their  children,  some  of  the  sentiment  of  what  she 
said  was  shared  more  generally.  Despite  the  reservations  many  participants  expressed 
about  the  medical  and  health  profession's  role  in  the  debate,  there  were  occasions  when 
participants  talked  about  their  own  experiences  of  asking  their  GP  and  health  visitor  to 
give  them  advice  on  MMR.  This  was  particularly  noticeable  among  the  less  experienced 
first-time  parents,  compared  to  their  more  experienced  counterparts,  who  rarely 
mentioned  asking  their  GP  or  health  visitor  for  advice.  A  few  participants  felt  their 
concerns  about  MMR  safety  were  dismissed  out  of  hand  by  their  own  GP,  and  that  there 
was  little  room  for  discussion  about  the  pros  and  possible  cons  of  MMR.  However,  as 
indicated  in  Joanne's  (New  Mothers  Group)  comments  earlier,  other  health  visitors  gave 
ambiguous  answers.  On  the  other  hand,  when  Louise  told  Joanne  that  her  health  visitor 
was  adamant  about  the  safety  of  MMR,  she  ended  up  having  to  defend  her  health  visitor's 
categorical  response  on  MMR  safety: 
Louise:...  my  health  visitor  is  completely  pro  it,  the  two  of  them  stood  there  and  said  there  is  no 
link  at  all.  They  are  so  adamant. 
Sally:  But  how  do  they  know?  If  the  experts  don't  know  -  how  do  they  know?  Do  they  not  lose 
credibility  by  saying  that  so  adamantly? 
Louise:  No,  because  one  of  them  is  well  respected  in  the  group  and  she  was  annoyed  about  kids 
not  getting  vaccinated. 
New  Mothers  Group;  Joanne  aged  37;  Louise  aged  29;  Sally  aged  34 
This  discussion  in  the  New  Mothers  Group  highlights  the  difficult  task  that  health  visitors 
face.  Some  participants  appeared  to  want  someone  to  air  their  worries  to  about  MMR, 
whilst  others  wanted  their  health  visitors  to  take  a  more  pro-active  advisory  role.  When 
health  visitors  sounded  too  resolute  about  the  safety  of  MMR,  some  parents  questioned 
their  motives  and  knowledge,  but  when  they  sounded  too  vague,  some  parents  interpreted 
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participants  did  not  appreciate  being  pressurised  into  making  decisions  in  order  to  keep  to 
the  allotted  timetable  of  the  Childhood  Immunisation  Programme.  Several  of  the 
participants  who  had  either  decided  to  delay,  or  had  opted  not  to  have  MMR,  spoke  of 
their  health  visitors  applying  unwanted  pressure  and  in  some  cases  ostracising  them  for 
not  complying  with  the  recommended  vaccines.  For  example,  Jenny  and  Dave  who  had 




I  come  from  a  village,  I'm  the  only  person  in  the  village  who  has  decided  to  get  single 
vaccines,  but  see  the  pressure  I've  had  and  you  know...  in  the  village  I've  had  the  health  visitors, 
you  know,  they've  been  phoning  me  non-stop  and,  em,  I  went  down  because  there  was  someone 
else  in  one  of  the  other  villages  in  one  of  the  surgeries  was  giving,  em,  rubella  to  them.  They'd 
gone  through  to  Edinburgh  and  they  were  getting  their  jags  done  through  in  Edinburgh  in  one  of 
the  other  clinics,  well,  she  was  giving  rubella  out.  So  I  said  to  my  health  visitor  `could  I  not  get 
rubella  cos  obviously  that  would  save  me  a  bit  of  money  if  I  got  rubella  done  on  the  NHS?  '  and 
they  said  'no'  and  I've  been  like  shunned  ever  since.  You  know,  I  can't  get  appointments  and  I 
feel  like,  you  know,  I  feel  almost  like  I've  been  blackballed. 
Dave:  That's  right.  I  mean  it's...  that's  right.  She's  right,  because  it's  just  like  us.  We've  had  so 
many  phone  calls  you  know,  every  time  like  phone  calls,  come  down  and  get  your  MMR,  come 
down  and  get  your  MMR  from  the  health  visitor  and  it's  just  wee  subtle  things,  you  know.  It's  not 
overt,  it's  actually  quite  covert,  you  know?  Yeah,  like  you  say,  you  can't  get  an  appointment. 
You  know,  there's  such  pressure  put  on  and  you  just  think,  you  know,  these  are  people  that  are 
supposed  to  be,  you  know,  on  your  side  and  you  just  don't  feel  that  they  are.  You  know,  they're 
not  there  for  you.  They  don't  give  you  the  information  that  you  ask  for.  And  you  wonder,  you 
know,  who  is  it  that's...  who  is  it  that's  actually  benefiting  out  of  all  of  this?  All  this  pressure? 
You  know,  is  it  the  drug  companies?  No,  I  mean  you  don't  make  huge  profits  from  vaccines.  I 
mean  antibiotics,  yeah,  you  make  big  profits  but  not,  you  know,  Glaxo  Smith  and  Kline  aren't 
making  big  profits  from  vaccines.  You  know,  you  think  who  is  making  all  the  gains  here?  You 
know,  why  is  there  such  pressure? 
They  go  on  to  expand  on  the  pressure  they  felt  was  exerted  on  them. 
Facilitator.  So  how  does  this  all  make  you  feel? 
Dave:  Suspicious,  very  suspicious. 
Jenny:  Well,  it  just  makes  you  wonder,  you  know.  Is  it  all  just  to  do  with  GPs  and  health  visitors 
trying  to  meet  their  targets?  The  way  I  feel  about  it  is  that  I  was  looking  out  for  my  boy  and  I  just 
felt  he...  he's  already  allergic  to  that  much  and  I  just  thought  well,  is  one  person  gonna  make  that 
much  difference,  but  you  know... 
Single  Vaccine  Group;  Dave  aged  38;  Jenny  aged  19;  Joe  aged  36 
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being  left  on  their  answer  machines,  the  participants  who  had  opted  to  have  the  single 
vaccines  appeared  to  feel  particularly  aggrieved  by  this  unwelcome  pressure  as  they  felt 
they  were  acting  responsibly,  and  ultimately  in  their  own  child's  best  interest. 
4.3  Discussion  of  the  findings 
Generally  participants  did  not  feel  there  was  enough  evidence  to  prove  that  there  was  not 
a  link  between  the  MMR  vaccine  and  the  subsequent  development  of  autism  in  children. 
Some  participants  cautioned  that  in  time  further  evidence  may  come  to  light  that  shows 
that  for  some  children  the  MMR  vaccine  might  be  damaging.  In  this  respect  they  spoke 
about  the  `jury  still  being  out'.  Other  participants  were  unsure  of  the  link  because  they 
found  it  difficult  to  understand  the  scientific  and  anecdotal  evidence  and  come  to  any 
firm  conclusion.  This  led  them  to  feel  unconvinced  about  the  safety  of  the  MMR  vaccine 
and  these  participants  often  delayed  having  it  given  to  their  children.  Indeed,  despite 
participants  being  extremely  interested  in  the  debate  and  in  trying  to  understand 
Wakefield's  claims,  the  overriding  feeling  was  that  the  evidence  was  difficult  for  lay 
people  to  understand. 
In  the  absence  of  feeling  well  equipped  to  make  a  sound  judgment  about  the  scientific 
plausibility  of  Wakefield's  theory,  there  was  a  tendency  for  participants  to  focus  their 
attention  on  what  they  considered  to  be  the  facts  about  the  epidemiology  of  autism. 
Participants  often  mentioned  the  fact  that  autism  was  becoming  more  prevalent,  and 
talked  speculatively  about  which  children  they  thought  might  be  at  most  risk  from 
developing  the  disorder.  Participants  identified  two  groups  of  children  to  be  at  greater 
risk  of  developing  autism.  Firstly  boys  were  considered  to  be  at  greater  risk  than  girls 
based  on  the  fact  that  they  were  aware  that  there  is  a  higher  incidence  of  autism  among 
boys.  This  meant  that  parents  of  boys  seemed  particularly  anxious  about  the  MMR 
vaccine  and  amongst  participants'  children  there  were  more  boys  who  had  their  MMR 
vaccine  delayed  or  not  given  than  girls.  The  second  group  that  some  participants  felt 
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deficient  immune  systems.  Participants  identified  childhood  illnesses  such  as  multiple 
allergies;  recurrent  ear  and  chest  infections,  and  asthma  and  eczema  as  indicators  of  a 
slightly  deficient  immune  system.  This  led  some  participants  to  consider  that  future 
immunisation  research  might  eventually  suggest  that  children  with  severe  cases  of  these 
conditions  should  not  be  immunised  with  combined  -vaccines  such  as  MMR.  Participants 
often  expressed  these  concerns  hesitantly  and  for  the  most  part  without  conviction; 
however  participants  also  identified  a  need  for  more  research  to  be  conducted  into  the 
causes  of  autism  and  into  whether  children  with  multiple  allergies,  asthma  and  eczema  or 
recurrent  ear  and  chest  infections  are  susceptible  to  it.  Participants  also  suggested  a  need 
for  further  research  to  confirm  or  refute  Wakefield  and  colleagues'  theory  of  a  causal 
association  between  MMR  and  autism  and  for  this  to  be  written  in  a  way  that  parents  can 
understand.  The  general  perception  was  that  there  was  a  lack  of  research  in  these  areas 
and  this  made  participants  feel  as  if  the  Government  was  not  taking  their  concerns  or 
those  of  Dr  Wakefield  seriously. 
Participants  were  often  dismissive  of  messages  from  politicians  and  scientists  such  as  `no 
proven  risk,  '  `minimal  risk,  '  and  of  blanket  assurances  that  MMR  is  safe,  as 
untrustworthy.  Participants  interpreted  messages  of  `no  proven  risk,  '  or  `minimal  risk' 
as  tantamount  to  saying  `no  risk  known  at  present'.  One  of  the  problems  with  using 
language  such  as  'minimal'  to  convey  messages  about  the  risks  posed  by  the  MMR 
vaccine  was  that  participants  had  difficulty  in  deciphering  how  minimal,  minimal  was. 
Indeed  terms  such  as  `probable',  `unlikely',  `rare'  and  so  on  have  been  shown  to  convey 
'elastic'  concepts  and  thus  to  mean  different  things  to  different  people  depending  on  their 
interpretation  of  these  concepts  (Cohn  et  al.,  1995;  Edwards  et  al.,  2002).  For  similar 
reasons,  it  was  clear  that  participants  in  this  study  found  the  subjective  term  'minimal' 
unhelpful  in  enabling  them  to  assess  the  extent  of  the  risk  posed  by  the  MMR  vaccine. 
However,  it  may  also  be  the  case  that  participants  felt  uneasy  and  even  sceptical  about  the 
use  of  language  to  convey  'elastic'  concepts  because  they  recognise  that  this  language  also 
allows  the  person  communicating  the  risk  greater  scope  for  being  able  to  mask  what 
participants  viewed  as  the  actual  risk.  This  observation  is  based  on  the  fact  that 
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public  about  the  risks  posed  by  BSE  and  that  of  MMR.  Participants  commonly 
mentioned  that  during  the  BSE  crisis  the  Government  had  failed  to  accurately 
communicate  risks  to  the  public.  Participants  were  of  the  view  that  the  Government's 
reassurances  about  the  risk  being  so  infinitesimally  small  that  it  could  be  said  that  there 
was  no  risk  posed  to  humans  by  BSE  greatly  underplayed  the  actual  risk. 
Just  as  the  image  of  John  Gummer  feeding  his  daughter  a  hamburger  during  the  BSE 
crisis  came  to  symbolise  the  Government's  handling  of  the  crisis,  the  image  participants 
associated  with  the  MMR  controversy  was  of  Tony  Blair  refusing  to  confirm  whether  his 
son  Leo  had  had  MMR.  This  image  was  seen  to  be  a  metaphor  for  the  way  the 
Government  treats  the  public  and  for  the  `nanny  state'  mentality  at  odds  with  providing 
information  in  a  healthy  democracy.  The  close  comparisons  participants  drew  between 
these  two  public  health  scares  and  images  was  interesting  because  participants  did  not 
differentiate  between  the  fact  that  they  were  handled  by  two  different  administrations, 
suggesting  politicians  were  being  viewed  generically.  Indeed,  perhaps  Tony  Blair's 
refusal  to  publicly  endorse  the  MMR  vaccine  through  his  son  was  an  attempt  to  learn 
lessons  from  John  Gummer's  public  discredit,  both  as  a  politician  and  perhaps  more 
importantly  as  a  parent,  following  the  announcement  that  scientists  had  discovered  a  link 
between  BSE  and  a  new  variant  of  CJD.  The  sentiment  behind  much  of  the  conversation 
about  John  Gummer's  actions  was  that  he  was  seen  to  have  put  politics  before  parenting. 
Nevertheless,  Tony  Blair  may  have  not  only  misjudged  an  opportunity  to  be  seen  as  a 
parent  rather  than  as  a  politician,  but  also  he  may  have  contributed  to  the  uncertainty 
about  MMR.  By  refusing  to  disclose  to  the  public  whether  his  son  had  had  MMR  on  the 
grounds  of  it  being  a  private  matter,  he  had  chosen  to  act  in  his  role  as  a  politician  rather 
than  as  a  parent.  Unsurprisingly  many  participants  questioned  his  motives  for  doing  so 
and  some  concluded  that  he  had  done  so  because  his  son  Leo  had  not  had  MMR 
vaccination.  Indeed,  despite  Bellaby's  (2003)  assertion  that  parents  want  to  be  reassured 
that  the  risk  is  zero,  Whitfield  (1997)  believes  that  of  all  the  lessons  to  be  drawn  from  the 
BSE  crisis,  the  most  important  is  not  to  comfort  the  public  with  messages  of  no  risk. 
However,  in  relation  to  the  MMR  controversy,  although  public  health  officials  and 
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as  !  minimal'  risk  appear  to  have  added  to  rather  than  reduced  the  sense  of  uncertainty 
surrounding  the  safety  of  the  MMR  vaccine.  Notably  absent  were  any  discussions  about 
the  risk  of  instituting  an  untested  programme  of  three  separate  vaccines.  This  was  only 
referred  to  briefly,  and  supports  Lewis  and  Speers'  (2003)  suggestion  that  scientists  and 
public  health  professionals  have  failed  to  communicate  this  fact  to  the  public. 
Participants  were  divided  about  the  role  that  the  media  has  played  in  the  MMR 
controversy.  Some  participants  viewed  the  media  as  pivotal  players  in  much  of  the 
unsettling  dialogue  played  out  in  news  reports  in  newspapers  and  on  the  television.  This 
finding  is  consistent  with  Clements  and  Ratzan's  (2003)  suggestion  that  the  media  have 
been  alarmist.  In  contrast,  other  participants  viewed  the  media  as  useful  in  providing 
information  to  the  public  and  seemed  quite  unquestioning  about  some  of  the  stories  they 
heard  and  read.  A  few  participants  commented  on  the  way  newspapers  and  television 
programmes  have  reported  the  MMR  controversy.  These  participants  were  concerned 
that  reports  tended  to  contrast  the  scientific  and  anecdotal  evidence  alongside  each  other 
and  spoke  of  feeling  particularly  drawn  to  anecdotal  stories  involving  real  people. 
Participants  suggested  that  as  parents  they  found  other  parents'  stories  more  convincing 
than  the  statistics,  comments  and  reassurances  from  scientists  and  politicians  who  they 
felt  they  had  less  in  common  with  and  who  may  have  ulterior  motives.  In  contrast, 
parents'  stories  were  viewed  as  being  impartial  and  as  having  no  hidden  agenda  (ironic 
since  they  are  probably  the  most  partial,  but  then  this  is  probably  part  of  their  appeal). 
These  attributes  seemed  to  make  this  kind  of  evidence  very  persuasive  and  in  turn  these 
anecdotal  stories  often  appeared  to  carry  a  disproportionate  weight.  Indeed,  this  supports 
Hargreaves  and  colleagues  (2003)  assertion  that  media  coverage  has  given  a  misleading 
impression  that  the  evidence  for  the  link  was  as  substantial  as  the  evidence  against  it.  It 
was  also  observed  that  for  many  participants  the  level  of  media  coverage  afforded  to  the 
MMR  controversy  became  tantamount  to  evidence  itself  that  MMR  is  unsafe.  Hence  any 
story  about  autism  or  MMR  vaccination  appeared  to  be  newsworthy  and  to  perpetuate  the 
public's  interest  in  the  debate. 
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and  health  professionals  have  played  in  the  MMR  controversy.  Whilst  few  of  the 
experienced  first-time  parents  spoke  about  finding  health  visitors  helpful,  the  more 
experienced  parents  were  less  positive.  Participants  spoke  about  health  visitors  offering 
ambiguous  advice  and  seeming  ambivalent  about  their  position  on  MMR  safety,  a  fording 
consistent  with  Smailbegovic  et  al.  's  (2003)  study.  A  few  participants  felt  their  concerns 
about  MMR  safety  were  dismissed  out  of  hand  by  their  own  GPs,  others  spoke  about 
being  pressurised  into  making  decisions  about  MMR,  and  in  a  few  cases  participants  felt 
ostracised  for  not  complying  with  the  recommended  vaccines.  An  important  theme  to 
have  emerged  in  relation  to  the  medical  and  health  professions  was  that  many  participants 
appeared  to  face  the  dilemma  of  not  knowing  whom  to  trust  to  give  them  impartial 
advice.  Some  participants  were  suspicious  of  their  GPs'  motives  and  viewed  them  as  part 
of  the  system  of  dispensing  MMR  rather  than  as  having  an  impartial  role,  a  fording 
consistent  with  Evans  et  al.  (2003)  and  Flynn  and  Ogden  (2004).  This  sense  of  mistrust 
and  suspicion  seemed  to  be  exacerbated  by  the  fact  that  GPs  receive  payments  for 
meeting  government  immunisation  targets.  This  issue,  more  than  any  other,  seemed  to 
have  forced  some  participants  to  question  the  extent  to  which  they  could  trust  their  GP  to 
act  in  their  child's  best  interest,  as  opposed  to  acting  as  advocates  of  public  health  policy. 
There  were  also  conflicting  beliefs  about  the  roles  that  Dr  Wakefield  and  his  colleagues 
have  played  in  the  debate.  Participants  were  divided  about  Dr  Wakefield's  character  and 
whether  he  was  a  courageous  individual  standing  up  for  his  beliefs  and  those  of  ordinary 
parents  in  his  care,  or  whether  he  was  to  blame  for  causing  all  the  uncertainty 
surrounding  the  safety  of  the  MMR  vaccine.  However,  even  when  participants  felt  he 
was  responsible  for  much  of  the  furore  surrounding  MMR,  they  often  tempered  negative 
comments  by  mentioning  that  there  was  already  a  climate  of  mistrust  following  the  BSE 
crisis.  In  this  respect  participants  believed  that  any  attempt  to  exaggerate  his  role  in  the 
MMR  controversy  would  be  to  misrepresent  the  facts.  Attempts  by  politicians  and  public 
health  spokespersons  to  discredit  Dr  Wakefield  and  his  co-authors  were  viewed  as 
political  manoeuvring,  and  were  not  seen  as  reassuring  to  participants.  Indeed,  a  few 
participants  even  implied  that,  as  doctors,  Wakefield  and  co-authors  were  more  likely  to 
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viewed  as  acting  primarily  in  their  own  interests. 
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This  chapter  explores  parents'  experiences  of  making  the  decision  about  whether  or  not 
to  vaccinate  their  children  with  the  MMR  vaccine,  at  a  time  when  there  was  still 
speculation  and  concern  about  its  safety.  It  begins  by  briefly  examining  the  literature  on 
vaccine  decision-making,  before  presenting  the  views  of  the  parents  who  took  part  in  the 
focus  groups.  The  chapter  concludes  by  considering  how  these  parents'  experiences  of 
MMR  decision-making  compare  with  findings  from  the  literature  on  vaccine  decision- 
making.  It  also  highlights  findings  that  may  be  useful  in  guiding  strategies  for  improving 
MMR  uptake. 
5.1  Summary  of  literature  on  vaccine  decision-making 
As  suggested  in  Chapter  One,  there  are  many  factors  that  influence  parents'  decisions 
about  immunisation.  It  has  been  suggested  that  some  parents  forgo  immunisation 
because  of  practical,  social,  or  economic  difficulties  or  because  of  cultural  or  religious 
beliefs  (Peckham  et  al.,  1989;  New  and  Senior,  1991;  Pearson  et  al.,  1993;  Simpson  et  al., 
1995).  It  has  also  been  suggested  that  the  information  parents  receive  from  health 
professionals  and  from  the  media  exerts  an  influence  on  their  decisions  (Sporton  and 
Francis,  2001).  Parents  may  also  be  influenced  by  the  decisions  that  other  parents  make 
for  their  children  (Meszaros  et  al.,  1996).  For  example,  they  may  choose  to  vaccinate 
their  children  to  ensure  that  their  own  child  is  protected  against  infectious  diseases.  In 
doing  so,  they  contribute  to  maintaining  high  levels  of  uptake  in  the  population,  thus 
conferring  protection  to  those  around  the  individual,  termed  `herd'  or  `population' 
immunity.  It  is  this  second  form  of  protection  that  prevents  the  outbreaks  of  diseases  that 
Hershey  and  colleagues  (1994)  focused  on.  Their  work  led  them  to  suggest  that  people 
factor  the  actions  of  others  into  their  own  decisions  about  whether  or  not  to  vaccinate. 
Thus,  Hershey  and  colleagues  believe  that  some  people  seek  immunisation  partly  to 
contribute  to  the  overall  control  of  diseases  within  their  community.  However,  they  also 
154 suggest  that  a  high  uptake  of  immunisation  creates  an  opportunity  for  some  individuals  to 
use  herd  immunity  to  gain  the  benefits  of  an  immunisation  programme  without  taking 
any  of  the  perceived  risks  associated  with  the  vaccines. 
As  noted  in  Chapter  One,  studies  by  Ritov  and  Baron  (1990)  and  Asch  et  al.  (1994)  have 
been  useful  in  gaining  a  deeper  understanding  of  the  cognitive  processes  involved  in 
vaccine  decision-making.  They  have  shown  that  if  parents  believe  the  risk  of  harm  from 
the  vaccine  is  greater  than  that  from  the  disease  then  they  may  refuse  immunisation, 
believing  that  doing  nothing  is  less  harmful.  This  action  termed  `omission  bias,  '  was 
observed  to  have  occurred  during  the  pertussis  controversy  in  the  1970s  when  many 
parents  preferred  to  take  the  risk  of  their  children  contracting  whooping  cough  than  to 
intervene  and  potentially  cause  damage  through  vaccination.  Whilst  it  is  likely  that  there 
are  some  valuable  parallels  between  the  decision-making  behaviours  of  parents  during 
the  pertussis  controversy  and  during  the  current  MMR  debate,  there  may  be  some 
important  differences,  not  least  because  the  context  in  which  parents  make  those 
decisions  has  changed. 
Since  the  publication  of  Dr  Wakefield's  paper  (1998)  cast  doubt  over  the  safety  of  the 
MMR  vaccine,  several  studies  have  been  particularly  useful  in  gaining  new  insights  into 
understanding  parents'  decisions  about  the  MMR  vaccine.  For  example,  Ramsay  et  al. 
(2002)  described  some  of  the  trends  in  mothers'  attitudes  to  the  MMR  vaccine.  They 
observed  that,  unlike  other  vaccines  in  the  programme,  the  decline  in  acceptability  of 
MMR  appeared  to  be  greater  among  more  socio-economically  advantaged  parents. 
Evans  et  al.  's  (2001)  study  offered  the  first  in-depth  account  describing  the  decision- 
making  processes  parents  used  to  decide  whether  or  not  to  have  their  children  vaccinated 
with  the  MMR  vaccine.  Similar  to  other  observations  during  the  pertussis  controversy 
(Ritov  and  Barron,  1990;  Asch  et  al.,  1994),  Evans  and  colleagues  found  that  parents  try 
to  weigh  up  the  risks  and  benefits.  They  found  that  for  many  parents  it  is  easier  to  live 
with  the  risk  of  their  child  naturally  contracting  one  of  the  diseases  than  with  the  risk  of 
causing  their  child  damage  through  vaccination.  Further,  although  these  parents  accepted 
that  their  unvaccinated  children  might  contract  a  disease,  they  were  optimistic  that  their 
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immunisers  felt  that  the  potential  risks  from  MMR  outweighed  the  potential  risks  of 
contracting  the  diseases,  and  were  reluctant  to  comply  with  a  policy  that  offered  them  no 
choice.  Raithatha  et  al.  (2003)  also  proposed  that  parents  weigh  up  the  risks  associated 
with  vaccines  against  the  risks  posed  by  the  diseases.  They  found  that  parents  who 
immunise  their  children  have  concerns  about  the  risks  associated  with  vaccines  and  warn 
that  it  is  vital  not  to  assume  that  parents  who  at  present  immunise  will  continue  to  do  so. 
They  suggested  that  the  recent  MMR  vaccine  scare  might  have  triggered  a  more 
widespread  reappraisal  of  vaccine  risk.  In  2004  Flynn  and  Ogden  published  their 
findings  from  a  study  which  aimed  to  identify  the  best  predictors  of  uptake  of  MMR  by 
the  age  of  two  years.  They  found  past  vaccination  history  predicted  MMR  vaccination 
uptake.  This  led  them  to  suggest  that  doctors  should  encourage  the  uptake  of  earlier  less 
controversial  vaccines  and  use  these  vaccines  as  an  opportunity  to  encourage  the  uptake 
of  MMR  by  creating  a  culture  of  vaccination  uptake.  However,  McMurray  et  al.  (2004) 
also  explored  parents'  accounts  of  MMR  decision-making  in  order  to  identify 
determinants  of  uptake  and  suggested  that  the  opportunity  for  primary  care  providers  to 
encourage  the  uptake  of  MMR  is  limited  by  the  fact  that  parents  do  not  view  them  as 
financially  or  politically  impartial.  They  suggested  that  there  is  a  need  for  new 
approaches  to  increase  parents'  understanding  of  medical  science  in  order  to  secure  more 
informed  decisions  in  the  face  of  health  controversy.  They  went  on  to  warn  that  at 
present,  for  most  parents,  scientific  and  medical  evidence  plays  little  role  in  that  decision. 
To  date  these  studies  have  been  useful  in  gaining  a  better  understanding  of  the  cognitive 
processes  involved  in  MMR  decision-making  and  in  identifying  that  parents  weigh  up  the 
risks  and  benefits  they  associate  with  the  vaccine  and  diseases.  However,  they  have  often 
fallen  short  of  describing  the  risks,  and  of  exploring  parents'  beliefs  about  how  these 
risks  may  damage  their  children's  health.  At  the  time  of  planning  and  conducting  this 
study  there  was  little  debate  about  whether  children's  immune  systems  could  be 
overwhelmed  by  receiving  too  many  vaccines  combining  too  many  antigens.  Indeed,  as 
yet  no  studies  have  been  published  that  specifically  explored  parents'  views  on  this  issue. 
This  gap  in  the  literature  means  that  it  is  unclear  what  role  parents'  views  about  their 
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notion  of  immune-overload.  The  lack  of  research  on  this  topic  offered  an  opportunity  for 
this  study  to  explore  how  parents  conceptualise  their  child's  immune  system  and  relate 
these  concepts  to  their  own  children,  not  least  because  it  may  affect  the  decisions  they 
make  about  immunisation  in  the  future. 
Tö  date  the  only  paper  to  have  touched  on  this  aspect  of  the  debate  has  been  that  by 
Miller  et  al.  (2003).  They  challenged  the  claim  that  the  MMR  vaccine  induces 
immunosuppression,  thus  causing  increased  susceptibility  to  infection  in  the  post- 
vaccination  period.  Using  computerised  discharge  records  from  several  hospitals  in  the 
Thames  region  of  England  they  identified  436  cases  of  children  aged  between  12  and  23 
months,  admitted  to  hospital  between  1991  and  1995  with  a  bacterial  infection.  After 
reviewing  each  child's  clinical  and  medical  histories,  children  with  any  underlying 
disorders  predisposing  them  to  bacterial  infection  were  excluded.  They  tested  for 
clustering  of  bacterial  infection  in  the  12  week  period  post-MMR  vaccination  in  the  395 
children  identified  as  eligible  to  be  included  in  the  case  series.  Since  the  incidence  of 
bacterial  infection  varies  with  age  and  by  season  these  factors  were  adjusted  for  by 
stratifying  the  analysis  by  calendar  month  and  by  age  in  26  two-week  intervals.  None  of 
the  post-vaccination  risk  periods  showed  a  relative  incidence  significantly  greater  than 
1.0,  thus  suggesting  that  MMR  vaccine  does  not  impair  the  ability  to  respond  to  the 
immune  challenge  of  infection.  One  potential  criticism  of  the  study  may  be  that  one  of 
the  funders  of  this  research  was  the  pharmaceutical  company,  GlaxoSmithKline,  one  of 
the  manufacturers  of  the  MMR  vaccine  that  parents  are  planning  legal  action  against. 
The  obvious  conflict  of  interests  may  make  this  research  newsworthy  for  the  wrong 
reasons,  alienating  rather  than  persuading  anxious  parents  that  the  scientific  community  is 
attempting  to  provide  them  with  balanced  and  unbiased  information. 
In  summary,  although  there  have  been  new  papers  published  on  MMR  decision-making 
since  fieldwork  for  this  thesis  commenced,  there  is  still  a  need  for  a  more  in-depth 
research  that  focuses  attention  on  exploring  and  describing  how  parents  conceptualise 
putative  MMR  associated  risk  as  damaging  their  children's  health.  This  study  attempts  to 
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does  not  exist  in  a  vacuum  and  that  parents'  concerns  about  vaccines  may  not  be  confined 
to  the  MMR  vaccine.  As  such,  although  the  focus  of  this  chapter  is  on  parents' 
experiences  of  making  the  decision  about  the  MMR  vaccine,  their  discussions  also 
involved  other  vaccines  in  the  Childhood  Immunisation  Programme.  Without  viewing 
MMR  decisions  in  this  broader  context,  it  is  difficult  to  ascertain  whether  the  current 
reappraisal  of  vaccine  risk  that  Raithatha  and  colleagues  highlight  is,  as  they  suggest,  a 
consequence  of  the  recent  MMR  debate,  or  whether  it  is  part  and  parcel  of  a  wider  sense 
among  parents  that  children  are  becoming  over-immunised  against  diseases  that  pose 
little  threat.  With  this  in  mind,  I  will  now  consider  the  views  of  the  participants  that  took 
part  in  this  study. 
5.2  Making  the  decision 
To  date  it  has  been  suggested  that  when  parents  make  decisions  about  whether  or  not  to 
immunise  their  children,  they  carry  out  a  risk  assessment  that  is based  on  two  key  factors: 
their  assessment  of  the  risk  posed  by  the  diseases,  and  of  the  vaccines  aimed  at 
preventing  these  diseases  (Smailbegovic  et  al.  2003).  However  in  relation  to  MMR 
decision-making  my  research  has  identified  three  factors  that  appeared  to  play  equally 
important  roles  in  influencing  whether  participants  will  seek  or  withhold  MMR 
immunisation. 
"  The  perceived  seriousness  of  a  disease  and  the  likelihood  of  catching  it. 
"  The  perceived  safety  and  efficacy  of  the  vaccine. 
"  The  perceived  ability  of  their  child's  immune  system  to  cope  with  the  vaccine,  or 
fight  the  disease. 
Conversations  about  the  seriousness  of  the  diseases  and  beliefs  about  the  vaccines  were 
topics  I  included  in  the  topic  guide.  However,  conversations  about  the  ability  of  their 
child's  immune  system  to  cope  with  the  vaccine,  or  fight  diseases,  were  topics  that 
participants  themselves  identified  when  asked  to  recall  the  main  factors  that  had 
influenced  their  decision  about  MMR.  Participants  often  talked  about  weighing  up  these 
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were  carrying  out  an  informal  risk-benefit  assessment  to  help  process  these  factors  into 
an  equation  with  the  aim  being  to  minimise  risks  to  their  child's  health. 
At  this  stage  it  may  also  be  useful  to  be  aware  of  the  difference  between  two  closely 
related  terms,  immune-overload  and  immune-vulnerability,  liberally  referred  to  by 
participants  in  this  chapter.  For  the  purposes  of  clarity  I  interpreted  and  thematically 
coded  the  two  concepts  separately  after  considering  the  context  in  which  participants 
used  these  terms.  I  observed  that  immune-overload  was  used  to  describe  the  notion  that 
the  immune  system  is  overwhelmed  by  receiving  too  many  antigens.  By  contrast  when 
participants  spoke  about  their  children's  immune  system  being  vulnerable  they  were 
usually  referring  to  their  assessment  of  how  well  their  child's  immune  system  seemed  to 
cope  with  the  invasion  of  pathogens  generally,  and  not  just  with  the  antigens  contained 
within  vaccines. 
5.2.1  Weighing  up  the  risks/benefits  associated  with  diseases:  assessing  which  diseases 
need  immunising  against 
As  suggested  in  Chapter  Three,  participants'  perceptions  of  the  severity  and  prevalence 
of  the  diseases  informed  their  assessment  of  which  diseases  posed  the  greatest  and  least 
threat  to  their  children,  and,  in  turn,  which  diseases  to  vaccinate  against.  These  factors 
appeared  to  be  influenced  by  participants'  knowledge,  experience,  and  beliefs  about  the 
diseases  but,  as  highlighted  in  Chapter  Three,  participants'  knowledge  about  some  of  the 
diseases  were  quite  limited  and  they  were  often  ambivalent  about  the  threat  posed  by 
them.  For  example  participants  were  unsure  whether  measles  and  whooping  cough  were 
severe  and  knew  very  little  about  mumps,  haemophilus  influenza  or  diphtheria.  Perhaps 
for  this  reason  they  considered  mumps  and  haemophilus  influenza  to  pose  little  threat, 
deeming  them  mild  and  fairly  innocuous  diseases.  Likewise,  diphtheria  and  polio  were 
viewed  as  posing  little  threat  to  children  living  in  the  UK  because  for  some  years  these 
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sense  that  meningitis  posed  a  major  threat  to  their  children  based  on  the  fact  that 
participants  perceived  the  disease  to  be  severe  and  prevalent. 
In  the  context  of  this  chapter,  I  wish  to  consider  the  extent  to  which  participants'  beliefs 
and  descriptions  of  the  diseases  related  to  the  decisions  they  had  made  about  the 
vaccines,  paying  particular  attention  to  decisions  made  about  MMR.  First  it  is  important 
to  note  that  it  was  more  common  for  participants  to  consider  several  diseases  together, 
rather  than  as  separate  entities.  For  example,  in  the  Low  Uptake  Group  Joan,  a  20-year- 
old,  spoke  about  being  undecided  about  the  severity  and  prevalence  of  measles,  mumps 
and  rubella.  But  in  order  for  her  to  make  a  decision  about  MMR,  she  felt  she  needed 
more  information  on  the  diseases  and  so  asked  her  health  visitor  for  advice.  She  recalled 
her  meeting  with  her  health  visitor: 
Joan:  Em...  well  the  health  visitor,  she  had  showed  me  pictures  of  children  who  had  measles  and 
the  mumps  and  whatever,  side  effects  they  had  like  sick  children  were  disabled  and  that  through  it. 
Facilitator.  Right. 
Joan:  And  I  thought,  oh  God  not  that.  I  wouldnae  forgive  myself  if  she  got  older,  had  children, 
took  the  mumps  and  measles  and  it  affected  her  children  or  that.  I  wouldn't  forgive  myself  if  it 
turned  oot  like  that  so... 
Low  Uptake  Area  Group;  Joan  aged  20 
The  experience  of  being  shown  pictures  of  children  with  these  diseases  had  shocked  her 
and  persuaded  her  that  opting  not  to  immunise  her  daughter  with  MMR  was  putting  her 
daughter  and  even  her  grandchildren  at  risk.  Although  she  assumed  incorrectly  that  it 
was  measles  or  mumps  that  could  have  implications  for  her  daughter's  children  instead  of 
rubella,  the  end  result  was  that  she  felt  concerned  enough  to  take  her  daughter  along  for 
MMR.  In  contrast,  the  association  that  many  participants  made  between  mumps  and 
male  infertility  meant  there  was  a  tendency  for  parents  of  boys  to  worry  more  about 
mumps.  The  MMR  vaccine  was  unusual  in  this  respect,  because  whilst  parents  of  boys 
seemed  more  anxious  about  mumps,  parents  of  girls  worried  more  about  rubella  and 
therefore  MMR  seemed  relevant  to  parents  of  children  of  both  genders.  As  such,  many 
160 parents  spoke  about  using  MMR  to  protect  their  children  against  one  disease  in  particular 
and  viewed  the  additional  protection  for  the  remaining  two  diseases  as  an  added  bonus  of 
combined  vaccines.  The  direct  approach  used  by  Joan's  health  visitor  appeared  to  work 
best  with  younger  participants.  Older  participants  were  less  appreciative  of  this 
approach.  A  few  participants  recalled  a  similar  situation  in  which  a  health  visitor  had 
shown  a  group  of  mothers  a  video  of  a  child  who  was  extremely  distressed  as  a 
consequence  of  coughing  with  whooping  cough.  This  approach  seemed  to  backfire  as 
they  viewed  it  as  a  desperate  measure,  described  as  `scaremongering'  (Non-MMR  Group: 
Non-Vaccine  Group). 
Nevertheless,  it  was  common  for  participants  to  mention  that  they  were  more  likely  to 
immunise  their  children  if  they  perceived  the  disease  to  be  severe.  For  example,  Dawn, 
pregnant  with  her  third  child,  stated  that  her  criterion  for  deciding  whether  or  not  it  is 
important  to  vaccinate  her  children  is  whether  the  disease  could  kill  them.  If  not,  then 
she  was  not  keen  on  them  being  vaccinated  (Antenatal  Group;  Dawn  aged  36).  Dawn 
stated  that  she  did  not  perceive  whooping  cough  to  be  severe,  or  for  rubella  to  be 
important  if  boys  contracted  it,  and  thus  had  not  vaccinated  her  youngest  boy  against 
either  disease.  She  also  assessed  that  tetanus  was  not  a  threat  to  a  young  baby  and  had 
decided  that  her  unborn  child  would  not  require  it  until  he,  or  she,  was  at  least  a  year  old. 
In  this  respect  Dawn's  assessment  of  the  severity  of  each  of  the  diseases  was  quite 
consistent  with  the  decisions  she  had  made  about  vaccination.  However,  Dawn's 
decision-making  strategy  was  quite  unusual  and  it  was  uncommon  for  participants  to 
assess  diseases  separately.  Indeed,  making  decisions  about  the  vaccines  based  on 
assessing  individual  diseases  is  problematic  for  two  reasons.  Firstly,  it  requires  an 
accurate  assessment  of  the  diseases,  which,  as  indicated  in  Chapter  Three,  is  not  always 
the  case.  Secondly,  it  ignores  the  fact  that  the  Childhood  Immunisation  Programme 
includes  combined  vaccines  (DTP,  MMR)*  to  offer  immunisation  against  three  diseases 
in  one  vaccine.  The  way  some  parents  addressed  this  problem  was  to  pay  privately  to 
have  single  vaccines. 
*Modifications  to  the  UK  Childhood  Immunisation  Programme  announced  from  September  2004  include 
the  introduction  of  a  new  pentavalent  vaccine  (DtaP/IPV/Hib)  brand  name  Pediacel. 
161 For  example,  Anna,  a  mother  of  four,  had  decided  in  relation  to  MMR  to  withhold  it  for 
both  her  two  youngest  girls.  This  decision  was  based  on  the  fact  that  she  considered  that 
they  had  already  contracted  wild  measles,  and  that  mumps  was  irrelevant  for  her 
daughters  to  have.  She  stated  that  she  planned  to  pay  privately  for  them  to  have  the 
single  rubella  vaccine  because  she  feared  rubella  could  be  harmful  if  contracted  whilst 
they  were  pregnant  (High  Uptake  Group;  Anna  aged  33).  In  contrast,  Dawn  mentioned 
that  she  did  not  plan  to  pay  for  the  rubella  vaccine  for  her  boys,  but  planned  to  pay  for  the 
mumps  vaccine  because  she  feared  mumps  could  be  harmful  to  her  sons'  fertility  if 
contracted  in  adolescence  (Antenatal  Group;  Dawn  aged  36).  However,  it  is  of  note  that 
the  reason  mumps  was  introduced  into  the  Childhood  Immunisation  Programme  was  to 
reduce  the  incidence  of  viral  meningitis.  Indeed,  the  general  medical  consensus  is  that  it 
is  not  thought  that  mumps  causes  any  infertility  problems.  Further,  Dawn's  suggestion 
that  the  rubella  vaccine  was  irrelevant  for  her  boys  caused  Fiona,  a  midwife  and  mother 
of  two  girls,  offense.  Fiona  looked  and  sounded  irritated  as  she  reacted  to  Dawn's 
comments,  and  retorted  that  rubella  vaccination  is  important  for  all  children  to  have  in 
order  to  reduce  the  incidence  of  congenital  rubella. 
The  fact  that  some  health  visitors  showed  videos  or  pictures  of  the  diseases  to  participants 
may  have  been  because  they  believed  that  the  more  experience  that  participants  had  of 
the  diseases  causing  harm,  the  more  likely  they  were  to  view  them  as  risky,  and  therefore 
to  seek  vaccination.  For  example,  Karen,  a  mother  of  three,  had  heard  from  her  sister 
about  a  friend  whose  child  had  contracted  measles  and  had  been  left  with  long-term 
damage.  Although  she  did  not  know  this  child,  her  reservations  about  the  safety  of  MMR 
were  overshadowed  by  the  fear  that  measles  could  cause  long-term  damage,  and  this  fear 
had  influenced  her  to  act  and  have  her  son  immunised  with  MMR  (High  Uptake  Group; 
Karen  aged  36).  Likewise,  Charlotte  in  the  First-Time  Mothers  Group,  and  Dave  in  the 
Single  Vaccine  Group  had  both  had  whooping  cough  as  children,  but  neither  considered 
it  to  be  severe,  nor  remembered  being  particularly  ill  with  it.  As  a  consequence  both  of 
them  questioned  whether  whooping  cough  should  be  included  in  the  immunisation 
programme  at  all.  However,  despite  their  reservations,  all  of  their  children  had  been 
162 immunised  with  pertussis  as  part  of  the  DTP  combined  vaccine.  On  one  hand  this  may 
seem  like  a  contradiction,  but  alternatively,  this  could  be  another  demonstration  of  how 
participants  make  decisions  about  vaccines  based  on  the  assessment  of  several  diseases 
rather  than  on  individual  diseases.  This  highlights  how  complex  the  relationship  is 
between  participants'  experiences  of  disease  and  their  subsequent  decisions  about  the 
vaccines  aimed  at  preventing  it.  Past  experience  of  a  disease  does  not  necessarily  mean 
that  a  person  will  have  a  negative  impression  of  it,  particularly  if  the  person  made  an 
uneventful  recovery,  or  fords  it  difficult  to  remember.  In  these  cases,  having  experienced 
the  disease  may  make  the  disease  seem  more  familiar  and  less  formidable.  This  may  lead 
some  participants  to  underestimate  the  potential  risks  associated  with  the  disease. 
Whilst  it  was  generally  common  for  participants  to  make  decisions  about  immunisation 
by  weighing  up  the  risks  of  the  disease,  the  few  participants  who  preferred  to  use 
homeopathic  and  herbal  alternatives  to  orthodox  medicines  did  not  appear  to  view  the 
diseases  as  risky.  Indeed,  the  participants  in  the  Non-Vaccine  Group  did  not  appear  to 
believe  it  was  necessarily  advantageous  to  avoid  diseases  altogether.  These  participants 
frequently  questioned  the  wisdom  of  avoiding  diseases  by  vaccination,  on  the  basis  that  a 
healthy  individual  may  benefit  from  contracting  a  disease  and  developing  life-long 
immunity  to  it.  This  was  deemed  to  be  particularly  beneficial  to  women  in  relation  to  the 
rubella  vaccine,  as  it  was  believed  they  would  pass  on  some  of  this  immunity  to  their 
children.  Further,  these  participants  often  cited  the  fact  that  as  disease  prevalence  has 
reduced  over  the  years,  so  too  has  disease  threat,  and  for  them  the  need  for  a  continuing 
immunisation  programme  in  the  UK  seemed  to  have  become  out-dated.  However,  this 
group  of  participants  also  tended  to  under-estimate  the  contribution  mass  immunisation 
has  made  in  bringing  about  reduced  disease  prevalence,  preferring  to  attribute  it  solely  to 
improved  sanitation,  water  supply  and  living  conditions.  These  participants  generally 
perceived  disease  threat  to  be  low  and  appeared  to  play  down  the  severity  of  the  diseases. 
These  findings  are  consistent  with  much  of  the  literature  on  vaccine  decision-making  that 
suggests  that  parents  who  consider  the  diseases  to  pose  little  or  'no  threat  to  their  child's 
health  are  more  likely  not  to  vaccinate.  However,  it  is  also  worth  noting  that  this 
particular  group  of  participants  held  quite  different  beliefs  about  the  risks  posed  by 
163 diseases  as  they  felt  that  there  were  benefits  to  allowing  healthy  children  to  contract 
them.  In  this  respect  any  immunisation  campaign  aimed  at  encouraging  these  particular 
parents  to  immunise  seems  likely  to  fail,  as  they  question  the  whole  premise  that  mass 
childhood  immunisation  still  has  a  role  to  play  in  contemporary  Britain. 
5.2.2  Assessing  the  risks  and  benefits  associated  with  vaccines:  fears  of  long-term 
damage 
The  second  part  of  the  risk  assessment  that  participants  discussed  related  to  assessing  the 
risks  associated  with  the  MMR  vaccine.  The  controversy  surrounding  MMR  safety 
meant  that  it  was  widely  viewed  as  being  a  particularly  risky  vaccine.  As  suggested  in 
Chapter  Four,  participants'  assessment  of  MMR  appeared  to  have  been  informed  by  their 
assessment  of  the  current  state  of  evidence  about  its  safety,  and  their  assessment  of  the 
roles  the  Government,  the  media,  and  the  medical  and  health  professions  played  in  the 
handling  of  the  MMR  debate.  However,  perhaps  one  of  the  most  interesting  and 
surprising  aspects  of  these  discussions  was  the  way  participants  spoke  about  their 
concerns  about  autism.  When  participants  were  asked  to  describe  their  main  concerns 
about  vaccines,  participants  rarely  identified  autism  as  being  their  main  worry;  instead 
they  spoke  about  their  fears  that  over-immunising  young  children  by  giving  them  too 
many  vaccines  might  result  in  long-term  damage  to  their  child's  immune  system.  In  fact, 
although  autism  was  clearly  a  concern  because  participants  occasionally  recounted  stories 
to  each  other  of  children  they  knew  with  autism,  and  on  several  occasions  spoke  about 
the  rise  in  incidence  of  autism,  they  tended  to  speak  about  autism  using  more  generic 
terms  such  as  having  `long-term  damage'.  For  instance,  towards  the  end  of  one  focus 
group  in  which  the  participants  had  been  very  informed  and  opinionated,  I  noticed  that 
the  group  had  not  specifically  mentioned  autism,  and  questioned  them  further  on  this: 
Facilitator. 
... 
The  only  thing  that  hasn't  really  come  up  that  was  interesting  to  me  is  autism,  it 
hasn't  really  come  up  and  I  was  wondering  why...  if  you  had  any  images  about  autism  what  it  is. 
And  what  you  feel  about  that  whole  link  with  MMR  that's  been  made? 
Hannah:  I  think  I  mentioned  earlier  about  that  ... 
is  it  this  Finnish  study  I  think?  There's  no  link 
between  MMR  and  Crohn's  disease  or  autism.  So  that... 
164 [People  talking  at  same  time] 
Sue:  (spoken  in  high  surprised  sounding  voice)  I  never  mentioned  autism  because  I  took  it  as 
read  that  that  was  part  of  it,  if  you  see  what  I  mean.  I  didn't  specifically  mention  it  because  I 
assumed  that's  what  were  talking  about  and  we...  all  knew  about  it. 
Non-MMR  Group;  Sue  aged  36;  Hannah  aged  40 
It  was  clear  from  their  faces  that  this  question  seemed  slightly  foolish  to  them  and  that 
they  worried  that  I  had  not  really  been  listening  or  fully  understanding  their  concerns 
about  vaccines.  With  hindsight  it  would  have  been  useful  to  probe  participants  more  on 
what  they  meant  when  they  spoke  about  `long-term  damage'  in  order  to  gain  a  deeper 
understanding  of  their  fears  about  the  MMR  vaccine.  It  seems  likely  that  when 
participants  were  talking  about  `long-term  damage'  they  were  actually  speaking  about 
autism,  and  in  this  respect  long-term  damage  was  a  euphemism  for  autism.  Indeed,  this  is 
evident  in  some  of  the  comments  made  by  participants  on  MMR  decision-making.  For 
instance,  Violet  thought: 
... 
before  the  MMR  thing,  a  side  effect  was  a  mild  fever,  I  don't  think  of  long-term  problems  that 
you  were  going  to  have  to  cope  with  for  the  rest  of  your  child's  life  probably  ever  crossed  your 
mind.  I  think  now  whatever  your  child  is  immunised  against,  I  would  certainly  be  looking  for 
much  more  information  than  the  standard  leaflet  that  comes  out  from  the  manufacturer's 
instructions 
NCI'  Group;  Violet  aged  36 
Similarly,  William  also  spoke  about  the  fact  that  the  MMR  debate  has  raised  questions 
more  generally  over  vaccine  safety.  He  considered  that  before  the  MMR  controversy 
parents  were  unaware  that  there  were  any  risks  attached  to  immunisation  and  the 
possibility  of  long-term  damage  was  not  something  parents  confronted  whilst  making 
their  decisions.  However,  he  felt  that  since  the  MMR  debate  had  begun,  parents  had 
become  more  questioning  and  they  now  faced  a  dilemma  about  whether  to  immunise  or 
not  (Single  Men's  Group;  William  aged  51). 
165 The  fear  of  long-term  damage  arose  spontaneously  in  all  the  groups.  The  main  concern 
appeared  to  centre  on  the  fact  that  participants  were  anxious  that  too  many  antigens  given 
together  could  potentially  overwhelm  the  child's  immature  immune  system,  causing 
health  problems  at  a  later  date.  This  fear  led  Anna  to  refuse  MMR.  She  stated:  "the 
worry  is  putting  all  three  in  at  one  time,  into  that  wee  body.  Individual  ones  for  me  is,  it 
makes  sense  to  not  bombard  it  with  too  much  chemicals  all  at  one  go"  (High  Uptake  Area 
Group;  Anna  aged  33).  Indeed,  the  three  participants  who  had  sought  single  vaccines  for 
their  children  had  done  so  partially  to  space  out  the  vaccines  and  to  reduce  this  perceived 
risk  of  overwhelming  their  children's  immune  systems.  Joe  explained: 
I  mean  but  you  think  about  it,  you  know,  if  you  were  given  a  shot  of  caffeine  and  it  was  just 
caffeine  with  no  water  in  it,  you  know,  that's  gonna  be  far  more  potent  for  your  body  than  you 
know,  giving  it  with  water,  caffeine  with  water.  You  know,  so  why  would  you  not  expect  your 
children  to  have  a  bad  reaction  if  they're  given  something  that's  so  potent? 
Single  Vaccine  Group;  Joe  aged  36 
But  this  reasoning  is  inherently  illogical  in  that  many  of  the  participants  who  talked  about 
increasing  the  time  between  the  MMR  vaccine  components,  had  already  given  their 
children  combined  DTP  vaccines  at  two,  three  and  four  months  of  age,  and  seemed  quite 
unconcerned  about  it.  These  inconsistencies  in  their  argument  were  evident  throughout 
the  discussion  and  reflect  the  fact  that  many  participants  seemed  ambivalent  about  the 
nature  of  the  link  between  their  child's  state  of  health  and  immune  overload.  This  rather 
obvious  inconsistency  was  even  noticed  by  a  few  participants  themselves.  For  instance, 
Cassie  observed: 
Cassie:  I  was  actually  going  to  say  that  because  the  diphtheria  and  the  one  that  they  get  when  they 
are  so  young  is  actually  a  combined...  because  I  remember  somebody  said  that  you  have  already 
given  her  a  combined  injection  and  I  hadn't  really  thought  about  it  like  that. 
Facilitator.  So  why  is  that  then  that  you  haven't  thought  about  it? 
Cassie:  I  never  thought  (unintelligible),  but  then  sometimes  you  wonder  if  that's  because  it's  done 
so  young  ....  and  you  have  not  had  a  chance  to  think... 
High  Uptake  Area  Group;  Cassie  aged  29 
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"funny  enough  we  are  all  just  in  the  middle  of  our  first  jabs  and  suddenly  with  the  MMR 
thing-  I  thought  heck-  I  didn't  even  really  think  about  what  the  side  effects  were  of  those" 
(New  Mothers  Group;  Joanne  37). 
The  only  explanation  to  be  given  by  participants  to  account  for  this  inconsistency  was 
that  these  first  combined  vaccines  are  given  at  a  time  when  parents  are  overwhelmed  with 
the  new  task  of  parenthood  and  as  such  have  not  had  an  opportunity  to  fully  consider  the 
various  arguments  about  immunisation.  For  example,  Violet  reflected  back  on  her  earlier 
decisions  about  immunisation  and  believed  that  she  had  not  had  time  to  assess  the  risks  of 
the  combined  DTP  vaccines.  She  spoke  about  just  emerging  from  a  `state  of  not  knowing 
whether  it  was  night  or  day'  when  she  was  told  her  daughter  should  have  DTP.  She  went 
on  to  assert:  "I'm  sure  if  the  timing  of  diphtheria,  tetanus,  whooping  cough  and  HIB  was 
later  like  MV  R,  there  would  be  a  lot  more  discussion  about  it"  (NCT  Group;  Violet  aged 
36).  However  another  explanation  to  account  for  why  so  many  participants  only 
attributed  immune  damage  to  the  combined  MMR  vaccine  may  be  due  to  the  press 
release  that  accompanied  publication  of  Wakefield's  paper.  This  press  release  stated  that 
Dr  Wakefield  was  of  the  opinion  that  there  is  a  case  for  separating  the  three  vaccines  into 
separate  measles,  mumps,  and  rubella  components  and  administering  them  individually 
spaced  by  at  least  one  year.  Across  the  groups  many  participants  felt  that,  if  given  the 
choice  by  the  NHS,  they  would  follow  Dr  Wakefield's  advice  and  opt  to  space  the 
vaccines  out  and  give  their  children  the  single  vaccines  in  favour  of  the  combined  MMR 
vaccine. 
On  the  whole,  participants'  concerns  about  vaccines  tended  to  focus  on  the  MMR  vaccine 
and  less  on  the  other  vaccines  in  the  programme.  Participants  often  changed  their  minds, 
contradicted  themselves  and  spoke  with  uncertainty  and  ambiguity  on  matters  of  vaccine 
safety.  Nevertheless,  there  were  a  few  participants  whose  children  were  fully  immunised 
(or  planned  to  have  all  the  vaccines  given  to  their  children)  who  voiced  concerns  about 
the  number  of  vaccines  given  to  young  babies.  For  example,  Joanne,  looked  at  the 
Childhood  Immunisation  Schedule  handed  out  (Appendix  L)  and  asked:  "  ...  you  are  told 
167 you  need  all  these  injections,  but  like  you  say  (looking  at  Sally)  we  didn't  need  these 
injections,  you  know  are  we  over  immunising  our  kids?  I  don't  know 
... 
I  just  feel  they 
are  putting  all  these  drugs  into  the  kids  and  at  some  stage  you  have  to  say  stop,  that's 
enough,  they  don't  need  any  more  vaccinations...  "  (New  Mothers  Group;  Joanne  aged 
37). 
The  most  vocal  groups  to  speak  critically  about  the  MMR  vaccine  and  vaccination  in 
general  were  the  Non-Vaccine  Group  and  the  Non-MMR  Group.  In  the  Non-Vaccine 
Group,  Molly,  a  herbalist,  argued  that  administering  three  antigens  in  one  vaccine  is  an 
unnatural  way  of  encountering  diseases.  She  stated: 
Well  from  what  I've  heard,  em,  it's  like  a  sudden  onslaught,  normally  you  would  catch  it  through 
the  mouth  and  there  are  so  many  defences  that  it  goes  past  before  it  gets  there.  But  when  they 
inject  them,  it  goes  straight  into  the  bloodstream  and  it  doesn't  pass  all  those  defences  and  the 
body  just  gets  a  shock,  where  did  this  come  from? 
Non-Vaccine  Group;  Molly  aged  37 
In  the  Non-MMR  Group  Aleena,  a  stay-at-home  mother  of  four,  also  mentioned  that  she 
feared  long-term  damage  and  stated  that:  "I  don't  think  they  know  enough  about  the 
immune  system  when  they're  two  months  old,  it's  still  developing...  "  (Non-MMR 
Group;  Aleena  aged  35).  Both  these  groups  represent  some  of  the  least  enthusiastic 
voices  on  immunisation  and  unlike  most  participants  their  concerns  about  the  risks 
associated  with  vaccines  were  not  confined  to  MMR. 
5.23  Conceptualising  immune  overload 
Despite  fears  about  some  children  being  prone  to  `immune  overload',  getting  participants 
to  articulate  this  fear  more  specifically  in  the  groups  was  quite  difficult.  When 
participants  were  asked  to  describe  what  they  meant  by  `overloading'  the  immune 
system,  the  question  was  often  met  by  silence.  Nevertheless,  the  Low  Uptake  Area 
Group  attempted  to  explain  what  they  meant  by  this  term: 
168 Sheila:  You  can  just  overload  their  immune  systems. 
Facilitator.  What  does  that  mean? 
Sheila:  They'd  probably  become  immune  to  jags  eventually  I  think. 
Alan:  I  feel  as  if  their  immune  systems  would  go  to  pot.  You  can  only  immunise  so  much. 
Low  Uptake  Area  Group;  Alan  aged  33;  Sheila  aged  36 
Words  like  `go  to  pot'  and  `knacker'  the  immune  system  did  not  really  shed  light  on  the 
precise  mechanisms  of  overloading  the  immune  system.  William,  Kenny  and  Robert 
tried  to  illuminate  the  problem  and  explained  their  fears  about  over-immunisation  by 
reflecting  back  on  their  respective  experiences  of  immunisation: 
William: 
... 
I  think  sometimes  that  you  can  clean  up  things  so  well,  that  the  body  breaks  down  in 
its  immune  system,  you  know?  As  this,  as  an  old  wives  tale  says,  a  happy  kid's  a  dirty  kid.  And 
you'd  go  out  and...  you  would  rummage  the  bins  when  you  were  young  and  everything  else.  And 
you  didn't  catch  diseases.  (People  talking  at  the  same  time) 
Robert:  Right,  right?  And  you  didn't  catch  diseases. 
Kenny:  They  made  themselves  immune. 
William:  So  in  those  days  you  had  a  bath  once  a  week  or  something,  right? 
Robert:  Still  the. 
William:  Right?  But,  nowadays  all  the  emphasis  is  on  cleanliness  and  no-one's  actually  telling 
us  that  if  you  re  not  getting  attacked  by  germs,  then  when  you  do  get  attacked  by  deadly  germs, 
your  immune  system  breaks  down. 
Robert:  Aye,  'cause...  You  know...  I've  drunk  water  out  of  empty  cans... 
Facilitator.  So  what  are  you  saying  here...  though,  what  are  you  saying  about  immunisation? 
William:  What  I'm  saying  is  are  we  over  doin'it,  you  know?  If  you're  having  a...  if  you're 
having  a  major  breakdown,  if  there's  measles  coming  in,  in  the  comer,  right?  Okay,  fair  enough. 
In  my  days,  kids  had  measles,  right?  So  therefore,  why  prevent  measles?  It  was  part  and  parcel 
40  year  ago.  Okay,  the  policies  are  changed  now  and  they're  saying  okay,  rather  than  have  it.  But 
as  Kenny  says,  your  system  builds  up  its  immune  system  because  you  do  get  attacked  by  viruses, 
germs  and  eh,  eh... 
169 Kenny:  Bacteria? 
William: 
...  eh  ... 
illnesses.  You  know?  So  you're  breaking,  so  you're  breaking  down  your  body's 
defences. 
Kenny:  Every  weans  catch  wee  illnesses  a  lot  easier  now.  (People  talking  over  each  other) 
William:  They  were  hardier  in  those  days.  Right?  We  were  hardier  40  year  ago  than  what  they 
are  today,  right?  Know? 
Single  Vaccine  Group;  William  aged  51;  Kenny  aged  43;  Robert  aged  47 
This  perception  was  interesting.  On  one  hand,  it  would  be  easy  to  dismiss  the  idea  that 
children  were  healthier  40  years  ago,  simply  by  comparing  the  morbidity  and  mortality 
rates  of  childhood  infectious  diseases  over  the  past  few  decades.  However,  to  consider 
only  epidemiological  data  may  be  to  miss  the  point.  I  think  that  implicit  in  this 
conversation  is  the  perception  that  environmental  sterility  may  itself  breed  new  risks. 
The  risk  that  William,  Robert  and  Kenny  identify  is  that  they  feel  children's  immune 
systems  nowadays  are  less  well  equipped  to  cope  with  illness.  In  effect  when  William 
asks:  "are  we  over  doin'  it?  "  he  is  questioning  whether  vaccines  could  have  played  a  role 
in  bringing  about  this  situation  as  he  perceives  it.  They  did  not  appear  to  be  talking  about 
the  perils  of  over-immunising  with  any  sense  of  conviction,  but  rather  there  was  an 
unmistakable  undertone  of  uncertainty  running  through  this  conversation.  They  phrased 
their  comments  on  this  subject  as  questions  to  each  other  and  used  the  word  `right?  ' 
repeatedly  as  if  to  look  for  reassurances  from  each  other. 
Joanne  also  mentioned  that  `too  sterile  an  environment'  may  breed  new  risks.  She  feared 
that,  by  over-immunising  children,  we  in  the  West  are  modifying  our  children's  immune 
systems,  making  them  more  vulnerable  to  contracting  diseases  in  the  future  (New 
Mothers  Group;  Joanne  aged  37).  Both  Kenny  and  Joanne  mentioned  the  unexplained 
rise  in  the  incidence  of  childhood  asthma  and  allergies  as  evidence,  that  children  in  the 
21"`  century  face  new  health  threats.  Nevertheless,  there  were  a  few  participants  who  did 
170 not  share  this  concern  about  over-  immunisation.  Margaret,  a  20-year-old  took  a 
different  stance.  She  stated: 
Margaret:  See  Ah  think  a  jist  think  a  lot  mair  because  ma  wee  boy's  always  no  well.  Fae  the  day 
he's  been  bom  he's  just  been  constantly  no  well. 
Facilitator.  Right 
Margaret:  And  there's  been  like  hunners  of  different  things  wrang  wi  him,  like  he's  spewing 
constantly  and  things  like  that,  and  Ah  always  worry  aboot  everything  wi  him  so  Ah  dae... 
Facilitator.  Yeah. 
Margaret: 
... 
it  could  be  anything  at  aw,  but  Ah'm  right  doon  the  doctor's  wi  him  jist  in  case. 
Facilitator.  So  if  you've  got  a  child  that's  not  really  that  well,  do  you  think  that  that  makes  you 
feel  more  like  you  want  to  get  them  immunised  or  less? 
Margaret:  Aye,  main. 
Facilitator.  Right. 
Margaret:  Cos Ah  feel  as  if  like-  if  they  get  aw  the  jags  then  like,  because  he  is  no  well  aw  the 
time... 
Facilitator.  Yeah. 
Margaret: 
...  then  maybe  if  he  gets  aw  these  jags  it  might  prevent  him  fae  getting  so  no  well,  do 
you  know  what  I  mean?  He  might  feel  a  bit  better  eftir  getting  them. 
Facilitator.  Yeah. 
Young,  Single  Mothers  Group;  Margaret  aged  20 
Margaret's  viewpoint  that  her  son  appeared  to  contract  infections  easily,  and  thus  would 
benefit  from  the  added  protection  of  immunisation  was  unusual  as  participants  often 
viewed  their  child's  ability  to  avoid,  or  quickly  fight,  infection  as  evidence  that  their 
child's  immune  system  was  robust  and  healthy.  However,  more  puzzling  was  the  fact 
that  the  same  logic  did  not  appear  to  be  applied  to  children  deemed  to  have  healthy 
immune  systems.  Indeed,  some  participants  who  believed  that  their  children  were 
healthy  with  robust  immune  systems  suggested  that  this  meant  they  would  be  unlikely  to 
benefit  from  immunisation.  For  example,  Dawn  considered: 
171 I'm  really  lucky  because  my  two  are  extremely  healthy,  you  know  look  up  the  dictionary,  the  word 
healthy  there  would  be  pictures  of  my  two  in  there.  But  where  I  start  to  worry  is  when  you  know, 
my  wee  boy  is  up  at  the  creche  at  the  moment-  what  if  he  is  playing  with  some  other  child  less 
fortunate  than  he  is  that  is  when  it  starts  to  bother  me.  It  is  all  very  well  me  saying,  I'm  not  going 
to  bother,  they  will  be  fine,  there  are  big  issues  there. 
Antenatal  Group;  Dawn  aged  36 
Therefore  for  some  participants  childhood  immunisation  seems  to  be  a  `no-win'  situation, 
their  argument  being  if  your  child  is  unhealthy,  or  seen  as  vulnerable,  then  you  don't 
want  MMR;  and  if  they  are  healthy  they  don't  need  it. 
5.2.4  Fears  about  the  MAIW  vaccine  rendering  the  immune  system  unable  to  respond  to 
other  infections 
Whilst  many  participants  feared  that  MMR  could  cause  long-term  damage  to  the  immune 
system,  there  were  only  a  few  participants  who  had  had  any  direct  experience  of  any 
adverse  reactions  (excluding  the  parents  of  children  with  autism,  see  Chapter  Six). 
Participants  generally  spoke  of  their  children  having  had  a  mild  reaction  post-vaccination. 
However,  two  members  of  the  Saturday  Club  Group  related  how  their  children 
experienced  more  severe  and  unexpected  reactions.  Cathy  recalled  her  daughter's 
experience  of  MMR  and  Bob  recounted  his  older  son's  reactions. 
Cathy:  Annabel  got  her  first  MMR,  and  it  turned  out  it  was  an  ear  infection  in  both  ears,  went 
into  her  throat  and  everything.  And  that  was  a  week  after  her  MMR. 
Bob:  And  what  did  they  say? 
Cathy:  She  just-  it  was  actually  my  health  visitor,  my  GP  kept  on  shrugging  it  off-  'oh  yeah,  it's 
just  a  bug'  you  know  and  I  spoke  to  my  health  visitor  at  the  time  and  she  was  a  fabulous  woman. 
Kept  me  so  informed,  and  she  actually  did  say  to  me  at  one  time  you  know,  `you  ask  so  you  get  to 
know  more',  you  know,  whereas  other  people  are  just  basically  left  alone. 
Facilitator.  Did  that  ear  infection  affect  how  you  thought  about  your  decision  with  your  son,  or? 
Cathy:  I  don't  think  so,  I  just  thought  that  was,  well,  it  was  an  ear  infection  and...  a  course  of 
antibiotics  cleared  it  up,  you  know,  it  wasn't-  but  I  did  know  that  it  was  the  MMR  that  caused  it 
because  my  health  visitor  told  me. 
(Over-talking) 
FJIa:  Did  you  say  it  was  about  a  week  after  and  then  it  went  away. 
172 Bob:  And  is  this...  going  into  the  data,  I'd  like  to  know  whether  anyone  records  it  in  the  data... 
Cathy:  Yes,  of  course,  I  mean  is  it? 
Ella:  That's  quite  common  cos  any  vaccination  you're  getting  a  dose  of  the  problem,  what  you're 
actually... 
Facilitator:  What  about  anyone  else? 
Bob:  He  (referring  to  older  son)  was  in  hospital  for,  for  8  days  after  the  MMR.  8  days.  His 
whole  system  closed  down  and  we  were  told  he  was  brain  damaged.  At  three  o'clock  in  the 
morning  by  a  staff  nurse-  no,  a  staff  doctor  who  was  the  ward  doctor,  who  was  just  qualified.  And 
she  told  my  wife  at  half  past  three  in  the  morning  that  he  was  brain  damaged,  his,  his  heart  rate 
had  halved,  his  temperature  was,  went  up  to  a  fever  and  went  down  to  a  ridiculously  low,  say  20, 
and  they  couldnt  understand  why  his  lips  weren't  blue.  I  mean,  the  only  person  monitoring  him 
for  the  whole  time  was  me,  because  nobody  else  was  looking  at  his  stats  and  his-  his  blood  oxygen 
levels  had  halved  as  well,  so  he  wasn't  getting  any  oxygen  into  his  blood.  And  I,  and  obviously 
we  all  said  'well,  MMR'?  And  they  went  no'.  And  as  I  said  that's  not  gone  into  any  of  the  studies, 
so  are  they  doing  a  study  that  when  they  collect  data,  are  they  ticking  like  MMR,  had  the  MMR- 
any  bad  response  afterwards? 
Saturday  Club  Group;  Cathy  aged  29;  Bob  aged  31;  Ella  aged  45 
Not  only  did  Bob's  experience  of  seeing  his  son  so  unwell  colour  his  views  about  the 
potential  harm  of  MMR,  but  it  also  led  him  to  question  how  accurately  adverse  reactions 
to  vaccines  are  recorded.  Whilst  a  few  participants  associated  vaccination  with  having  an 
extreme  reaction  in  their  child,  it  was  more  common  for  participants  to  offer  third-hand 
accounts  of  other  parents'  experiences  of  adverse  reactions.  Alison  spoke  about  hearing 
about  a  child  who  developed  lumps  in  their  neck  after  receiving  the  vaccine.  To  the 
disquiet  of  the  other  group  members  she  then  went  on  to  tell  them  that  her  cousin's 
daughter  developed  meningitis  a  week  after  receiving  MMR.  Although  she  diluted  the 
story  by  implying  that  it  could  have  been  a  coincidence  and  that  the  child  may  have 
caught  it  from  a  cup  at  nursery,  the  sceptical  looks  on  the  faces  of  the  other  group 
members  suggested  that  they  did  not  subscribe  to  this  explanation.  Indeed,  Anna  seemed 
compelled  to  offer  a  more  plausible  explanation  to  the  other  group  members.  She  stated: 
"but  her  immune  system's  maybe  down  a  bit  because  she  had  had  the  injection  and  that 
just  triggered  it"  (High  Uptake  Group;  Alison  aged  31;  Anna  aged  33).  Anna's 
explanation  appeared  to  be  a  more  acceptable  account  of  what  had  happened,  as  the  other 
group  members  nodded  approvingly.  This  was  an  interesting  response  by  the  group 
because  it  highlighted  the  fact  that  the  participants  were  more  inclined  to  believe  the 
173 explanation  of  a  parent,  in  preference  to  that  given  by  the  health  professionals 
investigating  the  meningitis  outbreak  at  the  nursery. 
5.2.5  Fears  about  vaccines  not  working,  or  not  offering  lasting  protection 
Concerns  about  the  efficacy  of  vaccines  arose  in  almost  half  the  groups.  These 
discussions  tended  to  focus  on  either  how  effective  some  vaccines  were  in  offering  long- 
term  protection  to  an  individual,  or  on  what  percentage  of  the  population  are  protected  by 
each  vaccine.  For  instance,  Aleena  was  concerned  that  rubella  efficacy  might  not  be 




Do  they  know  how  effective  it  is?  Do  they  ever  take  blood  and...  and  see  how  the 
antibodies  levels  are,  and  also  I  read  somewhere  that  just  because  you've  got  the  antibodies  in 
your  blood,  doesn't  particularly  mean  you're  immune  to  it,  you  know,  you  can  still  have,  I  think 
there  have  been  cases  of  people  having  high  antibodies  against  particular  diseases  and  they  still  get 
them. 
Sue:  Do  you  think...  that's  right!  Do  you  remember  that  case  a  year  ago  or  so  in  Dundee  and  there 
was  two  children  who  had  got  measles?  Both  of  them  had  had  the  MMR,  you  know,  so  its  all  a  bit 
vague  who  becomes  immune  and  who  doesn't. 
Non-  MMR  Group;  Aleena  aged  35;  Sue  aged  36 
Rhona  also  questioned  the  efficacy  of  the  rubella  part  of  the  vaccine,  believing  it  was  not 
long-lasting  (First-time  Mothers  Group;  Rhona  aged  31).  Likewise,  Ella  had  felt 
confused  about  why  some  vaccines  needed  to  be  followed  by  a  booster,  and  had  asked 
her  health  visitor  to  explain  this  to  her.  From  this  explanation  Ella  had  understood  that: 
Ella:...  its  because  they  don't  know  if  the  first  one  is  effective  or  not.  They  don't-  the  only  way 
they  could  know  if  it  was  effective  would  be  to  give  it  to  every  child  and  do  a  blood  test. 
In  a  later  conversation  she  was  asked: 
Facilitator.  So  you're  not  planning  to...  then  get  the  booster  at  the  moment? 
Ella:  I  don't  really  see  the  point,  because  if  he's  immune  you  know,  I'm  thinking  about  asking  for 
a  blood  test  to  check  if  he  is,  or  not. 
Saturday  Club  Group;  Ella  aged  45 
174 Bob,  who  worked  as  a  researcher,  had  recently  been  listening  to  a  radio  programme  about 
the  rising  incidence  of  tuberculosis  in  the  United  Kingdom;  he  felt  confused  about  what 
the  professor  taking  part  in  the  discussion  was  saying  about  the  efficacy  of  the  BCG 
vaccine,  and  stated: 
... 
he  was  only  telling  us  that  it's  effective  for  20  years  and  that  you  can't  have  it  again  because  it 
doesnt  work  like  that,  you  can't  have  it  again  and  it'll  only  lasts  20  years.  And  none  of  this  has 
been  told  to  me,  well,  I  can't  remember,  I'll  have  to  talk  to  my  parents.  And  then  he  said  it's  only 
75%  effective.  Now,  I  couldnt  work  out  whether  that  was  75%  of  the  sample  that  are  given  it,  or 
75%  effective  as  in  you've  got  a  25%  chance,  25%  chance  of  getting  it.  So  he  didn't  explain  it,  so 
you  can  immunise  100%  of  the  people  or  everybody,  true-  is  one  person  still  going  to  get  it?  Or 
are  we  saying  that  everybody's  75%  you  know,  only  immunised? 
Saturday  Club  Group;  Bob  aged  31 
Although  some  participants  felt  confused  about  the  efficacy  rates  of  vaccines,  Dave  who 
also  worked  as  a  researcher,  questioned  whether  vaccines  work  at  all,  stating: 
I  used  to  work,  you  know,  when  I  was  working  as  a  biochemist  I  was  working  with  this  guy  and  I 
needed  to  go  over  to  Turkey  and  I  needed  to  get  the  typhoid  jag  and  anyway  I  was working  with 
this  guy,  you  know,  it  was quite  a  long  time  ago  but  I  was working  with  this  guy  who  actually 
developed  the  typhoid  jags  and  he  said,  you  know,  I  was  ill  for  three  days  after,  it  was  like  oh,  I 
just  felt  awful.  Anyway,  after  I  got  back  from  this  holiday,  you  know,  I  was  talking  one  time  to 
him  and  he  said  `you  know,  we  know  it  doesn't  work,  the  jag,  we  know  it's  the  best  that  we've  got 
at  the  moment  but  we  know  it's  not  really  all  that  good'  and  it  makes  you  think,  well...  you  know, 
and  that  was  then.  That  was  the  people  that  had  developed  it  and  they're  telling  me  it's  not 
worked,  it  hasn't  worked... 
Single  Vaccine  Group;  Dave  aged  38 
Many  of  parents'  fears  about  the  vaccine  efficacy  appeared  to  stem  from  their  feelings 
that  they  were  inadequately  informed  about  how  vaccines'  efficacy  rates  are  calculated  or 
monitored.  This  fear  seemed  to  be  exacerbated  by  hearing  or reading  anecdotal  accounts 
of  where  vaccines  had  failed.  Although  several  participants  recalled  these  stories,  there 
was  only  one  participant  who  mentioned  that  a  vaccine  had  not  worked.  Cara  spoke 
about  her  daughter  developing  measles  a  few  months  after  being  vaccinated  with  MMR 
(Outpatient  Cancer  Group;  Cara  aged  36).  Despite  these  concerns  about  the  efficacy  of 
some  vaccines,  there  was  little  mention  of  whether  the  issue  affected  making  decisions 
about  vaccines.  Ella  was  the  only  participant  who  explicitly  spoke  about  it  being  factored 
into  her  decision  not  to  vaccinate.  Whilst  Dave  and  Bob  raised  concerns  over  efficacy, 
175 neither  of  them  suggested  that  this  had  influenced  their  decisions.  In  fact  the  general 
consensus  across  the  groups  was  that  vaccines  must  be  effective  because  diseases  in 
general  are  well  controlled.  Nevertheless,  the  fact  that  the  issue  of  efficacy  was  discussed 
in  almost  half  the  groups  suggests  that  it  was  an  issue  even  if  participants  were  unsure  as 
to  how  to  address  it. 
5.2.6  Immune  vulnerability:  assessing  their  child's  immune  system's  ability  to  respond 
to  the  challenge  of  vaccination,  or  to  fight  the  disease 
The  third  influence  that  participants  identified  on  their  decisions  about  MMR 
immunisation  was  their  assessment  of  their  child's  ability  to  cope  with  vaccines,  or  fight 
disease.  As  yet,  researchers  have  not  explored  this  aspect  of  vaccine  decision-making. 
Nevertheless,  this  topic  arose  in  all  the  groups  and  participants  spoke  at  length  about 
factoring  their  child's  state  of  health  into  their  decisions  about  immunisation. 
Participants  commonly  spoke  about  ensuring  that  their  children  were  in  good  health  on 
the  day  of  immunisation  and  about  how  they  would  not  take  an  ill  child  to  vaccination 
even  if  the  illness  was  slight.  However,  there  were  many  instances  where  participants 
spoke  about  deciding  not  to  immunise  with  MMR  on  the  grounds  that  they  believed  that 
their  child's  immune  system  was  unable  to  cope  with  the  stress  of  receiving  several 
antigens  at  once.  Across  the  groups  participants  mentioned  that  common  colds,  recurrent 
ear  and  chest  infections,  urinary  tract  infections,  eczema,  asthma,  and  allergies  were  signs 
of  a  child  with  a  more  fragile  immune  system.  The  main  concern  that  participants 
expressed  was  that,  for  some  children  who  already  appear  to  have  difficulty  coping  with 
common  infections,  the  MMR  vaccine  could  overwhelm  their  already  fragile  immune 
system  potentially  causing  long-term  damage.  These  participants  often  described  their 
children  as  being  particularly  susceptible  to  damage.  Indeed,  all  three  participants  who 
opted  to  pay  privately  for  the  single  measles,  mumps  and  rubella  vaccines  did  so  because 
of  this  fear.  Jenny  spoke  about  her  reasons  for  opting  for  the  single  vaccine.  She  stated: 
Jenny:  Well,  my  boy,  he  has  been  ill,  see  from  day  one  he  has  been  ill  with  everything, 
everything. 
Facilitator.  What  kind  of  things? 
176 Jenny:  Everything.  You  name  it...  he's  had  colds,  just  one  after  the  other,  he's  got  eczema  all 
over  him  and  then  just  allergies,  everything.  When  he  had  the  meningitis  jag,  his  legs  all  blew  up 
and  he  was  really  ill  with  it.  I  went...  I  went  to  the  doctor  and  they  said  no,  that  wasn't  to  do  with 
meningitis  C  but  I  knew  it  had  to  do  with  meningitis  C  and  I  just  thought  no,  what's  in  that? 
Single  Vaccine  Group;  Jenny  aged  19 
It  was  common  for  participants  to  mention  that  they  felt  children's  immune  systems 
varied  greatly,  and  that  some  children  were  better  at  fighting  infections  or  more 
susceptible  to  contracting  infections.  Participants  with  several  children  spoke  about  the 
differences  they  had  noticed  between  their  children.  For  example,  Sue,  a  mother  of  three, 
explained  her  reasons  for  deciding  not  to  immunise  her  middle  child  with  MMR.  She 
stated: 
...  the  second  one  had  lots  of  colds,  he  had  allergies  and  eczema,  and  em,  it  just  seemed  to  be  too 
much  on  his  wee  immune  system  and  I  just  felt  it  was  too  risky,  whereas  the  third  one  is  a  much 
more  robust  child... 
Non-MMR  Group;  Sue  aged  36 
She  later  mentioned  that  she  had  given  what  she  considered  was  a  less  potent 
homeopathic  alternative,  and  was  surprised  that  he  had  had  quite  a  severe  reaction  to  it. 
This  reinforced  her  opinion  that  this  son's  immune  system  was  more  susceptible  and 
more  delicate  than  both  her  other  sons,  and  she  spoke  about  feeling  reassured  that  she  had 
made  the  right  decision  for  her  son  (Non-MMR  Group;  Sue  aged  36). 
Likewise  the  Non-Vaccine  Group  participants  spoke  about  the  belief  that  a  healthy  child 
would  be  better  equipped  to  fight  disease  and  they  rejected  the  whole  premise  that 
diseases  are  caused  by  micro-organisms.  Fundamental  to  this  group's  belief  was  the  idea 
that  a  healthy  body  can  resist  disease.  Molly  and  Debbie  both  believed  that  disease  only 
invades  the  body  when  there  is  already  an  illness  causing  disruption  to  the  body's  normal 
ecology.  These  participants  considered  that  receiving  three  antigens  at  once  would 
disrupt  the  body's  normal  functioning  and  that  this  could  be  harmful.  Molly  stated: 
...  the  body  does  not  encounter  these  pathogens  directly  into  its  bloodstream  and  certainly  not  in  a 
combined  way,  you  know,  it's  highly  unlikely  to  encounter  all  these  pathogens  at  the  same  time. 
Plus  the  immune  system  does  not  stop  developing  until  you're  about  18  years  old,  not  18  months 
177 old,  18  days  old  or  18  weeks  old  and  em  the  human  body  is  not  designed  for  this  kind  of 
onslaught  of  pathogen  invasion... 
Non-Vaccine  Group;  Molly  aged  37 
Molly  and  Debbie's  ideas  are  more  in  keeping  with  traditional  Chinese  medicine  where 
disease  is  mainly  thought  of  as  disharmony  within  the  body,  than  with  orthodox 
medicine,  which  is  largely  based  on  Pasteur's  nineteenth  century  germ  theory  of  disease. 
5.2.7  Deciding  aboutMMR:  disruptions  to  usual  vaccine  decision-making  behaviour 
Participants  were  asked  to  describe  how  they  had  arrived  at  a  decision  about  whether  to 
vaccinate  or  withhold  MMR  immunisation.  Although  the  decision  had  been  easy  for 
some  participants,  it  was  more  common  for  participants  to  describe  MMR  decision- 
making  as  being  difficult  and  as  having  risks  attached  to  it.  For  instance,  Kenny 
compared  it  to  gambling: 
Doesn't  matter  how  small.  If  it's  only  one  percent  ... 
I'll  still  question  it...  should  you,  you  throw 
the  dice  and  get  the  jag.  You  throw  the  dice  and  get  the  jag  for  that  small  percentage.  You  know? 
A  gamble,  'cause  before,  you  didnt  know  so  it  wasnae  a  gamb  ... 
if  that  gamble  wasn't  there  the 
fact  that  you've  got  your,  got  to  gamble  with  your  kids  life  is  unfair.  Because  you're  put  under  that 
pressure  of  gambling,  where  before  you  weren't.  You  werent.  So  if  something  did  happen,  right? 
You'd  take  that  part  and  parcel  an'  take  the  blame,  even  though  you're  cornered  by  a  no  choice 
situation. 
Single  Fathers  Group;  Kenny  aged  43 
Ella  also  considered  that  she  was  gambling  with  her  son's  health  and  she  recalled  seeing 
her  son  having  his  MMR: 
... 
I  remember  when  they  put  the  needle  in  his  arm  when  he  was,  he  looked  at  me,  he  was  only  a 
wee  baby,  and  he  looked  at  me  like  that,  and  I  felt  I  am  taking  a  risk  with  your  life  even  though 
Pm  trying  to  protect  your  life.  And  that,  it's,  you  know,  it's  a  lottery,  I  felt  as  if  I  was  taking  risks, 
it  was  like,  what's  that  game  you  play  with  the  gun?  Russian  roulette. 
Saturday  Club  Group;  Ella  aged  45 
In  making  the  comparison  with  gambling  both  Kenny  and  Ella  suggest  that  they  are 
taking  an  unknown  risk  with  their  children's  health.  For  this  reason  they  both  mentioned 
178 that  they  felt  particularly  anxious  about  having  their  sons  vaccinated  with  MMR.  This 
anxiety  was  evident  not  only  in  what  participants  said  about  MMR,  but  also  in  what  they 
said  about  the  decisions  they  had  made  about  the  other  vaccines  in  the  programme.  For 
example,  it  was  common  for  mothers  to  refer  to  themselves  as  being  the  decision-makers 
and  their  partners  as  having  a  secondary  role  in  decisions  about  vaccination  in  general. 
However,  in  relation  to  the  MMR  vaccine,  it  was  noted  that  fathers  appeared  to  play  a 
more  prominent  role  in  the  decision.  Indeed,  when  mothers  spoke  about  deciding  about 
MMR  they  often  mentioned  that  they  had  sought  the  support  of  their  partners,  a  fact  not 
mentioned  when  discussing  decisions  about  other  vaccines  in  the  programme.  In  this 
respect,  the  debate  surrounding  MMR  safety  appeared  to  have  disrupted  normal  decision- 
making  patterns.  Whilst  mothers  spoke  about  ultimately  having  the  final  say,  they 
appeared  keen  to  have  the  support  of  their  partners  in  the  decision  and,  in  turn,  fathers 
appeared  keen  to  take  a  more  active  role  in  weighing  up  the  advantages  and 
disadvantages  of  MMR  immunisation.  The  members  of  the  NCT  Group  debated  this 
issue  and  Mel  mentioned  that  although  she  was  the  "driver  in  the  decision,  "  she  had 
sought  her  husband's  approval  because  she  did  not  want  to  shoulder  all  the  responsiblity, 
or  guilt,  if  things  went  wrong.  Likewise,  Trudie  also  referred  to  herself  as  being  the 
"driving  force,  "  but  spoke  about  her  and  her  partner  making  the  decision  together. 
However,  trying  to  come  to  a  joint  decision  had  caused  Violet  and  her  husband  some 
difficulty.  Violet  explained: 
Violet: 
... 
if  it  was  left  up  to  him,  I  don't  think  Annabel  would  have  the  MMR  Which  is  quite 
difficult  because...  because  I  think  he  does  now  agree  that  she  should  have  it  (interrupted) 
Mel:  Because  of  the  egg  allergy? 
Violet:  Well,  partly  because  of  that,  and  partially  because  he  just  feels  very  strongly  that  `there  is 
no  smoke  without  fire'  and  he  thinks  parents  know  their  children  better  than  anybody.  So  if  all 
these  people  are  saying  they  saw  a  perfectly  healthy  child  up  to  that  point,  then  they  had  the 
injection  and  suddenly  they  were  not  well.  If  he  totally  didn't  agree  with  it  I  wouldn't  go  for  it 
because  -  what  if  something  did  happen  to  her.  But  then  ...  so  we  have  discussed  it  `up  hill  and 
down  dale'  finally  I  think  we  are  agreed.  We're  going  for  it. 
NCT  Group;  Violet  aged  36;  Mel  aged  35;  Trudie  aged  38 
179 Another  interruption  to  normal  patterns  of  vaccine  decision-making  behaviour  was 
caused  by  the  high  profile  nature  of  the  public  health  debate  surrounding  MMR,  which 
had  forced  participants  to  engage  more  actively  in  the  decision-making  process.  Indeed, 
whilst  it  was  not  uncommon  for  participants  to  describe  some  of  their  earlier  decisions  as 
being  almost  an  automatic  response  to  receiving  the  letter  to  attend  for  immunisation,  this 
was  not  the  case  for  MMR.  The  only  group  of  participants  who  seemed  quite  passive 
about  MMR  was  the  Young,  Single  Mothers  Group.  They  recalled: 
Kate:  Just  get  em  done,  dont  really  think  aboot  whit  it  is 
...  well  I  donne  anyway.  Ah  never  sat 
and  read  the  leaflets  that  they  gave  you  on  your  jags  and  a'that. 
Lisa:  Naw,  see  ah  never  either.  And  the  doctor  says  they've  to  get  their  jags  like  every  couple  of 
months... 
Kate: 
...  and  Ah  wiz  just  like  that,  just  get  em  dun'.  If  they  need  them,  just  get  them  dun. 
Facilitator.  Is  that  how  you  feel  about  the  whole  thing? 
Kate:  The  only  reason  wi  the  MMR,  the  only  reason  Ah  kinda  thought  main  intae  it  wiz  because 
o'  the  stuff  that's  been  on  telly  aboot  it  and  a'  that. 
Facilitator  Right. 
Kate:  That's  the  only  reason  that  Ah  really  worried  aboot  it  a  wee  bit  more,  but  the  rest  eh  them's 
fine.  But  Ah'll  get  it  done.  Ah  will  get  it  done.  Jist  thought  aboot  it  a  wee  bit  more  ... 
Ah  didnae 
think  twice  aboot  it,  Ah  jilt  went  and  got  them. 
Other.  Aye. 
Facilitator.  Mmm. 
Kate:  There's  nae  point  in  thinking  twice.  If  MMR  was  something  they  didnae  need  done,  why 
the  hell  the  they  have  the  jag  fir  it? 
Young,  Single  Mothers  Group;  Kate  aged  22  ;  lisa  aged  20 
Deferring  MMR  immunisation  was  common,  and  participants  gave  several  explanations 
to  account  for  this  action.  A  few  participants  spoke  about  delaying  because  they  wanted 
to  wait  until  their  children  were  beyond  the  age  at  which  autism  first  shows  signs  of 
developing.  For  example,  Cassie  and  Alison  both  mentioned  that  they  were  waiting  until 
their  children  were  past  eighteen  months  old  in  order  to  ensure  that  they  first  met  the 
expected  developmental  milestones  (High  Uptake  Area  Group;  Cassie  aged  29;  Alison 
aged  31).  Likewise,  Mel  in  the  NCT  Group  explained: 
180 Well,  I  have  an  older  son  who  is  now  four,  and  I  waited  until  he  was  about  18  months  before  I 
gave  it  to  him.  I  just  had  reservations  about  giving  it,  there  was  just  something  telling  me  not  to 
give  it  so  early.  So  this  time  with  Lousie  she  is  already  15  months  and  has  been  called  three  times 
for  it,  but  I  have  just  told  the  doctor  -  I'm  putting  it  off  again.  And  also  when  I  spoke  to  the  doctor 
recently  she  said  ... 
She  said  `you  are  quite  right  not  to  give  it  initially  when  they  call  you  up  for 
it.  Wait  till  they  are  18  months,  they  are  a  bit  more  mature,  you  can  see  them  walking,  talking  and 
all  the  things  they  are  meant  to  do  at  that  stage'.  So  I'm  just  going  to  do  that,  I'll  wait  till  early 
September  before  I  give  it  to  her.  They  have  been  fine,  I  think  you  just  have  to  go  with  your  gut 
reaction  really. 
NCT  Group;  Mel  aged  35 
Although  Mel  does  not  specifically  refer  to  autism,  her  comments  suggest  that  her 
decision  to  defer  vaccination  was  based  on  her  fear  that  her  daughter  could  develop 
autism.  Indeed,  it  was  common  for  participants  who  opted  to  delay  MMR  immunisation 
to  do  so  because  they  believed  that  doing  nothing  was  better  than  doing  something  that 
could  have  negative  repercussions  later.  For  example,  Michelle  and  Patsy  reasoned: 
Michelle:  Well  I  havnae  had  it  done,  I  put  it  off  cos  I  couldnae  cope  on  ma  own  wi  a  mentally 
handicapped  wean.  It's  too  much  oa  risk  especially  wi  boys. 
Patsy:  Aye  that's  right  it's  too  risky.  You  know  when  you  have  a  perfectly  healthy  wean.  You'd 
be  mad  tae  take  the  chance  tae  loose  them  tae  this  mad  autism  disease... 
Multiple  Parenting  Problems  Group;  Michelle  aged  21;  Patsy  aged  23 
likewise  in  the  High  Uptake  Group,  Anna  spoke  about  there  being  too  much  uncertainty 
and  conflicting  evidence  to  make  a  decision,  and  said  that  she  had  opted  to  do  nothing  at 
the  moment  and  review  the  evidence  in  a  year  or  two  because  she  felt  this  to  be  a  safer 
option  (The  High  Uptake  Group;  Anna  aged  33).  However,  there  were  also  several 
participants  who  considered  this  action  to  be  dangerous.  For  instance  Kate  suggested: 
Kate:  If  you  miss  wan  eh  they  jags,  do  you  know  what  Ah  mean?  Yer  gonny  feel 
Ah  think  a  lot  of  people  would  feel  guilty  for  no  getting  their  wean  that  jag  if  they  end  up  wi  wan 
o'  they,  know  how,  diseases? 
Facilitator.  Yeah. 
181 Kate:  And  they  could  have  prevented  it.  Ah  wid,  Ah  wid  feel  dead  guilty  so  Ah  wid.  If  Ah  never 
got  aw  they  vaccinations  and  then  wan  day  if  ma  wean  does  end  up  wi-  and  Ah  could  have 
prevented,  do  you  know  whit  Ah  mean?  Ah  would  feel  dead  guilty. 
Natalie:  Ah  would  feel  dead  guilty. 
Young,  Single  Mum  Mothers  group;  Kate  aged  22;  Natalie  aged  18 
Similarly  Alan  had  delayed  taking  his  son  for  the  MMR  vaccine,  but  had  felt  anxious 
about  delaying.  He  argued:  "I  think  if  you  get  the  chance  to  give  them....  the  jag  and  you 
decided  not  to  give  them  it,  you  would  feel  worse  if  they  catched  it".  However,  he  also 
mentioned  that  he  had  waited  until  a  friend  had  had  his  child  immunised  with  the  MMR 
vaccine  and  seen  for  himself  that  the  child  did  not  have  a  bad  reaction  before  taking  his 
son  for  his  vaccine  (Low  Uptake  Group;  Alan  aged  33).  Indeed,  it  was  common  for 
participants  to  want  to  hear  what  their  friends  and  other  parents  had  decided  for  their  own 
child  because  they  were  seen  as  facing  the  same  dilemma  and  as  having  no  hidden 
agenda. 
5.3  Discussion  of  the  findings 
In  summary,  it  was  clear  that  the  debate  surrounding  the  safety  of  the  MMR  vaccine  had 
made  participants  extremely  anxious  about  making  a  decision  about  whether 
immunisation  was  in  the  best  interests  of  their  children.  Participants  commonly  spoke 
about  ensuring  that  their  children  were  in  good  health  on  the  day  of  immunisation  and 
similar  to  the  findings  of  New  and  Senior  (1991),  reported  that  they  were  reluctant  to  take 
ill  children  for  vaccination  even  if  the  illness  was  minor.  In  particular  it  was  noticed  that 
participants'  thinking  about  MMR  vaccination  had  altered  several  aspects  of  their  usual 
vaccine  decision-making  behaviours.  Firstly,  consistent  with  New  and  Senior's  (1991) 
finding,  the  mothers  in  this  study  spoke  about  being  predominantly  responsible  for 
matters  relating  to  immunisation.  However,  in  relation  to  the  MMR  vaccine  it  was 
observed  that  fathers  appeared  to  play  a  more  prominent  role  in  the  decision  than  for  the 
other  vaccines  in  the  programme.  One  possible  explanation  for  this  change  in  behaviour 
was  that  mothers  may  have  considered  the  vaccine  to  be  too  risky  to  make  the  decision  on 
182 their  own,  fearing  guilt  or  reprisal  if  anything  should  go  wrong.  Secondly,  it  was  noted 
that,  while  some  participants  spoke  of  having  an  automatic  response  to  taking  their 
children  along  for  immunisation  following  receiving  notification  that  their  child  was  due 
his  or  her  vaccines,  this  was  generally  not  seen  in  the  case  of  the  MMR  vaccine. 
Therefore  although  some  participants  described  taking  a  more  passive  role  in  vaccine 
decision-making,  in  general  in  respect  of  the  MMR  vaccine  it  was  more  common  for 
them  to  describe  becoming  involved  in  weighing  up  the  evidence  and  trying  to  come  to  a 
decision  about  it.  Nevertheless,  after  considering  the  evidence,  these  participants  tended 
to  opt  to  have  their  children  immunised.  The  third  alteration  to  parents'  usual  decision- 
making  behaviours  was  that  some  participants  had  difficulty  reaching  a  decision  at  all.  In 
the  event,  they  opted  to  defer  the  decision  by  delaying  it,  an  option  rarely  spoken  about 
for  any  other  vaccine  in  the  programme.  Two  reasons  were  given  by  participants  to 
account  for  this  action.  Firstly,  participants  wanted  to  wait  until  their  child  had  passed 
the  age  at  which  autism  first  appears  so  that  should  their  child  become  autistic  they  would 
know  that  they  themselves  had  not  contributed  to  their  child's  condition.  Secondly,  by 
delaying  the  decision  some  participants  considered  that  it  gave  their  child's  immune 
system  time  to  develop  and  thus  less  likely  to  be  overwhelmed  by  the  combined  antigens 
within  the  MMR  vaccine.  Many  participants  considered  that  it  was  preferable  not  to  act, 
than  to  act  and  cause  long-term  damage  as  this  action  was  viewed  as  being  less  risky  and 
as  having  less  guilt  attached  to  it.  This  fording  is  consistent  with  Ritov  and  Baron's 
(1990)  observations  about  the  vaccine  decision-making  behaviours  of  parents  during  the 
pertussis  controversy,  which  they  termed  omission  bias. 
To  date,  much  of  the  literature  on  vaccine  decision-making  has  identified  two  factors  that 
play  an  important  role  in  assisting  parents  to  decide  whether  or  not  to  immunise  their 
children.  These  are  the  perceived  seriousness  of  a  disease,  and  the  likelihood  of  catching 
it,  and  the  perceived  safety  and  efficacy  of  the  vaccine  (Hershey  et  al.,  1994;  Evans  et  al., 
2001;  Sporton  and  Francis,  2001;  Smailbegovic  et  al.,  2003).  However,  in  relation  to  the 
MMR  vaccine  my  study  identified  three  factors  that  appeared  to  play  equally  important 
roles.  In  addition  to  their  assessments  of  the  diseases  and  of  the  vaccines,  participants  in 
183 this  study  spoke  about  assessing  the  ability  of  their  child's  immune  system  to  be  able  to 
cope  with  the  challenge  of  combined  vaccines,  or  to  fight  the  disease. 
Consistent  with  the  findings  in  Chapter  Three,  there  was  evidence  that  the  relationship 
between  parents'  experience  of  disease  and  decision-making  outcomes  appears  complex 
and  not  always  predictable;  experiencing  the  disease  first-hand  did  not  necessarily  mean 
participants  would  decide  to  immunise.  This  was  particularly  the  case  when  participants 
remembered  their  experience  of  a  disease  as  innocuous  and  had  an  uneventful  recovery 
from  it.  Such  participants  often  seemed  more  likely  to  underestimate  the  risks  associated 
with  the  disease  and  in  some  cases  to  withhold  vaccination.  Similarly,  there  were 
instances  where  participants  had  no  experience  of  the  disease  but  had  heard  stories  about 
a  disease  causing  harm  or  death  and  this  anecdotal  evidence  had  acted  as  an  incentive  to 
immunise. 
This  study  found  that  when  deciding  about  a  combined  vaccine,  participants  often 
considered  all  the  diseases  it  protects  against  at  the  same  time,  rather  than  as  separate 
entities.  This  makes  sense  given  the  fact  that  most  of  the  diseases  in  the  Childhood 
Immunisation  Programme  are  prevented  by  combined  vaccines  in  which  several  antigens 
are  given  in  one  vaccine.  However,  it  was  observed  that  for  some  parents  the  fact  that 
they  decided  about  a  combined  vaccine  by  assessing  the  diseases  together  produced  a 
situation  whereby  each  of  the  diseases  became  less  well  defined,  and  seemed  to  create  a 
level  of  ambiguity  about  which  disease  caused  which  health  problem.  This  may 
contribute  to  poor  understanding  of  the  diseases. 
When  participants  spoke  about  their  decision-making  outcome  in  relation  to  the  MMR 
vaccine,  it  was  noted  that  there  were  some  notable  divisions  between  the  parents  of  boys 
and  girls.  For  instance,  some  participants  who  spoke  about  deciding  not  to  immunise 
their  boys  with  rubella  appeared  to  cause  offense  to  parents  of  girls  who  viewed  their 
decision  as  potentially  putting  their  girls  at  risk.  The  parents  of  boys  seemed  less 
offended  by  the  decisions  of  parents  of  girls,  who  mentioned  that  they  did  not  think 
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participants  questioned  the  efficacy  of  the  rubella  component  of  the  MMR  vaccine. 
These  concerns  seemed  to  stem  from  hearing  or  reading  anecdotal  accounts  about  vaccine 
failure,  and  feeling  inadequately  informed  about  how  vaccines'  efficacy  rates  are 
calculated  or  checked.  This  finding  highlights  the  importance  of  reassuring  parents  about 
the  efficacy  of  the  MMR  vaccine  and  in  particular  about  the  rubella  component  of  the 
vaccine. 
Raithatha  and  colleagues  (2003)  have  suggested  that  the  MMR  controversy  may  have 
triggered  a  more  widespread  reappraisal  of  vaccine  risk  and  there  was  some  support  for 
this  idea  in  my  data.  Although  many  participants  tended  to  focus  attention  on  the  MMR 
vaccine  and  less  on  the  other  vaccines  in  the  programme,  some  participants  were 
concerned  about  combined  vaccines  more  generally.  However,  participants  often 
changed  their  minds,  contradicted  themselves  and  spoke  with  uncertainty  and 
ambivalence  on  matters  of  vaccine  safety.  For  example,  although  many  of  the 
participants  talked  negatively  about  the  fact  the  MMR  vaccine  combines  three  antigens 
into  one  vaccine,  many  of  these  parents  had  already  given  their  children  combined  DTP 
vaccines  at  two,  three,  and  four  months  of  age  and  did  not  seem  unduly  concerned  about 
them.  These  inconsistencies  between  participants'  views  and  actions  were  evident 
throughout  conversations  on  this  matter,  and  reflect  the  fact  that  many  participants 
seemed  anxious,  and  confused  about  the  whole  concept  of  combined  vaccines  over- 
whelming  the  immune  system.  In  this  respect  participants  did  not  confine  their  concerns 
about  the  safety  of  MMR  to  fears  about  autism.  Although  participants  were  clearly 
concerned  about  autism,  they  tended  to  speak  about  it  in  terms  of  worrying  about  immune 
damage.  Participants  seemed  particularly  anxious  about  the  posibility  these  combined 
vaccines  could  be  detrimental  to  their  child's  health  in  the  long-term.  This  fear  appeared 
to  centre  on  the  concern  that  too  many  antigens  given  together  could  potentially 
overwhelm  the  immature  immune  system  causing  long-term  damage.  This  fear  led  three 
participants  to  pay  privately  to  have  single  mumps,  measles  and  rubella  instead  of  MMR 
and  lead  many  participants  to  refuse,  or  delay  MMR.  In  fact  it  was  common  for 
participants  to  believe  that  immunisation  initially  suppresses  rather  than  boosts  the 
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interesting  in  that  this  is  the  exact  opposite  of  its  intended  effect.  Indeed  a  recent  study 
suggests  that  immediately  post-MMR  vaccination  the  immune  system  is  not 
compromised  and  is  able  to  respond  to  fight  other  infections  (Miller  et  al.,  2003). 
However,  although  many  participants  feared  MMR  could  cause  damage,  there  were  only 
a  few  participants  who  had  had  negative  experiences  with  it,  which  led  them  to  view 
MMR  as  dangerous.  It  was  more  common  for  participants  to  offer  third-hand  accounts  of 
other  parents'  experiences  of  adverse  reactions  and  these  stories  acted  as  powerful 
reminders  that  vaccines  have  risks  attached  to  them. 
Consistent  with  the  findings  of  Offit  et  al.  (2002)  and  Miller  et  al.  (2003)  participants  in 
this  study  feared  their  child's  immune  system  might  be  vulnerable  to  the  stress  of 
receiving  several  antigens  at  once.  Participants  commonly  spoke  about  deciding  not  to 
immunise  with  MMR  on  the  basis  that  they  considered  their  child's  immune  system  to  be 
vulnerable  to  the  stress  of  receiving  several  antigens  at  once.  Across  the  groups 
participants  mentioned  that  common  colds,  recurrent  ear  and  chest  infections,  urinary 
tract  infections,  eczema,  asthma,  and  allergies  were  symptoms  of  a  deficient  immune 
system.  The  main  concern  that  participants  expressed  was  that  for  some  children  with 
deficient  immune  systems,  the  MMR  vaccine  could  be  harmful  and  could  potentially 
cause  long-term  damage.  It  was  common  for  participants  to  mention  that  they  felt 
children's  immune  systems  varied  greatly  and  for  participants  with  several  children  to 
compare  and  talk  about  the  differences  between  their  children.  More  puzzling  was  the 
fact  that  the  same  logic  did  not  appear  to  be  applied  to  children  deemed  to  be  healthy 
with  robust  immune  systems.  Indeed,  some  participants  who  believed  that  their  children 
were  healthy  suggested  that  this  meant  that  they  would  be  unlikely  to  benefit  from 
immunisation.  However,  these  ideas  tended  to  be  expressed  by  participants  who  rejected 
the  whole  premise  that  diseases  are  caused  by  micro-organisms  and  who  considered  that 
it  is  not  necessarily  advantageous  to  avoid  diseases  altogether.  They  believed  that  a 
healthy  individual  may  benefit  from  contracting  a  disease  and  developing  life-long 
immunity  to  that  disease,  and  suggested  that  mass  immunisation  in  the  UK  has  become 
out-dated. 
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participants'  fears  about  their  children  having  deficient  immune  systems  was  a  common 
reason  for  participants  to  delay  or  withhold  MMR  immunisation.  It  seems  likely  that 
concern  about  immune  overload  may  have  stemmed  from  the  press  release  that 
accompanied  the  publication  of  Wakefield's  paper.  Although  no  participants  recalled  this 
event,  it  seems  possible  that  issuing  this  statement  has  increased  concerns  that  the 
combined  MMR  vaccine  might  place  too  much  stress  on  the  immune  system. 
The  findings  in  this  chapter  are  particularly  relevant  because  in  August  2004  the 
government  announced  plans  for  the  introduction  of  a  new  five-antigen  vaccine  into  the 
Childhood  Immunisation  Programme.  Although  Bedford  and  Elliman  (2004)  have  been 
quick  to  point  out  that  this  change  to  the  programme  is  "...  a  natural  progression  in  the 
light  of  changes  in  the  epidemiology  of  polio  and  advances  in  vaccine  technology 
developments"  (p.  411)  it  seems  likely  that  in  the  coming  years  this  aspect  of  the  debate 
about  vaccine  safety  will  take  precedence  over  any  concerns  about  MMR  causing  autism. 
It  therefore  seems  wise  for  policy  makers  to  address  these  concerns  to  persuade  parents 
that  combined  vaccines  are  safe.  Until  further  work  is  directed  at  educating  parents  about 
their  children's  immune  systems  and  dispelling  parents'  fears  about  immune-overload, 
this  misconception  may  continue  to  seriously  undermine  the  efforts  to  improve  MMR 
uptake  and  may  leave  parents  casting  a  more  critical  eye  over  the  entire  programme. 
187 Chapter  Six:  The  MMR  controversy  from  the  perspectives  of 
parents  caring  for  autistic  children  and  of  immuno- 
compromised  children 
6.1  Introduction 
This  chapter  investigates  the  experiences  and  views  of  the  MMR  controversy  as 
expressed  by  parents  caring  for  autistic  children  or  immuno-compromised  children.  I 
anticipated  that  both  these  groups  of  parents  would  have  a  particular  interest  in  the  debate 
and  in  the  public's  response  to  it,  for  quite  different  reasons.  Firstly,  the  speculation  in 
the  media  surrounding  Wakefield's  theory  about  a  causal  link  between  MMR  and  autism 
suggested  that,  in  order  to  understand  the  various  dimensions  of  the  MMR  controversy,  it 
was  important  to  include  parents  of  children  with  autism  in  the  study.  As  yet  no  research 
has  been  published  on  how  the  MMR  controversy  has  affected  these  parents,  despite 
autism  playing  a  central  role  in  the  debate.  In  contrast,  parents  whose  children  have 
compromised  immune  systems  have  had  no  such  obvious  role  in  the  debate,  but  I 
wondered  what  effect  the  reduced  MMR  uptake  was  having  on  these  parents  whose 
children  are  dependent  on  high  population  immunity  to  offer  them  protection.  Again,  as 
yet  no  research  has  been  published  on  this  aspect  of  the  debate.  Yet,  it  seemed  likely 
these  parents  were  also  being  affected  by  the  way  the  MMR  controversy  has  unfolded 
and  impacted  their  on  lives,  and  this  seemed  like  an  original  aspect  of  the  debate  worthy 
of  investigation. 
This  exploratory  chapter  is based  upon  analysis  of  the  discussions  in  four  focus  groups. 
Two  groups  were  conducted  with  parents  whose  children  have  autism,  and  two  with 
parents  caring  for  children  with  compromised  immune  systems  due  to  the  effects  of 
chemotherapy  treatment  for  cancer.  The  topic  guides  used  for  these  groups  were  adapted 
from  the  main  guide  (See  Appendix  M  and  N).  These  guides  were  kept  brief  in  order  to 
encourage  participants  to  take  charge  of  much  of  the  direction  of  the  discussion  and  to 
explore  the  issues  important  to  them.  In  the  event,  this  meant  that  some  of  the  data 
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the  agenda  led  to  some  unforeseen  and  original  issues  being  raised,.  Further,  as  no  papers 
have  been  published  specifically  examining  the  MMR  debate  from  the  perspectives  of 
either  of  these  groups  of  parents,  it  offered  an  ideal  opportunity  to  let  these  participants 
take  the  lead  in  shedding  some  light  on  these  less  obvious  aspects  of  the  debate. 
6.2  The  MMR  controversy  from  the  perspectives  of  parents  caring  for 
autistic  children 
All  six  participants  in  these  two  focus  groups  had  sons  with  autism.  Four  participants 
who  were  part  of  the  legal  action  felt  certain  that  MMR  was  responsible.  The  remaining 
two  participants  felt  unsure  whether  MMR  had  caused  their  child's  autism,  although 
neither  of  them  ruled  out  the  possibility  of  a  link.  In  order  to  protect  the  identity  of  these 
participants  and  any  children  involved  in  legal  action  their  ages  and  those  of  their 
children  are  omitted  from  this  thesis  in  addition  to  being  given  pseudonyms.  Both  these 
focus  groups  turned  out  to  produce  extremely  moving  and  often  emotional  accounts  of 
parents  trying  to  come  to  terms  with  their  child's  diagnosis  of  autism,  against  a  backdrop 
of  growing  speculation  that  MMR  may  have  triggered  it.  All  of  them  had  received  their 
son's  diagnosis  of  autism  since  Wakefield's  paper  was  published  in  1998.  In  order  to  do 
justice  to  these  very  personal  accounts,  slightly  longer  extracts  have  been  used  to  let  them 
tell  their  story  in  their  own  words.  However,  in  order  to  condense  some  of  the  longer 
discussions  into  a  more  manageable  size,  summaries  are  also  included. 
6.2.1  Overloading  a  deficient  immune  system  and  subsequent  feelings  of  guilt 
An  important  theme  to  have  emerged  from  these  discussions  was  that  participants 
considered  that  with  hindsight  their  children  should  never  have  received  any  combined 
vaccines,  and  they  felt  guilty  about  having  made  the  decision  to  have  them  vaccinated. 
This  sense  of  guilt  seemed  to  centre  on  the  fact  that  all  of  the  participants  except  Lesley 
felt  that  from  a  young  age  their  child  displayed  signs  of  having  a  deficient  immune 
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that  her  son  Jack  should  not  have  received  any  vaccines: 
... 
he  had  like  chest  infections,  coughs,  colds.  I  was  at  the  doctor  twice,  maybe  three  times,  every 
month.  And  he  was  on  all  these  antibiotics  and  that.  He  really  shouldnae  have  had  his  vaccine, 
but  no  only  his  MMR.  Em...  I'm  sure  they  should  be,  they  should  be  three  month  clear  at  least  o 
antibiotics.  For  Jack's  second  DTP  he  had  these  coughs  and  colds  and  UTI  (urinary  tract 
infection).  I  don't  know  how  many  times  that's  wrote  in  his  medical  record.  Em,  after  his  first 
vaccination  that's  where  they  started,  so  his,  like,  immune  system  was  assaulted.  This  is  the  way 
I've  looked  at  it.  This  has  come  in,  assaulted  his  immune  system  and  he  cannae  cope,  so  he's 
getting  all  these  coughs,  colds,  you're  thinking  it's  away-  two  days  later  it's  back,  you're  back  at 
the  doctors.  `Try  these  antibiotics',  so  he  got  antibiotics  for  a  week.  Went  back  the  following 
week  and  the  antibiotics  hadnae  worked,  so,  `try  these  ones'.  So  that's  like  two  courses  o 
antibiotics.  Go  back  the  following  week  and  the  cough  and  cold's  cleared,  OK  for  immunisation. 
So  I  mean  his  system  was  totally  oot  anyway  wi  one  course  o  antibiotics  but  he  had  two  and  I 
believe  that  this  is  when  it  started  ... 
by  the  time  it  got  to  the  MMR  it  was  like  over. 
She  later  commented: 
See,  if  my  boy's  immune  system  cannae  throw  a  scab  oot?  Cannae...  get  into  gear  and  send  the 
immune  army  up  there  to  clear  that  wee  scab,  what  chance  did  he  have  against  measles,  mumps, 
rubella,  all  the  chemicals,  the  animal  proteins  and  the  polio  and  everything  else  that  he  was  given? 
Autism  Club  Group;  Dianna 
In  the  same  group  Jacqueline  was  also  adamant  that  MMR  had  caused  her  son's  autism. 
Like  Dianna  she  felt  that  she  should  not  have  had  her  son  immunised,  and  later  said  that 
she  regretted  not  paying  more  attention  to  'warning  signs'  that  his  immune  system  was 
deficient.  She  recalled  Max's  health  in  his  first  year: 
Max  was  just  one  of  these  typical  wee  boys  that  you  were  never  away  from  the  doctor  with. 
Snottery  noses,  coughs,  colds,  chest  infections...  everything,  absolutely.  If  you  gave  me  a  list  of 
things  that  Max  could  have  had,  he  had  them.  He  was  also  very  badly  affected  with  eczema.  So 
he  had  a  very  low  immune  system,  so  low  that...  I  feel  a  doctor,  a  health  visitor  and  a  nurse  should 
have  had  the  common  sense  to  say  this  child  isn't  fit  enough  for  any  of  these  vaccinations,  because 
he  wasn't  fit.  He  had  so  so  much...  never  off  antibiotics. 
Autism  Club  Group;  Jacqueline 
A  similar  picture  was  presented  in  the  Autism  Support  Group.  Stella,  Caroline  and 
Alison  all  recalled  the  medical  histories  of  their  children.  Stella  mentioned  the  fact  that 
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if  I  had  researched  to  any  extent  I  would  have  found  out  that  my  children  were  so 
susceptible. 
Facilitator.  Mmhm.  So  why  do  you  think  they're  so  susceptible? 
Alison:  Because  there's  an  auto-...  I  had  an  auto-immune  disorder.  Eh 
... 
Facilitators:  You,  yourself? 
Alison:  I  have  uhuh,  when  I  had  the  children  eh  I  had 
...  chronic  ME  for  15  years. 
Facilitator.  ME,  right. 
Alison:  and  eh  I  suffered  really  badly  with  migraines,  my  brother  is  hospitalised  twice  a  year  with 
migraines,  eh,  my  sister  has  eczema  and  irritable  bowel  syndrome,  all  the  kind  of  susceptible 
family  traits  we  had  in  abundance  in,  in  the  3  children  in  my  family.  You  know,  and  I...  I  mean 
independently  I'm  doing  research  into  how  many  parents  of  children  with  autism  have  any  ME 
connection  and  it's  huge. 
Autism  Support  Group:  Alison 
Lesley  was  the  only  participant  in  either  of  the  groups  who  spoke  about  her  son  being  a 
healthy  baby,  or  of  feeling  uncertain  as  to  whether  MMR  had  contributed  to  her  son's 
autism.  Nevertheless  she  did  not  discount  the  possibility  that  MMR  may  have  triggered 
it,  and  found  all  the  speculation  surrounding  MMR  upsetting: 
Lesley:  It  makes  you  feel  pretty  damn  rotten.  I  feel  as  if  at  the  time  I  did  the  best  for  my  boy,  I 
believe...  I  believe  at  the  time,  I  wouldn't  have  put  my  child  through  anything  that  I  think  would 
harm  him,  so  if  the  doctor  who  I  implicitly  trust  tells  me  that  my  child  needs  an  MMR,  I  go  to  my 
doctor  and  at  that  time  I  would  say  `you  know  best,  I'm  gonna  give  it...  '  I  don't  blame  myself  at 
all  if  that's...  (all  talking  at  once) 
Autism  Club  Group;  Lesley 
It  was  interesting  that  Lesley  was  the  only  participant  who  talked  about  not  blaming 
herself  for  her  son's  autism.  All  the  other  participants  talked  about  feeling  responsible 
and  spoke  angrily  about  MMR.  In  contrast,  Lesley  spoke  with  composure  and  talked 
191 about  not  looking  to  blame  anyone,  but  on  focusing  her  efforts  constructively  on  looking 
to  her  son's  future  and  what  is  best  for  him.  A  major  factor  in  her  not  feeling  to  blame 
seemed  to  be  the  fact  that  Lesley  was  able  to  look  back  on  her  son's  early  development 
safe  in  the  knowledge  that  he  had  always  seemed  healthy.  This  seemed  to  console  her:  as 
a  parent  she  had  done  her  best  for  her  son.  However,  the  other  participants  were  not  able 
to  rationalise  their  actions  so  easily.  The  anguish  and  turmoil  they  felt  about  the  fact  that 
they  had  ignored  early  signs  that  their  children  were  not  healthy  and  then  sanctioned  a 
vaccine  that  may  have  caused  autism  placed  an  unbearable  burden  of  guilt  on  them.  This 
guilt  was  evident  throughout  the  discussions.  Participants  spoke  about  feeling 
inadequate  as  parents,  and  talked  almost  confessionally  about  having  let  their  children 
down.  For  instance  Alison  stated: 
Alison: 
... 
I  feel  like  just  I've  failed  my  children  so  badly  by  not  researching  that.  I  feel  as  though 
I've  bought  organic  food,  I  bought  organic  jars  of  food,  I  breastfed  for  as  long  as  I  could,  I  did 
everything,  you  know,  I'd  Dettox  every  fuckin'  surface,  nothing  would  get  into  them.  And  then  I 
never  questioned  what  was  in  the  vaccine...  and  I  know,  you  know  everyone  always  says  'oh,  you 
know,  you  can't  blame  yourself'  ut  I  do  blame  myself.  And  I  should  blame  myself  because  I 
should  have  looked  into  that,  I  should  have  questioned  that  before  I  took  my  child  along  and  got 
them  injected  (tears  in  her  eyes). 
Stella:  You  weren't  to  know  (touches  Alison's  shoulder). 
Autism  Support  Group:  Alison 
The  distress  these  participants  felt  occasionally  spilled  over  into  tears,  and  whilst  other 
participants  often  tried  to  find  words  of  comfort,  these  words  often  seemed  hollow  as 
they  too  appeared  to  share  in  this  same  sense  of  guilt.  One  particular  event  that 
participants  seemed  to  feel  guilty  about  was  the  day  they  took  their  children  to  receive 
MMR. 
6.2.2  The  MMR  autism  story:  feeling  guilt  and  trying  to  get  answers 
Jacqueline  spoke  about  the  day  that  she  took  her  son  Max  to  a  major  children's  hospital 
to  have  an  egg-free  MMR,  due  to  allergies.  She  referred  to  it  as  "the  day  that  changed 
her  and  her  wee  boy's  life  forever",  and  recalled:  "...  I'll  never  forget  the  day  we  took 
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getting  his  MMR.  They  give  him  it,  you  wait  an  hour  and  you  take  him  home.  And 
then  ...  (spoken  in  low  grave  voice)  your  life  changes  so  much...  so,  so  much"  (Autism 
Club  Group;  Jacqueline).  She  talks  about  him  deteriorating  before  her  eyes,  and  recalls: 
It  was  his  speech  that  really  went  first  and  then  the  whining  started,  and  the  whining  never 
stopped.  And  he  whined  for  everything.  He  used  to  hang  upside-down,  obsessive  about  videos, 
he  used  to  want  to  watch  the  same  video  1500  times  a  day  and  he  screamed  when  you  were 
rewinding  it.  I  felt  as  if  all  I  was  doing  as  a  mother  was  screaming  at  him,  shouting  and  bawling  at 
him,  wanting  to  absolutely  kill  him  but  not  realising  that  he's  in  absolute  agony  to  everything... 
Autism  Club  Group;  Jacqueline 
The  passion  with  which  Jacqueline  spoke  about  her  son's  sudden  deterioration  was 
moving  and  even  compelling.  She  realised  when  looking  at  video  footage  of  him  how 
quickly  he  had  deteriorated  after  his  MMR,  and  became  convinced  that  MMR  had 
triggered  his  autism.  In  the  Autism  Support  Group,  Alison  also  told  a  similar  story  about 
her  son  being  immunised  with  MMR,  and  described  how  she  noticed  an  immediate 
deterioration  in  him.  She  recollected: 
Alison:...  he  missed  the  first  call  for  his  vaccination,  at  18  months  he  was  ill  or  19  months.  So  I 
don't  think  he  got  the  vaccination  to  21  months  and  by  22  months  he  couldn't  speak  and  all  he  did 
was  smash  his  face  off  concrete. 
Facilitator.  So  was  it  very  quickly  then? 
Alison:  Uhuh.  (Nodding  head  yes) 
Facilitator.  Did  you  associate  it  yourself? 
Alison:  No,  cos  I  didn't  know  there  was  any  risk  involved  so  I  would  have  associated  it  as  much 
as  giving  him  the  cream  egg  the  day  before,  do  you  know  what  I  mean?  I  had  no  idea  there  was  a 
potential.  So  my...  my...  my...  I  wasn't  affected  at  all  at  that  point. 
Facilitator.  When  did  you  associate  it?  When 
...? 
Stella:  I  think  it  was  in  the  media  when  it  came  out. 
Alison:  No,  because  you  see  ...  uhuh,  but  he  took  very  ill  after  the,  the  vaccination. 
Facilitator.  Right,  what  kind  of  ill? 
193 Alison:  He  just...  he  was  just 
... 
ill.  He,  he,  just  as  if,  you  know,  when  they're  really,  really 
poorly  and  they're  pure...  temperature  and  they've  just  got  that  look  of,  I'm  not  here,  just  that 
scary  as  a  parent,  you're  scared.  And  then  when  he  finally  kind  of  a  woke,  you  know,  during  that 
time,  he  had  the  deadest  eyes,  it  was  like  all  the  life  had  gone  from  his  eyes,  all  this...  but  I  know 
that  sounds  really... 
Stella:  No,  Ewan  has  been  like  that  as  well. 
Alison:  It  was  like  before  he  was  like  wee  boy,  twinkly  eyes  and  after  it,  it  was  just  like  the  same 
eyeballs  but  as  if,  the  glare  had  been  taken  out  of  them  or  something  and  he  just... 
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Alison,  like  Jacqueline,  was  adamant  that  her  son's  adverse  reaction  to  MMR  and 
subsequent  sudden  deterioration  was  evidence  that  MMR  had  triggered  her  son's  autism. 
Although  Alison  also  talked  about  feeling  sure  that  MMR  was  responsible,  she  also 
mentioned  the  fact  that  at  the  time  she  was  not  aware  of  any  risk  associated  with  MMR. 
According  to  Alison  it  was  only  when  her  daughter  developed  severe  eczema 
immediately  after  receiving  her  MMR  that  she  began  to  become  convinced  that  MMR 
was  not  safe.  Dianna  told  a  similar  story  and  had  also  become  increasingly  convinced  of 
the  link.  Her  fears  seemed  to  be  confirmed  when  sifting  through  her  son's  health  records 
and  video  footage  of  him  as  a  baby  and  young  toddler.  Both  groups  spoke  about  realising 
that  MMR  had  been  the  trigger  and  then  having  to  deal  with  their  son's  diagnosis.  For 
example  Jacqueline  and  Lesley  reflected  on  their  experience  of  coming  to  terms  with 
having  a  child  with  autism,  and  stated: 
Jacqueline:...  We'll  never  have  the  child  that  we  lost. 
Lesley:  Absolutely. 
Jacqueline:  And  that's  a  process  that  we've  been  through  as  well.  You  grieve  for  that  child. 
Lesley:  Oh,  absolutely. 
Jacqueline:  A  grieving  process. 
Lesley:  Well  I  mean  cos  you've  got  your  own  idea  how  your  child  is  gonna  be  like-  I  mean  you 
always  want  better  for  your  children,  same  as  my  mum  wanted  better  for  me  and  all  the  rest  of  it. 
You  want  your  child  to  do  the  best  that  they  can  and  you  don't  want  ??  (all  talking  at  once) 
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194 Jacqueline,  Alison  and  Dianna  stood  out  as  being  the  parents  most  affected  by 
Wakefield's  theory.  Indeed,  on  comparing  their  sons'  histories  with  major  events  in  the 
MMR  debate  it  was  interesting  to  note  that  the  period  during  which  their  sons  were 
beginning  to  display  signs  of  severe  autism  coincided  with  the  publication  of  Wakefield's 
study  in  1998.  These  participants  may  therefore  have  been  more  sensitised  to  and 
influenced  by  the  debate  than  they  now  consider  themselves  to  have  been.  Indeed,  these 
three  participants  talked  about  searching  for  answers,  and  Dianna  and  Jacqueline  both 
spoke  of  travelling  down  to  London's  Royal  Free  Hospital  in  the  hope  of  understanding 
more  about  the  bowel  problems  their  sons  had.  Dianna  and  Jacqueline  also  spoke  about 
travelling  to  hear  Dr  Viera  Scheibner  speak  on  one  of  her  tours. 
I  mean  we  went  to,  we  went  to  hear  this  woman  speaking,  a  lovely  woman.  Bulgarian,  Hungarian- 
Dr  Viera.  She  was  absolutely  superb.  She's  right  up  on  these  vaccines  and  she's  from  the  old 
school,  you  know.  She's  Hungarian  I  think  she  is.  And  all  these  studies  on  baby's  breathing  and 
all  that.  She's  done  studies  on  baby's  breathing,  she  developed  this  map  cos  she  was  fed  up  of 
hearing  of  children  dying  of  cot  death  in  her  native  country.  But  when  she  studied  these  children, 
see  as  soon  as  a  baby  died,  she  was  chapping  on  the  mother's  door.  `Can't  help  your  child  but  I 
can  help  somebody  else's...  will  you  please  help  me  doing  this  study?  '.  Now,  you're  talking 
twenty,  thirty  years  ago  where...  you  know,  you're  intruding  on  grieving  parents,  but...  her 
persistence  and  her  energy  was  amazing.  She  done  studies  that  showed  ...  that  specifically  showed 
that  between,  what  was  it...  the  twelfth  and  the  sixteenth  day  after  vaccination  is  when  a  cot  death 
occurs... 
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In  searching  for  answers  to  their  son's  condition,  these  participants  spoke  of  reading  anti- 
vaccination  articles  and  of  becoming  interested  in  hearing  the  stories  of  people  who 
oppose  immunisation.  Like  Dr  Viera  Scheibner,  Dr  Andrew  Wakefield  was  viewed  as 
being  on  the  side  of  ordinary  parents  and  standing  up  to  authority  on  their  behalf. 
6.23  Views  on  the  association  between  autism  and  bowel  problems 
All  of  the  participants  were  convinced  of  a  connection  between  their  child's  bowel 
symptoms  and  worsening  behaviour  and  talked  at  great  length  on  the  subject.  For 
195 example,  Jacqueline  spoke  about  her  second  visit  to  the  Royal  Free  Hospital  in  2001. 
She  recalled  the  experience: 
... 
`you  need  to  get  doon  here.  His  condition  merits,  what  we've  found  in  his  blood  merits,  em, 
further...  investigation'.  He  went  down  the  following  month  and  got  a  colonoscope  and  an 
endoscope  and  when  he  was  in  the  recovery  room  Dr  X  who  is...  is  em...  Andrew  Wakefield's 
sidekick  sort  of  thing-  he  came  in  and  he  produced  these  photos  but  you're  no  really  taking  these 
photographs  in  cos  you're  worried  about  your  child  lying  there  full  o'  anaesthetic,  which  an 
autistic  child  shouldnae  even  get  anyway.  It  buggers  them  up,  you  know,  it  just-  it's  no  good  for 
them.  So  you're  worried  about  the  anaesthetic,  blah  blah,  blah,  and  he  come  in  and  he  said  well 
`Max  basically...  he's  got  cysts,  he's  got  pockets  of  inflammation,  he's  producing  too  much  acid 
in  his  gullet,  he  has  got  polyps,  he  has  got  a...  a  misshapen  colon  obviously  due  to  the  compacted 
constipation  over  the  years,  he's  got...  infection,  inflation,  blah  blah  blah,  inflammation'.  Em... 
so  that's  fine,  he  goes  away  and,  you  know,  the  next  day  he  comes  in  before  you're  going  home 
and  I  said  `right,  how  do  we  treat  this?  '  and  again  he  told  us  exactly  what  he  had  found.  But  while 
he  was  in  the  recovery  room  I  said  well  `how  did  he  get  all  this?  '  and  he  mentioned  MMR  before  I 
did  because  we  still  hadn't  mentioned  anything  to  do  with  MMR  just  because  I  was  determined. 
Dianna:  Not  to  mention  it. 
Jacqueline:  I  was  not  going  doon  that  road.  Em...  he  said  `well,  you  know,  it's  some  parents' 
belief  that  the  MMR  caused  this  and  we  really  don't  know  yet'  and  I  said  `well,  we  believe  it  was 
the  MMR'.  Might  as  well  tell  him  now,  you  know?  So  the  next  day  he  came  in...  and  there  was 
loads,  loads  of  people  in  with  Max  He  was...  I  got  the  impression  that  the  doctor  was  very,  very 
excited  about  what  he'd  found  in  Max. 
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Dianna  and  Jacqueline  both  spoke  about  wanting  to  get  some  answers  about  their  sons' 
autism  and  bowel  problems,  but  instead  felt  let  down  by  the  medical  team  at  the  Royal 
Free  Hospital.  Jacqueline  believed  that  the  medical  team  looking  after  Max  felt  they  had 
found  something  exciting,  and  she  went  on  to  describe  travelling  home  feeling  delighted 
and  hopeful  that  her  son's  autism  might  improve  if  his  bowel  problems  were  treated. 
However,  she  went  on  to  say  that  when  she  visited  her  GP  she  was  bitterly  disappointed 
to  find  that  the  hospital  had  sent  a  discharge  letter.  She  described  how  this  could  have 
been  written  for  `Joe  Bloggs',  and  how  subsequently  she  has  received  no  assistance  with 
his  condition,  other  than  a  course  of  laxatives.  On  this  subject  she  spoke  angrily, 
concluding  that  there  had  been  a  clampdown  on  the  medical  team  investigating  the  link 
between  bowel  disease  and  autism  since  Dr  Wakefield's  departure  in  2001.  Dianna  also 
considered: 
196 ...  one  minute  there  are  all  these  open  people  and  then  they're  no  wanting  to  say  nothing  to  you. 
They're  going  fae  that  side  o'  the  fence  to  that  side  o'  the  fence,  but  in  the  middle  is  these  parents 
who  are  daeing  their  damnedest  to  try  and  find  something  to  help  their  kids,  because  in  the  hoose 
could  be  this  wee  boy,  could  be  a  wee  boy  in  a  comer  spinning  plates  still,  you  know...  but  I'm 
quite  lucky  that  I  got  my  wee  boy  out  o'  that  foetal  position. 
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In  retelling  her  story  Jacqueline  highlighted  an  important  aspect  of  the  debate  which  may 
have  been  over-shadowed  by  the  furore  about  a  possible  causal  association  between 
MMR  and  autism;  that  is,  of  Wakefield  and  colleagues'  observation  that  there  may  be  an 
association  between  autism  and  inflammatory  bowel  disease.  Indeed,  both  Dianna  and 
Jacqueline  implied  that  the  MMR  debate  had  been  unhelpful  in  their  quest  for  help  for 
their  sons'  bowel  problems,  because  they  perceived  that  the  medical  profession  appeared 
to  be  trying  to  distance  itself  from  Dr  Wakefield's  work.  In  this  respect,  they  considered 
that  politics  was  interfering  with  their  ability  to  manage  their  sons'  conditions,  and  that 
the  medical  establishment  had  turned  their  backs  on  them.  In  turn,  they  spoke 
optimistically  about  the  possibility  of  the  pending  legal  case  obtaining  answers  for  them. 
In  the  absence  of  orthodox  medicine  recognising  and  treating  their  sons'  bowel  problems 
all  of  the  participants  had  turned  to  homeopathic  alternatives,  with  the  exception  of 
Caroline,  who  stated  that  she  was  not  able  to  afford  this  treatment.  Indeed,  Lesley  also 
felt  concerned  about  how  expensive  these  alternatives  are,  mentioning  that  she  pays  £79 
every  time  she  goes  to  see  that  her  homeopath,  in  addition  to  the  cost  of  all  the 
medication  that  they  prescribe  as  well.  Despite  the  expense  she  felt  that  she  needed  to  get 
this  help  for  her  son,  and  asserted:  "...  you  know,  if  someone's  had  a  really  positive 
response,  you  look  into  it  hoping...  you  try  things"  (Autism  Club  Group;  Lesley). 
However,  Lesley  stated  that  she  was  not  sure  whether  she  had  seen  a  change  in  her  son, 
and  stated:  "...  I  mean  they  play  on  your  fears.  Everybody  plays  on  your  fears".  All  of 
the  participants  talked  quite  extensively  and  positively  about  their  experiences  with 
homeopaths,  and  felt  that  their  children  were  improving  as  a  consequence  of  homeopathy. 
This  was  in  stark  contrast  to  their  experience  of  and  comments  on  mainstream  autism 
care  which  seemed  to  them  to  be  woefully  inadequate  in  addressing  the  problems  they 
197 faced  and  in  caring  for  and  treating  children  with  autism  (an  area  outwith  the  scope  of 
this  thesis). 
6.3  Discussion  of  the  findings 
In  summary,  the  sense  of  grief  that  these  participants  felt  was  unmistakable,  and  during 
conversations  it  seemed  apparent  that  the  MMR  controversy  had  added  to  this  sense  of 
grief  and  guilt.  One  of  the  most  striking  features  of  these  focus  groups  with  parents 
caring  for  children  with  autism  was  the  level  of  agreement  between  them.  This  was 
particularly  evident  in  their  descriptions  about  fording  out  their  sons  had  autism,  and  in 
the  search  for  treatment  to  reverse  their  sons'  cognitive  and  social  deterioration.  All  the 
participants  told  heartrending  stories  and  appeared  to  have  been  served  badly  by  the 
MMR  controversy. 
An  important  theme  to  have  emerged  from  these  discussions  was  that,  with  hindsight, 
participants  considered  that  their  children  should  never  have  received  any  combined 
vaccines  because  they  now  believed  in  retrospect  that  their  children  had  displayed  signs 
of  having  a  deficient  immune  system  from  a  young  age.  Participants  recalled  their 
children's  medical  histories  and  family  histories  of  conditions  such  as  allergies,  asthma, 
eczema,  ME  and  recurrent  ear  and  chest  infections.  They  considered  that  giving 
combined  vaccines  had  overloaded  their  immune  systems,  causing  irreparable  damage 
and  the  subsequent  development  of  autism.  As  such  they  displayed  a  mix  of  emotions 
including  anger  at  the  medical  profession  for  failing  to  give  them  better  advice  for  their 
children,  guilt  that  as  parents  they  felt  that  they  had  ignored  signs  that  their  children's 
immune  systems  were  deficient  and  sanctioned  a  vaccine  condemning  their  children  to  a 
life  with  autism,  and  dismay  at  the  Government  for  stopping  research  that  might  help 
them  to  discover  and  treat  their  children's  bowel  problems.  They  were  particularly 
anxious  about  what  they  perceived  to  be  a  clampdown  on  research  into  the  link  between 
bowel  disease  and  autism  as  researchers  tried  to  distance  themselves  from  Wakefield's 
work.  Recognition  and  subsequent  treatment  of  their  sons'  bowel  problems  had  ceased. 
198 Participants  spoke  about  turning  to  the  legal  profession  to  build  a  case  against  the 
pharmaceutical  companies  responsible  for  manufacturing  the  vaccine.  However,  for 
some  participants  in  this  study,  gathering  evidence  and  viewing  hours  of  video  footage  of 
their  child's  development  was  a  sobering  experience  that  confirmed  their  worst  fears,  that 
as  parents  they  might  not  have  protected  their  child  from  MMR.  In  the  absence  of  help 
from  orthodox  medicine,  most  of  the  participants  had  turned  to  homeopathic  alternatives 
and  opponents  of  vaccination  for  answers.  Although  their  experiences  of  homeopathy 
were  generally  positive,  they  considered  it  to  be  expensive,  but  they  felt  they  had  no 
alternative  because  mainstream  autism  care  was  inadequate. 
6.4  The  MMR  controversy  from  the  perspectives  of  parents  caring  for 
immuno-compromised  children 
The  second  and  less  obvious  group  of  parents  that  were  identified  as  having  specific 
concerns  given  the  falling  rate  of  MMR  uptake  was  those  caring  for  immuno- 
compromised  children  due  to  the  effects  of  chemotherapy  treatment  for  cancer.  Intensive 
chemotherapy  regimes  cause  a  decline  in  leucocytes  and  antibody  levels  acquired  from 
immunisation.  Consequently,  during  and  immediately  after  chemotherapy  treatment 
these  immuno-compromised  children  are  at  increased  risk  from  an  array  of  bacterial, 
fungal  and  viral  pathogens,  some  of  which  are  particularly  hazardous.  Whilst  the 
outcome  for  many  of  these  children  has  improved  considerably  over  the  past  30  years, 
and  at  present,  70  -90%  of  children  are  cured  with  appropriate  chemotherapy  treatment 
(Paste,  1998;  Pinkerton,  1999),  as  more  children  recover  from  their  cancer  and  re- 
integrate  back  into  their  normal  life  there  is  a  greater  need  to  consider  the  immune  status 
of  these  children  post  chemotherapy  treatment.  In  recognition  of  this  fact  the  Royal 
College  of  Paediatrics  and  Child  Health  published  a  Best  Practice  Statement  on  the 
immunisation  of  the  immuno-compromised  child  in  February  2000.  Although  the 
199 publication  offers  detailed  guidance  on  the  re-vaccination  of  children  post-chemotherapy 
treatment,  it  also  warns: 
...  there  is  a  clear  and  important  need  for  further  research  in  immunocompromised  children 
concerning  immunisation  in  general,  and  specific  vaccines  in  particular  (p.  4). 
A  German  study  investigated  the  impact  of  chemotherapy  treatment  on  levels  of  vaccine 
antibodies  before,  during  and  after  chemotherapy  (Reinhardt  et  al.,  2003).  The  authors 
recommended  the  re-vaccination  of  children  3  to  5  months  after  the  cessation  of 
chemotherapy,  although  they  also  observed  that  re-vaccination  failed  in  some  children. 
They  suggested  that  these  children  may  have  a  decreased  reactability  to  vaccination, 
indicating  they  would  remain  vulnerable  to  diseases  such  as  measles  and  chicken  pox. 
Accordingly,  these  children  are  forced  to  rely  on  high  population  immunity  to  offer  them 
protection. 
Reviewing  the  literature  suggests  that  little  is  known  about  parents'  experiences  or  the 
problems  they  face  integrating  their  child  back  into  society  post-chemotherapy  treatment. 
I  decided  to  carry  out  two  focus  groups  with  parents  whose  children  had  recently 
recovered  from  cancer  to  explore  their  experiences  of  caring  for  a  child  with  a 
compromised  immune  system.  In  particular,  I  hoped  to  explore  some  of  the  issues 
parents  encountered  in  trying  to  protect  and  integrate  their  children  back  into  mainstream 
society  at  a  time  when  MMR  uptake  rates  were  well  below  the  95%  target  level  required 
to  sustain  population  immunity. 
The  main  criterion  for  inclusion  was  that  participants'  children  had  completed  their 
chemotherapy  treatment  for  cancer  within  the  past  four  years  and  were  considered  to  be 
fully  recovered,  or  in  remission  from  cancer.  At  this  stage  I  did  not  that  think  the  age  of 
the  child  was  particularly  relevant,  and  participants  with  children  under  the  age  of  sixteen 
years  old  were  eligible  to  take  part  in  the  focus  groups.  However  analysis  did  suggest 
that  the  age  of  the  child  was  important  particularly  in  relation  to  the  problems  they 
encountered  when  trying  to  re-integrate  their  children  back  into  their  normal  lives,  as  will 
200 be  discussed  in  the  chapter.  Similar  to  the  groups  conducted  with  parents  of  autistic 
children,  the  sensitive  subject  matter  and  the  need  to  ensure  that  each  participant  would 
have  enough  time  to  speak  about  their  experiences  meant  that  the  groups  were  kept  small, 
with  three  participants  in  each.  In  the  event,  all  six  participants  gave  lengthy,  extremely 
poignant  and  highly  personal  accounts  of  their  experience  of  living  with  a  child  with 
cancer.  Although  all  of  their  discussions  were  interesting,  for  the  purposes  of  this  chapter 
I  have  focused  on  the  most  relevant  aspects  to  immunisation.  These  aspects  are: 
participants'  views  on  the  MMR  controversy;  their  accounts  of  trying  to  protect  their 
vulnerable  child  from  infections  and  diseases;  the  issues  they  encountered  trying  to  re- 
integrate  their  child  back  into  mainstream  society;  and  how  they  think  the  problems  they 
encountered  could  be  overcome. 
6.4.1  Views  on  the  MMR  controversy 
The  groups  were  asked  what  they  thought  about  the  MMR  vaccine  and  the  debate 
surrounding  its  use.  These  participants  were  unconvinced  of  a  causal  link  between  MMR 
and  autism  based  on  the  current  evidence,  but  felt  wary  of  reassurances  from  politicians 
and  stories  in  the  media  as  they  thought  these  sources  were  often  biased  and  inaccurate. 
In  particular,  they  were  anxious  to  highlight  the  fact  that  their  children's  needs  had  not 
been  mentioned  in  anything  they  had  read  or  heard  about  MMR.  For  example,  Pamela,  a 
mother  of  three  whose  youngest  daughter  developed  leukaemia  four  years  earlier  when 
she  was  four  years  old,  believed  that  her  daughter's  needs  had  not  been  considered.  She 
stated: 
I  don't  know,  in  all  the  recent  talk  to  do  with  MMR,  I  don't  remember  hearing  very  much  about  if 
you  didn't  get  your  child  vaccinated,  you  know,  the  problems  it  can  be  for  other  people.  It  was  all 
about  the  children  with  autism,  you  know... 
Cancer  Support  Group;  Pamela  aged  42 
likewise,  Sally,  a  mother  of  three  whose  son  had  developed  leukaemia  and  had  a  bone 
marrow  transplant  at  six-years-old,  agreed  and  questioned: 
201 ... 
I  mean  it  is  such  a  major  issue.  Why  is  it  never  been...  I  mean  you  see  an  advert  on  the  TV  or 
something,  you  know,  `get  your  child  immunised'.  I  mean  there  was  a  lot  o'  adverts  at  the  time 
when  there  was  a  big  hype  about  it.  I  mean  there  should  have  been  part  of  that  saying  `if  you 
don't  get  your  child  immunised,  this  is  what  they'll  be  like,  they'll  have...  they'll  be  ill  for  a  few 
days  but  this  could  stem  onto  all  these  people  in  all  different  walks  of  life  and  ages'.  You  know, 
you're  gonna  infect  all  them  and  possibly  kill  half  o'  them  as  well  just  because  you  chose  not  to 
have  your  child  immunised. 
Cancer  Support  Group;  Sally  aged  45 
Similarly  the  participants  in  the  Out-Patient  Cancer  Group  also  considered  that  the  needs 
of  their  children  were  not  considered  when  parents  make  decisions  about  the  MMR 
vaccine.  Jessie,  a  mother  of  three  whose  son  developed  leukaemia  three  years  earlier 
when  he  was  thirteen  years  of  age,  seemed  more  sympathetic  to  the  situation  that  parents 
with  autistic  children  face.  She  spoke  about  relating  to  these  parents'  need  to  search  for 
answers  about  the  cause  of  their  child's  autism.  She  felt  that  she,  too,  had  done  this  when 
her  son  was  first  diagnosed  with  cancer,  and  that  this  was  a  `normal'  response.  However, 
she  also  suggested  that  the  general  population  should  be  given  more  balanced  information 
so  that  they  know  about  the  needs  of  other  more  vulnerable  children. 
... 
You  know,  I  know  it's  difficult  for  people  making  the  decision,  but  you  do  see  it  differently 
when  your  own  child's...  in  this  kind  of  thing...  affected.  When  you  know  other  people  could 
protect,  could  do  something  to  help  yours  and  they're  openly  going  against  the  advice. 
Out-Patient  Cancer  Group;  Jessie  aged  53 
Cara,  a  mother  of  two  whose  daughter  developed  leukaemia  when  she  was  four,  also 
spoke  about  feeling  upset  with  parents  who  were  opting  not  to  immunise  their  children 
with  MMR.  She  believed  that  the  benefits  of  MMR  immunisation  outweigh  the  small 
risks  of  any  side  effects,  and  summed  up  immunisation  as:  "...  there  for  the  greater  good 
of  the  health  of  the  nation...  "  (Out-Patient  Cancer  Group;  Cara  aged  36).  Jill,  a  mother 
of  three  whose  sixteen-year-old  daughter  had  just  completed  chemotherapy  treatment  for 
Non-Hodgkins  Lymphoma,  was  also  less  sympathetic.  She  suggested  that  immunisation 
should  be  compulsory,  but  then  seemed  to  backtrack  slightly  by  stating  that  she  was  only 
202 taking  such  an  extreme  stance  because  of  her  experiences  with  her  daughter  (Out-Patient 
Cancer  Group;  Jill  aged  38). 
Participants  were  asked  to  elaborate  on  their  experiences  of  caring  for  a  child  with 
cancer.  One  of  the  problems  they  highlighted  was  that  in  their  experience  most  other 
parents  were  oblivious  to  the  fact  that  children  with  cancer  are  vulnerable  to  infections 
and  diseases,  and  that  these  diseases  could  be  life-threatening  to  their  children.  This 
meant  that,  in  relation  to  the  MMR  debate,  these  participants  had  on  occasion  to  listen  to 
other  parents  speaking  about  the  rights  of  parents  to  choose  not  to  immunise  their 
children  with  MMR.  For  example,  Cara  spoke  about  a  conversation  with  a  parent  who 
was  adamant  she  would  not  have  her  child  immunised  with  MMR.  She  recalled  the 
conversation: 
». 
Em,  one  of  my  friends  is  adamant.  I  mean  I  didnae  fall  out  with  her  about  it  but  I  just  didnae 
say  anything,  inside  I  could  feel  myself  getting  kinda  angry  cos  her  view  is,  `well  I'm  no  risking 
ma  child  having  the  MMR,  em,  in  case  there's  any  adverse  reaction'  and  I  said  'Well,  that  means 
that,  you  know,  you  could  be  contributing  to  an  outbreak  of  measles  or  mumps  or  whatever,  if 
she's  not  protected,  if  everybody  thought  like  that,  we'd  be  back  to  where  we  were  years  ago'. 
And  her  attitude  was,  `well,  you  know,  you  look  out  for  number  one,  your  own  family,  I  don't 
really  care  about  other  people's  kids',  even  though  it  was  going  to  affect  Emma  (Cara's  daughter) 
and  it  was...  I  could  feel  my  hands...  (wringing  them  in  anger). 
Out-Patient  Cancer  Group;  Cara  aged  36 
Later  Cara  mentioned  that  she  has  not  spoken  to  this  woman  since.  Although  Cara  spoke 
about  being  aware  that  parents  make  decisions  about  immunisation  on  the  basis  of  doing 
what  is  best  for  their  own  child,  she  felt  frustrated  by  some  parents'  lack  of  sensitivity  to 
her  daughter's  predicament.  This  frustration  may  have  been  exacerbated  by  the  fact  that 
she,  like  all  the  other  participants  who  took  part  in  these  two  groups,  had  played  their  part 
in  contributing  to  population  immunity  when  they  had  had  the  choice  (all  their  children 
were  fully  immunised).  However,  it  was  also  very  evident  that  the  problem  of  people 
being  insensitive  to  or  ignorant  of  the  needs  of  their  children  on  post-chemotherapy 
treatment  went  beyond  any  issues  arising  from  the  MMR  debate.  Indeed,  for  these 
participants  the  fear  of  their  children  contracting  infections  or  diseases  was  something 
they  spoke  about  with  a  real  sense  of  foreboding,  particularly  in  relation  to  chickenpox. 
203 6.4.2  The  experience  of  protecting  immuno-compromised  children  from  contracting 
diseases 
One  of  the  most  important  and  relevant  aspects  of  these  discussions  was  participants' 
experiences  of  protecting  their  immuno-compromised  children  from  contracting 
infectious  diseases.  Unprompted,  participants  reflected  back  on  some  of  the  practical 
ways  that  they  had  tried  to  protect  their  children  from  coming  into  contact  with  diseases 
or  infections  during  the  time  that  their  children  were  most  vulnerable.  For  example,  the 
Cancer  Support  Group  spoke  about  the  fact  that  they  had  completely  stopped  allowing 
visitors  to  the  house.  Sally  stated  that  she  had  no  visitors  for  more  than  two  years,  during 
and  in  the  months  following  her  son's  bone  marrow  transplant  and  intensive 
chemotherapy  regime.  Likewise,  Pamela  stated  that  to  avoid  her  daughter  contracting  a 
disease  or  infection  she  would  have  "...  locked  Nicola  in  a  room  for  two  years  I  would 
have,  you  know?  "  (Cancer  Support  Group;  Pamela  aged  42).  Jill  described  this  period 
when  her  child  was  on  treatment  and  particularly  vulnerable  to  infections  as  `mind- 
blowing'  (Out-Patient  Cancer  Group;  Jill  aged  38).  Cara  recalled:  "...  everything  just 
stopped  for  me,  social  life,  everything  stopped"  (Out-Patient  Cancer  Group;  Cara  aged 
36).  Participants  in  the  Cancer  Support  Group  spoke  about  some  of  the  emotions  they 
experienced  during  this  period  when  a  key  objective  was  to  protect  their  child  from 
infectious  diseases  and  infections.  For  example,  Sally  recalled  her  experience  to 
Rebecca,  a  mother  of  four  whose  eight-year-old  daughter  was  diagnosed  with  a  tumour 
when  she  was  four. 
Sally:  I  was  petrified,  yes.  Well,  I  mean  it's  potentially  life-threatening.  I  mean  you're  not... 
there's  nothing  we  can  do  for  the  cancer...  I  mean  OK,  the  leukaemia  is  life-threatening  and  I  just 
had  to  trust  that  they  gave  him  and  did  everything  that  could  to  help  that  and  I  had  no  control  over 
that,  but  I  did  have  control  over  people  coming  with  any  kind  o'diseases  or  ... 
Rebecca:  Infections. 
Sally:  Yeah.  You  know,  and  I  mean  imagine  him  fighting  the  leukaemia,  getting  through  that  and 
because  somebody  came  to  my  house  with  something  that  I  allowed  them  in  and...  and  he  died. 
Because  of  that,  you  would  never  forgive  yourself,  especially  knowing  how  dangerous  it  was,  so  I 
just  felt  it  was easier  to  say  to  people  `please  don't  come'  and  everybody  respected  that. 
204 Rebecca:  I  think  in  a  sense,  really,  you  know  so  much,  but  because  you're  not  medical  and  you're 
just  a  parent,  you  know,  you  take  the  information  that  they  get  and  you  can't  really  decipher  it, 
you  know,  you  can't  think...  OK,  I  think  that's  maybe  OK,  but  maybe  it'll  not  be  quite  OK,  you 
actually  just  take  a  more  a  blanket  view  on  it,  don't  you?  And  you  think...  right,  I  just  know  that 
that's  potentially  dangerous,  I'm  not  quite  sure  whether  it's  here,  here  or  here,  or  what  exactly  that 
means,  so  I'm  just  gonna  take  the  whole  thing... 
Cancer  Support  Group:  Sally  aged  45;  Rebecca  aged  49 
Rebecca's  comment  that  parents  take  a  `blanket  view'  that  all  infections  and  diseases 
should  be  avoided  is  supported  by  the  fact  that  all  six  participants  decided  to  isolate  their 
children  completely  from  having  contact  with  people  outside  the  family.  However,  both 
groups  also  went  on  to  identify  measles  and  chickenpox  as  being  diseases  that  they  felt 
particularly  concerned  about.  Jill  stated  that  just  hearing  the  word  'chickenpox'  made  her 
panic.  She  also  mentioned  the  fact  that  her  job  as  a  schoolteacher  brought  her  into 
contact  with  lots  of  children  and  that  she  continuously  worried  about  transmitting  a 
disease  to  her  daughter  when  her  daughter  was  neutropenic  (Out-Patient  Cancer  Group; 
Jill  aged  38).  Likewise  Pamela  recalled  an  incident  in  which  she  found  out  that  her 
daughter  may  have  come  into  contact  with  someone  with  measles: 
When  Nicola  was  at  nursery,  the  nursery  again  was  like  Sara's,  very  good,  and  they  sent  notices 
out  to  all  the  parents  and  the  same  when  Nicola  went  to  school  as  well.  They  were  excellent.  But 
when  Nicola  was  at  nursery,  I  got  a  phone  call  one  day  to  say  that  somebody  had  phoned  in  to  say 
their  child  had  measles  and  it  had  just  been  confirmed  by  the  doctor  it  was  measles  and  I  was 
straight  up,  you  know,  took  Nicola  out  and  we  were  straight  into  Sick  Kid's  to  get  a  jag  and  I 
remember  cursing  the  parents  of  the  child  for  not  having  their  child  immunised,  but  it  turned  out 
they  had  had  them  immunised  and  it  was  just,  you  know,  it's  no  guarantee  they're  not  gonna  get  it, 
they  were  just  unlucky.  Well,  unlucky  for  us. 
Caner  Support  Group:  Pamela  aged  42 
As  Pamela  spoke  about  rushing  Nicola  up  to  the  hospital  she  looked  anxious  and  patted 
her  heart  as  if  indicating  to  the  other  participants  that  her  heart  was  pounding.  Both  Sally 
and  Rebecca  nodded  their  heads  indicating  empathy  with  Pamela's  predicament. 
205 6.43  The  challenge  of  re-integrating  immuno-compromised  children  back  into  society 
Although  participants  deemed  the  protective  action  of  isolating  their  child  as  necessary 
during  and  immediately  following  intensive  chemotherapy,  they  also  spoke  about  finding 
it  difficult  to  relinquish  this  protection.  Participants  spoke  at  length  about  finding  this 
period  of  adjustment  very  difficult  and  about  it  creating  new  anxieties.  The  main 
challenge  participants  identified  was  that  as  their  children  began  to  feel  better  and  wanted 
to  participate  more  in  usual  everyday  activities,  this  increased  contact  with  people  and 
also  increased  their  likelihood  of  contracting  an  infection  or  disease.  During  this  period, 
participants  spoke  about  the  difficulty  of  making  sound  judgments  about  how  contagious 
the  different  diseases  were,  and  of  assessing  the  suitability  of  some  activities  that  their 
children  wished  to  partake  in.  For  example,  Sally  recalled  her  experience  of  her  son  first 
being  discharged  from  hospital  after  completing  an  intensive  course  of  chemotherapy: 
You  just  want  to  sit  at  your  child's  bedside  and  protect  them....  You  know...  I  mean  as  I  say,  we 
were  in  for  seven  month,  so  going  out  wasnae  a  problem,  but  they  were  only  coming  in  for  a 
couple  of  days  treatment  and  then  going  home  or  sometimes  even  a  couple  o'  hours  treatment  and 
going  home  and  you  did  have  to  think  about  these  things,  and  to  be  told  'oh  don't  go  in  enclosed 
places,  cm...  stay  away  fae  chickenpox'  and  you  go  home,  you  think  `what  did  they  mean  by 
that?  ',  em,  you  know,  and  `did  they  mention  such  and  such?  '  or  `I  hear  that  somebody's  child  up 
the  road's  got  such  and  such,  do  you  think  that  would  be  harmful?...  '  And  you  dinnae  want  to 
phone  the  hospital,  you  dinnae  want  to  be  a  pest  and...  you  say  what  do  I  do  about  it?... 
Cancer  Support  Group:  Sally  aged  45 
Both  groups  identified  that  for  quite  long  periods  of  time  they  avoided  taking  their 
children  near  large  groups  of  people,  or  to  enclosed  areas  with  air  conditioning.  Cara 
mentioned  that  she  stopped  going  out  altogether.  For  example,  she  stopped  going  to  the 
supermarket,  to  restaurants,  to  activities  such  as  swimming  with  her  younger  son,  and 
took  a  year  off  her  work  to  stay  at  home  with  her  daughter.  Looking  back,  she  stated: 
"...  I  just  stopped  taking  any  risks  at  all,  em,  and  I  didnae  really  notice  at  the  time  because 
you're  still  kinda  in  shock  in  the  beginning  but  now,  I  realise  how  much  more  we're 
doing  now".  She  later  stated:  "You  know,  you  feel  as  though  you're  kind  of  out  on  a 
limb,  but  now  we're  coming,  or  I'm  coming  back  in  again"  (Out-Patient  Cancer  Group; 
Cara  aged  36). 
206 Participants  were  asked  whether  they  found  people  understanding  and  helpful  when  they 
were  trying  to  re-introduce  their  child  back  into  mainstream  society.  Both  groups 
mentioned  that  generally  other  parents,  school  teachers  and  nursery  teachers  were 
sympathetic  and  tried  to  cooperate  with  them.  However,  there  was  one  exception.  Sally 
recounted  her  experience  of  her  son  Robert  returning  to  school  following  a  period  of  time 
during  which  he  was  educated  by  a  tutor  at  home.  She  described  the  headmaster  as 
`horrible,  '  `ignorant,  '  and  `uncooperative'.  The  main  problem  was  that  the  headmaster  at 
her  son's  school  would  not  accept  the  fact  that  following  Robert's  bone  marrow 
transplant  and  chemotherapy  he  was  more  vulnerable  to  the  side  effects  of  diseases  such 
as  chickenpox.  As  such,  he  refused  permission  to  have  letters  distributed  to  other  parents 
asking  them  to  notify  the  school  should  their  child  have  chickenpox,  to  enable  Sally  to 
seek  medical  advice  for  her  son.  She  recalled: 
Well,  I  tried  to  explain  to  him,  you  know,  `this  is  life-threatening  to  my  son',  especially  when  he 
first  went  back,  em...  but  he  just  would  not  take  it  on  board.  He  says  `no,  I  have  never  heard  of  it, 
it's  utter  nonsense'  and  it  didnae  matter  what  I  said  to  him,  you  know?  I  mean  a  couple  of  years 
later  when  I  did  meet  him  one  day  and  I  said,  you  know,  `it  was  alright  for  you  not  to  know  about 
that,  but  it  wasn't  alright  for  you  not  to  want  to  know'.  You  know,  he  didn't  want  to  know.  It  was 
just...  you  know,  `go  away,  you're  a  paranoid  mother'  and  that's  the  way  he  looked  at  it.  And 
Robert  did  take  shingles  and  he  was  very  very  ill.  He  had  to  go  on  ...  go  on  a  drip.  He  had  to  go 
on  the  drip  and  things,  he  was  very  ill.  It  was  right  round  his  waist.  And  then  he  took  it  a  second 
time  a  few  months  later. 
She  later  went  on  to  state  that  eventually  she  took  control  and  began  informing  parents 
herself,  and  involved  the  hospital  liaison  nurse. 
By  the  time  we  got  the  liaison  nurse  down  it  was  after  Robert  had  had  shingles  twice,  you  know, 
and  we  were  like  demented  because  we  thought  how  many  more  times  is  he  gonna  get...  and  this 
headmaster  still  wouldnae  inform  the  parents  and  so  by  the  time...  that  took  months  to  get  all 
sorted  out.  She  came  down,  we  all  went  into  a  meeting  and  I  thought  'thank  God,  at  last  we're 
gonna  get  this  sorted  out'  and  the  headmaster  said  'is  Robert  at  risk?  '  and  she  said  'well,  this  far 
on,  no,  not  really'.  And  that  was  it  because  by  this  time  he  was...  oh,  he  was  months,  months  after 
his  treatment  and  he'd  been  given  the  okay  that  his  immune  system  could  cope.  About  eight 
month  I  think.  Wasnae  as  much  as  a  year,  I'd  say  about  eight  month.  Even  still  you  don't  feel 
sure...  and  you  worry. 
Cancer  Support  Group;  Sally  aged  45 
207 Sally's  experience  was  in  stark  contrast  to  the  experience  of  the  other  participants.  They 
had  found  their  liaison  nurses  to  be  highly  involved  in  the  process  of  educating  both 
teachers  and  parents,  and  had  found  teachers  and  parents  to  be  extremely  receptive  to 
assisting  them  in  any  way  they  could.  Nevertheless,  Sally's  experience  unintentionally 
highlighted  another  important  aspect  mentioned  by  other  participants.  Namely,  that  even 
after  they  were  told  by  their  child's  paediatric  oncologist  that  their  son  or  daughter's 
immune  system  would  be  able  to  cope  with  infections  and  diseases,  parents  continued  to 
feel  concerned  about  the  risks  posed  by  diseases.  Indeed,  all  of  the  participants  identified 
that  they  still  felt  anxious  about  their  children  contracting  a  childhood  infectious  disease. 
For  example,  Cam  illustrated  the  point  by  recalling  an  event  that  had  happened  that  day. 
-Emma 
had  spots  on  her  legs  tonight,  I  turned  round  and  looked  at  her  in  the  car,  she  had  spots 
all  down  her  thighs  and  then  her  forearms  but  they  were  wee  tiny  spots  and  I  said  (spoken  in  a 
loud  panicky  voice)  'What's  that  on  your  arm?  Why  have  you  got  all  those  spots?  '  and  she  says  'I 
don't  know,  didn't  have  them'  she's  kind  of  looking  about  and  she  said  'Do  you  think  it's 
chickenpox?  '.  So  it's  been  on  her  mind  as  well  although  we  don't  talk  about  it  often.  And  I  said 
'No,  I  don't  think  it  is,  what  were  you  doing  at  Calum's?  '  'We  were  just  playing  oot'.  I  said 
'Were  you  in  bushes?  '  'Yeah,  I  was  because  the  wall  went  in'  and  I  thought,  well  it's  just  like  a 
wee  prickly  rash  and  it  went  away  after  about  an  hour  I  checked,  I  didn't  want  to  make  a  big  fuss. 
I  thought,  I'm  not  having  her  panicking  cos  of  me,  because  that  would  be  the  question  she  would 
ask  then  is, 'Do  I  have  to  go  up  to  the  hospital?  '  She  still  thinks  that's  what  going  to  happen  when 
she's  ill. 
Out-Patient  Cancer  Group;  Cara  aged  36 
Although  Cara  knew  her  daughter  was  fully  recovered  from  leukaemia,  she  seemed  less 
sure  about  how  well  her  immune  system  would  cope  with  fighting  an  infection  or  disease. 
This  fear  may  have  stemmed  from  the  fact  that  all  the  participants  spoke  about  feeling 
unsure  of  their  child's  immune  status,  post  chemotherapy.  The  participants  seemed 
unsure  to  what  extent  the  chemotherapy  had  destroyed  their  child's  immunity  gained 
from  immunisation,  or  if  they  were  to  be  re-vaccinated  against  these  diseases  at  a  later 
date.  This  ambiguity  may  explain  why  participants  continued  to  feel  anxious  about  these 
diseases,  despite  feeling  confident  about  the  cancer. 
Another  factor  that  seemed  to  affect  the  experience  of  re-integration  seemed  to  be  the  age 
of  the  child.  For  example,  Jill  felt  that  her  sixteen-year-old  daughter,  Laura,  was  able  to 
208 detect  potentially  hazardous  situations  and  diseases  herself.  Jill  stated  that  this  helped  her 
enormously  when  Laura  first  returned  to  school  (Out-Patient  Support  Group;  Jill  aged 
38).  In  contrast,  Pamela,  Cara  and  Rebecca  all  spoke  about  the  difficulties  they  faced  in 
trying  to  re-introduce  their  young  children  back  into  nursery.  They  identified  two  main 
problems.  Firstly,  the  increased  incidence  of  chickenpox  amongst  very  young  children 
made  it  difficult  to  find  a  time  when  it  was  safe  to  let  their  children  return  to  nursery. 
This  was  especially  difficult  during  the  winter  months  when  chickenpox  prevalence  rates 
are  generally  higher.  Secondly,  participants  felt  more  anxious  because  their  children 
were  wholly  reliant  on  others,  being  too  young  to  detect  potential  signs  of  infection 
themselves.  Both  these  problems  meant  that  all  their  children  missed  out  most  of  their 
pre-school  year  at  nursery  and  some  of  their  early  years  at  school. 
6.4.4  Educating  people  about  the  needs  of  immure-compromised  children 
Both  groups  considered  that  people  generally  underestimate  the  severity  of  childhood 
infectious  diseases  and  are  unaware  of  the  damage  these  diseases  can  do  to  immuno- 
compromised  children.  For  instance,  in  the  case  of  chickenpox  Rebecca  considered: 
Rebecca: 
... 
I  think  people  actually  even  kids  who  have  it,  and  you  can  see  them  maybe  out  and 
about  in  the  community  and  clearly  they're  still  infectious  because  you  can  see  the  spots  are  not 
scabbed  over  or  whatever. 
Sally:  That's  right.  But  all  they're  thinking  about  is  `och,  my  poor  wee  boy,  he's  been  in  his  bed 
for  three  days,  he  needs  to  get  out  and  get  some  fresh  air,  granny  said  it'  but  I  mean,  you  know, 
infecting  all  our  kids  that  potentially  is  life-threatening. 
Rebecca:  People  I  think  are  ignorant  actually.  People  generally  don't  know  that  people  with 
diseases  are  dangerous...  I  mean  not  just  to  cancer,  but  other  diseases  actually  lower  your  immune 
system  and  you're  more  susceptible  to  catching  it. 
Sally:  I  wouldnae  have  thought  about  it  years  and  years  ago.  I  wouldn't  have  thought  about  it. 
Facilitator.  Why  do  you  think  people  are  ignorant  about  it? 
Sally:  I  don't  think  there's  enough...  I  mean,  have  you  ever  read  anything  anywhere,  publicly, 
that  says  if  your  child  has  a  disease...  you  know,  stay  indoors,  you  know,  or  please  think  if  you 
ever  have  any  disease  about  children  who...  or  anybody  wi'  a  low  immune...  I  mean  you  don't 
think  o'  things  like  that  and  unless  somebody  tells  you,  you're  no  gonnae  work  it  out  yourself... 
Cancer  Support  Group;  Rebecca  aged  49;  Sally  aged  45 
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parents  were  keen  to  co-operate  once  they  were  made  aware  of  the  situation,  they 
suggested  that  there  is  a  need  for  a  poster  and  leaflet  campaign  every  couple  of  years. 
They  also  suggested  that  general  practitioners  and  health  visitors  could  play  a  more 
prominent  role  in  educating  parents  by  using  immunisation  clinics  and  consultations 
about  childhood  infectious  diseases  to  highlight  the  needs  of  immuno-compromised 
children.  Cara  also  believed  there  was  a  need  to  educate  parents  more  generally  about 
children  with  cancer.  She  mentioned  that  she  had  over  heard  a  conversation  in  which 
another  parent  was  telling  their  child  to  keep  away  from  her  daughter,  whose  appearance 
had  been  altered  by  chemotherapy,  in  case  they  contracted  an  illness  from  her.  She 
stated:  "...  they  see  the  kids  with,  you  know,  wi'  no  hair  and  looking  bloated  or  looking 
really...  looking  ill,  it's  like,  you  know,  'Steer  clear  of  them  or  you'll  catch  something' 
although  it's  the  other  way  round"  (Out-Patient  Support  Group;  Cara  aged  36). 
6.5  Discussion  of  the  findings 
In  relation  to  the  MIR  controversy  parents  of  immuno-compromised  children  were  keen 
to  highlight  that  the  needs  of  their  children  had  been  overshadowed  by  debates  on  the 
rights  of  parents  to  have  choices  about  immunisation.  Despite  participants  showing 
some  sympathy  for  parents  who  feel  their  child's  autism  may  have  been  caused  by  the 
MMR  vaccine,  they  felt  concerned  that  more  generally  parents  who  decide  to  withhold 
the  MMR  vaccine  from  their  children  are  unaware  that  their  actions  put  other  children's 
health  at  risk.  During  the  process  of  integrating  their  child  back  into  their  daily  routines 
participants  had  generally  found  other  parents  to  be  ignorant  of  the  fact  that  their  children 
were  more  susceptible  to  contracting  infections  and  diseases  post-chemotherapy.  They 
suggested  that  there  was  a  need  to  educate  parents  so  that  they  can  make  informed 
decisions  about  immunisation  taking  account  of  the  fact  that  their  decisions  may  affect 
other  children.  Both  groups  suggested  that  future  immunisation  campaigns  should 
emphasise  the  role  that  population  immunity  plays  in  protecting  the  more  vulnerable 
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acknowledged  the  limitations  of  such  campaigns  in  an  increasingly  choice-driven  society 
where  some  parents  will  choose  to  opt  out  of  any  immunisation  if  there  is  doubt  over  its 
safety,  and  thus  opt  out  of  a  public  health  intervention  which  is  intended  to  benefit  the 
wider  population.  In  these  circumstances  participants  recognised  that  parents  had  the 
right  to  decide  to  opt  out,  in  favour  of  pursuing  a  more  parent-centered  approach  to 
protect  their  own  individual  children.  However,  they  suggested  that  they  should  only  do 
so  after  considering  the  wider  implications  of  their  decisions.  This  is  not  the  case  at 
present. 
In  the  initial  period  following  their  child's  return  home  after  intensive  chemotherapy, 
participants  described  taking  a  blanket  approach  to  avoiding  all  infections  and  diseases  by 
isolating  their  child  in  the  house,  including  isolating  them  from  contact  with  people 
outside  the  family.  However,  as  their  child  began  to  recover  and  gained  the  strength  and 
desire  to  re-join  their  normal  activities,  participants  described  facing  several  difficulties. 
It  was  noted  that  the  experience  of  re-integration  raised  different  problems  depending  on 
the  age  of  the  child.  In  relation  to  avoiding  infections  and  diseases  older  children  were 
considered  to  be  better  able  to  protect  themselves,  as  they  were  able  to  detect  and  avoid 
potentially  hazardous  situations  and  diseases  themselves.  However,  participants  with 
younger  children  attending  nursery  and  primary  school  spoke  about  the  difficulties  they 
faced  trying  to  re-introduce  their  younger  children  into  nursery  and  school.  They 
suggested  that  the  increased  incidence  of  chickenpox  amongst  this  age  group  and,  the  fact 
that,  in  the  days  before  the  first  spots  appear  apparently  healthy  children  are  infectious 
make  it  impossible  for  parents  to  detect  and  the  children  are  too  young  to  detect  signs  of 
infection  themselves.  The  fact  that  chickenpox  can  be  life-threatening  to  these  children 
made  it  difficult  to  re-introduce  their  children  into  their  nursery  or  primary  schools,  and 
thus  they  had  missed  long  period  of  schooling. 
It  seemed  that  another  difficulty  they  were  implying  was  that  it  was  difficult  to  assess 
how  contagious  and  severe  different  diseases  were,  and  to  assess  when  to  seek  medical 
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transmission  of  diseases  may  explain  this.  However,  participants  also  mentioned  that 
they  were  unsure  how  well  their  children's  immune  systems  would  cope  with  fighting  an 
infectious  disease,  even  when  their  child  had  long  completed  chemotherapy  and 
recovered  from  cancer.  None  of  the  participants  knew  their  children's  immune  status  to 
vaccine  preventable  diseases,  and  they  continued  to  feel  anxious  about  these  diseases 
long  after  feeling  reassured  about  the  cancer.  These  anxieties  suggest  that  there  is  a  need 
for  parents  to  receive  greater  reassurance  and  information  about  the  long-term 
implications  of  having  undergone  chemotherapy  in  relation  to  their  child's  vulnerability 
to  childhood  infectious  diseases. 
6.6  Conclusion 
This  exploratory  work  on  parents  caring  for  autistic  children  or  immuno-compromised 
children  was  intended  to  identify  how  the  MMR  controversy  had  impacted  on  their  lives. 
At  the  outset  this  work  was  speculative  and  the  small  number  of  groups  conducted 
reflects  this.  However,  the  fact  at  the  time  of  writing  up  this  chapter  almost  seven  years 
had  passed  since  Wakefield's  paper  was  published  and  no  studies  have  been  published 
considering  either  group  of  parents'  views  illustrates  how  limited  the  focus  has  been  to 
date.  It  is  clear  that  there  is  a  need  for  research  with  both  groups  of  parents.  In  particular 
this  research  highlighted  some  of  the  problems  faced  by  parents  trying  to  integrate  their 
child  back  into  mainstream  society  because  people  often  underestimated  how  devastating 
diseases  might  be  to  their  child.  But  perhaps  the  most  overlooked  aspect  of  the  debate 
has  been  the  views  of  parents  with  autistic  children.  There  is  an  urgent  need  for  a  larger 
exploratory  study  to  investigate  how  parents  caring  for  autistic  children  have  been 
affected  by  the  debate,  for  without  hearing  the  stories  of  these  parents  how  can  the  full 
extent  of  the  MIR  controversy  truly  be  assessed  and  appreciated. 
212 Chapter  Seven:  Conclusion 
This  study  aimed  to  examine  how  parents  have  conceptualised  the  MMR  controversy  and 
to  explore  parental  immunisation  behaviours,  in  order  to  provide  an  assessment  of 
parents'  perceptions  about  childhood  immunisation.  A  thorough  review  of  the  literature 
was  conducted  to  ascertain  what  work  had  been  done  in  this  area  and  to  provide  the 
context  for  this  study.  This  review  critically  examined  the  scientific  evidence  and  events 
leading  up  to,  and  following,  the  publication  of  Wakefield  and  colleagues'  1998  paper. 
The  review  examined  the  impact  that  the  long-running  controversy  about  the  safety  of  the 
MMR  vaccine  has  had  on  parents  and  reviewed  studies  on  vaccine  decision-making 
behaviour.  From  this,  several  gaps  in  the  literature  were  identified  and  research  questions 
were  developed  to  address  these  gaps.  This  chapter  revisits  and  answers  these  questions. 
It  is  divided  into  three  parts.  The  first  part  reflects  on  the  study  and  on  the  exploratory 
approach  used  which  allowed  me  to  uncover  new  ideas  and  novel  insights  into  parents' 
perceptions  about  childhood  immunisation.  The  second  part  answers  the  study's  research 
questions  by  highlighting  the  main  findings  from  this  study  and  by  comparing  them  to  the 
findings  from  other  studies.  The  final  part  sets  out  key  implications  and 
recommendations  from  this  research,  and  suggests  a  plan  for  the  dissemination  of  these 
findings. 
7.1  Part  One:  Reflections  on  the  study 
A  great  strength  of  this  study  has  been  that  it  provides  a  much  broader  assessment  of 
parents'  perceptions  about  childhood  immunisation  than  previously  available.  For 
example,  by  comparing  parents'  understanding  and  experience  of  the  diseases  covered  by 
the  childhood  immunisation  programme  with  their  beliefs  about  the  importance  of 
preventing  these  diseases,  a  greater  understanding  has  been  gained  about  parents' 
immunisation  behaviours.  Similarly,  exploring  parents'  views  on  the  different  roles 
people  and  key  agencies  have  played  in  the  MMR  controversy  allows  lessons  to  be 
highlighted  that  may  be  important  for  shaping  future  immunisation  policy  and  practice. 
These  findings  are  considered  later  in  the  chapter.  Another  strength  of  this  study  was  that 
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backgrounds  and  with  different  levels  of  experience  of  parenting,  including  first-time 
parents  and  more  experienced  parents.  The  study  also  included  parents  with  different 
views  on  immunisation  and  with  different  vaccine  decision-making  histories.  One  of  the 
most  original  aspects  of  this  study  is  that  for  the  first  time  the  MMR  controversy  has  been 
considered  from  the  perspectives  of  parents  caring  for  autistic  children  and  immuno- 
compromised  children.  To  date  both  these  groups  of  parents  have  been  marginalised 
from  the  debate  about  vaccine  safety  and  their  stories  offer  new  and  important 
perspectives.  I  would  argue  that  the  wide  range  of  topics  considered  and  the  diversity  of 
the  parents  included  sets  this  study  apart  from  other  studies  and  creates  new  opportunities 
for  understanding  and  learning  lessons  about  the  MMR  controversy  and  about 
immunisation  more  generally. 
However  this  PhD  study  was  not  without  problems.  In  addition  to  the  methodological 
limitations  discussed  in  Chapter  Two,  I  also  faced  the  problem  that  this  research  was 
being  carried  out  concurrently  with  the  public  debate  about  the  safety  of  the  MMR 
vaccine.  This  meant  that  I  had  to  keep  abreast  of  new  developments  and  newly  published 
findings  to  ensure  the  continuing  relevance  of  the  study.  For  instance,  the  focus  of  this 
research  was  determined  by  the  fact  that  when  I  began  this  study  in  December  2001,  there 
was  very  little  exploratory  work  published  which  explored  the  perspectives  of  parents. 
This  gap  has  recently  begun  to  be  addressed  (Raithatha  et  al.,  2003;  Smailbegovic  et  al., 
2003  and  McMurray  et  al.,  2004).  Another  problem  facing  this  study  was  the  possibility 
that  major  policy  changes  might  be  introduced  (such  as  the  single  measles,  mumps  or 
rubella  vaccine  being  introduced),  or  that  new  media  revelations  could  inflame,  or  even 
extinguish  the  debate.  Indeed  perhaps  the  greatest  achievement  of  this  study  is  that  it 
seems  more  relevant  now,  three  years  on,  as  the  scientific  community  begins  to  reflect  on 
the  lessons  that  can  be  learnt  from  the  MMR  controversy.  Indeed,  in  this  respect  it  is 
anticipated  that  this  study  has  the  potential  to  make  a  genuine  and  original  contribution  to 
future  research,  practice  and  policy  on  childhood  immunisation  in  the  UK 
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The  first  research  question  which  I  sought  to  answer  was: 
7.2.1  What  are  parents'  knowledge,  understanding  and  beliefs  about  childhood 
infectious  diseases,  and  how  do  their  experiences  of  disease  affect  their  evaluations  of 
the  importance  of  preventing  these  diseases? 
The  literature  on  vaccine  decision-making  suggests  that  when  parents  decide  whether  to 
vaccinate  their  children,  they  do  so  by  weighing  up  the  risks  associated  with  the  diseases 
against  those  associated  with  the  vaccines  (Raithatha  et  al.,  2003).  However,  I  found  no 
studies  that  provided  an  in-depth  assessment  of  parents'  knowledge  about  vaccine- 
preventable  diseases.  Further,  the  few  studies  to  examine  parents'  understandings  and 
beliefs  about  childhood  diseases  in  any  detail  have  tended  to  focus  on  perceptions  about 
the  severity  of  diseases,  and  often  report  contradictory  findings.  For  example,  Flynn  and 
Ogden  (2004),  Pareek  and  Pattison  (2000)  and  Smailbegovic  et  al.  (2003)  found  measles 
to  be  considered  as  `severe'  or  `serious',  while  participants  in  other  studies  assessed  it  as 
`mild'  or  `less  serious'  (Gellin  et  al.,  2000;  Bond  and  Nolan,  1998;  Sporton  et  al.,  2001). 
Similarly  mumps  and  rubella  have  been  reported  as  both  `serious'  (Flynn  and  Ogden, 
2004;  Pareck  and  Pattison,  2000)  and  `mild'  (Bond  and  Nolan,  1998;  Sporton  et  al., 
2001)  and  no  studies  have  considered  parents'  views  on  haemophilus  influenza.  One 
further  limitation  of  these  studies  is  that  they  tend  to  offer  a  one-dimensional  account  of 
parents'  assessments  of  the  diseases,  without  any  explanation  of  the  underlying  beliefs 
that  may  have  informed  these  assessments. 
In  contrast,  my  study  offers  a  much  more  comprehensive  picture,  exploring  parents' 
knowledge,  beliefs  and  experience  about  each  of  the  vaccine-preventable  diseases 
included  in  the  programme.  This  research  found  that  parents'  knowledge  about  vaccine- 
preventable  diseases  was  limited.  Parents  often  had  serious  misunderstandings  about  the 
mode  of  transmission,  severity  and  prevalence  of  diseases  and  this  limited  their  ability  to 
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with  male  infertility,  tetanus  was  confused  with  rabies,  and  diphtheria  was  confused  with 
cholera-like  illness.  Parents'  knowledge  about  meningococcal  disease  and  its  associated 
meningitis  was  the  exception,  as  parents  described  the  signs  and  symptoms  and  potential 
consequences  of  this  disease  accurately.  Similar  to  the  findings  of  Bond  and  Nolan 
(1998),  this  research  found  that  parents  assessed  meningococcal  disease  and  its  associated 
meningitis  as  the  most  severe  and  life-  threatening  of  all  the  diseases  they  were  asked  to 
consider.  Parents  associated  meningitis  with  the  potential  to  cause  death  or  long-term 
damage  to  their  child's  health,  even  though  no  parents  had  had  direct  experience  of 
meningococcal  disease  either  themselves,  or  as  a  parent. 
So  why  was  meningococcal  disease  perceived  to  be  the  most  severe  by  parents  in  this 
study?  Two  reasons  were  identified:  firstly,  the  popular  media's  interest  in  meningitis 
and  other  parents'  harrowing  stories  about  children  dying  or  being  left  with  long-term 
damage  from  meningitis  together  contributed  to  parents'  views  of  this  disease  as  a  major 
and  tangible  threat  to  their  child's  health.  Secondly,  this  view  was  reinforced  by  the  high 
profile  Men  C  campaign.  The  campaign  seemed  to  signal  to  parents  that  the  `experts' 
were  particularly  concerned  about  the  threat  posed  by  this  disease.  The  Men  C  poster 
campaign  appeared  to  have  been  particularly  successful,  as  parents  described  seeing  it  in 
their  GPs'  surgeries.  The  cumulative  effect  of  the  media's  involvement,  other  parents' 
stories  and  the  Men  C  campaign  was  that  most  parents  concluded  that  it  was  important  to 
protect  their  children  with  the  Men  C  vaccine. 
A  compelling  reason  why  haemophilus  influenza  might  be  perceived  as  a  threat  to  a 
child's  health  is  that  it,  too,  can  cause  meningitis.  However,  in  contrast  to  parents' 
concerns  about  meningococcal  disease,  most  parents  knew  very  little  about  haemophilus 
influenza  and,  on  the  basis  of  its  name,  often  guessed  that  the  disease  was  related  to  the 
flu,  and  that  the  Hib  vaccine  was  a  flu  vaccine.  In  turn  this  led  to  concerns  being  raised 
that  children  are  becoming  vaccinated  against  mild  infections.  Although  these 
misunderstandings  could  be  addressed  in  the  debriefing  sessions  that  followed  the  focus 
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considered  to  be  plausible  explanations  for  diseases  they  knew  little  about. 
The  lack  of  knowledge  about  haemophilus  influenza  led  some  parents  to  underestimate 
the  threat  posed  by  it.  In  contrast,  other  parents  overestimated  the  extent  to  which  they 
could  control  the  threat  posed  by  other  diseases.  For  example,  the  fact  that  tetanus  cannot 
be  eradicated  because  it  exists  in  the  soil  and  therefore  poses  a  constant  threat  makes  it 
unrealistic  for  parents  to  protect  their  children  by  limiting  contact  with  the  source  of  this 
infection.  Many  parents  thought  that  a  child  would  be  most  likely  to  contract  tetanus 
from  rusty  nails  and  dog  bites  which  they  believed  very  young  children  would  be  unlikely 
to  encounter.  Further,  the  fact  some  parents  knew  they  could  seek  tetanus  vaccination 
post-  infection  appeared  to  diminish  any  sense  of  urgency  or  need  for  tetanus  vaccination 
as  a  prophylactic  measure.  Similarly,  some  parents  questioned  the  need  for  very  young 
children  to  have  rubella  vaccination,  believing  that  they  could  prevent  its  transmission  to 
pregnant  women  by  isolating  any  infected  child.  However,  this  belief  fails  to  recognise 
the  fact  that  the  signs  and  symptoms  of  rubella  infection  are  often  mild  and 
inconspicuous,  making  its  transmission  difficult  to  contain  effectively  without  the  mass 
immunisation  of  young  children  who  are  often  in  close  contact  with  pregnant  women. 
This  research  also  found  that  parents  had  little  direct  experience  of  most  of  the  diseases 
prevented  by  the  immunisation  programme.  Bedford  and  Elliman  (2000)  have  proposed 
that,  because  many  parents  have  little  or  no  experience  of  the  diseases  prevented  by 
immunisation,  they  do  not  appreciate  how  damaging  these  diseases  can  be.  This  study 
supports  Bedford  and  Elliman's  observation  and  suggests  that  as  parents  become  less 
familiar  with  the  diseases  and,  more  importantly,  less  knowledgeable  about  them, 
growing  numbers  of  parents  are  questioning  the  need  for  so  many  vaccines  to  be  included 
in  the  Childhood  Immunisation  Programme.  However,  the  association  between  personal 
experience  of  the  disease  and  subsequent  assessment  of  the  importance  of  preventing  it 
appears  complex.  Even  parents  who  have  experienced  diseases  such  as  measles,  mumps, 
rubella  and  whooping  cough  often  underestimated  their  severity.  This  may  be  because 
they  felt  that  modem  medicine  is  now  so  advanced  that  serious  complications  of  these 
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encountering  it  having  successfully  fought  off  the  disease  themselves.  In  fact  not  only 
did  this  research  find  that  experiencing  a  disease  themselves  (either  as  a  parents  caring 
for  a  child  or  as  a  child  themselves)  does  not  necessarily  make  that  disease  more 
threatening,  but  it  also  found  that  hearing  second  or  even  third-hand  accounts  of  stories  of 
other  children  suffering  serious  complications  was  often  a  more  frightening  prospect. 
For  this  reason  although  no  participants  had  experienced  meningococcal  disease 
themselves,  stories  of  other  people's  children  having  long-term  damage  from  meningitis 
meant  parents  feared  their  own  child  contracting  it. 
Parents  seemed  to  find  other  parents'  anecdotal  evidence  and  personal  stories  very 
persuasive.  This  may  be  one  of  the  reasons  why  parents  appear  to  have  had  such 
difficulty  in  assessing  the  threat  posed  by  measles,  mumps  and  rubella  compared  to  that 
posed  by  the  MMR  vaccine.  On  the  one  hand,  parents  have  read  and  listened  to  stories  of 
seemingly-well  children  becoming  autistic  after  receiving  MMR  vaccination,  whilst  on 
the  other,  they  have  read  or  been  told  of  children  developing  long-term  damage  from 
contracting  measles  infection.  The  point  here  is  that  anecdotal  evidence  is  extremely 
persuasive  and  is  capable  of  swaying  parents  in  a  way  scientific  evidence  often  seems 
powerless  to  do.  Perhaps  this  is  one  of  the  reasons  why  Wakefield's  research  was  so 
amenable  to  translation  by  journalists  into  stories  that  ordinary  parents  could  relate  to, 
and  why  it  had  an  appeal  and  impact  disproportionate  to  the  weight  of  scientific  evidence 
presented  by  the  study.  Indeed,  as  more  parents  currently  assessing  the  importance  of 
preventing  diseases  have  less  and  less  experience  of  those  diseases  it  is  likely  that  their 
views  will  rely  more  heavily  on  the  stories,  including  the  `horror  stories',  of  other  parents 
and  media  reports.  The  challenge  facing  health  educators  is  that  they  need  to  find  a  way 
to  educate  parents  about  diseases  in  a  responsible  and  persuasive  way. 
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7.2.2  What  are  parents'  views  of  mass  childhood  immunisation  and  of  the  vaccines 
included  in  the  Childhood  Immunisation  Programme  in  the  light  of  the  MMR 
controversy? 
The  public's  reaction  to  the  MMR  debate  should  be  viewed  in  a  broader  historical 
context.  The  MMR  controversy  followed  the  foot  and  mouth  crisis,  the  BSE  crisis  and 
scares  caused  by  salmonella  and  Escherichia  coli  0157  food  poisoning  in  which  the 
Government  and  Government  agencies  responsible  for  food  safety  were  perceived  to 
have  put  the  interests  of  food  producers  before  those  of  consumers.  More  recently,  the 
public  have  witnessed  debates  over  the  safety  of  genetically  modified  food.  This  growing 
distrust  of  Government  in  safeguarding  public  health  is  the  backdrop  against  which 
parents  have  assessed  the  MMR  controversy.  One  of  the  most  important  lessons  to  be 
drawn  from  the  MMR  controversy  is  that  the  public  find  it  difficult  to  know  who  to  trust 
to  offer  balanced  and  accurate  information  on  which  they  can  make  sound  judgments. 
As  such  the  publication  and  subsequent  publicity  surrounding  Wakefield's  paper 
provoked  immediate  anxiety  among  parents,  leading  to  a  decreased  MMR  uptake  which 
remains  well  below  the  ideal  95%  target  rate  (Wakefield  et  al.  1998).  The  consequences 
have  been  a  rise  in  the  incidence  of  mumps  since  the  late  1990s  and  clusters  of  measles 
cases.  It  is  possible  both  may  grow  if  greater  numbers  of  children  remain  unvaccinated. 
Like  many  medical  interventions,  vaccination  is  not  entirely  free  from  risk.  Usually  any 
adverse  reactions  are  minor,  although  they  may  be  more  severe  in  a  minority  of  cases. 
The  publication  of  Wakefield's  paper  provoked  considerable  anxiety  among  parents, 
leading  to  a  decreased  MMR  uptake  which  remains  well  below  the  95%  target  rate 
(Wakefield  et  al.  1998).  Indeed,  there  has  been  a  dramatic  rise  in  the  incidence  of  mumps 
since  the  late  1990s  and  there  is  likely  to  be  a  growing  number  of  measles  cases  in  the 
next  few  years  as  greater  numbers  of  children  remain  unvaccinated  with  MMR.  Like 
many  medical  interventions,  vaccination  is  not  entirely  free  from  risk.  Usually  any 
adverse  reactions  are  minor,  although  they  may  be  more  severe  in  a  minority  of  cases. 
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term  consequences  perceived  to  be  associated  with  immunisation  and  supports,  to  an 
extent,  Raithatha  et  al.  's  (2003)  claim  that  the  MMR  vaccine  scare  may  have  triggered  a 
wider  reappraisal  of  vaccine  risk.  However,  it  is  clear  from  the  literature  review  (Chapter 
One)  that  parental  concerns  about  the  safety  of  vaccines  pre-date  the  publication  of 
Wakefield's  controversial  paper  (Lambert  and  Siegrist,  1997),  and  that  they  are  neither 
confined  to  the  UK  (Offit  et  al.,  2002)  nor  to  the  MMR  vaccine  (Bond  and  Nolan,  1998). 
In  this  respect,  there  is  a  limit  to  which  Wakefield's  paper  can  take  responsibility  for 
claims  of  a  vaccine  reappraisal  by  parents.  Perhaps  a  fairer  assessment  of  the  situation  is 
that  the  MMR  controversy  appears  to  have  added  to  parents'  growing  concerns  that  too 
many  vaccines  could  do  more  harm  than  good,  and  Wakefield  has  offered  parents  a 
plausible  explanation  for  their  fears.  Indeed,  it  is  arguable  whether  Wakefield's  paper 
would  have  been  able  to  create  the  uncertainty  it  did  had  better  attempts  been  made  to 
educate  the  public  about  the  diseases  prevented  by  vaccines,  and  about  the  benefits  and 
safety  of  combined  vaccines.  Nevertheless,  Wakefield's  comments  at  his  press 
conference  and  subsequently  about  splitting  the  MMR  into  three  separate  vaccines 
undoubtedly  added  to  parents'  concerns.  What  parents  seemed  to  have  understood  from 
Wakefield's  statement  was  that  some  children  could  be  more  vulnerable  to  immune 
damage  from  vaccines,  of  whom  those  who  later  manifested  autistic  syndromes  could  be 
one  example.  Unfortunately,  no  research  has  been  published  to  date  that  focuses  on 
these  concerns  of  parents,  so  there  is  little  to  compare  these  findings  with  although  Miller 
et  al.  's  (2003)  study  has  been  useful  in  refuting  Wakefield's  claims  of  immune  overload. 
My  research  suggests  that  parents  were  struggling  to  identify  other  signs  that  their  child 
might  be  amongst  a  group  of  potentially  vulnerable  children;  children  with  asthma, 
multiple  allergies  and  recurrent  infection  were  all  thought  to  be  potentially  more 
susceptible  to  immune  damage  from  vaccines.  Parents  whose  children  had  any  of  these 
conditions  seemed  to  have  had  a  particularly  difficult  time  making  the  decision  about 
MMR  vaccination.  However,  it  was  also  evident  that  parents  were  inconsistent  in  their 
thinking  about  combined  vaccines,  as  they  almost  exclusively  focused  these  concerns  on 
the  MMR  vaccine  and  seldom  on  the  combined  DTP  vaccine.  Nevertheless,  if  these 
concerns  extend  to  the  new  pentavalent  vaccine  (introduced  into  the  Childhood 
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vaccine  are  perceived  to  exist,  this  research  suggests  that  parents  may  defer  or  refuse 
vaccination  as  they  have  done  when  the  safety  of  the  pertussis  vaccine  and  MMR  vaccine 
has  been  in  dispute. 
Both  mumps  and  rubella  vaccination  were  found  to  be  strongly  gendered;  the  mumps 
component  of  the  MMR  vaccine  was  viewed  as  irrelevant  for  girls  and  the  rubella 
component  as  irrelevant  for  boys.  Current  health  education  materials  aim  to  persuade 
parents  that  immunisation  is  in  their  own  child's  best  interest  by  concentrating  messages 
on  individual  risk.  The  main  problem  with  this  approach  is  that  it  unwittingly  sends  out 
mixed  messages  which  add  to  a  sense  of  mistrust  and  confusion.  If  most  parents  believe 
that  mumps  was  introduced  into  the  programme  to  reduce  the  risk  of  male  sterility  and 
parents  are  being  told  that  seeking  immunisation  is  in  their  own  child's  best  interest, 
parents  of  girls  may  conclude  that  policy  makers  have  overlooked  their  daughter's  needs. 
Focusing  so  much  attention  on  individual  risk  to  the  exclusion  of  community  risk  distorts 
the  actual  risk,  alienating  some  parents  and  adding  to  a  growing  sense  that  blanket 
policies  are  responsible  for  children  becoming  over-immunised.  Although  research 
suggests  that  parents  make  decisions  on  the  basis  of  their  own  individual  child,  rather 
than  being  motivated  to  immunise  for  the  benefit  of  others  (Hershey  et  al.,  1994),  it 
seems  possible  that  confused  messages  about  immunisation  hinder  parents'  decisions. 
There  is  a  need  for  greater  transparency  in  health  education  material  and  immunisation 
campaigns  about  who  benefits  from  immunisation.  For  instance,  tetanus  is  not  a 
communicable  disease  and  therefore  in  the  UK  tetanus  vaccination  largely  benefits  the 
individual  child.  By  contrast,  rubella  is  a  mild  disease  for  most  children  and  rubella 
vaccination  of  children  largely  provides  protection  for  the  babies  of  pregnant  women 
from  developing  congenital  abnormalities  associated  with  rubella  infection.  Whilst 
immunising  pre-pubertal  girls  will  protect  any  future  pregnancies  of  their  own  in  the 
future,  immunising  boys  is  largely  for  the  benefit  of  others  (including,  of  course,  their 
own  future  children).  As  such,  boys  play  an  equally  important  role  in  reducing  the  spread 
of  rubella  infection. 
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long-term  side-effects  of  the  vaccines  than  about  the  diseases,  and  many  believed  that 
vaccines  place  stress  on  the  immune  system  rather  than  strengthening  it.  These  findings 
are  consistent  with  those  of  Bond  et  al.  (1998).  Some  of  these  parents  who  subscribed  to 
alternative  health  care  beliefs  and  choose  not  to  immunise  at  all  considered  mass 
immunisation  to  be  an  out-dated  public  health  intervention  in  the  face  of  low  disease 
threat.  These  parents  were  ideologically  anti-immunisation.  Indeed,  it  is  questionable 
how  successful  any  attempts  might  be  to  persuade  these  parents  of  the  benefits  of 
immunisation.  Nevertheless,  the  current  system  that  places  the  emphasis  on  the 
individual  child  seems  particularly  problematic  and  unlikely  to  encourage  them  to 
immunise.  Any  more  effective  approach  would  have  to  embrace  a  more  holistic  stance 
that  places  greater  emphasis  on  the  importance  of  community  benefits  and  on  reducing 
the  spread  of  disease  to  more  vulnerable  members  of  society.  In  this  respect,  Hunt  and 
Emslie's  (2001)  argument  for  acknowledging  the  prevention  paradox  more  directly  in 
health  education  materials  may  offer  one  means  of  making  vaccination  campaigns  more 
open  and  acceptable. 
The  third  major  research  question  I  sought  to  answer  was: 
7.23  What  are  parents'  perceptions  about  the  current  MMR  controversy  and  how  do 
these  perceptions  translate  into  the  parental  decision-making  process  about  whether  to 
immunise,  or  not? 
This  question  is  answered  by  considering  parents'  perceptions  about  the  MMR 
controversy,  including  the  perceptions  of  parents  caring  for  autistic  children  and  those 
caring  for  immuno-compromised  children,  and  by  considering  parents'  experiences  and 
views  on  MMR  decision-making. 
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Parents  generally  viewed  Andrew  Wakefield  as  a  `good'  doctor  who  was  revealing 
startling  new  evidence  to  parents.  He  was  viewed  as  an  `insider'  (as  an  NHS  consultant) 
who  was  standing  up  to  politicians  and  public  health  officials  because  he  believed  it  his 
duty,  both  as  a  parent  himself  and  most  importantly  as  an  advocate  of  autistic  children. 
Indeed,  this  gave  him  an  unrivalled  standing  with  parents  compared  with  the  perceived 
hypocrisy  of  public  health  officials  and  politicians,  exemplified  by  the  British  Prime 
Minister  Tony  Blair's  refusal  to  let  the  public  know  his  son's  MMR  immunisation  status. 
However,  not  all  the  parents  in  this  study  were  positive  about  Andrew  Wakefield.  Some 
parents  considered  he  was  a  scaremonger,  to  blame  for  causing  parents  to  lose  confidence 
in  an  important  public  health  intervention.  Ironically,  parents  in  this  study,  including 
those  with  autistic  children  who  were  perhaps  the  most  affected  by  the  debate,  were  less 
vicious  in  their  attack  and  more  forgiving  than  many  of  his  more  public  opponents. 
Indeed,  in  his  book  Richard  Horton  (2004)  acknowledges  the  often  extreme  reaction  of 
Wakefield's  opponents  and  states  there  was  something  deeply  unpleasant  about 
Wakefield's  public  humiliation,  and  about  protagonists  openly  stating  their  intention  to 
`rub  out'  Wakefield  (p.  13).  Nevertheless,  at  the  height  of  the  controversy  this  kind  of 
excessive  reaction  from  opponents  appeared  to  have  been  unhelpful  to  parents  trying  to 
make  sense  of  the  debate.  This  is  because  parents  see  politics  and  political  manoeuvring 
taking  over  from  the  real  issues,  such  as  the  need  for  further  research  into  the  aetiology  of 
autism  and  the  safety  of  the  MMR  vaccine.  In  effect,  these  political  point  scoring 
exercises  marginalise  parents  from  the  debate,  and  in  turn,  they  become  more  sceptical 
that  their  or  their  children's  needs  are  considered  important. 
Parents  in  this  study  found  that  the  language  used  by  politicians  and  public  health 
spokespersons  to  convey  messages  about  the  risks  posed  by  the  MMR  vaccine  did  not 
help  them  assess  these  dangers.  Elastic  concepts  such  as  `minimal',  `probable',  `likely', 
and  `rare',  meant  different  things  to  different  people.  Parents  felt  that  politicians  could 
use  ambiguous  language  deliberately  to  mask  and  underplay  the  actual  risk.  In  this 
respect  parents  drew  parallels  between  the  dialogue  used  to  reassure  the  public  about  the 
risks  posed  by  BSE,  and  MMR.  Parents  wanted  to  know  how  many  children  had  a 
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serious  complication  following  measles  infection,  so  that  they  could  weigh  up  the  risks  of 
MMR  against  the  risk  posed  by  the  diseases.  However  parents  also  questioned  how 
accurately  adverse  reactions  are  monitored  and  wanted  more  information  on  this. 
Although  parents  were  unsure  about  the  link  between  MMR  and  autism,  they  were  under 
the  impression  that  there  was  as  much  evidence  showing  a  link,  as  showing  no  link.  This 
finding  parallel  Hargreaves  et  al.  's  (2003)  observation  that  the  media  coverage  of  MMR 
has  given  a  misleading  impression  that  the  evidence  `for'  a  link  with  autism  was  as 
substantial  as  the  evidence  `against'  it.  The  key  sources  from  which  parents  obtained 
information  about  the  safety  of  MMR  were  the  popular  media,  health  professionals  and 
other  parents.  However  parents  often  questioned  the  motives  of  health  professionals  such 
as  GPs  and  health  visitors,  who  were  viewed  as  maintaining  the  status  quo  on  childhood 
immunisation  policy  and  were  held  to  be  part  of  the  system  of  dispensing  it  rather  than 
questioning  it.  Perhaps  inadvertently  the  MMR  controversy  has  drawn  health 
professionals  into  the  debate  because  GPs  receive  payments  if  they  meet  Government 
vaccination  targets,  set  at  70%  and  90%.  The  fact  that  GPs  and  health  visitors  (who  are 
often  attached  to  GP  practices)  are  primary  providers  of  immunisation  advice  makes  it 
difficult  for  parents  to  trust  that  this  advice  is  completely  impartial.  This  supports  Sporton 
and  Francis's  (2001)  fording  that  health  visitors  were  not  perceived  as  providing  balanced 
information,  and  this  was  identified  as  an  impediment  to  parental  decision-making.  It 
also  explains  why  parents  in  this  study  were  often  scathing  and  dismissive  of  their  health 
visitors'  and  GPs'  attempts  to  encourage  immunisation,  and  suggests  that  this  incentive 
scheme  could  be  potentially  damaging  to  the  patient-doctor/nurse  relationship. 
Issues  about  the  rights  of  parents  to  choose  dominated  the  single-vaccine-versus-MMR- 
vaccine  debate,  and  there  was  an  absence  of  any  discussion  about  the  risk  of  instituting  an 
untested  programme  of  three  separate  vaccines.  This  suggests  that  politicians,  scientists 
and  public  health  professionals  have  failed  to  communicate  this  fact  effectively  to  the 
public.  In  turn,  parents  opted  to  delay  or  refuse  immunisation  altogether  rather  than  opt 
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suggests  that  the  Government  may  have  been  wise  not  to  introduce  the  single  vaccines  as 
an  alternative  to  the  MMR  vaccine,  as  some  parents  may  not  have  protected  their  girls 
against  mumps,  or  boys  against  rubella. 
7.23.2  Parents  caring  for  autistic  children:  perceptions  about  the  MMR  controversy 
In  December  2002,  when  I  conducted  the  two  focus  groups  with  parents  caring  for 
autistic  children,  Wakefield  had  already  resigned  from  his  post  at  London's  Royal  Free 
Hospital  and  had  moved  to  the  USA  to  continue  his  work  on  autism.  Parents  in  this 
study  were  anxious  that  Wakefield's  research  into  the  link  between  autism  and  bowel 
disease  should  continue.  However,  they  also  were  keen  for  researchers  in  the  UK  to 
continue  to  be  supported  in  their  work  in  this  field,  and  were  concerned  that  funding 
might  be  stopped.  Some  of  these  parents  with  autistic  children  were  also  part  of  a 
pending  legal  action  against  the  pharmaceutical  companies  responsible  for  manufacturing 
the  MMR  vaccine,  and  felt  hopeful  they  would  win  their  High  Court  case.  However,  in 
October  2003  the  Legal  Services  Commission  decided  to  remove  funding  for  the  MMR 
litigation  on  the  grounds  that  there  was  a  lack  of  evidence  of  a  link  between  the  MMR 
vaccine  and  autism. 
The  fact  that  no  studies  have  been  published  that  considers  the  views  of  parents  of 
autistic  children  is  an  omission  that  needs  to  be  addressed  as  a  matter  of  urgency. 
Although  I  only  had  a  limited  number  of  parents'  experiences  to  draw  on,  in-depth 
analysis  of  their  six  stories  suggests  that  the  impact  has  been  immense.  In  particular 
parents  felt  guilty  that  they  may  have  inadvertently  caused  their  child's  condition  by 
agreeing  to  have  them  immunised.  This  guilt  seemed  to  be  increased  because,  with 
hindsight,  they  believed  that  at  an  early  age  their  child  displayed  signs  that  their  immune 
system  was  inadequate.  Recurrent  ear,  eye,  chest  and  urinary  infections  along  with 
multiple  allergies  and  asthma  were  described  as  early  warning  signs,  that  they  felt  should 
have  alerted  them  to  the  possibility  that  their  child's  immune  system  may  not  have  be 
able  to  cope  with  combined  vaccines. 
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three  separate  parts  made  great  sense  to  them.  However,  they  failed  to  recognise  the 
inconsistency  in  this  `immune-overload'  argument  since  all  their  children  had  already 
received  the  triple  DTP  vaccine,  yet  they  only  suggested  that  the  overload  happened  post- 
MMR  vaccination.  Nevertheless,  in  the  absence  of  any  other  plausible  explanation  for 
their  child's  developmental  regression,  they  seemed  relieved  to  have  someone  (i.  e., 
Wakefield)  identify  a  possible  cause  of  their  child's  condition.  Perhaps  for  this  reason 
these  parents  were  positive  about  Wakefield  and  felt  that  he,  unlike  many  other  doctors 
and  scientists,  took  their  concerns  seriously.  Indeed,  they  all  believed  that  there  is  a  link 
between  autism  and  bowel  disease  on  the  basis  of  their  experiences  with  their  own 
children.  All  six  parents  spoke  of  the  difficulties  they  faced  in  dealing  with  their  child's 
bowel  and  dietary  problems,  and  that  this  aspect  of  their  child's  needs  is  often 
overlooked.  These  difficulties  included  incontinence,  diarrhoea,  constipation,  and  bowel 
pain  and  these  aspects  of  their  child's  health  often  dominated  their  already  complicated 
and  stressful  lives.  The  fact  that  these  parents'  children  had  bowel  problems  and  that 
Wakefield  was  one  of  the  first  doctors  to  recognise  a  possible  link  between  autism  and 
bowel  problems  convinced  them  that  he  was  correct  in  his  assertion  that  MMR  is  linked 
to  autism.  However,  this  belief  led  them  to  feel  immensely  guilty  that  they  had  allowed 
their  children  to  be  vaccinated,  and  they  spoke  of  feeling  a  loss  almost  akin  to 
bereavement. 
If  anything,  Dr  Wakefield  seemed  to  represent  to  these  parents  a  means  of  obtaining 
answers  to  the  complex  problem  that  is  autism,  in  contrast  to  the  perceived  lack  of 
understanding  and  willingness  on  the  part  of  the  medical  establishment,  scientists, 
politicians  and  public  health  officials  to  offer  explanations  about  its  causes.  These 
parents  considered  that  they  had  generally  been  served  poorly  by  the  medical  profession 
and  as  a  result  some  had  turned  to  alternative  health  care,  which  was  often  extremely 
expensive.  However,  whilst  alternatives  such  as  homeopathy  and  herbal  remedies 
appeared  to  have  offered  some  hope  to  these  parents,  and  some  spoke  of  seeing 
improvements  in  their  child's  health,  these  parents  seemed  extremely  vulnerable  to 
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trying  to  prevent  any  further  developmental  regression  and  convinced  that  vaccination 
had  damaged  their  child's  fragile  immune  system,  were  keen  to  prevent  any  further 
damage. 
7.233  Parents  caring  for  immunocompromised  children:  perceptions  about  the  MMR 
controversy 
Another  group  of  parents  completely  marginalised  from  the  MMR  debate  has  been 
parents  of  immunocompromised  children,  whose  children  rely  on  herd  immunity  for 
protection.  As  yet,  no  research  have  been  published  that  explore  these  parents'  views  or 
consider  how  their  children's  lives  may  have  been  affected  by  the  MMR  controversy. 
This  is despite  the  fact  that  these  parents  have  much  to  lose  should  there  be  an  epidemic 
of  measles.  These  parents  were  keen  to  highlight  the  fact  that  the  needs  of  their  children 
had  been  overshadowed  by  debates  on  the  rights  of  parents  to  have  choices  about 
immunisation  and  they  felt  hugely  saddened  that  in  their  experience  parents  tend  to  only 
take  into  account  their  own  children's  needs.  During  the  process  of  integrating  their 
children  back  into  their  daily  routines  these  parents  had  generally  found  other  parents  to 
be  ignorant  of  the  fact  that  their  children  were  more  susceptible  to  contracting  infections 
and  diseases  post-chemotherapy.  They  suggested  that  there  was  a  need  to  educate  parents 
so  that  they  could  make  informed  decisions  about  immunisation,  while  taking  account  of 
the  fact  that  their  decisions  may  affect  other  more  vulnerable  children.  As  such,  they 
were  keen  that  any  future  immunisation  campaigns  should  emphasise  the  role  that 
population  immunity  plays  in  protecting  those  more  vulnerable  members  of  society  who 
are  unable  to  protect  themselves. 
7.23.4  Parents'  experiences  of  MMR  decision-maldng  and  views  on  MMR 
The  fall  in  MMR  vaccination  uptake  rates  following  adverse  publicity  about  MMR  safety 
is  evidence  that  parents'  usual  patterns  of  immunisation  decision-making  behaviour  were 
altered.  This  study  identified  two  alterations  to  the  usual  patterns  of  behaviour  that  have 
important  implications  for  the  way  vaccine  information  is  targeted  at  parents.  Firstly, 
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than  for  other  vaccines  in  the  programme.  This  suggests  that  for  many  couples  both 
parents  are  actively  involved  in  trying  to  assess  the  evidence.  Therefore  it  may  be  useful 
for  health  professionals  to  be  aware  of  this  when  offering  advice  about  MMR 
vaccination.  Secondly,  parents  were  more  likely  to  delay  MMR  immunisation  and  found 
pressure  from  health  professionals  to  immunise,  unhelpful.  This  is  consistent  with 
Raithatha  et  al.  's  (2003)  recommendation  that  parents  are  not  pressurised  to  immunise,  as 
this  increases  their  feeling  of  lack  of  control.  Parents  preferred  to  withhold  MMR 
vaccination  because  of  the  perception  that  the  action  of  MMR  vaccination  (commission) 
may  cause  long-term  damage  and  be  more  harmful  than  deferring  vaccination  or  inaction 
(omission).  This  finding  is  reminiscent  of  Ritov  and  Baron  (1990)  and  Asch  and 
colleagues'  (1994)  work  on  omission  bias,  and  suggests  that  omission  bias  has  played  an 
important  role  in  parents'  decisions  about  MMR  vaccination.  The  horrendous  stories  of 
children  suffering  from  autism  and  the  unimaginable  guilt  faced  by  their  parents  meant 
that  the  decision  about  MMR  was  extremely  difficult.  For  many  parents  deciding  about 
MMR,  it  was  easier  to  live  with  the  unlikely  risk  of  their  child  naturally  contracting  one 
of  the  diseases  than  with  the  risk  of  causing  their  child  permanent  damage,  as  they 
perceived  other  parents  may  have  unwittingly  done.  Therefore  this  research  supports  the 
more  recent  findings  of  Sporton  and  Francis  (2001)  and  Evans  et  al.  (2001)  which 
suggests  that  parents  choose  not  to  immunise  because  they  fear  the  risks  of  side-effects. 
Both  these  studies  found  that  parents  considered  that  it  was  preferable  not  to  act,  than  to 
act  and  potentially  be  responsible  for  causing  long-term  damage. 
Indeed,  Hershey  et  al.  's  (1994)  claim  that  people  usually  seek  medical  interventions 
which  appear  to  offer  them  the  best  perceived  balance  of  risks  and  benefits,  holds  true  for 
MMR  vaccination.  Consistent  with  Smailbegovic  et  al.  's  (2003)  findings,  the  current 
research  found  that  parents  were  weighing  their  child's  likelihood  of  catching  a  disease 
and  the  perceived  seriousness  of  the  disease,  against  the  perceived  safety  and  efficacy  of 
the  vaccine.  When  parents  considered  that  the  diseases  posed  a  tangible  threat  to  their 
child's  health,  and  when  they  considered  immunisation  to  be  both  safe  and  effective  they 
were  unwavering  about  the  need  to  have  their  children  vaccinated.  This  was  the  case 
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little  or  no  threat  to  their  child's  health,  and  when  they  considered  immunisation  to  be 
ineffectual  or  risky,  they  were  more  likely  not  to  immunise  their  children,  as  was 
sometimes  the  case  for  MMR  vaccination.  This  research  found  that  in  addition  to 
weighing  up  the  risks  and  benefits  associated  with  the  diseases  and  with  the  vaccines, 
parents  assessed  the  ability  of  their  child's  immune  systems  to  cope  with  the  challenge  of 
vaccines,  or  fight  the  disease.  Parents  feared  that  combining  the  antigens  causes  the 
vaccine  to  become  too  potent  for  young  children  whose  immune  systems  are  not  fully 
developed,  and  feared  that  for  some  children  the  vaccine  could  cause  long-term  damage. 
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7.3.1  Implications  for  policy 
The  fact  that  parents'  knowledge  about  and  understanding  of  the  transmission  of  most  of 
the  vaccine-preventable  diseases  was  often  so  poor  suggests  that  there  is  a  need  for  a 
renewed  campaign  to  educate  parents  about  the  diseases.  This  recommendation  stems 
not  only  from  a  need  to  equip  parents  with  information  in  order  to  make  informed 
decisions,  no  matter  whether  the  outcome  is  to  immunise  or  not,  but  also  from  an 
obligation  to  explain  and  justify  immunisation  policy  to  parents  so  that  they,  in  turn,  can 
assess  its  importance  and  relevance.  Indeed,  whilst  recommending  a  need  for  a  renewed 
education  campaign,  I  also  acknowledge  that  merely  targeting  parents  with  information 
about  the  diseases  will  not  necessarily  have  the  effect  of  persuading  parents  to  immunise, 
consistent  with  assumptions  underpinning  the  deficit  model  (Irwin  and  Wynne  1996). 
Indeed,  in  Sturgis  and  Allum's  (2004)  critique  of  what  they  describe  as  the  "rather 
simplistic  deficit  model"  of  health  information  they  state:  "it  is  quite  clear  that  culture, 
economic  factors,  social  and  political  values,  trust,  risk  perception,  and  worldviews  are 
all  important  in  influencing  the  public's  attitude  towards  science"  (p.  58).  A  key  factor 
identified  in  this  suggestion  is  the  belief  that  knowledge  of  science  is  influenced  by  the 
level  of  trust  that  the  public  places  in  the  institutions  and  experts  that  are  imparting  the 
information.  On  one  hand,  many  parents  in  this  study  spoke  of  mistrusting  the 
Government  and  government  spokespersons  defined  as  public  health  officials.  On  the 
other  hand  they  also  spoke  about  trusting  immunisation  `experts'  that  had  identified  the 
need  for  the  Men  C  campaign  because  they  perceived  the  campaign  as  evidence  that 
experts  were  worried  about  the  risks  posed  by  this  disease.  Clearly  parents  were  making 
some  distinction  between  the  various  information  providers  and  this  highlights  what 
Sturgis  and  Allum  (2004)  describe  as  the  `complex  and  interacting  nature  of  the 
knowledge-attitude  interface'.  It  also  highlights  the  fact  that  parents  are  not  passive 
receivers  of  information  and  that  they  will  take  different  meanings  from  the  same 
information.  A  more  comprehensive  critique  of  audience  reception  and  the  deficit  model 
of  health  information  is  outwith  the  scope  of  this  thesis,  but  would  be  central  to  any 
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parents'  knowledge  in  order  to  offer  guidance  on  the  content  of  such  a  campaign,  rather 
than  on  the  most  effective  methods  of  communication  in  future  campaign.  Clearly  any 
campaign  should  draw  on  current  theories  of  trust,  risk  perception,  communication  and 
the  public's  understanding  of  science. 
In  consideration  of  the  content  of  a  campaign  this  study  recommends  there  is  a  need  to 
educate  parents  about  modes  of  transmission  and  the  potential  threats  they  pose,  and  to 
challenge  some  of  the  myths  surrounding  these  diseases  (for  instance  that  mumps  is 
causally  associated  with  male  infertility,  that  Hib  is  a  flu  vaccine,  that  rubella  is 
unimportant  for  boys  or  that  rabies  is  associated  with  tetanus).  It  is  important  to  tackle 
these  inaccurate  beliefs,  not  only  so  that  parents  can  make  more  informed  decisions,  but 
also  because  these  unchallenged  myths  appear  to  be  contributing  to  a  wider  sense  that 
children  are  being  over-immunised  against  diseases  that  are  mild  and  of  no  great  threat. 
There  is  also  a  need  to  educate  parents  about  the  importance  of  maintaining  high  vaccine 
uptake  levels  even  when  disease  prevalence  in  the  UK  is  minimal.  In  this  respect  it 
seems  advisable  that  greater  efforts  are  concentrated  on  persuading  parents  of  the 
constant  threat  posed  by  the  resurgence  of  `old'  diseases.  For  example,  modern  lifestyles 
mean  that  global  travel  provides  greater  opportunities  for  diseases  such  as  diphtheria  and 
polio  to  be  reintroduced  back  into  the  UK  from  parts  of  the  world  in  which  these  diseases 
still  remain  endemic.  (Most  parents  were  unaware  of  this,  which  meant  they  often 
questioned  the  need  for  the  continuation  of  these  vaccines  in  the  programme).  There  is 
also  a  need  for  parents  to  be  encouraged  to  be  realistic  about  their  own  ability  to  control 
disease.  For  instance,  tetanus  cannot  be  eradicated  because  the  spores  exists  in  the  soil 
and  therefore  poses  a  constant  threat.  Parents  should  also  be  made  aware  that  seeking 
tetanus  vaccination  after  an  injury  has  occurred  is  not  a  safe  strategy  for  preventing 
tetanus  infection. 
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campaign  appears  to  be  considerable.  The  high  level  of  understanding  of  the  risks  of 
meningococcal  disease  and  their  positive  attitude  to  Men  C  vaccination  suggests  that  the 
Men  C  campaign  may  be  a  successful  model  to  follow  in  communicating  the  risks  of 
other  vaccine-preventable  diseases.  It  was  clear  that  the  poster  campaign  had  been  a 
particularly  successful  aspect  of  this  campaign.  These  findings  suggest  that  a  similar 
follow  up  campaign  with  a  central  focus  on  reducing  the  prevalence  of  meningitis  may  be 
equally  successful  as  a  means  of  educating  about  haemophilus  influenza  and  mumps 
infection.  Both  these  diseases  were  considered  to  be  minor  because  parents 
misunderstood  them.  By  building  on  the  success  of  the  Men  C  and  by  adding  these  two 
vaccines  into  the  new  campaign  parents  could  be  educated  about  the  fact  that  Hib  was 
introduced  to  reduce  the  incidence  of  meningitis  (among  other  conditions),  and  that 
mumps  vaccination  was  introduced  into  the  programme  to  reduce  the  incidence  of  viral 
meningitis.  This  has  the  two-fold  benefit  of  challenging  the  myths  about  mumps  and 
Hib  vaccines  and  thus  educating  parents  about  the  rationale  for  their  inclusion  in  the 
programme,  and  perhaps  reducing  parents'  concerns  that  children  are  becoming  over 
immunised  against  diseases  that  pose  little  risk. 
The  findings  from  this  research  also  suggest  that,  since  parents  seem  to  find  personal 
stories  very  persuasive,  these  may  have  a  role  to  play  in  health  education  materials  and 
campaigns.  It  seems  that  any  future  campaign  would  be  wise  to  encompass  accurate  and 
factual  information  about  the  diseases,  with  a  campaign  that  places  an  appropriate  level 
of  emphasis  on  the  important  community  benefits  of  immunisation  as  well  as  those 
pertaining  to  the  individual.  One  benefit  of  increasing  the  emphasis  on  the  community 
benefits  of  immunisation  is  that  it  recognises  the  public  health  contribution  of 
immunisation  more  openly.  In  the  case  of  rubella  vaccination  this  would  challenge  the 
view  held  by  some  parents  that  rubella  immunisation  is  irrelevant  for  boys  since  it  is  their 
sisters,  aunts,  future  female  partners  and  potentially  their  own  children  who  could  benefit 
from  the  protection.  Acknowledging  the  dual  role  of  immunisation  more  openly  would 
more  accurately  reflect  the  fact  that  vaccines  offer  both  individual  and  community 
protection.  It  would  also  allow  more  debate  about  the  important  role  vaccination  plays  in 
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with  compromised  immune  systems  due  to  a  range  of  illnesses,  or  brothers  and  sisters 
who  are  too  young  to  be  vaccinated.  Whilst  the  current  climate  of  individual  choice  is 
important,  so  too  is  responsibility  and  it  may  be  time  for  health  education  to  embrace  this 
aspect  of  immunisation  more  comprehensively. 
But  perhaps  the  most  pressing  and  urgent  need  of  any  immunisation  campaign  is  the  need 
to  address  parents'  growing  concerns  and  fears  about  over-immunisation.  At  present 
parents  are  anxious  and  confused  about  whether  combined  vaccines  do  overwhelm  the 
immune  system.  Whilst  educating  parents  about  the  individual  diseases  may  help  parents 
appreciate  the  need  to  include  each  of  the  vaccines  in  the  current  programme,  parents  also 
need  reassurances  based  on  sound  evidence  that  giving  these  vaccines  in  a  combined 
form  is  safe.  As  the  new  pentavalent  vaccine  (DtaP/IPV/Hib)  is  introduced  into  the 
programme,  it  is  crucial  that  parents'  concerns  about  immune  overload  are  taken  into 
account  to  reassure  parents  in  their  wider  reappraisal  of  vaccine  risk. 
7.3.2  Implications  for  practice 
In  this  study,  health  professionals,  particularly  GPs  and  health  visitors,  were  often  viewed 
by  parents  as  offering  ambiguous  advice  and  being  ambivalent  about  MMR  safety.  This 
added  to  parents'  sense  of  uncertainty  about  the  safety  of  MMR  and  about  whether  MMR 
immunisation  was  in  their  child's  best  interest.  Some  parents  spoke  of  their  concerns 
about  the  MMR  vaccine  being  dismissed  out  of  hand  by  health  professionals,  or  of 
feeling  pressurised  into  making  quick  decisions.  Parents  found  this  kind  of  pressure 
unhelpful  and  were  resentful  of  it  when  trying  to  make  such  a  difficult  decision.  It  is 
imperative  that  health  professionals  are  sensitive  to  parents'  needs  and  that  they  receive 
up-to-date  assessments  of  the  evidence  about  MMR  safety  and  any  new  developments  in 
autism  research  to  assist  them  in  supporting  parents  to  reach  an  informed  decision. 
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were  aware  that  they  receive  payments  from  the  Government  to  reach  immunisation 
targets.  This  target  payment  scheme  appears  to  be  undermining  the  very  programme  it 
seeks  to  promote,  and  may  be  potentially  damaging  to  the  parent-practioner  relationship. 
Parents  appeared  to  find  negative  comments  about  Wakefield  unhelpful.  They  also  found 
the  fact  that  the  aetiology  of  autism  is  still  not  fully  understood  unsettling  and  added  to 
their  general  sense  of  uncertainty.  Therefore  it  may  be  wise  for  health  professionals  to 
distance  themselves  from  politicians  by  avoiding  using  the  kind  of  rhetoric  they  have 
used  to  discredit  Wakefield  and  his  findings.  Instead  health  professionals  could 
concentrate  on  the  positive  messages  such  as  the  good  safety  record  of  the  MMR  vaccine 
and  the  overwhelming  support  from  the  scientific  community  for  the  MMR  vaccine  as 
the  safest  vaccine  available  for  preventing  measles,  mumps  and  rubella  infection. 
The  MMR  controversy  appears  to  have  increased  parents'  fears  about  combined  vaccines 
potentially  overwhelming  and  damaging  their  child's  immune  systems.  Health 
professionals  may  need  to  offer  greater  reassurance  and  advice  on  this  aspect  of 
immunisation  to  parents  who  are  worried,  or  whose  children  have  asthma  or  multiple 
allergies.  As  such,  health  visitors,  GPs  and  practise  nurses  need  to  be  provided  with  up- 
to-date  information  and  be  prepared  to  discuss  this  topic  with  parents.  Health 
professionals  may  need  to  reassure  parents  that  their  own  child's  immune  system  is 
capable  of  coping  with  multiple  antigens,  and  to  discuss  the  benefits  combined  vaccines 
offer  their  child.  They  may  also  need  to  advise  parents  that  combined  vaccines  offer  their 
child  protection  against  several  diseases  at  once,  and  at  a  younger  age  than  would  be 
possible  if  given  separately,  and  that  this  is  important  because  many  infectious  diseases 
are  most  dangerous  to  very  young  children.  However,  some  parents  may  continue  to 
have  reservations  about  vaccines  and  may  still  decide  not  to  immunise.  The  decisions  of 
these  parents  should  be  respected  and  they  may  need  to  be  encouraged  to  learn  about  the 
signs  and  symptoms  of  the  diseases  so  that  they  could  recognise  early  infection  and  seek 
medical  assistance. 
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This  research  suggests  that  parents  are  anxious  that  combined  vaccines  could  be 
detrimental  to  their  child's  health  both  immediately  following  vaccination  and  in  the 
long-term.  Further  research  in  these  areas  could  help  alleviate  some  of  these  anxieties 
and  return  greater  confidence  to  the  use  of  combined  vaccines.  This  is  essential  as  new 
combined  vaccines  are  introduced  into  the  programme. 
This  study  also  highlighted  a  need  for  further  research  with  parents  caring  for 
immunocompromised  children  and  immunisation.  It  seems  sensible  that  the  wider 
community  benefits  of  immunisation  should  receive  more  consideration  than  at  present. 
Further  research  is  warranted  to  determine  how  this  could  best  be  incorporated  into  an 
immunisation  campaign. 
The  anguish  and  grief  that  the  MMR  controversy  has  caused  for  parents  who  believe  they 
are  in  part  responsible  for  their  child's  autism  is  so  unimaginable  that  it  is  imperative  that 
lessons  are  drawn  from  this  whole  unfortunate  affair.  The  need  for  further  research  with 
these  parents  is  central  to  this  process  of  learning.  In  particular  there  is  an  urgent  need 
for  a  larger  exploratory  study  to  investigate  how  parents  caring  for  autistic  children  have 
been  affected  by  the  debate,  so  that  the  medical  and  health  professions  can  address  these 
needs  more  effectively. 
Parents  also  want  more  research  into  the  aetiology  of  autism,  into  the  relationship 
between  autism  and  the  immune  system,  and  whether  immunisation  is  safe  for  autistic 
children.  It  is  essential  that  this  research  is done  and  that  the  findings  are  disseminated 
quickly  to  parents  so  that  they  have  closure  on  the  MMR  controversy.  The  Government's 
pledge  in  February  2002  of  £2.5  million  towards  further  autism  research  effort  is  a 
positive  step  in  this  direction. 
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This  study  has  provided  an  original  and  unique  insight  into  perceptions  of  the  MMR 
controversy,  and  on  parents'  views  on  childhood  immunisation  and  vaccine-preventable 
diseases.  It  is  anticipated  that  the  findings  from  this  PhD  research  will  be  relevant  to 
public  health  policy  on  immunisation  and  will  be  presented  in  scientific  medical  journals 
(a  paper  has  been  submitted)  and  at  public  health  conferences.  Indeed,  as  the  MMR 
controversy  slowly  fades,  this  research  suggests  that  new  debates  may  emerge  that  will 
focus  attention  on  whether  children  are  becoming  over-immunised  against  diseases 
perceived  to  posed  no  real  threat.  Although  many  parents  will  continue  unquestioningly 
to  accept  immunisation,  it  is  possible  that  growing  numbers  will  not.  It  is  therefore 
important  that  future  immunisation  policy  takes  a  proactive  stance  in  educating  parents 
about  the  diseases.  Parents  need  to  be  given  clear  and  accessible  public  health 
information  about  the  vaccines  and  diseases  included  in  the  programme  as  this  will 
determine  the  future  success  of  the  Childhood  Immunisation  Programme.  The  completion 
of  this  PhD  study  coincides  with  a  more  reflective  period  in  the  MMR  controversy,  at  a 
time  when  scientists,  journalists,  policy  makers,  public  health  officials  and  health 
professionals  are  beginning  to  ponder  on  the  lessons  that  may  be  learned  from  this  public 
health  scare.  It  is  hoped  that  this  research  will  usefully  contribute  to  this  process  of 
reflection. 
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United  Kingdom  Childhood  Immunisation  Programme 
VACCINE/  HOW  IT  IS  GIVEN  AGE  VACCINE  GIVEN 
DISEASE 
Diphtheria/tetanus/  Combined  5  in  1  injection  2  months 
Pertussis/  Hib  &  polio 
(DtaP/IPV/Hib) 
Men  C  One  injection  2  months 
Diphtheria/tetanus/  Combined  5  in  1  injection  3  months 
Pertussis/  Hib  &  polio 
(DtaP/IPVfHib) 
Men  C  One  injection  3  months 
Diphtheria/tetanus/  Combined  5  in  1  injection  4  months 
Pertussis/  Hib  &  polio 
(DtaP/IPV/Hib) 
Men  C  One  injection  4  months 
Measles/mumps/  Combined  3  in  1  injection  12  to  15  months 
rubella  (MMR) 
Diptheria/tetanus/  Combined  4  in  1  injection  3  to  5  years 
Pertussis  &  polio 
(dTaP/IPV  or 
DtaP/IPV) 
Measles/mumps/  Combined  3  in  1  injection  3  to  5  years 
rubella  (MMR) 
Source:  Department  of  Health  2004  www.  immunisation.  nhs.  uk Appendix  C 
Timeline  showing  the  major  changes  to  the  Childhood  Immunisation  Programme  between  1940  and  2004 
(not  to  scale). 
1941-  Diptheria  vaccine  introduced 
1956-  Pertussis  vaccine  introduced 
1957-  Inactivated  poliomyelitis  vaccine  introduced 
1961-  Tetanus  vaccine  introduced  nationally 
1 
1962-  Inactivated  poliomyelitis  vaccine  replaced  by  attenuated  live  oral  vaccine 
1968-  Measles  vaccine  introduced 
1970-  Rubella  vaccine  introduced  for  pre-pubertal  girls  and  non-immune  women 
1975-  Pertussis  scare-  uptake  of  pertussis  vaccine  reduces  and  over  the  next  decade  the  UK  has  several  whooping  cough 
i  epidemics. 
1980-  Smallpox  eradicated  and  smallpox  immunisation  ceases 
1988-  MMR  vaccine  replaces  measles  and  rubella  vaccines  and  introduces  mumps  vaccination  into  the  programme 
1990-  Hib  vaccine  introduced 
1994-  National  MR  catch  up  programme  targeted  at  school  children  not  given  MMR 
I  vaccination 
1996-  Second  dose  MMR  introduced 
1999-  Men  C  vaccine  introduced  with  Men  C  campaign 
2004-  DTP  and  Hib  and  live  oral  polio  vaccine  replaced  by  pentavalent  vaccine 
(DtaP/IPV/Hib) Timeline  showing  the  timing  of  PhD  fieldwork  in  relation  to  major  Appendix  D 
events  in  the  MMR  controversy 
liming  of  PhD  research  Major  events  In  MMR  Controversy 
PhD  study  commences 
Ja  2002  Measles  outbreak  in  Wales 
Fe¢  1998  The  Lancet  publish  Wakefield  and  colleagues'  paper 
De  -  2001  Dr  Wakefield  resigns  from  his  job  at  London's  Royal  Free  Hospital 
A  MRC  review  of  autism  research  concludes  no  evidence  of  a  link  between 
MMR  and  autism 
Tony  Blair  the  British  Prime  Minister  refuses  to  reveal  Leo's  MMR  status 
Feb  2002  Measles  outbreak  in  London  and  Fife 
Panorama  television  documentary  broadcast  featuring  Dr  Wakefield 
defending  his  theory 
Government  pledge  2.5  million  pounds  towards  further  autism  research 
Pilot  work  commences  (three  focus  groups 
and  four  individual  interviews) 
Second  tranche  of  pilot  work  commences  -  Oct  2002  -Media  coverage  of  MMR  debate  lessens  as  speculation  grows  of  war 
(two  focus  groups)  I  with  Iraq 
Main  fieldwork  conducted  Nov  2002- 
(fifteen  focus  groups)  Mir  2003 
Mar  2002 
Summer  Growing  media  speculation  of  an  impending  legal  action 
22 
OS 
Oct  2003  Legal  services  commission  withdraws  funding  for  MMR  litigation 
Nov  2003  Dr  Murch,  one  of  Wakefield's  former  colleagues  at  the  Royal  Free,  states  no 
link  between  MMR  and  autism 
Dec  2003-Channel  5  documentary  aired  'Hear  The  Silence'  the  programme  is  widely 
I  criticised  by  immunisation  specialists  as  being  'biased'  and  'unscientific' 
Feb  2004  -Judicial  review  supports  earlier  decision  to  withdraw  funding  for  MMR 
litigation 
GMC  conducts  an  investigation  into  Wakefield's  alleged  conflict  of  interests 
Ir 
2004-The  Lancet  publishes  a  statement  by  the  editors  and  a  retraction  by  ten  of 
Wakefield's  co-authors  to  formally  disassociate  themselves  from  the 
autism/MMR 
Seat  2004  Richard  Horton's  book  published 
Nov  2004-Television  documentary  broadcast  'What  doctors  dont  tell  you?  ' 
Dec  2004  -Health  experts  warns  of  impending  measles  epidemic  this  winter  and  of  rising 
mumps  cases  among  teenagers Appendix  E 
CHECK  LIST 
1.  Check  has  everyone  received  and  read  the  information  sheet? 
2.  Introduce  self  and  research. 
3.  Re-state  the  following: 
-Length  of  time  (approx  1  hr). 
-Voluntary  nature  of  participation. 
-Recording  the  group  discussion. 
-Confidentiality  -  (information  kept  in  locked  drawer  in  MRC  unit  &  not  disclosed  to  anyone  outside  the  research  team). 
-Anonymity-  (all  documents  and  data  identifiable  only  through  ID  number  and  any  extracts  used  in  presentations  or 
publications  given  pseudonyms  to  protect  identity). 
-Expenses. 
4.  Check  if  there  are  any  questions  or  concerns  about  the  study. 
5.  Get  the  consent  form  signed  and  personal  detail  form  completed. 
6.  Give  out  discussion  material. 
7.  Switch  on  microphone  and  recorder. 
S.  Map  positions  of  participants  -  (name,  no  of  children  &  age  of  children). Appendix  E  cont 
TOPIC  GUIDE  (not  in  order) 
EXPERIENCES  OF  CHILDHOOD  IMMUNISATION/  PERCEPTIONS  ABOUT  VACCINES 
"  Words  /  images  associated  with  immunisation. 
"  Experience  of  immunisation  so  far. 
"  Views  on  the  current  Childhood  Immunisation  Programme. 
(Hand  out  Immunisation  Programme  see  Appendix  L) 
PERCEPTIONS  ABOUT  CHILDHOOD  INFECTIOUS  DISEASES 
"  Words  /  images  associated  with:  -  Diptheria,  tetanus,  whooping  cough  (or  pertussis),  meningococal  disease,  mumps, 
poliomyelitis,  measles,  rubella  and  haemophilus  influenzae  (or  Hib). 
"  Find  out  which  disease's  parents'  feel  most  and  least  severe? 
"  Find  out  which  disease's  parents'  feel  most  and  least  prevalent? 
"  Find  out  which  disease's  parents'  feel  threatens  their  child's  health  most  and  least  ? 
"  Explore  parents  knowledge/  understaning  about  how  they  think  each  disease  is  transmitted. 
"  Do  parents  have  any  direct  experiences  of  any  of  the  diseases  either  as  parents  themselves  or  as  children? 
"  Does  this  affect  their  perceptions  about  the  disease  and  in  what  way? 
"  If  parents  have  no  direct  experience  of  childhood  infectious  diseases,  what  or  who  has  helped  them  make  their 
assessments  of  these  diseases? 
BELIEFS  ABOUT  HEALTH  &  THE  IMMUNE  RESPONSE 
"  How-  vaccines  works  /  explore  parents'  understanding  of  the  body  reaction  to  vaccination  or  to  disease? 
"  Explore  notions  of  `healthiness'  with  immunisation  and  perceived  threat  of  disease. 
Is  there  any  relationship  between  -general  health  and  need  for  immunisation? 
-general  health  and  threat  of  disease? Appendix  E  cont 
BELIEFS  ABOUT  CHOICE  &  RESPONSIBILITY 
"  Individual  choice  V's  societal  responsibility.  Is  it  okay  to  opt  out?  &  When? 
PERCEPTIONS  ABOUT  THE  MMR  VACCINE  /  DEBATE 
"  Feelings  about  the  MMR  vaccine? 
"  Feelings  about  the  MMR  debate? 
"  Beliefs  about  the  `state  of  the  evidence. 
"  Feelings  about  the  Dr  Wakefield? 
THE  EXPERIENCE  OF  DECIDING  ABOUT  MMR 
"  MMR  decision  mating  experiences.  Was  it  an  easy  or  difficult  decision? 
"  Influential  factors  in  the  1"  &  2nd  MMR  dose.  Were  they  different? 
"  Identify  other  people  involved  in  the  decision.  Any  informal  support? 
"  Explore  which  of  the  other  vaccines  easy  /  difficult  to  decide  about?  Why? 
If  autism  brought  up  by  group- 
"  Explore  words  /  images/  fears  about  autism. 
"  Experience  of  autism. 
"  Feelings  /  perceptions  re:  `the  evidence'. 
CHECK 
1.  Ensure  each  person  given  list  of  contacts  &  reply  paid  envelopes. 
2.  Expenses  given. 
3.  Thank  parents. Appendix  F 
Parents'  perceptions  of  childhood  infectious  diseases, 
MMR  and  other  childhood  immunisation. 
"  What  is  this  study  about? 
I  would  like  to  talk  to  parents  about  their  experiences  and  beliefs  about  childhood  infectious  diseases  and  childhood 
immunisation.  I  am  interested  in  hearing  about  your  experiences  of  the  immunisation  service,  of  the  current  immunisation 
programme,  what  you  feel  about  the  measles,  mumps  and  rubella  vaccine  (MMR)  and  what  factors  influence  your 
decisions  about  whether  to  get  your  child  immunised,  or  not. 
"  Why  are  your  views  important? 
I  am carrying  out  a  small  number  of  discussion  groups  with  parents  of  young  children  in  various  parts  of  Glasgow  and  surrounding 
areas.  Whilst  the  study  is  unlikely  to  be  of  direct  benefit  to  yourselves  and  there  is,  of  course  no  obligation  to  take  part  in  the  study,  it 
is  hoped  that  your  participation  in  the  study  will  help  future  parents.  If  you  are  interested  in  the  findings  of  this  study,  a  summary  will 
be  available  to  you  on  request  once  the  study  is  completed. 
"  What  do  you  have  to  do? 
The  group  discussion  today  will  take  approximately  one  hour  and  will  be  recorded  to  ensure  1  get  an  accurate  account  of 
what  is  said.  If  you  are  willing  to  take  part,  you  will  be  given  a  consent  form  to  sign  and  details  of  when 
and  where  in  the  clinic  the  group  discussion  is  planned  to  take  place. 
"  What  will  the  data  be  used  for? 
The  Medical  Research  Council  is  funding  this  research  project.  The  information  collected  from  all  the  groups  will  be  studied  and  the 
findings  used  as  the  basis  of  a  PhD,  published  in  academic  journals  and  presented  to  policy  makers. 
9  Will  the  information  provided  be  kept  confidential? 
Yes,  short  quotes  of  what  you  say  may  be  used  in  articles  in  research  journals,  but  I  will  not  use  your  name  or  anything 
that  could  identify  you,  so  that  you  remain  anonymous.  Only  members  of  the  research  team  will  have  access  to  the  tapes 
and  written  material  relating  to  the  tapes  and  the  Medical  Research  Council  requires  us  to  keep  all  research  documents  in 
a  locked  drawer  for  ten  years,  in  accordance  with  the  MRC  guidelines  on  good  practice. 
"  What  should  you  do  if  you  wish  to  take  part  or  want  more  information? 
Please  let  me  know  if  you  have  any  questions  about  the  study,  or  wish  to  take  part.  If  you  decide  that  you  would  like  a 
summary  once  the  study  is  completed  my  contact  details  are  as  follows: 
Direct  line  0141357  7537 
Email  shona(  )msoc.  mrc.  a.  ac.  uk 
Address  MRC,  Social  &  Public  Health  Sciences  Unit,  4  Lilybank  Gardens,  Glasgow,  G12  8RZ. Consent  form  Appendix  G 




Parents'  perceptions  of  childhood  infectious  diseases,  MMR  and 
other  childhood  immunisation. 
The  purpose  of  this  agreement  is  to  ensure  that  your  contribution  to  the  above  research  project  is  in  strict 
accordance  with  your  wishes. 
Please  tick  as  appropriate  :- 
oI  have  read  the  information  sheet  that  describes  this  study,  and  agree  to  take  part  in  a  group  discussion. 
QI  give  permission  for  brief  extracts  of  what  I  say  to  be  used  for  research  purposes  (including  research  publications  and 
reports),  with  strict  preservation  of  anonymity.  I  understand  that  the  recorded  discussions  will  remain  confidential 
and  become  the  property  of  the  MRC  Social  &  Public  Health  Sciences  Unit. 
I  understand  that  I  do  not  need  to  answer  all  the  questions  if  I  do  not  wish  to  and  that  I  may  leave  the  discussion  at  any 
time. 
I  am  aware  that  any  information  I  provide  will  be  treated  in  the  strictest  of  confidence.  Tapes  and  transcripts  will  be 
locked  away  and  only  available  to  the  research  team. 
Signed  .................................................................. 
Date............................... 
Name  (Block  capitals  please)  ................................................................................ 
Address 
........................................................................................................ 
MRC  Social  &  Public  Health  Sciences  Unit,  4  Lilybank  Gardens,  Glasgow,  G12  8RZ.  Tel:  (357  3949) Characteristics  of  focus  groups  Appendix  H 
Group  Characteristics 
The  sampling  frame  included  a  diverse  range  of  parents  to  ensure  maximum  variation  in  terms  of  age,  socio- 
economic  circumstances  (including  deprived  and  more  affluent  communities),  likely  views  about  vaccination 
(including  parents  living  in  high  and  low  uptake  areas,  as  well  as  with  groups  of  parents  who  had  opted  for 
single  measles,  mumps  and  rubella  vaccines  instead  of  MMR,  parents  who  rejected  the  MMR,  and  rejected  all 
vaccination)  and  family  circumstances  (including  first-time  mothers,  more  experienced  mothers,  single  parents 
and  parents  with  multiple  social  problems).  Four  focus  groups  were  conducted  with  parents  who  were 
anticipated  to  have  a  particular  interest  in  the  debate:  two  with  parents  who  had  autistic  children  and  two  with 
parents  whose  child  had  recently  had  a  compromised  immune  system  following  chemotherapy. 
The  profile  of  the  18  focus  groups  is  represented  below 
GROUP  1:  NC  r  GROUP  (PILOT) 
Recruited  from  the  National  Childbirth  Trust  (pre-existing  group) 
Participant's  Pseudonyms  Trudie  Violet  Mel 
Participant's  Age  38  36  35 
Occupation  by  social  class  11  1  At  home  full-time 
1'  Child's  gender,  age,  Girl,  8  yrs,  fully  immunised  Girl,  2yrs,  partially  immunised-  Boy,  4yrs,  fully  immunised  - 
unisation  status  delayed  1'  MMR  (egg  allergy)  delayed  MMR  until  he  was  2yrs 
old 
2°d  Child's  gender,  age,  Girl,  7mths,  fully  immunised  Girl,  15mths,  partially 
imihunisation  status  immunised-plans  to  delay  MMR 
until  she  is  2  yrs  old 
GROUP  2:  NEW  MOTHERS  GROUP  (PILOT) 
Recruited  from  a  postnatal  support  group  (pre-existing  group) 
Participant's  Pseudonyms  Joanne  Elaine  Louise  Beathan 
Participant's  Age  37  34  29  29 
Occupation  by  social  class  11  1  11  11 
V  Child's  gender,  age, 
immunisation  status 
Boy,  5mths,  fully 
immunised 
Boy,  4mths,  fully 
immunised 
Boy,  5mths,  fully 
immunised 
Girl,  6mths,  fully 
immunised Appendix  H  cont 
GROUP  3:  ANTENATAL  GROUP  (PILOT) 
Recruited  from  an  antenatal  group  for  second  time  mums  (pre-existing  group) 
Participant's  Sian  Dawn  Ruth  Beatrice  oonn 
Pseudonyms 
Participant's  Age  32  36  29  29 
F 
tion  by  social  Occupa  Did  not  complete  At  home  full-time  1  11 
class 
1'  Child's  gender,  1`  child  died  at  Boy,  4yrs,  partially  Boy,  12mths,  fully  Boy,  18mths,  Boy,  12yrs,  fully 
age,  immunisation  birth  immunised-not  immunised  partially  immunised 
status  given  MMR  immunised-not 
given  MMR 
2'd  Child's  gender,  age,  Boy,  3yrs,  -  Girl,  7yrs,  fully 
immunisation  status  partially  immunised 
immunised-not 
planning  to  give 
pertussis  or  MMR 
3rd  Child's  gender,  Girl,  5yrs,  fully 
age,  immunisation  immunised 
status 
4th  Child's  gender,  Boy,  3yrs,  fully 
age,  immunisation  immunised 
status 
GROUP  4:  LOW  UPTAKE  AREA  GROUP  (deprived  area) 
Recruited  from  a  recreational  centre  in  DEPCAT  7  area  with  low  MMR  uptake  rate  less  than  75%  (specially  convened  group) 
Participant's  Pseudonyms  Joan  Sheila  Alan 
Participant's  Age  20  36  33 
Occupation  by  social  class  At  home  full-time  At  home  full-time  111M 
1"  Child's  gender,  age, 
immunisation  status 
Girl,  20mths,  fully  immunised  Boy,  2lmths,  fully  immunised  Boy,  2yrs,  Partially  lmmuniscd  -not 
had  1'  MMR 
2  Child's  gender,  age, 
immunisation  status 
Girl,  l0yrs,  fully  immunised 
3rd  Child's  gender,  age, 
immunisation  status 
Girl,  3yrs7mths, 
fully  immunised Appendix  H  cont 
GROUP  5:  HIGH  UPTAKE  AREA  GROUP  (affluent  area) 
Recruited  from  a  private  nursery  in  DEPCAT  1  area  with  high  MMR  uptake  rate  greater  than  95%  (specially  convened  group) 
Participant's  Fiona  Alison  Lauren  Cassie  Karen  Anna 
Pseudonyms 
Participant's  Age  32  31  29  29  36  33 
Occupation  by  social  I11M  At  home  full-  1  11  11  At  home 
class  time  full-time 
1'  Child's  gender,  age,  Girl,  6yrs,  fully  Boy,  15mths,  Boy,  14mths,  Girl,  3yrs,  fully  Girl,  7yrs,  fully  Girl,  7yrs, 
immunisation  status  immunised  partially  Partially  immunised  immunised  fully 
immunised  immunised  immunised 
delaying  1'  delaying  1' 
MMR  MMR 
2  Child's  gender,  age,  Boy,  5mths,  Boy,  9mths,  Girl,  4yrs,  fully  Boy,  4yrs, 
immunisation  status  fully  fully  immunised  partially 
immunised  immunised  immunised 
not  givien 
2id  MMR 
3  Child's  gender,  age,  Boy,  4mths,  Girl,  3yrs, 
immunisation  status  fully  Partially 
immunised  immunised 
no  MMR 
4d'  Child's  gender,  age,  Girl.  lyr 
immunisation  status  2mths 
partially 
immunised 
no  MMR 
GROUP  6:  SATURDAY  CLUB  GROUP  (deprived  area) 
Recruited  from  a  Saturday  club  in  DEPCAT  6  area  with  low  MMR  uptake  rate  less  than  75%  (specially  convened  group) 
Participant's  Pseudonyms  Cathy  Bob  Ella  Helen 
Participant's  Age  29  31  45  39 
Occupation  by  social  class  11  1  Self-employed  11 
1'  Child's  gender,  age,  Girl,  3yrs  6mths,  fully  Boy  3yrs  2mths,  fully  Boy,  5yrs,  partially  Girl,  4yrs  7mths, 
immunisation  status  immunised  immunised-  but  not  immunised  (only  had  fully  immunised 
getting  2"  MMR  (adverse  DTP) 
reaction  to  1'  MMR). 
2  Child's  gender,  age,  Boy,  2yrs  lmth,  fully  Boy,  7mths,  fully  Boy,  2yrs  7mths, 
immunisation  status  immunised  immunised  not  planning  fully  immunised 
to  give  MMR Appendix  H  cont 
GROUP  7:  CRAFTS  GROUP  (deprived  area) 
Recruited  from  a  crafts  group  in  DEPCAT  6  area  with  high  MMR  uptake  rate  greater  than  95%  (pre-existing  group) 
Participant's  Tracy  Samantha  Lydia  Angie  Mary 
Pseudonyms 
Participant's  Age  32  24  39  29  43 
Occupation  by  social  Unemployed  Unemployed  111N  111M  At  home  full- 
class  time 
1`  Child's  gender,  Boy,  10yrs,  fully  Boy,  l6mths,  Boy  Boy,  6yrs,  fully  Boy,  5yrs,  fully  Girl,  5yrs,  fully 
age,  immunisation  immunised  immunised  immunised  immunised 
status 
2id  Child's  gender,  age,  Girl,  4yrs,  fully  Boy,  l8mths,  fully 
immunisation  status  immunised  immunised 
3rd  Child's  gender,  Girl,  2yrs  2mths, 
age,  immunisation  fully  immunised 
status 
NB:  Lydia  mentions  that  she  has  six  children,  but  only  fills  in  details  for  her  youngest. 
GROUP  8:  YOUNG  SINGLE  MOTHERS  GROUP  (deprived  area) 
Recruited  from  a  family  resource  unit  in  DEPCAT  7  area  with  MMR  uptake  rate  approx.  85%  (pre-existing  group) 
Participant's  Kate  Margaret  Lisa  Ann  Lynne  Natalie  Ros  Lucy 
Pseudonyms 
ParticipAge  22  20  20  16  20  18  20  15 
Occup  by  Unemp  Unemployed  Unemployed  Unemployed  Unemployed  Unemployed  Unemployed  Unemployed 
social  class  loyed 
1`  Child's 
gender,  age,  Boy,  Boy,  2yrs  Girl,  2yrs  Boy,  6mths  Boy  13mths  Boy,  l5mths,  Boy,  20mths,  Boy,  11wks, 
immunisation  2yrs,  3mths,  llmths,  fully  fully  fully  fully  fully  fully 
status  fully  partially  immunised  immunised  immunised  immunised  immunised  immunised 
immunised 
not  had 
MMR 
2°"  Child's 
gender,  age,  Boy,  lyr 
immunisation  llmths,  fully 
status  immunised Appendix  H  cont 
GROUP  9:  FIRST-TI  MME  MOTITERS  GROUP  (affluent  area) 
Recruited  from  a  baby  massage  class  in  a  DEPCAT  1  area  with  MMR  uptake  rate  89%  (pre-existing  group) 
Participant's  Rhona  Catrina  Judith  Charlotte  Celia 
Pseudonyms 
Participant's  Age  31  27  34  29  33 
Occupation  by  social  At  home  full-time  At  home  full-time  11  At  home  full-time  At  home  full- 
class  time 
1'  Child's  gender, 
age,  immunisation  Boy,  llwks,  fully  Girl,  11wks,  fully  Girl,  llwks,  fully  Girl,  5mths,  fully  Girl,  6mths, 
status  immunised  immunised  immunised  immunised  fully 
immunised 
GROUP  10:  SINGLE  FATHERS  GROUP  (deprived  area) 
Single  fathers  group  recruited  from  a  family  resource  unit  in  DEPCAT  7  area  with  MMR  uptake  rate  approx  85%  (pre-existing  group) 
Participant's  Pseudonyms  William  Kenny  Robert 
Participant's  Age  51  43  47 
Occupation  by  social  class  Unemployed 
Sole  Carer 
Unemployed  Unemployed 
Sole  Carer 
1"  Child's  gender,  age, 
immunisation  status 
Girl,  12yrs  llmths,  fully 
immunised 
Boy,  3yrs,  immunisation 
status  unknown 
Girl,  l7yrs,  fully  immunised 
2  Child's  gender,  age, 
immunisation  status 
Girl,  5yrs  2mths,  fully 
immunised 
Boy,  3mths,  fully  immunised  Boy,  6yrs,  fully  Immunised 
NB:  William  also  has  three  older  boys  who  have  left  home  (aged  17,19  and  21). 
GROUP  11:  MULTIPLE  PARENTING  PROBLEMS  GROUP  (deprived  area) 
Parents  with  drug  addictions  recruited  by  snowballing  through  a  community  project  from  derived  area  DEPCAT  score  7  (specially  convened  group)  Michelle  was 
certain  her  young  6mth  baby  had  had  four  DTP's. 
Participant's  Pseudonyms  Sheena  Michelle  Patsy  Frank 
Participant's  Age  24  21  23  31 
Occupation  by  social  class  Unemployed  Unemployed  Unemployed  Unemployed 
1"  Child's  gender,  age,  Girl,  7yrs,  fully  Boy,  2yrs  2mths,  fully  Boy  (twin)  3yrs,  fully  As  for  Patsy 
immunisation  status  immunised  immunised  but  delayed  immunised  but 
MMR  delayed  MMR 
2'  Child's  gender,  age,  Boy,  6yrs,  fully  Girl,  6mths,  fully  Boy  (twin)  3yrs,  fully  As  for  Patsy 
immunisation  status  immunised  immunised-  stated  she  immunised  but 
had  4  DTP's  delayed  MMR 
3rd  Child's  gender,  age,  Boy,  2yrs,  fully  Boy,  2mths  no  As  for  Patsy 
immunisation  status  immunised,  but  delayed  immunisation  given 
1`  MMR  yet  but  plans  to 
immunise Appendix  H  cont 
GROUP  12:  SINGLE  VACCINE  GROUP 
Recruited  from  a  private  health  care  clinic  (specially  convened  group) 
Participant's  Pseudonyms  Dave  Jenny  Joe  (male) 
Participant's  Age  38  19  36 
Occupation  by  social  class  11  At  home  full-time  At  home  full-time 
1'  Child's  gender,  age,  Girl,  7yrs  7mths,  fully  Boy,  2yrs  lmth,  partially  Boy,  2yrs  3mths,  partially 
immunisation  status  immunised-given  single  immunised  in  the  process  of  immunised-  in  the  process  of 
measles,  mumps  and  rubella  getting  single  measles,  getting  single  measles, 
vaccines  mumps  and  rubella  vaccines  mumps  and  rubella  vaccines 
2  Child's  gender,  age,  Girl,  lyr  9mths,  partially 
immunisation  status  immunised-  in  the  process  of 
getting  single  measles,  mumps 
and  rubella  vaccines 
GROUP  13:  NON-MMR  GROUP 
Recruited  from  the  National  Childbirth  Trust,  homeopathic  and  herbal  shops  (brought  together  group) 
Participant's  Pseudonyms  Sue  Alcena  Hannah 
Participant's  Age  36  35  40 
Occupation  by  social  class  11  11  At  home  full-time 
1'  Child's  gender,  age,  Boy,  6yrs  6mths,  partially  Girl,  5yrs  6mths,  no  Boy,  4yrs  3mths,  partially 
immunisation  status  immunised-  not  given  2nd 
MMR 
immunisation  given  at  all.  immunised-  not  given  MMR 
2  Child's  gender,  age,  Boy,  4yrs  8mths,  partially  Girl,  3yrs  4mths,  no  Boy,  2yrs  8mths,  partially 
immunisation  status  immunised  -not  given  immunisation  given  at  all  immunised-  not  given  MMR 
MMR.  Given  homeopathic 
alternative 
3  Child's  gender,  age,  Boy,  13mths,  fully  Girl,  Smths,  no  immunisation 
immunisation  status  immunised,  but  plans  to  given  at  all 
delay  MMR Appendix  H  cont 
GROUP  14:  NON-VACCINE  GROUP 
Recruited  from  alternative  parenting  organisations  (specially  convened  group) 
Participant's  Pseudonyms  Molly  Kitty  Lola  Debbie 
Participant's  Age  37  37  32  33 
Occupation  by  social  class  11  11  At  home  full-time  11 
1'  Child's  gender,  age,  Boy,  5yrs  10mths,  no  Boy,  6yrs,  partially  Boy,  6yrs  6mths,  Boy,  5yrs  4mths, 
immunisation  status  immunisation  given,  immunised  -  not  given  partially  immunised-  partially 
homeopathic  alternative  Men  C  or  MMR  not  given  Men  C  immunised 
given  instead. 
2"  Child's  gender,  age,  Boy,  2yrs  9mths,  no  Boy,  4yrs,  partially  Boy,  4yrs  10mths,  Boy,  3yrs  6mths, 
immunisation  status  immunisation  given,  immunised  -  not  given  partially  immunised-  no  immunisation 
homeopathic  alternative  Men  C  or  MMR  not  given  Men  C  given  or  planned 
given  instead. 
3rd  Child's  gender,  age,  -  Boy,  2yrs,  no  Boy,  2yrs  5mths,  no  Girl,  lyr  llmths 
immunisation  status  immunisation  given  or  immunisation  given  or  no  immunisation 
planned  planned  given  or  planned 
4th  Child's  gender,  age,  Girl,  4wks,  no 
immunisation  status  plans  to 
immunise 
GROUP  15:  AUTISTIC  CLUB  GROUP 
Recruited  from  a  club  for  autistic  children  (specially  convened  group) 
Participant's  Pseudonyms  Lesley  Dianna  Jacqueline 
Participant's  Age  omitted  omitted  omitted 
Occupation  by  social  class  omitted  omitted  omitted 
1"  Child's  gender  & 
immunisation  status 
Boy,  fully  immunsed  Boy,  partially  immunised 
omitted 
Boy,  partially  immunised 
2  Child's  gender  & 
immunisation  status 
Boy,  partially  immunised 
not  given  2°d  MMR 
Boy,  no  plans  to  immunise  Boy,  partially  immunised Appendix  H  cont 
GROUP  16:  AUTISM  SUPPORT  GROUP 
Recruited  from  the  National  Autistic  Society  (specially  convened  group) 
Participant's  Pseudonyms  Stella  Alison  Caroline 
Participant's  Age  omitted  omitted  omitted 
Occupation  by  social  class  omitted  omitted  omitted 
1"  Child's  gender  & 
immunisation  status 
Boy,  fully  immunised  Boy,  partially  immunised  Boy,  partially  immunised 
2m  Child's  gender  & 
immunisation  status 
Boy,  partially  immunised  Boy,  partially  immunised  Boy,  partially  immunised 
GROUP  17:  CANCER  SUPPORT  GROUP 
Recruited  through  a  parent  support  group  (specially  convened  group) 
Participant's  Pseudonyms  Sally  Rebecca  Pamela 
Participant's  Age  45  49  42 
Occupation  by  social  class  11  At  home  full-time  (used  to  be  11 
a  nurse) 
Child's  gender,  age,  Girl,  25yrs,  fully  Boy,  21yrs,  fully  immunised  Boy,  l3yrs,  fully  immunised 
immunisation  status  immunised 
2  Child's  gender,  age,  Boy,  20yrs,  fully  Girl,  l7yrs,  fully  immunised  Girl,  l  lyrs,  fully  immunised 
immunisation  status  immunised 
3rd  Child's  gender,  age,  Boy,  9yrs,  no  known  Girl,  l2yrs,  fully  immunised  Girl,  8  yrs,  no  known  antibody 
immunisation  status  antibody  immunity  due  to  immunity  due  to  treatment  for 
treatment  for  cancer.  Not  cancer.  Not  re-vaccinated 
re-vaccinated 
4th  Child's  gender,  age,  Girl,  8yrs,  no  known  antibody 
immunisation  status  immunity  due  to  treatment  for 
cancer.  Not  re-vaccinated Appendix  H  cont 
GROUP  18:  OUTPATIENT  CANCER  GROUP 
Recruited  through  snowballing  from  parents  knowing  each  other  from  out-patient  clinics  at  hospital  visits  (specially  convened  group) 
Participant's  Pseudonyms  All  Cara  Jessie 
Participant's  Age  38  36  53 
Occupation  by  social  class  11  11  At  home  full-time 
is  Child's  gender,  age,  Girl,  16yrs,  no  known  Girl,  8yrs,  no  known  antibody  Girl,  25yrs,  fully  immunised 
immunisation  status  antibody  immunity  due  to  immunity  due  to  treatment  for 
treatment  for  cancer.  Not  cancer.  Not  re-vaccinated 
re  vaccinated 
2  Child's  gender,  age,  Boy,  14yrs,  fully  Boy,  6yrs,  fully  immunised  Girl,  l9yrs,  fully  immunised 
immunisation  status  immunised 
3rd  Child's  gender,  age,  Boy,  14yrs,  fully  Boy,  16  yrs,  no  known  antibody 
immunisation  status  immunised  immunity  duo  to  treatment  for 




Dear  Parent, 
MRC Medical  Research  Council 
Social  and  Public  Health  Sciences  Unit 
University  of  Glasgow 
4  Lilybank  Gardens 
G12  8RZ 
My  name  is  Shona  Hilton.  I  am  a  researcher  at  Glasgow  University  carrying  out  a  study  on 
parents'  perceptions  of  childhood  infectious  diseases,  MMR  and  other  childhood  immunisation. 
At  present  I  am  recruiting  parents  with  different  views  and  experiences  of  childhood 
immunisation.  I  plan  to  hold  a  discussion  group  with  parents  who  have  children  with  autism 
here  in 
.............. 
Community  Centre  in  November.  If  you  would  be  willing  to  take  part  in  a 
group  discussion  on  immunisation  I  would  be  happy  to  hear  from  you. 
Further  details  of  the  study  are  attached  along  with  my  contact  details.  However,  if  you  prefer 
you  can  send  me  with  your  contact  details  in  the  attached  envelope  and  I  will  make  contact  with 
you. 
If  you  are  willing  to  take  part  I  would  be  very  grateful.  Thank  you  very  much  for  your  help. 
Yours  sincerely 




Appendix  J 
MRC Medical  Research  Council 
Parents'  perceptions  of  childhood  infectious  diseases,  MMR  and  other  childhood  immunisation. 
Name: 
...  ...  ...  ...  ...  ...  ...  ...  ...  ...  ...  ...  ...  ...  ...  ...  ...  ...  ...  ...  ... 
Age:...................... 
Address 
.......................................................................................  . 
Post-code: 
...  ...  ...  ...  ...  ...  ...  ...  ... 
Occupation 
................................................  . 
Marital  Status  (please  tick) 
Q  Married 
Q  Cohabiting 
o  Single 
Q  Separated 
o  Divorced 
o  Widowed Please  fill  in  the  grid  below  using  a  new  row  for  each  of  your  children. 
Child's  age  Boy  or  Girl  Immunisation  status 
Example:  Tick  box  if  your  child  has  had  each 
lyr  2mths  Girl  vaccine,  if  not  please  state  whether  you 
plan  to  have  it,  or  not. 
Q  DTP/Hib/Men  C  1St  @  2mths 
Q  DTP/Hib/Men  C  2nd 
@  3mths 
o  DTP/Hib/MenC  3rd  @  4mths 
o  Polio  1st  @  2mths 
o  Polio  2nd  @  3mths 
Q  Polio  3rd  @  4mths 
o  MMR  ist  between  12  and  15mths 
Q  MMR  2nd  pre-school  booster 
o  DTP/Hib 
pre-school  booster 
Q  Polio  pre-school  booster 
Q  DTP/Hib/Men  C  Ist  @  2mths 
o  DTP/Mb/Men  C  2nd  @  3mths 
o  DTP/Hib/MenC  3rd  @  4mths 
o  Polio  1st  @  2mths 
o  Polio  2nd  @  3mths 
o  Polio  3rd  @  4mths 
Q  MMR  1st  between  12  and  15mths 
o  MMR  2nd  pre-school  booster 
o  DTP/Hib 
preschool  booster 
El  Polio  pre-school  booster 
Q  DTP/Hib/Men  C  1"  @  2mths 
Q  DTP/Hib/Men  C 2nd  @  3mths 
Q  DTP/Hib/MenC  3rd  @  4mths 
o  Polio  1st  @  2mths 
Q  Polio  2nd  @  3mths 
Q  Polio  3rd  @  4mths 
o  MMR  ist  between  12  and  15mths 
o  MMR  2nd  pre-school  booster 
o  DTP/Hib  preschool  booster 
Q  Polio  pre-school  booster 
Q  DTP/Mb/Men  C  1St  @  2mths 
Appendix  J  cont o  DTP/Hib/Men  C  2nd 
@  3mths 
o  DTP/Hib/MenC  3rd  @  4mths 
o  Polio  1st  @  2mths 
o  polio  2nd  @  3mths 
o  Polio  3rd  @  4mths 
o  MNm  ist  between  12  and  15mths 
MMR  2nd  pre-school  booster 
C3 
Q  DTP/Hib  pre-school  booster 
Q  Polio  pre-school  booster 
Q  DTP/Hib/Men  C  1st  mt 
o  DTP/Hib/Men  C  2nd 
@  3mths 
o  DTP/Hib/MenC  3rd  @  4mths 
Q  Polio  1st  @  2mths 
o  Polio  2nd  @  3mths 
Q  Polio  3rd  @  4mths 
o  MMR  1st  between  12  and  15mths 
o  MMR  2nd  pre-school  booster 
o  DTP/Hib 
pre-school  booster 
o  Polio  preschool  booster 
o  DTP/Hib/Men  C  lst  mt 
o  DTP/Hib/Men  C  2°d  @  3mths 
o  DTP/Hib/MenC  3rd  @  4mths 
o  Polio  Ist  @  2mths 
o  Polio  2nd  @  3mths 
o  Polio  3rd  @  4mths 
o  MMR  2nd  pre-school  booster 
o  DTP/Hib  preschool  booster 
o  Polio  preschool  booster 
If  none  of  the  above  apply,  please  describe  your  children's  immunisation  status 
overleaf  ..................................................................... 
THANK  YOU 
Any  further  comments Appendix  K 
Descriptions  of  the  vaccine  preventable-diseases  included  in  the  Childhood 
Immunisation  Programme 
Source:  www.  scieh.  org.  uk Diphtheria 
Causative  Agent 
Corynebacterium  diphtheriae  (toxin  producing  strains). 
Clinical  Description 
Diphtheria  is  an  acute  bacteria]  disease  resulting  from  toxigenic  C.  diphtheriae  or  more  rarely 
C.  ulcerans  infection  of  the  upper  respiratory  tract  and  occasionally  the  skin.  An  inflamed  thick 
greyish  adherent  membrane  forms  at  the  site  of  infection,  which,  in  severe  cases,  may  cause 
respiratory  obstruction  (croup).  Other  severe  complications  can  include  toxin-induced 
myocarditis  and  peripheral  neuritis.  The  case  fatality  ratio  for  respiratory  diphtheria  is  5-10%. 
Transmission 
Respiratory  transmission  through  contact  with  an  infectious  individual,  or,  rarely,  indirectly  via 
fomites.  The  incubation  period  is  usually  two  to  five  days.  A  patient  with  clinical  diphtheria  is 
infectious  for  two  to  four  weeks  after  onset,  although  rarely  chronic  carriers  may  shed 
bacteria  for  up  to  six  months. 
Surveillance  In  Scotland 
Laboratory  reports  of  toxigenic  Corynebacterium  diphtheriae. 
Statutory  notification  of  respiratory  diphtheria  by  clinical  diagnosis.  (The  disease  is  also 
statutorily  notifiable  under  its  previous  nomenclature  of  membranous  croup). 
Definition  for  Surveillance 
Notification  (suggested) 
Any  person  with: 
-  laryngitis 
or 
-  pharyngitis 
or 
-  tonsillitis 
and 
adherent  membrane  of  the  tonsil(s),  pharynx,  and/or  nose.  (CDC/WHO) 
Laboratory  Report 
Laboratory  reports  of  toxigenic  Corynebacterium  diphtheriae  or  Corynebacterium  ulcerans 
Incidence 
Recently  there  have  been  very  few  notifications  for  diphtheria  and  laboratory  reports  of 
toxigenic  C.  diphtheriae  are  extremely  rare.  There  have  been  only  four  notifications  of 
diphtheria  and  no  laboratory  reports  of  toxigenic  C.  diphtheriae  during  the  decade  1990-99. 
However  the  threat  from  imported  organisms  remains,  most  notably,  in  recent  years,  from  the 
former  Soviet  Union  states. 
2001  zero  notifications 
2001  zero  laboratory  reports Prevention 
Vaccination  against  diphtheria  was  introduced  in  the  1940's.  Diphtheria  vaccine  is  still 
included  in  the  UK  childhood  immunisation  schedule,  with  routine  primary  vaccination 
recommended  at  two,  three  and  four  months,  a  booster  dose  at  three  to  five  years  and  a  low 
dose  booster  at  13-18  years. 
Further  information  on  diphtheria  can  be  found  on  page  4  of  the  Review  of  Communicable 
Diseases  in  Scotland  1999  (pdf  document  -  Acrobat  Reader  required) 
Top Haemophilus  influenzae  type  b 
Causative  Agent 
Haemophilus  influenzae  type  b. 
Clinical  Description 
Invasive  infection  with  Haemophilus  influenzae  type  b  (Hib)  most  commonly  presents  as 
meningitis  and  bacteraemia  (approximately  60%  of  cases),  followed  by  epiglottitis  (15% 
cases)  and  septicaemia  (10%  cases).  Cases  of  Hib  pneumonia,  septic  arthritis,  cellulitis, 
osteomyelitis,  pericarditis  and  empyema  also  occur.  Prior  to  the  introduction  of  Hib  vaccine, 
rates  of  disease  were  highest  in  children  under  the  age  of  one.  Neurological  complications  of 
Hib  meningitis  occur  in  15-30%  of  survivors  and  include  deafness,  convulsions  and  learning 
disabilities  and  mental  retardation.  The  case  fatality  ratio  is  approximately  5%. 
Transmission 
Respiratory  transmission  from  infectious  carriers,  usually  asymptomatic  individuals.  The 
incubation  period  is  short,  probably  two  to  four  days. 
Surveillance  in  Scotland 
Laboratory  reports  for  Haemophilus  influenzae  type  b. 
Definition  for  Surveillance 
Notification 
Not  notifiable. 
Laboratory  Report 
Laboratory  reports  of  Haemophilus  influenzae  type  b  from  a  normally  sterile  site. 
Incidence 
Hib  disease  is  not  notifiable,  so  incidence  is  indicated  by  laboratory  reports.  The  number  of 
laboratory  reports  fell  dramatically  after  vaccine  introduction.  The  marked  reduction  is  not  just 
in  the  vaccinated  high-risk  age  group  (less  than  one  year),  but  also  in  older  age  groups.  This 
effect  is because  the  vaccine  not  only  protects  the  vaccinated  individual  against  disease,  but 
also  prevents  carriage  of  the  organism,  decreasing  transmission  of  the  organism  in  the  wider 
community. 
2001  13  laboratory  reports. 
Prevention 
Hib  vaccine  was  introduced  in  1992,  making  it  the  first  vaccine  available  to  protect  very 
young  children  (less  than  two  years)  against  bacterial  meningitis.  Hib  vaccine  is  included  in 
the  UK  Childhood  Immunisation  schedule,  with  routine  vaccination  recommended  at  two, 
three  and  four  months. 
Further  information  on  haemophilus  influenzae  type  b  can  be  found  on  page  5  of  the  Review 
of  Communicable  Diseases  in  Scotland  1999  (pdf  document  -  Acrobat  Reader  required) Measles 
Causative  agent 
Measles  virus 
Clinical  description 
Measles  is  an  acute  viral  disease  resulting  from  infection  with  measles  virus.  There  is 
prodromal  fever,  malaise,  conjunctivitis,  coryza,  cough  and  Koplik  spots.  A  maculopapular 
rash  spreads  from  the  head  to  the  body  and  limbs.  Complications  of  measles  occur  for 
around  one  in  15  notified  cases  and  include  otitis  media  bronchitis,  pneumonia,  convulsions 
and  encephalitis.  A  rare  complication  of  measles  is  subacute  sclerosing  panencephalitis 
(SSPE),  a  fatal  degenerative  neurological  disorder.  Measles  is  more  severe  for  infants  and 
adults  than  children.  The  case  fatality  ratio  is  approximately  one  to  two  deaths  per  1000 
cases.  The  case  fatality  ratio  is highest  for  children  under  one  year  of  age. 
Transmission 
Respiratory  transmission  from  infected  individuals.  The  incubation  period  is  about  10  days 
and  usually  14  days  until  the  appearance  of  rash.  A  measles  case  is  infectious  from  four 
days  before  the  appearance  of  rash  Cie  one  day  before  prodromal  phase)  to  four  days  after 
its  appearance. 
Surveillance  in  Scotland 
Statutory  notification  of  measles  by  clinical  diagnosis 
Laboratory  reports  for  measles  virus 
Laboratory  confirmation  of  notified  cases  by  salivary  testing 
Definition  for  surveillance 
Notification  (suggested) 
Any  person  with: 
"fever  (=38.3°C) 
and 
"  maculopapular  (i.  e.  non-vesicular)  rash  lasting  =3  days 
and 
cough,  coryza  (i.  e.  runny  nose)  or  conjunctivitis  (i.  e.  red  eyes)  (CDC) 
Laboratory  report 
Laboratory  reports  for  measles  virus,  excluding  those  following  vaccination 
Incidence 
Vaccination  has  led  to  a  dramatic  decrease  in  measles  notifications,  with  only  315  received 
during  2001.  This  is  in  marked  contrast  to  the  nearly  25,000  notifications  received  in  1970. 
No  laboratory  reports  were  received  for  measles  in  2001,  this  first  year  for  this  to  happen.  A 
salivary  surveillance  scheme  exists  in  which  all  notifying  GPs  are  strongly  encouraged  to 
submit  a  salivary  sample  from  all  notified  cases  for  laboratory  confirmation.  Additional 
epidemiological  information  such  as  vaccination  history,  recent  international  travel  and 
contact  with  similar  illness  is  requested  for  all  confirmed  cases.  Genotyping  to  determine  the 
possible  origin  of  the  virus  is  also  attempted.  In  2001,  of  the  147  salivary  samples  submitted 
for  measles  confirmation,  none  was  consistent  with  recent  measles  infection.  However,  three 
cases  of  measles  were  confirmed  in  Fife  in  March  2002,  the  first  since  April  2000.  Scotland 
had  recently  been  fortunate  in  not  having  any  outbreaks  of  measles  similar  to  those  seen  in 
England  and  the  Republic  of  Ireland.  However,  small  localised  outbreaks  are  an  inevitable 
consequence  of  reduced  uptake  of  MMR. 
2001  315  notifications 2001  zero  laboratory  reports 
Prevention 
Vaccination  against  measles  was  introduced  in  1968.  The  measles  antigen  was  combined 
with  mumps  and  rubella  with  the  introduction  of  the  combined  MMR  vaccine  in  1988. 
Increased  incidence  of  measles  in  1994  prompted,  later  that  year,  mass  schools  vaccination 
with  measles  and  rubella  (MR)  vaccine  for  all  children  aged  five  to  16  years,  as  mathematical 
modelling  predicted  more  cases  in  the  future.  A  second  dose  of  MMR  was  introduced  for  pre- 
school  children  in  1996,  as  a  one  dose  programme  would  not  support  eventual  measles 
elimination.  The  second  dose  protects  children  who  may  not  have  responded  to  the  first 
dose,  and  offers  a  further  opportunity  to  those  who  may  not  have  received  the  first  dose. 
Measles  vaccine  is included  in  the  UK  childhood  immunisation  schedule,  with  routine 
vaccination  recommended  at  12-15  months  and  three  to  five  years. 
Further  information  on  polio  can  be  found  on  p1  of  the  Review  of  Communicable  Diseases  in 
Scotland  1999. Meningococcal  Infection 
Causative  Agent 
Neisseria  meningitidis,  of  which  there  are  a  number  of  different  sero-groups,  is  classified 
according  to  its  outer  membrane  characteristics,  the  most  common  in  Scotland  and  the  UK 
being  sero-groups  B  and  C.  Sero-groups  Y,  W135,  and  X  are  also  regularly  encountered. 
Clinical  Description 
Meningitis:  includes  meningitis  of  any  infectious  cause  but  excluding  meningococcal 
septicaemia.  Enquiries  are  often  aimed  at  meningococcal  infection  rather  than  all  causes  of 
meningitis.  Meningococcal  infection  refers  exclusively  to  invasive  infections  of  Neisseria 
meningit;  drs,  whether  of  CSF,  blood  or  other  sterile  sites,  plus  meningococcal  conjunctivitis. 
Transmission 
Nersseria  meningiitkfis  is  a  very  common  infection  of  the  respiratory  tract  and  carriage  rate  is 
of  the  order  of  10%  or  higher.  The  vast  majority  of  individuals  who  are  colonised  remain 
asymptomatic  and  invasive  cases  invariably  acquire  their  infection  from  non  symptomatic 
carriers. 
Surveillance  In  Scotland 
Enhanced  surveillance  data  as  recorded  jointly  by  SCIEH  and  by  the  Scottish 
Meningococcal  &  Pneumococcal  Reference  Laboratory  (to  which  all  hospitals  in  Scotland 
send  their  samples)  is  used  for  the  most  up  to  date  recent  notifications  and  laboratory 
confirmed  cases  as  well  as  for  *more  complex  analyses  (age  groups,  sero-groups,  deaths 
etc). 
Trends  In  Scotland  (1995-2000) 
Notifications  of  meningococcal  infection  (meningitis,  septicaemia,  infection  of  normally 
sterile  sites,  conjunctivitis)  remained  fairly  stable  at  between  100  and  200  cases  per  year 
from  1977  untl  the  late  1990's,  when  the  increase  in  1997  was  sustained  throughout  1998 
and  1999.  An  unusually  large  influenza  outbreak  in  1999/2000  brought  about  a  further 
increase,  the  association  of  flu  outbreaks  (particularly  influenza  A)  and  meningococcal 
Infection  being  well  recognised. 
There  has  been  a  striking  oscillation  in  the  predominant  serogroup  causing  meningococcal 
disease  in  Scotland,  with  Group  B  and  Group  C  contributing  almost  equally  over  the  past 
few  years.  Group  C  infections  were  more  common  in  1998,  and  in  the  first  part  of  1999  prior 
to  the  MenC  conjugate  meningococcal  vaccine  programme  being  commenced  in  November 
1999.  Group  A  Infections  have  effectively  been  unknown  in  Scotland  for  many  years.  There 
has  also  been  a  shift  in  recent  years  towards  the  disease  affecting  older  age  groups. 
Incidence  and  Risk 
Between  300  and  400  notifications  of  meningococcai  disease  are  currently  notified  in 
Scotland  each  year,  with  the  majority  of  cases  in  children  and  young  adults.  There  has  been 
a  shift  towards  older  age  groups  In  recent  years  with  an  increasing  proportion  of  infections 
In  the  over  21  's. 
Prevention 
Since  the  bacteria  do  not  survive  long  outside  the  body,  prolonged  and  close  contact  with 
an  infected  individual  who  Is  either  III  or  a  carrier  is  required  to  transmit  the  germ. 
Wdespread  preventative  measures  are  therefore  generally  not  indicated.  Antibiotics  (one 
dose  or  a  very  short  course)  are  recommended  for  close  contacts  of  a  case  in  order  to 
prevent  further  spread  from  potential  carriers. Mumps 
Causative  agent 
Mumps  virus 
Clinical  description 
Mumps  is  an  acute  viral  disease  resulting  from  infection  with  mumps  virus.  Clinical  features 
include  fever,  headache  swelling  of  one  or  both  cheeks  or  sides  of  the  jaw  and  swollen 
glands.  The  fever  usually  lasts  for  1  to  6  days  and  the  parotitis  for  up  to  10  days,  or  more. 
Mumps  can  have  serious  complications,  including  aseptic  meningitis  (4-6  %  cases), 
encephalitis  (1  in  1000  cases),  inflammation  of  the  testes  (orchitis),  pancreatitis,  oophoritis 
and  permanent  deafness.  Neurological  involvement  occurs  in  10-20%  of  cases  and  may 
precede  or  follow  parotitis,  and  can  also  occur  in  its  absence.  Orchitis  is  the  most  common 
complication  of  mumps  in  adult  males  (4  out  of  10  cases).  Fulminant  encephalitis  is  rare,  but 
a  potentially  fatal  complication  of  mumps. 
Transmission 
Respiratory  transmission  from  infected  individuals.  The  incubation  period  ranges  from  12-25 
days.  and  is  usually  about  18  days.  A  mumps  case  is infectious  from  about  6-7  days  before 
onset  of  parotitis  urns  9  days  after,  although  clinical  inapparent  cases  can  also  be 
communicable. 
Surveillance  in  Scotland 
Statutory  notification  of  mumps  by  clinical  diagnosis 
Laboratory  reports  for  mumps  virus 
Laboratory  confirmation  of  notified  cases  by  salivary  testing 
Definition  for  surveillance 
Notification  (suggested) 
Any  person  with: 
acute  onset  of  unilateral  or  bilateral  tender,  self-limited  swelling  of  the  parotid  or  other 
salivary  gland,  lasting  =2  days,  and  without  other  apparent  cause  (CDC) 
Laboratory  report 
Laboratory  reports  for  mumps  virus,  excluding  those  due  to  vaccination 
Incidence 
Mumps  became  a  notifiable  disease  in  October  1988,  with  the  introduction  of  MMR  vaccine. 
There  were  3095  notifications  in  1989.  Just  over  a  decade  later,  in  2001,  there  were  only  155 
notifications  and  6  laboratory  reports  of  confirmed  infections.  A  salivary  surveillance  scheme 
exists  for  mumps,  in  which  all  notifying  GPs  are  strongly  encourage  to  submit  a  salivary 
sample  from  all  notified  cases  for  laboratory  confirmation.  Additional  information  such  as 
vaccination  history,  recent  international  travel  and  contact  with  similar  illness  is  requested  for 
all  confirmed  cases.  Genotyping  to  determine  the  possible  origin  of  the  virus  may  also  be 
attempted.  In  2001,  of  the  54  samples  submitted  for  mumps  confirmation,  only  one  was 
consistent  with  recent  mumps  infection.  In  the  first  half  of  2002,  there  has  been  a  localised 
outbreak  of  mumps,  in  Dumfries  and  Galloway  Health  Board,  mostly  in  teenagers  and  young 
adults.  M  increase  in  the  number  of  mumps  case  was  also  been  observed  in  England, 
Wales  and  Northern  Ireland  in  2001.  The  age  cases  in  these,  largely  schools-based 
outbreaks,  indicated  that  many  may  have  received  only  one  dose  of  mumps-containing 
vaccine,  or  none  at  sfl. 
2001  155  tatiftations 2001  6  laboratory  reports 
Prevention 
Protection  against  Humps  was  fast  offered  with  the  introduction  of  MMR  vaccine  in  October 
1988.  Mumps  vaccine  is  included  in  the  UK  Childhood  Immunisation  schedule,  with  routine 
vacciniation  recommended  12-15  months  and  3-5  years. 
Further  information  on  polio  can  be  found  on  p1  of  the  Review  of  Communicable  Diseases  in 
Scotland  1999. Poliomyelitis 
Causative  agent 
Poriovvuses  types  1.2  and  3  (wild  type) 
Clinical  description 
Poliomyelitis  is  an  acute  infection  caused  by  any  of  the  three  wild  type  polioviruses.  Over 
90%  of  infections  are  asymptomatic.  The  remainder  of  infections  result  in  clinical  illness, 
which  can  range  from  non-specific  febrile  illness  (5%  of  infections),  aseptic  meningitis  (1  %  of 
infections)  to  flaccid  paralysis  (<1%  of  infections).  The  risk  of  paralytic  poliomyelitis  varies 
wish  age,  rising  from  approximately  1  in  1000  infections  in  infancy  to  up  to  1  in  10  infections 
for  adutis.  Paralysis  is  more  likely  to  affect  the  legs  than  the  arms,  but  can  involve  all  four 
limbs.  Recovery  may  be  complete  or  only  partial  and  post-polio  syndrome,  a  deterioration  of 
the  originally  affected  muscles  has  been  reported  to  occur  30-50  years  later  in  many 
patients.  If  the  paralysis  also  affects  muscles  for  breathing  and  swallowing,  poliovirus 
infection  is  We  threatening  . 
Transmisslon 
primarily  person-to-person  transmission  through  the  faecal-oral  route.  The  incubation  period 
is  usually  7-14  days  for  paralytic  cases,  but  with  a  reported  range  of  3-  35  days.  An  infected 
person  may  transmit  virus  in  throat  secretions  for  3  -10  days  after  exposure  and  in  the 
faeces  for  up  to  6  weeks.  but  is  most  infectious  in  the  few  days  before  and  after  onset  of 
symptom.  As  humans  are  the  only  reservoir  of  infection,  eradication.  through  vaccination  is 
possible. 
Surveillance  In  ScoUand 
Statutory  notification  of  poi  omyehtis 
Laboratory  reports  for  wiidtype  polio  vies. 
Definition  for  surveiüance 
Notification 
Any  person  wish 
acute  onset  of  a  flaccid  paralysis  of  one  or  more  limbs  with  decreased  or  absent  tendon 
reflexes  in  the  affected  limbs,  without  other  apparent  cause,  and  without  sensory  or  cognitive 
loss  (CDC) 
Laboratory  report 
Laboratory  reports  for  wild  type  polio  virus  (as  opposed  to  live  attenuated  oral  polio  vaccine 
virus) 
tnddence 
There  have  been  no  cases  of  indigenous  wild  type  polio  in  the  UK  for  over  15  years  now. 
The  last  notsfication  of  polio  in  Scotland  was  in  1994,  and  was  vaccine-associated  paralytic 
polioc  t  des,  rather  than  derived  from  wild  type  virus.  The  patient  (male,  age  62  years)  had 
been  in  dose  contact  with  a  recent  recipient  of  oral  polio  vaccine.  The  European  Region  of 
the  World  Hea`ih  Organisation  was  certified  polio-free  in  June  2002,  having  been  free  of 
indigenous  polio  for  over  three  years.  However,  poliovirus  imported  from  polio-endemic 
countries  remains  a  threat. 
2001  zero  notfcalioris 
2001  Zero  taboralory  reports 
Prtwntion 
PoCio  vacänation  was  introduced  in  the  UK  in  1956,  in  the  wake  of  dramatic  paralytic poliomyetais  epidemics.  Injectable  inactivated  polio  vaccine  (IPV)  was  used  initially,  but  this 
was  replaced  with  oral  We  atenuated  vaccine  (OPV)  in  1962.  OPV  is  included  in  the  UK 
ChIdhood  Imn  ion  schedule,  with  routine  primary  vaccination  recommended  at  2,3 
and  4  months,  and  booster  doses  at  3-5  years  and  13-18  years. 
Further  information  on  polio  can  be  found  on  p4  of  the  Review  of  Communicable 
Diseases  In  Sco"Jwod  1999. Rubella 
Causative  agent 
Rubella  virus 
Clinical  description 
Rubefa  is  an  acute  viral  infection  caused  by  rubella  virus.  It  is  generally  a  mild  illness,  but  if 
acquired  by  women  in  earty  pregnancy  can  have  devastating  effects  on  the  unborn  child, 
Ieadng  to  congenital  rubella  syndrome.  The  virus  affects  all  fetal  organs  and  can  lead  to 
serious  birth  defects.  These  include  learning  difficulties,  cataracts,  deafness,  cardiac 
abnormalities,  retardation  of  intrauterine  growth  and  inflammatory  lesions  of  the  brain,  liver, 
tangs  and  bone  marrow.  Non-fetal  complications  include  arthritis  and  arthralgia  in  adults, 
especially  women,  and  encephalitis  (approxirnately  t  in  6000  cases),  which  can  be  fatal. 
Transmission 
dory  transmission  from  infected  individuals.  The  incubation  period  is  usually  14  to  21 
days.  A  nibeca  case  is  infectious  for  about  1  week  before  to  at  least  4  days  after  the  onset  of 
rash. 
Surveillance  in  Scotland 
Statutory  notification  of  rubella  by  clinical  diagnosis 
Laboratory  reports  for  rubella  virus 
Laboratory  confirmation  of  notified  cases  by  salivary  testing 
Definition  for  surveillance 
Notification  (suggested) 
Any  person  WUt 
"  acute  onset  of  generalized  macUopaputar  rash 
and 
"  teMeratue  (>37.2  °  C) 
and 
a  Rtualgia/aritvitis  or  lymphadenopathy  or  conjunctivitis  (CDC) 
Laboratory  report 
Laboratory  reports  for  rubella  vrus,  excluding  those  due  to  vaccination 
Incidence 
The  introduction  of  MMR  vaccine  in  October  1988  led  to  a  marked  decrease  in  the  incidence 
of  rubella.  as  the  previous  policy  of  selective  immunisation  had  little  impact  on  the  circulation 
of  rubella  in  the  communiity.  There  were  only  234  notifications  for  rubella  in  2001  and  two 
laboratory  confirmed  cases,  compared  to  6628  notifications  and  356  laboratory  confirmed 
cases  In  1989.  A  salivary  surveillance  scheme  exists  for  rubella,  in  which  all  notifying  GPs 
are  strongly  encourage  to  submit  a  salivary  sample  from  all  notified  cases  for  laboratory 
confirmation.  Additional  information  such  as  vaccination  history,  recent  international  travel 
and  contact  with  simian  illness  is  requested  for  all  confirmed  cases.  Genotyping  to  determine 
the  possible  origin  of  the  virus  may  also  be  attempted.  In  2001,  of  the  113  samples  submitted 
for  rubella  confirmation.  orgy  one  was  consistent  with  recent  rubella  infection.  The  small 
number  of  laboratory  confirmed  cases  still  oarring  indicate  that  females  of  child  bearing  age 
remain  at  risk  of  infection  through  circulating  virus,  unless  protected  by  vaccination. 
2001  358  notifications 
1999  2  laboratory  reports Prevention 
The  primary  airs  of  rubeAa  vaccination  is  to  protect  pregnant  women  from  rubella  infection, 
resittant  cortgtw  infection,  and  fetal  damage.  This  is  why  UK  policy,  when  the  vaccine 
was  orignaify  iintroduced  in  1970,  was  for  selective  immunisation  of  pre-adolescent  girls  and 
non4mmune  women  of  chid  bearing  age.  However,  as  this  strategy  has  little  impact  on  the 
circa  aiion  of  rubella  virus  in  the  community,  rubella  vaccination  was  offered  to  both  boys  and 
girls  with  the  introduction  of  MMR  vaccine  in  1988.  Rubella  antigen  was  also  include  in  the 
1994  schools  campaign  against  measles,  as  MR  vaccine,  with  the  specific  aim  of  reducing 
susaeptbüty  among  young  men,  who  may  be  in  close  contact  with  pregnant  women.  Rubella 
vaccine  is  inducted  in  the  UK  Childhood  Immunisation  schedule,  with  routine  vaccination 
recommended  12-15  months  and  3.5  years. 
F  rther  information  on  polio  can  be  found  on  p1  of  the  Review  of  Communicable  Diseases  in 
Scotland  1999. Tetanus 
CausaUw  Apwt 
CJfostridarrr  tetani. 
CnInlcal  Dsscriptlon 
TetarxA  is  an  acute  disease  induced  by  the  toxin  of  Clostridium  tetani,  a  bacterium  that 
grows  anaerobicalty  after  being  introduced  by  injury.  The  neurotoxin  causes  muscular  rigidity 
and  agonising  contractions.  These  tend  to  begin  as  spasms  in  the  masseter  and  neck 
muscles  (bdcjaw),  progressing  to  the  trunk  and  extremities.  Reported  case  fatality  ratios 
range  from  10.90%,  with  highest  ratios  for  infants  and  the  elderly. 
Transmission 
Wound  colonisation  by  tetanus  spores,  which  are  present  in  soil,  and  animal  faeces.  The 
inaibabon  period  is  usually  three  to  21  days,  but  may  range  from  one  day  to  several  months, 
depending  on  to  type  of  wound. 
Surveillance  in  Scotland 
S=Aory  rc  xficabon  of  tetanus  by  finical  diagnosis.. 
Laboratory  reports  of  toxigenic  fiiln  tetanr. 
Definition  for  Survslltancs 
Notification  (suggested) 
Any  person  v4h: 
acute  onset  of  hypertonia  and'or  painful  muscular  contractions  (usually  of  the  muscles  of  the 
jaw  and  neck)  and  generalized  muscle  spasms  without  other  apparent  medical  cause  (CDC). 
Laboratory  R.  port 
Laboratory  reports  of  poSVidixxn  tetani  (NB  laboratory  tests  are  not  normally  performed). 
lndd*nco 
7etarxis  is  now  extremely  rare.  During  the  years  1990-99  there  were  only  seven  notifications 
and  one  laboratory  report.  Nevertheless,  vaccination  against  tetanus  must  be  maintained,  as 
the  cordirx  ed  presence  of  the  causative  organism.  toxigenic  Clostridium  tetani  in  the 
ertvirormervt  makes  eradication  irnpossible.  This  is highlighted  by  a  clinical  case  of  tetanus  in 
Glasgow  in  Apri  2002  mew  Qrrent  Note  -  pdf).  The  patient  (male,  age  26  years)  reported 
sustairig  a  mild  arm  wound.  but  was  also  known  to  be  a  current  injecting  drug  user. 
2D01  zero  notifications 
2001  zero  laboratory  reports 
Prmntlon 
Tetanus  vaccination  has  been  offered  on  a  national  scale  since  the  1960s,  before  which  it 
was  offered  only  to  men  during  their  period  of  National  Service.  Tetanus  vaccine  is  included 
In  the  UK  Ch  &2=d  Inmrxnisation  schedule.  with  routine  primary  vaccination  recommended 
at  two,  three  and  four  moms,  and  booster  doses  at  three  to  five  years  and  13-18  years. 
Patients  who  have  had  clinical  tetanus  need  to  be  immunised  before  discharge. 
Furtttier  information  on  tetanus  can  be  found  on  page  5  of  the  Review  of  Communicable 
Diva=  h  Scc  wd1?  29  (pdf  document  -  Acrobat  Reader  required) Whooping  Cough  (Pertussis) 
Causattw  Agent 
Bardetelta  perriussis  and.  occasionafy.  &  paraperiussis. 
Clinical  Description 
Whooping  cough  is  an  acute  bacterial  disease  of  the  respiratory  tract,  resulting  from  infection 
with  BonJeteda  pe  t  sue,  or  occasionally  milder  disease  with  B.  parapertussis.  Onset  is 
insidious  with  an  initial  cattarthal  stage  causing  an  intermittent  irritating  cough  that  gradually 
becomes  paroxysms  within  one  to  two  weeks.  Paroxysms  comprise  a  series  of  coughs, 
without  opportur  ty  for  inspiration,  followed  by  the  characteristic  inspiratory  'whoop'.  The 
paroxysmal  phase  may  Last  for  two  to  three  months,  and  apnoea,  cyanosis,  and  post-tussive 
vomiting  may  occur.  Ccrnplications  of  whooping  cough  include  bronchopneumonia,  acute 
encephalopathy,  and  long-term  brain  damage  as  a  result  of  cerebral  hypoxia.  Complications 
and  deans  from  whooping  cough  are  most  frequently  seen  in  infants  less  than  six  months  of 
age;  this  prompted  the  introduction  of  an'accelerated'  UK  primary  immunisation  schedule  for 
vaccination  at  two,  three,  and  four  months  of  age.  Those  too  young  to  be  vaccinated  continue 
to  be  at  highest  risk  of  severe  disease.  The  disease  is  generally  mild  in  adolescents  and 
adds. 
Transmlulon 
Respira3ory  trartsrt  sion  through  contact  with  an  infectious  individual.  The  incubation  period 
is  between  sic  and  20  days,  usually  seven  to  ten  days.  Infected  individuals  are  most 
infectious  in  the  initial  catarrhal  phase,  before  onset  of  paroxysms.  Communicability  then 
deddnes,  and  by  t  ree  weeks  after  onset  of  paroxysms  an  individual  may  be  considered  non- 
infectious  for  nonfiousehold  contacts. 
Surveillance  In  Scotland 
Statutory  not:  ficalion  of  whooping  cough 
Lahoraioryreports  for  Bardefeda  pertussis  and  B.  parapertussis. 
Definition  for  Surveillance 
Notification  (suggested) 
Any  person  w4h  cough.  iiness  tasting  two  or  more  weeks  with  one  of  the  following: 
"  parocysrrts  (i.  e.  fxs)  d  cougtwwýg. 
"  iruýýory'rºtýoop.  ' 
"  or  post-tussive  VOfTlmlg. 
"  without  ott*r  apparwt  cause 
Laborstory  Report 
Laboratory  reports  for  &xdetiWU  Periusss,  or  B.  parapefussis. 
lncidonce 
prior  to  vaccine  k  oduction,  large  epidemics  of  whooping  cough  occurred  every  three  to  four 
years,  and  In  1951  there  were  nearly  23,000  notifications.  Marked  reductions  in  vaccine 
uptake  in  the  1970s.  as  Ow  resat  of  unfounded  public  and  professional  anxiety  about  the 
safety  of  pertussis  vaccine,  led  to  three  epidemics  of  the  disease.  It  has  only  been  in  the  last 
decade  that  the  incidence  of  whooping  cough  has  returned  to  levels  occurring  before  adverse 
pubic  y.  Whooping  cough  continues  to  show  an  epidemic  cycle,  but  with  much  smaller 
peaks.  The  last  perrod  of  increased  incidence  was  in  1997-98. 
2002  103  nOtd  '  (provisionaf) 2002  1  09  43boratory  reports  for  eardetea  pertussrs 
Prevention 
Immnisation  against  whooping  cough  was  introduced  in  the  UK  in  the  1950s.  Whole  cell 
pertussis  vaccine  is  stil  inctuded  in  the  UK  childhood  immunisation  schedule,  with  routine 
primary  vaccination  recommended  at  two,  three  and  four  months.  A  pre-school  booster  of 
ace&utar  pertussis  vaccne  was  recently  added  to  the  UK  Childhood  Immunisation  Schedule, 
v  rth  etted  from  January  2002  in  Scatiand.  The  booster  was  introduced  as  there  was 
evidence  that  Marts.  too  young  to  be  protected  through  vaccination,  may  be  catching 
pertu  sis  from  older  sb  ngs,  or  parents  with  waning  immunity.  Chief  Medical  Officer  letter,  9 
November  2001.  Current  pre-school  acellutar  pertussis  booster 
ta=/rw,.  ww  show  scat  nft  uk  d'outtca+ionsiCMO(2001)16.  Ddf 
Father  Warmaäon  on  pertussis  (wfi)oping  cough)  can  be  found  on  page  4  of  the  Review  of 
(pdf  document  -  Acrobat  Reader  required) Childhood  Immunisation  Programme  in  December  2001  Appendix  L 
U'sltrd  Klagdom  CkDdbood  Immunisation  Programme 
VACC1ti£I  1101Y  IT  IS  GIVEN  AGE  VACCINE  GIVEN 
IMSEASE 
Polio  By  mouth  2  months 
Dipätbcriatcta  W  Combined  4  in  1  injection  2  months 
Pcmnlis  (DTP)  A  III 
Mca  C  One  injection  2  months 
IIIIIIIIIIIIIIII;  I:  IIIIIIII'l/hW  /UIll(IWiiill  uiIIIIII/lalluNnNII/1I  N____________ýýýý________llllllll 
polio  By  mouth  3  months 
Dil+tbcria'ktanus/  Combined  4  in  1  injection  3  months 
pcrtuisis  (DTP)  & 
Ilib 
Men  C  One  injection  3  months 
IIIIIiIIIIlIIIIIIIIIIIIIIITh7hI1  II/IIIIII;  IIII/IIIIIIIIllltnu/IIIIIIIIIIII  /I/I/I/I//I////I//I//////I//I/////////////// 
polio  By  mouth  4  months 
DipRäcrittcuaus/  3  Combined  4  in  1  injection  4  months 
perts"is  (D'TI')  a 
I  iib 
Men  C  One  injection  4  months 
IIf1IIIIIIIIIIhiIIIIIIIIIIIIIIIIII  III/IIII/IIIIIII/IIIIIIIIIIIIIIIIIIIIIIIIIII  II/IIIIIIIIIIIIIIIIIIIIIIIIII/ll/lllllllllll 
Measks'asa/  Combined  3  in  1  injection  12  to  15  months 
tubcfl  s  (10.1R) 
In!  I!!!  I/UIIIIIII/IAIIIIIIIlluI  /II/IIIIIIIIIII/I/1IIIIIIIU/IJUIIUTAII/I  ///I////////I/I/I/////////////////I///////// 
Polio  By  mouth  3  to  5  years 
Dipthctialrtsares!  Combined  3  in  I  injection  3  to  5  years 
PMUSUS  {  (DT17 
Menmumw  Qimbiwd  3  in  1  injection  3  to  5  years 
nibclls  (MMR) 
Saut%.  v:  ptpunmcnt  of  E  icahh  r001  see  www.  immunisation.  nhs.  uk Appendix  M 
CHECK  LIST 
1.  Check  has  everyone  received  and  read  the  information  sheet? 
2.  Introduce  self  and  research. 
3.  Re-state  the  following: 
-Length  of  time  (approx  1  hr). 
-Voluntary  nature  of  participation. 
-Recording  the  group  discussion. 
-Confidentiality  -  (information  kept  in  locked  drawer  in  MRC  unit  &  not  disclosed  to  anyone 
outside  the  research  team). 
-Anonymity-  (all  documents  and  data  identifiable  only  through  ID  number  and  any  extracts 
used  in  presentations  or  publications  given  pseudonyms  to  protect  identity). 
-Expenses. 
4.  Check  if  there  are  any  questions  or  concerns  about  the  study. 
5.  Get  the  consent  form  signed  and  personal  detail  form  completed. 
'6.  Give  out  discussion  material. 
7.  Switch  on  microphone  and  recorder. 
8.  Map  positions  of  participants  -  (name,  no  of  children  &  age  of  children). Appendix  M  cont 
TOPIC  GUIDE/  PARENTS  OF  AUTISTIC  CHILDREN  (not  in  order) 
EXPERIENCES  OF  CHILDHOOD  IMMUNISATION/  PERCEPTIONS  ABOUT 
VACCINES 
"  Words  /  images  associated  with  immunisation. 
"  Experience  of  immunisation  so  far. 
"  Views  on  the  current  Childhood  Immunisation  Programme. 
(Hand  out  Immunisation  Programme  see  Appendix  L) 
PERCEPTIONS  ABOUT  CHILDHOOD  INFECTIOUS  DISEASES 
"  Words  /  images  associated  with:  -  Diptheria,  tetanus,  whooping  cough  (or  pertussis), 
meningococal  disease,  mumps,  poliomyelitis,  measles,  rubella  and  haemophilus 
influenzae  (or Hib). 
"  Find  out  which  disease's  parents'  feel  most  and  least  severe? 
"  Find  out  which  disease's  parents'  feel  most  and  least  prevalent? 
"  Find  out  which  disease's  parents'  feel  threatens  their  child's  health  most  and  least  ? 
"  Explore  parents  knowledge/  understaning  about  how  they  think  each  disease  is 
transmitted. 
"  Do  parents  have  any  direct  experiences  of  any  of  the  diseases  either  as  parents 
themselves  or  as  children? 
"  Does  this  affect  their  perceptions  about  the  disease  and  in  what  way? 
"  If  parents  have  no  direct  experience  of  childhood  infectious  diseases,  what  or  who  has 
helped  them  make  their  assessments  of  these  diseases? 
BELIEFS  ABOUT  HEALTH  &  THE  IMMUNE  RESPONSE 
"  How-  vaccines  works  /  explore  parents'  understanding  of  the  body  reaction  to  vaccination 
or  to  disease? 
"  Explore  notions  of  `healthiness'  with  immunisation  and  perceived  threat  of  disease. 
Is  there  any  relationship  between  -general  health  and  need  for  immunisation? 
-general  health  and  threat  of  disease? Appendix  M  cont 
BELIEFS  ABOUT  CHOICE  &  RESPONSIBILITY 
"  Individual  choice  V's  societal  responsibility.  Is  it  okay  to  opt  out?  &  When? 
PERCEPTIONS  ABOUT  THE  MMR  VACCINE  /  DEBATE 
"  Feelings  about  the  MMR  vaccine? 
"  Feelings  about  the  MMR  debate? 
"  How  the  MMR  debate  has  affected  them? 
"  Beliefs  about  the  `state  of  the  evidence. 
"  Feelings  about  the  Dr  Wakefield? 
"  Are  they  part  of  any  legal  action? 
THE  EXPERIENCE  OF  DECIDING  ABOUT  MMR 
"  MMR  decision  making  experiences.  Was  it  an  easy  or  difficult  decision? 
"  Influential  factors  in  the  1'  &  V'  MMR  dose.  Were  they  different? 
"  Identify  other  people  involved  in  the  decision.  Any  informal  support? 
"  Explore  which  of  the  other  vaccines  easy  /  difficult  to  decide  about?  Why? 
LIVING  WITH  AUTISM 
"  Getting  their  child  diagnosed  with  autism 
"  Daily  living 
"  Other  parents  understanding  of  autism 
"  Autism  health  care/  education 
CHECK 
1.  Ensure  each  person  given  list  of  contacts  &  reply  paid  envelopes. 
2.  Expenses  given. 
3.  Thank  parents. Appendix  N 
CHECK  LIST 
1.  Check  has  everyone  received  and  read  the  information  sheet? 
2.  Introduce  self  and  research. 
3.  Re-state  the  following: 
-Length  of  time  (approx  1  hr). 
-Voluntary  nature  of  participation. 
-Recording  the  group  discussion. 
-Confidentiality  -  (information  kept  in  locked  drawer  in  MRC  unit  &  not  disclosed  to  anyone 
outside  the  research  team). 
-Anonymity-  (all  documents  and  data  identifiable  only  through  ID  number  and  any  extracts 
used  in  presentations  or  publications  given  pseudonyms  to  protect  identity). 
-Expenses. 
4.  Check  if  there  are  any  questions  or  concerns  about  the  study. 
5.  Get  the  consent  form  signed  and  personal  detail  form  completed. 
6.  Give  out  discussion  material. 
7.  Switch  on  microphone  and  recorder. 
8.  Map  positions  of  participants  -  (name,  no  of  children  &  age  of  children). Appendix  N  cont 
TOPIC  GUIDE/  PARENTS  OF  IMMUNO-COMPROMISED 
CHILDREN  (not  in  order) 
EXPERIENCES  OF  CHILDHOOD  IMMUNISATION/  PERCEPTIONS  ABOUT 
VACCINES 
"  Words  /  images  associated  with  immunisation. 
"  Experience  of  immunisation  so  far. 
"  Views  on  the  current  Childhood  Immunisation  Programme. 
(Hand  out  Immunisation  Programme  see  Appendix  L) 
PERCEPTIONS  ABOUT  CHILDHOOD  INFECTIOUS  DISEASES 
"  Words  /  images  associated  with:  -  Diptheria,  tetanus,  whooping  cough  (or  pertussis), 
meningococal  disease,  mumps,  poliomyelitis,  measles,  rubella  and  haemophilus 
influenzae  (or  Hib). 
"  Find  out  which  disease's  parents'  feel  most  and  least  severe? 
"  Find  out  which  disease's  parents'  feel  most  and  least  prevalent? 
"  Find  out  which  disease's  parents'  feel  threatens  their  child's  health  most  and  least  ? 
"  Explore  parents  knowledge/  understaning  about  how  they  think  each  disease  is 
transmitted 
"  Do  parents  have  any  direct  experiences  of  any  of  the  diseases  either  as  parents 
themselves  or  as  children? 
"  Does  this  affect  their  perceptions  about  the  disease  and  in  what  way? 
"  If  parents  have  no  direct  experience  of  childhood  infectious  diseases,  what  or  who  has 
helped  them  make  their  assessments  of  these  diseases? 
BELIEFS  ABOUT  HEALTH  &  THE  IMMUNE  RESPONSE 
"  How-  vaccines  works  /  explore  parents'  understanding  of  the  body  reaction  to  vaccination 
or  to  disease? 
"  Explore  notions  of  `healthiness'  with  immunisation  and  perceived  threat  of  disease. 
Is  there  any  relationship  between  -general  health  and  need  for  immunisation? 
-general  health  and  threat  of  disease? Appendix  N  cont 
BELIEFS  ABOUT  CHOICE  &  RESPONSIBILITY 
0  Individual  choice  V's  societal  responsibility.  Is  it  okay  to  opt  out?  &  When? 
PERCEPTIONS  ABOUT  THE  MMR  VACCINE  /  DEBATE 
"  Feelings  about  the  MIR  vaccine? 
"  Feelings  about  the  1\  MR  debate? 
"  How  the  MAMR  debate  has  affected  them? 
"  Beliefs  about  the  `state  of  the  evidence'. 
"  Feelings  about  the  Dr  Wakefield? 
LIVING  WITH  A  CHILD  WITH  A  COMPROMISED  IMMUNE  SySTEM 
"  Getting  their  child's  cancer  diagnosis 
"  Critically  ill  period  in  hospital-preventing  disease  and  infections 
"  Initial  recovery  period-  preventing  disease  and  infections 
"  Re-integrating  their  child  back  into  society-problems  faced  and  why  they  managed  the 
situation 
"  Other  parents,  school,  nursery  school's  understanding  of  their  child's  needs 
CHECK 
1.  Ensure  each  person  given  list  of  contacts  &  reply  paid  envelopes. 
2.  Expenses  given. 
3.  Thank  parents. Appendix  N 
CHECK  LIST 
1.  Check  has  everyone  received  and  read  the  information  sheet? 
2.  Introduce  self  and  research. 
3.  Re-state  the  following: 
-Length  of  time  (approx  1  hr). 
-Voluntary  nature  of  participation. 
-Recording  the  group  discussion. 
-Confidentiality  -  (information  kept  in  locked  drawer  in  MRC  unit  &  not  disclosed  to  anyone 
outside  the  research  team). 
-Anonymity-  (all  documents  and  data  identifiable  only  through  ID  number  and  any  extracts 
used  in  presentations  or  publications  given  pseudonyms  to  protect  identity). 
-Expenses. 
4.  Check  if  there  are  any  questions  or  concerns  about  the  study. 
5.  Get  the  consent  form  signed  and  personal  detail  form  completed. 
6.  Give  out  discussion  material. 
7.  Switch  on  microphone  and  recorder. 
8.  Map  positions  of  participants  -  (name,  no  of  children  &  age  of  children). I 
Appendix  N  cont 
TOPIC  GUIDE/  PARENTS  OF  IMMUNO-COMPROMISED 
CHILDREN  (not  in  order) 
EXPERIENCES  OF  CHILDHOOD  IMMUNISATION/  PERCEPTIONS  ABOUT 
VACCINES 
"  Words  /  images  associated  with  immunisation. 
"  Experience  of  immunisation  so  far. 
"  Views  on  the  current  Childhood  Immunisation  Programme. 
(Hand  out  Immunisation  Programme  see  Appendix  L) 
PERCEPTIONS  ABOUT  CHILDHOOD  INFECTIOUS  DISEASES 
"  Words  /  images  associated  with:  -  Diptheria,  tetanus,  whooping  cough  (or  pertussis), 
meningococal  disease,  mumps,  poliomyelitis,  measles,  rubella  and  haemophilus 
influenzae  (or  Hib). 
"  Find  out  which  disease's  parents'  feel  most  and  least  severe? 
"  Find  out  which  disease's  parents'  feel  most  and  least  prevalent? 
"  Find  out  which  disease's  parents'  feel  threatens  their  child's  health  most  and  least  ? 
"  Explore  parents  knowledge/  understaning  about  how  they  think  each  disease  is 
transmitted. 
"  Do  parents  have  any  direct  experiences  of  any  of  the  diseases  either  as  parents 
themselves  or  as  children? 
"  Does  this  affect  their  perceptions  about  the  disease  and  in  what  way? 
"  If  parents  have  no  direct  experience  of  childhood  infectious  diseases,  what  or  who  has 
helped  them  make  their  assessments  of  these  diseases? 
BELIEFS  ABOUT  HEALTH  &  THE  IMMUNE  RESPONSE 
"  How-  vaccines  works  /  explore  parents'  understanding  of  the  body  reaction  to  vaccination 
or  to  disease? 
"  Explore  notions  of  `healthiness'  with  immunisation  and  perceived  threat  of  disease. 
Is  there  any  relationship  between  -general  health  and  need  for  immunisation? 
-general  health  and  threat  of  disease? Appendix  N  cont 
BELIEFS  ABOUT  CHOICE  &  RESPONSIBILITY 
"  Individual  choice  V's  societal  responsibility.  Is  it  okay  to  opt  out?  &  When? 
PERCEPTIONS  ABOUT  THE  AMIR  VACCINE  /  DEBATE 
"  Feelings  about  the  MMR  vaccine? 
"  Feelings  about  the  MMR  debate? 
"  How  the  MMR  debate  has  affected  them? 
"  Beliefs  about  the  `state  of  the  evidence'. 
"  Feelings  about  the  Dr  Wakefield? 
LIVING  WITH  A  CHILD  WITH  A  COMPROMISED  IMMUNE  SYSTEM 
"  Getting  their  child's  cancer  diagnosis 
"  Critically  ill  period  in  hospital-preventing  disease  and  infections 
"  Initial  recovery  period-  preventing  disease  and  infections 
"  Re-integrating  their  child  back  into  society-problems  faced  and  why  they  managed  the 
situation 
"  Other  parents,  school,  nursery  school's  understanding  of  their  child's  needs 
CHECK 
1.  Ensure  each  person  given  list  of  contacts  &  reply  paid  envelopes. 
2.  Expenses  given. 
3.  Thank  parents. 
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